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Abstract 
This thesis describes the isolation and molecular identification of a novel paramyxovirus found 
in Australian snakes. The virus is named Sunshine virus after the geographical origin of the first 
isolate: the Sunshine Coast of Queensland, Australia. For decades, Australian veterinarians 
have  been  presented  with  snakes  displaying  neurorespiratory  signs.  The  clinical  signs, 
pathological findings and the results of overseas diagnostic testing, have suggested that at 
least  some  of  these  snakes  were  infected  with  paramyxoviruses,  most  likely  ferlaviruses. 
Australian veterinarians provided 463 samples to be screened for the presence of viruses and 
nine were found from five snakes from two collections. For all isolates, cytopathic effects 
consisted of extensive syncytial cell formation with minimal cell lysis. Further characterisation 
was performed on one of these isolates, BHP1-Lung (from a lung homogenate of a black-
headed python [BHP], Aspidites melanocephalus with mild respiratory signs and stomatitis). 
Testing  this  isolate  for  haemagglutinating  and  neuraminidase  activity  provided  equivocal 
results. The virus could not be found by electron microscopy. Polymerase chain reaction to 
detect a broad range of paramyxoviruses, reoviruses, adenoviruses and herpesviruses was also 
non-contributory. 
 
Through  the  use  of  high-throughput  sequencing,  BHP1-Lung  was  identified  as  a  novel 
paramyxovirus.  Phylogenetic  analysis  of  the  nucleoprotein  (N),  matrix  (M),  fusion  (F)  and 
polymerase (L) proteins clustered this virus within the family Paramyxoviridae but outside of 
both  subfamilies.  Primers  were  designed  that  could  detect  Sunshine  virus  which  enabled 
clinical data that is associated with Sunshine virus infection to be described. Clinical signs are 
typically non-specific (e.g. regurgitation, lethargy, inappetence) and/or can be localised to the 
neurological  and/or  respiratory  systems.  Gross  pathology  is  usually  unremarkable. 
Histopathological  findings  consist  primarily  of  white  matter  spongiosis  and  gliosis  of  the 
hindbrain with a mild bronchointerstitial pneumonia. vii | P a g e  
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(UN3373). The open cylinder shows the three layers of packaging. 8 = Urine sample container (70mL) 
sometimes  used  for  submitting  FFPE  sections  and  fresh  tissue  samples.  9  =  Sterile  cotton-tipped 
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Figure 4.3 Uninfected Viper Heart cells (VH2) (above) and VH2 cells infected with Fer-de-Lance virus 
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Figure  4.4  Uninfected  Vero  cells  (above)  and  Vero  cells  infected  with  neotropical  ophidian 
paramyxovirus  (bottom).  Characteristic  cytopathic  effects  (CPE)  of  ferlavirus  can  be  seen  as  small 
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Figure 4.9 Attempt to establish a primary reptilian cell line using a sample of lung from a tiger snake 
(Notechis  scutatus).  Eight  days  after  explantation.  Top:  Cells  can  be  seen  propagating  around  the 
explant. Scale bar represents 1mm. Bottom: Cell morphology eight days after explantation. Scale bar 
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Figure 4.10 Attempt to establish a primary reptilian cell line using a sample of lung from a tiger snake 
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Molten candle wax is used to seal the plug (red arrows) before eggs are left to incubate at a viral 
permissive temperature. After incubation, the top of the egg is removed to gain access to the allantoic 
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Figure  4.13  Haemagglutination  titres  of  ferlavirus  after  incubation  in  embryonated  chicken  eggs. 
Significant  haemagglutination  activity  cannot  be  detected  in  any  of  four  eggs  inoculated  with  cell 
culture-adapted ferlavirus after five days of incubation (above). The allantoic fluid from all four eggs was 
collected  and  pooled  and  then  three  different  volumes  were  inoculated  into  four  more  eggs.  The 
relationship between haemagglutination titre and the volume that is inoculated into the allantoic cavity 
of embryonated chicken eggs was recorded (bottom). ............................................................................. 96 
Figure 4.14 Haemagglutination titres of two strains of ferlavirus (neotropical ophidian paramyxovirus 
and Fer-de-Lance virus) grown in the allantoic cavities of six embryonated chicken eggs. The aliquots of 
each strain of virus that were inoculated into each egg were identical. ................................................... 96 
Figure 4.15 Processing various sample types for use in a haemagglutination assay. Left: Swab tips in 
saline (left) or viral transport medium/cell culture medium (right). Right: Cell culture supernatant and 
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Figure 4.16 The first three rows of a microtitre plate showing a typical layout of positive and negative 
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Figure 4.17 Concentration of positive control ferlavirus by polyethylene-glycol precipitation (PEG-P). Fer-
de-Lance virus (FDLV) and neotropical ophidian paramyxovirus (nOPMV) were used as controls. Negative 
control was performed on a second plate and performed as expected. ................................................. 100 
Figure 4.18 Frozen-thawed samples submitted as “serum” containing decreasing amounts of haemolysis 
from left to right. Good quality erythrocyte-free sample on far right. .................................................... 101 
Figure 4.19 Blood clots (blue arrow) and haemolysis-free fibrin clots (green arrow) that were removed 
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Figure 4.20 Haemadsorbing serum samples to remove non-specific haemagglutinators. Normal settling 
of erythrocytes in a sample free of haemagglutinators (left) contrasted to a haemagglutinated sample, 
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Figure 4.21 Controls for a haemagglutination inhibition assay. Top row: Positive control consisting of 
serum from a western diamondback rattlesnake (Crotalus atrox) with previous exposure to ferlavirus. HI 
titre  =  16/50µL.  Middle  row:  Two-fold  serial  dilutions  of  virus  (neotropical  ophidian  paramyxovirus 
[ATCC VR-1408]) to determine the number of haemagglutinating units in each 50µL aliquot. HA titre = 
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Figure 4.22 Whole blood from a diamond python (Morelia spilota spilota) dried onto a disc of Whatman 
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Figure  4.23  Comparison  of  four  methods  to  elute  anti-ferlaviral  antibodies  from  filter  paper.  Each 
method was tested using two different positive controls and two different erythrocytes (RBCs) (chicken 
and  guinea  pig).  Haemagglutination  inhibition  (HI)  titres  were  recorded  one  hour  after  adding  the 
erythrocytes to each well but photos were taken several hours later. As such, it is difficult to determine 
the HI titre in some rows from this image and so angled double yellow lines have been added after the 
well that showed complete inhibition of haemagglutination. Two double lines are used when it was 
difficult to determine the titre. ................................................................................................................ 105 
Figure 4.24 Detection of anti-ferlaviral antibodies by haemagglutination inhibition after concentration 
using ultrafiltration. Positive control material was concentrated by factors of ~16 and ~22. The flow-
through was also tested to ensure that no antibodies could be detected by this assay. ........................ 107 
Figure 4.25 Haemagglutination inhibition (HI) assay showing unusual clumping of erythrocytes. * An HI 
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Figure 4.26 Comparison of two methods of erythrocyte preparation. The method used early in these 
studies (“old method”) did not involve vortexing the working suspension of erythrocytes whereas the 
later method (“new method”) did. Cleaner haemagglutination can be seen with the new method. PBS = 
phosphate-buffered saline. ...................................................................................................................... 110 
Figure  4.27  Impact  that  haemolysis  and  blood  clots  have  on  haemagglutination  inhibition  titres. 
Hyperimmune serum served as a positive control (HI titre 16/50µL, row 1) and was spiked into healthy 
snake blood (HI titre <2/50µL, rows 3 and 4) that contained clots (denoted as “serum”) with (row 5, HI 
titre 4/50µL) or without (row 6, HI titre 4-8/50µL) significant amounts of haemolysis.  .......................... 111 
Figure 4.28 Transmission electron microscopic (TEM) examination of several different sample types. 
Top: Cell culture media and infected cells were processed in various ways for examination by TEM after 
negative staining. Bottom: Infected cells and histological sections (in this case, inclusion bodies in a 
section of snake brain) were positively stained prior to examination by TEM. PEG = polyethylene glycol.
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Figure 4.29 Transmission electron microscopic view of two negatively stained human influenza virions 
(red arrows). The spiked envelope can be seen on the surface of each virion (a section of envelope has 
been bordered by two blue lines). ........................................................................................................... 116 
Figure 4.30 Transmission electron microscopic view of Nelson Bay orthoreovirus after negative staining. 
Top: Two intact virions. Bottom Left: Double capsid structure can be seen in this partially digested 
virion. Bottom Right: A typical empty shell. ............................................................................................ 116 
Figure  4.31  Myxovirus-induced  haemagglutination  of  chicken  erythrocytes.  Human  influenza  virus 
(2,048HA/50µL) (top right) and ferlavirus (256HA/50µL) (bottom right) are compared to a published 
report that used human influenza virus (Tawara et al., 1976) (left). Red arrows point to the bridging that 
is responsible for the macroscopic haemagglutination that is observed. ................................................ 119 
Figure  4.32  Various  sample  types  that  were  processed  for  the  detection  of  a  range  of  viruses  by 
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Figure 5.1 Swabs of nine snakes (samples 1-9) from a zoological collection in Queensland. Top: Cloacal 
swabs from six snakes sampled in early May-2007. Bottom: Cloacal and mouth swabs from three snakes 
sampled in late June-2007. In both assays, an attenuated strain of human influenza virus and phosphate-
buffered saline (PBS) were used as positive and negative controls respectively. Clear haemagglutination 
can be seen in Sample 3 and Sample 7 - Cloaca but not in any other samples.  ....................................... 137 
Figure 5.2 Swabs from two snakes (sample 3 (top) and sample 7 – cloaca (bottom), see Figure 5.1) after 
passing the sample through a 0.45µm filter. In both assays, an attenuated strain of human influenza 
virus and phosphate-buffered saline (PBS) were used as positive and negative controls respectively. .. 138 
Figure 5.3 Repeat sampling from two snakes (sample 3 (top) and sample 7 (bottom), see Figure 5.1) 
Top: Mouth and cloacal swabs were collected from this snake in the morning and afternoon 56 days 
after the original sample was collected. Despite some unusual red cell clumping in one sample (cloaca 
+56d (am)), no compelling evidence of haemagglutination can be seen.  Bottom: Mouth and cloacal 
swabs  were  taken  five  and  seven  days  after  the  original  sample  was  collected.  In  both  assays,  an 
attenuated strain of human influenza virus and phosphate-buffered saline (PBS) were used as positive 
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Figure 5.4 Section of brain from a Stimson’s python (Antaresia stimsoni) displaying neurological signs. 
Stained  with  haematoxylin  and  eosin  (H&E).  Top:  low-power  view  (40x).  Bottom:  Eosinophilic 
intranuclear inclusion bodies (arrows) can be seen in a large number of ependymal cells lining a ventricle 
(1,000x).  .................................................................................................................................................... 145 
Figure 5.5 Section of brain from a south-west carpet python (Morelia spilota imbricata) displaying subtle 
neurological signs. Stained with haematoxylin and eosin (H&E). Top: low-power view (40x). Bottom: 
Massive number of eosinophilic intranuclear inclusion bodies (arrows) can be seen throughout the brain 
(400x).  ....................................................................................................................................................... 146 
Figure 5.6 Transmission electron microscopic (TEM) view of an inclusion body in the brain of a Stimson’s 
python  (Antaresia  stimsoni)  displaying  neurological  clinical  signs  (top).  A  published  image  of  an 
intracytoplasmic  inclusion  body  (IC)  in  a  viper  heart  cell  infected  with  a  ferlavirus  is  provided  for 
comparison  (Jacobson  et  al.,  1997)  (bottom);  the  authors  state  that  the  inclusion  body  contains 
nucleocapsid material. Scale bar = 7µm. Top Left: Low power view of the nucleus of an ependymal cell 
showing the central inclusion body.  Right: Higher power view of the inclusion body revealing what 
appears to be amorphous material. ......................................................................................................... 147 
Figure 5.7 Unusual cell morphology seen in a flask of viper heart (VH2) cells. After several days, the cells 
became indistinguishable from the background population. Scale bars = 100µm. ................................. 151 
Figure 5.8 Timeline of events of a private collection of pythons from the Sunshine Coast in Queensland 
starting from the acquisition of seven jungle carpet pythons (Morelia spilota cheynei) and finishing when 
the entire collection was humanely euthanased several months later. .................................................. 154 
Figure 5.9 Uninfected viper heart (VH2) cells (above) and VH2 cells infected with the supernatant of a 
lung  suspension  from  a  black-headed  python  (Aspidites  melanocephalus)  that  died  with 
neurorespiratory signs of disease (bottom). Extensive formation of multinucleate giant cells can be seen 
in the infected culture. Scale bars = 100µm. ............................................................................................ 157 
Figure 5.10 Viper heart (VH2) cells infected with the supernatant of a brain suspension from a jungle 
carpet  python  (Morelia  spilota  cheynei)  that  died  with  neurorespiratory  signs  of  disease.  Extensive 
formation of multinucleate giant cells and a cell with a large amount of intracytoplasmic vacuolation 
(arrow) can be seen. Scale bar = 100µm. ................................................................................................. 158 
Figure 5.11 Uninfected viper heart (VH2) cells (top image) compared to BHP1-Lung throughout three 
passages (bottom two rows). The third day of the second passage (p2d3) shows early cytopathic effects 
(CPE) in the form of syncytial cell formation. Three days later (p2d6), further progression of CPE can be 
seen. Syncytial cells are larger and there is considerable cytoplasmic clearing around a central cluster of 
nuclei. Similar CPE can be seen during the next two passages (p3d7 and p4d8). Scale bars = 100µm. .. 160 
Figure 5.12 Viper heart (VH2) cells infected with BHP1-Lung. Above: Two days after BHP1-Lung-infected 
VH2 cells were split 1:3 (10% of monolayer was showing cytopathic effects [CPE] before this split). 
Approximately 50% of the monolayer is displaying CPE in the form of syncytial cell formation (arrows). 
Below: Two days after BHP1-Lung-infected cells (CPE was also 10%) were frozen, thawed, clarified and 
then the supernatant was inoculated onto uninfected VH2 cells. Only about 1% of the monolayer is 
displaying subtle signs of CPE. A small multinucleate cell can be seen (arrow). Scale bars = 100µm.  ..... 163 
Figure 5.13 A virus-like particle from a sample of BHP1-Lung (top row), viewed under TEM after negative 
staining  with  phosphotungstic  acid,  is  compared  to  two  published  images  that  show  ferlaviruses 
(bottom row). The size (~175nm), shape (spherical) and “spiked” surface of the “virus-like” particle are 
all  consistent  with  a  paramyxovirus  but  the  characteristic  “herring  bone”  appearance  of  the 
nucleocapsid protein (seen in a disrupted ferlavirus, bottom left (Ahne and Mayr, 2000)) cannot be 
seen. The staining pattern of the “virus-like” particle implies that it is hollow (compare to the intact 
ferlavirus, bottom right (Marschang et al., 2002)) and there is no evidence that the “membrane” was 
disrupted. Ferlaviral scale bars = 100nm .................................................................................................. 167 
Figure 5.14 Haemagglutination activity of the supernatant from four flasks of viper heart (VH2) cells with 
syncytial cell formation. Isolates were at the fourth day of their second passage. PBS = Phosphate-
buffered saline. Abbreviations for each sample are defined in Table 5.3. .............................................. 170 
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Figure 5.15 Haemagglutination (HA) activity of BHP1-Lung after concentration using polyethylene glycol 
(PEG)-precipitation. Both guinea pig and chicken erythrocytes (RBCs) were used as indicators of HA 
activity. This experiment was performed before a new erythrocyte processing method (Figure 4.26) was 
being used routinely and so although the first two wells of BHP1-Lung using the guinea pig erythrocytes 
appear to represent clumped red cells (Figure 4.25), they could be displaying haemagglutination.  ...... 170 
Figure 5.16 Haemagglutination activity (using guinea pig erythrocytes) of the supernatant from eight 
flasks of viper heart (VH2) cells with syncytial cell formation. Supernatant was collected at the end of the 
first (p1) and second (p2) passage. PBS = Phosphate-buffered saline. Abbreviations for each sample are 
defined in Table 5.3.  ................................................................................................................................. 171 
Figure  5.17  The  amount  of  neuraminidase  (NA)  activity  of  five-fold  serial  dilutions  of  BHP1-Lung 
compared  to  a  strain  of  ferlavirus  (ATCC  VR-1408,  128HA  /  50µL).  The  NA  substrate  (2’-(4-
methylumbelliferyl)-α-D-N-acetylneuraminic acid) is exposed to each isolate for a certain length of time 
(50 minutes [50m], two hours and 20 minutes [2h20m], three hours and 40 minutes [3h40m] or 20 
hours and 20 minutes [20h]) to produce a fluorescent substrate. The emission at 480nm provides an 
estimate of each isolate’s NA activity. ..................................................................................................... 176 
Figure 5.18 Haemagglutination inhibition (HI) assay of serum samples collected from a privately-owned 
collection of snakes that produced the isolate BHP1-Lung (sample 7 in this figure). The inadequate 
separation of erythrocytes from serum prior to freezing has provided varying shades of red in some 
wells. No HI titre exceeded eight. HA = haemagglutination..................................................................... 178 
Figure 6.1 Sequencing and assembling the rRNA-depleted total RNA from viper heart (VH2) cells infected 
with BHP1-Lung.  Total RNA  was extracted from infected cells and then depleted of  ribosomal RNA 
(rRNA). From this, 10,544,936 reads were sequenced and from these, 5,818 unique contigs could be 
assembled. An assembled contig that is 69 nucleotides long is provided as an example. The minimum 
coverage of this 69-nucleotide contig is one, the maximum coverage is all 36 contigs, the mean coverage 
is 19.8 and the standard deviation of coverage is 12.5. ........................................................................... 199 
Figure 6.2 Analysis of 5,818 unique assembled contigs to identify a single contig with strong similarity to 
a paramyxovirus. By searching all 5,818 unique contigs with the Basic Local Alignment Search Tool for 
Nucleotides (BLASTN), 326 were identified with search results that contained the word “virus”. 114 were 
excluded on the basis that they were viruses that occur in non-vertebrates (algae, plants, invertebrates, 
fungi and protozoa) or were of host DNA origin (e.g. virus receptors). Only one of the remaining contigs 
contained  open  reading  frames  (ORFs)  that  showed  strong  similarity  to  a  virus,  in  this  case,  a 
paramyxovirus. BLASTP = Basic Local Alignment Search Tool for Proteins. ............................................. 201 
Figure 6.3 Map of genomic RNA (3’ to 5’) of a 17,187 nucleotide length of sequenced genome from viper 
heart cells infected with BHP1-Lung. Numbers represent nucleotide lengths. ORF = open reading frame. 
Where GenBank similarity could not be validated, putative annotation has been used based on the ORF 
that is positioned at the corresponding position of other paramyxoviruses. .......................................... 204 
Figure 6.4 Bayesian phylogenetic tree of predicted 1,711-2,331 amino acid sequences of mononegaviral 
RNA-dependent-RNA  polymerase  based  on  MAFFT  alignment.  Bayesian  posterior  probabilities  of 
clusters  as  percentages  are  in  bold,  and  ML  bootstrap  values  for  clusters  are  given  to  the  right. 
Nyamanini virus (GenBank accession number NC012703) was used as the outgroup.  Sunshine virus is 
bolded. Thick brackets demarcate viral families, medium brackets indicate paramyxoviral subfamilies, 
and  thin  brackets  demarcate  paramyxoviral  genera.    Sequences  retrieved  from  GenBank  include 
Bornavirus  (GenBank  accession  #  NC_001607),  Nyamanini  (NC_012703),  Duvenhage  (EU293119), 
Flanders  (AAN73288),  Lake  Victoria  Marburg  (YP_001531159),  Sudan  Ebola  (YP_138527),  Newcastle 
disease virus (NC_002617), Avian Paramyxovirus 2 (HM159993), Avian Paramyxovirus 6 (NC_003043), 
Human  Parainfluenzavirus  2  (NC_003443),  Simian  Parainfluenzavirus  5  (NC_006430),  Mapuera 
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Figure 6.5 Bayesian phylogenetic tree of predicted 529-662 amino acid sequences of paramyxoviral 
fusion proteins based on MAFFT alignment. Bayesian posterior probabilities of clusters as percentages 
are in bold, and ML bootstrap values for clusters are given to the right. Atlantic salmon paramyxovirus 
(EF646380)  was  used  as  the  outgroup.    Sunshine  virus  is  bolded.  Medium  brackets  indicate 
paramyxoviral  subfamilies,  and  thin  brackets  demarcate  paramyxoviral  genera.  Sequences  retrieved 
from GenBank are from the same genomes as the L genes used in Figure 6.4. ...................................... 215 
Figure 6.6 Bayesian phylogenetic tree of predicted 142-377 amino acid sequences of mononegaviral 
matrix proteins based on MAFFT alignment.  Multifurcations are marked with arcs. Bayesian posterior 
probabilities of clusters as percentages are in bold, and ML bootstrap values for clusters are given to the 
right.    Bornavirus  (NC_001607)  was  used  as  the  outgroup.  Sunshine  virus  is  bolded.  Thick  brackets 
demarcate  viral  families,  medium  brackets  indicate  paramyxoviral  subfamilies,  and  thin  brackets 
demarcate paramyxoviral genera. Sequences retrieved from GenBank are from the same genomes as 
the L genes used in Figure 6.4. ................................................................................................................. 216 
Figure 6.7 Bayesian phylogenetic tree of predicted 370-738 amino acid sequences of mononegaviral 
nucleoproteins based on MAFFT alignment. Bayesian posterior probabilities of clusters as percentages 
are in bold, and ML bootstrap values for clusters are given to the right.  Nyamanini virus (GenBank 
accession  number  NC012703)  was  used  as  the  outgroup.  Sunshine  virus  is  bolded.  Thick  brackets 
demarcate  viral  families,  medium  brackets  indicate  paramyxoviral  subfamilies,  and  thin  brackets 
demarcate paramyxoviral genera. Sequences retrieved from GenBank are from the same genomes as 
the L genes used in Figure 6.4. ................................................................................................................. 217 
Figure 6.8 Assessment of the binding affinity of the Ahne L-gene PCR primer set (Ahne et al., 1999b) to 
Sunshine virus and Fer-de-Lance virus (FDLV). A translational alignment was performed where the  L 
gene nucleotide sequences were translated into amino acid sequences which were then aligned using 
CLUSTALW  (cross-referenced  with  MUSCLE)  and  finally,  nucleotides  were  reinserted  in  place  of  the 
amino acids. The four PCR primers (Ahne 5-8) were then positioned into their binding sites to assess 
their similarity to the corresponding area of the Sunshine virus genome. * = complementary sequence.
 .................................................................................................................................................................. 222 
Figure 6.9 Assessment of the binding affinity of the Tong L-gene PCR primer set (Tong et al., 2008) to 
Sunshine virus, Fer-de-Lance virus (FDLV) and Bovine respiratory syncytial virus (RSV). A translational 
alignment was performed using the same method described in Figure 6.8. The six PCR primers (PAR-F1, 
PAR-F2, PAR-R, PNE-F1, PNE-F2, PNE-R) were then positioned into their binding sites to assess their 
similarity to the corresponding area of the Sunshine virus genome. * = complementary sequence. ..... 223 
Figure  6.10  Four  primers  designed  for  the  detection  of  Sunshine  virus:  S1,  S2,  AS1  and  AS2.  Each 
amplicon (represented as rectangles) starts and finishes with the number of bases from the 3’ end of the 
polymerase gene. Primers can be used as three separate primer pairs (S1-AS1 = 153bp product; S2-AS2 = 
230bp product; S2-AS1 = 357bp product) or in two heminested polymerase chain reactions (S2-AS1 
followed by S1-AS1; or S2-AS1 followed by S2-AS2). bp = base pairs. ..................................................... 227 
Figure 6.11 Polymerase chain reaction amplicons of uninfected and infected viper heart cells. Infected 
cells  had  either  been  inoculated  with  BHP1-Lung  or  JCP1NT-Brain.  Lanes  1-3  =  primer  pair  AS1-S1 
(153bp); lane 1 = uninfected cells, lane 2 = BHP1-Lung, lane 3 = JCP1NT-Brain. Lanes 4-6 = primer pair 
AS2-S2 (230bp); lane 4 = BHP1-Lung, lane 5 = JCP1NT-Brain, lane 6 = uninfected cells, Lane 7 = molecular 
ladder. 100bp increments from 100-1,000bp, brightest band is 500bp, largest band is 1,500bp. Lanes 8-
10 = primer pair AS1-S2 (357bp); lane 8 = BHP1-Lung, lane 9 = JCP1NT-Brain, lane 10 = uninfected cells.
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Figure 6.12 Polymerase chain reaction of tissue samples of BHP1-Lung. Lanes 1-7 = primer pair AS1-S1 
(153bp); lane 1 = positive control (viper heart cells infected with BHP1-Lung), lane 2 = tissue sample 
BHP1-Lung – random hexamers, lane 3 = tissue sample BHP1-Lung – gene-specific primers (GSP), lane 4 
= formalin-fixed paraffin-embedded (FFPE) BHP1-Lung – random hexamers, lane 5 = FFPE BHP1-Lung – 
GSP, lane 6 = FFPE negative control (“unaffected” snake tissue)  – random hexamers, lane 7 = FFPE 
negative control – GSP, lane 8 = molecular ladder. 100bp increments from 100-1,000bp, brightest band 
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Figure 7.1 Partial sequences of three Sunshine virus polymerase genes amplified using the primer pair, 
SunshineAS1 and SunshineS2. Each sequence is compared to black-headed python 1 (Collection 1) and 
where there is no sequence variation a period (.) is inserted into the corresponding nucleotide position. 
Two base positions are marked with an asterisk (*) where silent mutations have been detected. SS = 
Sample Submission. Refer to page 232 for descriptions of each sample submission. ............................. 246 
Figure 7.2 Dorsal hindbrain, Berrimah Veterinary Laboratories, Collection A, jungle carpet python 1. 
Moderate patchy spongiosis involving primarily the white matter of the hindbrain (HB) and to a mild 
degree, the granular layer of the cerebellum (CB).  Note mild degree of associated gliosis and lack of 
inflammatory  cellular  infiltrate  in  the  meninges  (M).  CP=  choroid  plexus  in  the  fourth  ventricle. 
Haematoxylin and eosin stain. Bar = 200 µm. .......................................................................................... 249 
Figure  7.3  Brainstem,  Berrimah  Veterinary  Laboratories,  Collection  B,  carpet  python  2.    Severe 
spongiosis involving the complete dorsoventral height of the hindbrain (HB) with relative sparing of the 
cerebellum (CB), midbrain (MB, including optic tectum (OT)), cranial extent of the spinal cord (SP) and 
caudal extent of the forebrain (FB). The rectangle outlines the area of the inset in which moderate 
gliosis and neuronal necrosis (arrowheads) are evident. Haematoxylin and eosin stain. Main bar = 500 
µm. Inset bar = 50 µm. ............................................................................................................................. 250 
Figure 7.4 Lung, Berrimah Veterinary Laboratories, Collection A, carpet python. Mild hyperplasia and 
jumbling  of  the  luminal  respiratory  epithelium  (LRE)  with  scattered  necrotic  cells  and  associated 
moderate lymphoplasmacytic infiltration. Generalised moderate vascular congestion and mild septal (S) 
oedema. The few red blood cells in the air spaces (faveolae) between septae are interpreted as post-
mortem artefact rather than pre-mortem haemorrhage. Haematoxylin and eosin stain. Bar = 50 µm. . 251 
Figure 7.5 Renal collecting duct, Berrimah Veterinary Laboratories, Collection A, jungle carpet python 3. 
Basophilic intracytoplasmic inclusion bodies in epithelial cells (arrows). Haematoxylin and eosin stain. 
Bar = 10 µm. ............................................................................................................................................. 252 xxiii | P a g e  
 
List of Tables 
Table 2.1 Clinical signs of ferlaviral infection described in the literature. Only the references that report 
on original data are included here. ............................................................................................................ 15 
Table 2.2 Differential diagnoses for respiratory and neurological disease in snakes. Adapted from Girling 
and  Raiti  (2004)  and  Murray  (2006).  Secondary  and  tertiary  causes  of  neurological  and  respiratory 
disease (e.g. Pseudomonas sp. pneumonia) have been excluded for conciseness. ................................... 17 
Table 2.3 Gross pathological changes associated with ferlaviral infection ................................................ 18 
Table 2.4 Histopathological changes seen associated with ferlaviral infection. *These findings were in 
snakes that were experimentally infected with ferlavirus by endotracheal inoculation. 
§Brain was not 
examined histologically in Jacobson et al. (1981), Potgieter et al. (1987), Jacobson et al. (1992), Homer et 
al. (1995) or Jacobson et al. (1997). It is unclear whether the brain was examined in Oros et al. (2001) 
and Kolesnikovas et al. (2006). ................................................................................................................... 21 
Table 2.5 The various quarantine periods that are recommended in the ferlaviral literature. ................. 29 
Table 2.6 Adapted from Jacobson et al. (1997). Anti-ferlaviral titres (HI, haemagglutination inhibition) of 
western diamondback rattlesnakes (Crotalus atrox) after exposure to an inactivated ferlavirus vaccine. 
All snakes (n=16) and time  points (day  -56 to day 28) where an HI titre was not detected are not 
presented and taken as zero. ..................................................................................................................... 31 
Table  2.7  The  methods  that  have  been  reported  in  the  literature  to  isolate  paramyxoviruses  from 
reptiles. VH2 = viper heart cells. TH1 = terrapene heart cells. IgH2 = iguana heart cells. SPF = specific 
pathogen free. *Only those attempts where a paramyxovirus was successfully isolated using a different 
biological substrate are mentioned. This is to exclude the possibility that the unsuccessful attempt was 
because there was simply no virus in the inoculum. However, the possibility that the virus did grow in 
these cells but was not detected cannot be ruled out as further testing (e.g. polymerase chain reaction) 
was not performed. .................................................................................................................................... 39 
Table 2.8 The cytopathic effects of paramyxoviruses isolated from snakes and a lizard that have been 
described in the literature.
 §This isolate displayed CPE in nine reptilian and four mammalian cell lines 
after first being passaged through an embryonated snake egg. 
1Adapted from VH2 cells.
 2Adapted from 
IgH2 cells.
 3Adapted from TH1 cells. *Undescribed cytopathic changes were also seen when this isolate 
was propagated in hamster kidney cells (BHK-21), swine testicular cells (ST), Vero cells and primary 
bovine turbinate cells (BTU). 
#This isolate was obtained from a caiman lizard (Draecena guianensis). 
фTissue  homogenates  were  inoculated  onto  VH2  and  IgH2  cells  but  cell  line  that  the  isolate  was 
successful isolated with is not specified. .................................................................................................... 41 
Table 2.9 Diagnostic tests for ferlavirus that are commercially available. *Use the primer pairs designed 
by Ahne et al. (1999b) targeting the L-gene.  .............................................................................................. 59 
Table 3.1 Results of 65 serum samples from four Australian zoological collections that were sent to 
Texas  Veterinary  Medicine  Diagnostic  Laboratory  for  the  detection  of  anti-ferlaviral  antibodies  by 
haemagglutination inhibition (HI). No titre exceeded 256.  ........................................................................ 73 
Table 4.1 Steps of a haemagglutination inhibition assay that were altered to determine the cause of 
irregular erythrocyte clumping.  ................................................................................................................ 109 
Table 4.2 The amount of neuraminidase (NA) activity of an attenuated human influenza virus (hIV, 
512HA  /  50µL)  compared  to  various  uninfected  culture  substrates.  The  NA  substrate  (2’-(4-
methylumbelliferyl)-α-D-N-acetylneuraminic acid) is exposed to the virus for certain lengths of time to 
produce  a  fluorescent  substrate.  The  emission  at  480nm  provides  an  estimate  of  NA  activity.  For 
experiment one, hiV was propagated in the allantoic cavity of embryonated chicken eggs and then NA 
activity was assessed after dilution in three different diluents. For experiment two, uninfected allantoic 
fluid was mixed with allantoic-derived hIV to seven dilution rates. ........................................................ 113 
   xxiv | P a g e  
 
Table 4.3 Primers used for the detection of the polymerase gene (L) of paramyxoviruses, especially 
ferlaviruses. R = A or G; Y = C or T; W = A or T; K = G or T; M = A or C; D = A, G or T; N = A, C, G or T; 
I=inosine. *
#@Information not provided in original manuscript but estimated from binding sites in *Fer-
de-Lance virus (FDLV), see Figure 6.9, 
# Bovine respiratory syncytial cell virus (BRSV), see Figure 6.9 or 
@ 
human parainfluenza virus (GenBank accession number: FJ455842.2) ................................................... 126 
Table 4.4 Primers used for the detection of the haemagglutinin-neuraminidase gene (HN protein) of 
ferlaviruses. .............................................................................................................................................. 127 
Table 4.5 Primers used for the detection of the genes that code for the polymerase, σA capsid and inner 
coat  proteins  of  Reoviridae,  orthoreoviruses  and  aquareoviruses  respectively.  Primers  used  for  the 
detection of the polymerase genes of herpes- and adenoviruses are also included. R = A or G; Y = C or T; 
W = A or T; K = G or T; S = C or G; H = A, C or T; M = A or C; D = A, G or T; V = A, G or C; B = G, C or T; N = 
A, C, G or T. * First round PCR products were electrophoresed looking for appropriately-sized amplicons. 
#  Amplicon  size  influenced  by  species  of  herpesvirus.  Estimates  provided  here  are  for  human 
herpesvirus 1 (GenBank number: JN555585.1). ....................................................................................... 129 
Table 5.1 Snake samples screened for viruses from May-2007 to October-2009. In total, 463 samples 
were collected from 192 snakes from 36 reptile collections from six Australian states or territories. *A 
second swab taken from the same snake at a different time counts as two samples from one snake. If a 
sample was tested by HA first and VI second, and then a sample of cell culture supernatant (from the VI 
attempt) was retested for HA activity, this counts as one HA sample and one VI sample. 
#Samples that 
were tested for multiple viruses by PCR, were still only recorded as one sample. NSW = New South 
Wales, Qld = Queensland, WA = Western Australia, Vic = Victoria, SA = South Australia, NT = Northern 
Territory. Samples received after PCR primers had been designed to screen for Sunshine virus by PCR 
(August-2010) are not included in this table. Samples were not received between October-2009 and 
August-2010 as efforts were focussed on determining the identity of BHP1-Lung. ................................ 135 
Table 5.2 The neuraminidase (NA) activity present in five snake cloacal swabs collected from a zoological 
collection in Queensland. An attenuated strain of human influenza virus and a ferlavirus were used as 
positive controls while the medium that the swabs were stored in (cell culture medium) was used as a 
negative control. The NA substrate (2’-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid) was exposed 
to the sample for 18 hours at 30
0C. The emission at 480nm provides an estimate of the amount of NA 
substrate that has been cleaved into a fluorescent product. HAU = Haemagglutinating units. .............. 141 
Table 5.3 Positive virus isolation results from snakes from a source of samples submitted from the 
Sunshine Coast, Queensland and Berrimah Veterinary Laboratories, Northern Territory. Positive virus 
isolation was defined by characteristic cytopathic effects (CPE) (large syncytium with minimal cell lysis). - 
= negative. + = positive. n.s. = not sampled. pXdY = the passage number and days since the last passage. 
The day of cell inoculation = p1d1.  ........................................................................................................... 156 
Table  5.4  Percentages  of  viper  heart  (VH2)  cell  monolayers  displaying  cytopathic  effect  following 
inoculation of BHP1-Lung. Four methods of viral passage are compared. Viral passages are underlined 
and displayed in bold type and for these days, the percentage is representative of the CPE of the 
monolayer before the passage. ................................................................................................................ 162 
Table 5.5 Descriptions of the ultrastructural appearances of orthoreoviruses (Chappell et al., 2005), 
ferlaviruses (Richter et al., 1996), retroviruses (Linial et al., 2005) and herpesviruses (Davison et al., 
2005)......................................................................................................................................................... 166 
Table 5.6 The emission at 480nm of a strain of allantoic-derived ferlavirus (ATCC VR-1408, 128HA / 
50µL) and cell culture-derived BHP1-Lung after exposure to the neuraminidase  (NA) substrate 2’-(4-
methylumbelliferyl)-α-D-N-acetylneuraminic acid for 30 minutes, one hour or two hours. The emission 
at 480nm provides an estimate of each isolate’s NA activity. Uninfected allantoic fluid and uninfected 
cell culture supernatant were used as negative controls. HA = haemagglutination. ............................... 174 
Table 5.7 The chemical characteristics of orthoreoviruses (Chappell et al., 2005), ferlaviruses (Richter et 
al., 1996), retroviruses (Linial et al., 2005) and herpesviruses (Davison et al., 2005). Unique traits are 
bolded and underlined. ............................................................................................................................ 181 
   xxv | P a g e  
 
Table 5.8 Effect of ether, acid, a DNA synthesis inhibitor and two concentrations of chloroform on the 
viral titre (TCID50) of Equine herpes virus (EHV), an enveloped DNA virus, Nelson Bay orthoreovirus (NBV), 
an unenveloped RNA virus and BHP1-Lung. Experiment One: All three isolates were exposed to 33% 
(v/v) chloroform. One part of virus solution was exposed to nine parts of cell culture media with a pH of 
3 and then returned to a neutral pH. The DNA synthesis inhibitor, 5’ bromo-3’ deoxyuridine (BUDR), was 
added to each isolate to a final concentration in the flask of 100µg/mL. Only BHP1-Lung was exposed to 
ether. Experiment Two: Only NBV and EHV were analysed in this experiment. These two viruses were 
exposed to a lower concentration of chloroform (10% v/v), ether (20%), acid (pH = 3) and the DNA 
synthesis inhibitor (BUDR) using the methods of experiment one. ......................................................... 186 
Table  6.1  Pairwise  alignments  of  the  attachment  proteins  of  19  paramyxoviruses  using  CLUSTALW. 
Numbers represent percentage similarities. The similarities of the attachment proteins of viruses from 
the same genera are in adjacent columns and highlighted in red. BHP1-Lung has the only attachment 
protein that has less than a 15% similarity to each of the other 18 proteins. FDLV = Fer-de-Lance virus 
(GenBank accession number: NC_005084). Atlantic salmon PMV [Paramyxovirus] (EF646380). Sendai 
virus (NC_001552). Human PIV [Parainfluenza virus] (NC_003461). Menangle virus (NC_007620). Porcine 
RV  [Rubulavirus]  (NC_009640).  Mumps  virus  (NC_002200).  NCDV  =  Newcastle  disease  virus 
(NC_002617). Avian PMV2 [Paramyxovirus 2] (HM159993). Rinderpest virus (NC_006296). Measles virus 
(NC_001498). Hendra virus (NC_001906). Nipah virus (NC_002728). Beilong virus (NC_007803). Human 
RSV [Respiratory syncytial virus] (NC_001781). Bovine RSV [Respiratory Syncytial virus] (NC_001989). 
Human  MPV  [Metapneumovirus]  (NC_004148).  Avian  MPV  [Metapneumovirus]  (NC_007652).  HN  = 
Haemagglutinin-Neuraminidase. H = Haemagglutinin. G = Glycoprotein. AA = Amino acid. Unclass. = 
Unclassified.  Ferla.  =  Ferlavirus.  AquaPMV  =  Aquaparamyxovirus.  Respiro  =  Respirovirus.  Rubula.  = 
Rubulavirus.  Avula.  =  Avulavirus.  Morbilli.  =  Morbillivirus.  Henipa.  =  Henipavirus.  Pneumo.  = 
Pneumovirus.  ............................................................................................................................................ 206 
Table  6.2  Names  that  were  considered  for  the  new  Australian  snake  paramyxovirus.  Ultimately, 
Sunshine virus was chosen. ...................................................................................................................... 210 
Table  6.3  Comparison  of  the  primer  binding  sites  on  either  Fer-de-Lance  virus  (FDLV)  or  bovine 
respiratory syncytial virus (RSV) compared to Sunshine virus for each of ten primers. The number of 
bases that are identical to the primer sequence are presented, as are the similarities that exist at the 3’ 
end of the primer. .................................................................................................................................... 224 
Table 6.4 Primer sequences, and anticipated amplicon size, for the detection of Sunshine virus. PCR = 
polymerase chain reaction. bp = base pairs. ............................................................................................ 226 
Table 7.1 Samples that were tested for the presence of Sunshine virus by polymerase chain reaction. 
*Only one formalin-fixed paraffin-embedded (FFPE) sample was tested (Figure 6.12), the remaining 80 
samples consisted of freshly frozen tissue samples and serum. #Only FFPE material was tested by PCR.
 .................................................................................................................................................................. 236 
Table 7.2 PCR and virus isolation results from snakes that were positive for Sunshine virus by either test. 
Positive virus isolation was defined by a characteristic cytopathic effect (large syncytium with minimal 
cell lysis). - = negative. + = positive. n.s. = not sampled. n.t. = not tested. Ki-Li = combined kidney-liver 
sample. BVL = Berrimah Veterinary Laboratory. 2A/2B represents separate collections. *PCR performed 
on pooled formalin-fixed paraffin-embedded (FFPE) organs that included at least brain and lung. All 
individual organ samples were submitted fresh or freshly-frozen. Jungle carpet python = Morelia spilota 
cheynei. Black-headed python = Apidites melanocephalus. Woma python = Aspidites ramsayi. Spotted 
python = Antaresia maculosa. Carpet python = Morelia spilota. The “Spotted python 2” in this table is 
the same snake as the “Spotted python 2” mentioned in Table 7.3. ...................................................... 238 
Table 7.3 Polymerase chain reaction (PCR) results of combined oral-cloacal swabs from a zoological 
collection in Queensland (Sample Submission Three). - = negative. + = positive. n.s. = not sampled. * = 
dead prior to this sampling date. a = organ samples not retrieved for further testing. b = organ samples 
retrieved for further testing. # = separate cloacal-only and oral-only swabs were also PCR positive. n/a = 
not applicable.  The “Spotted python 2” in this table is the same snake as the “Spotted python 2” 
mentioned in Table 7.2. ........................................................................................................................... 242 xxvii | P a g e  
 
Acknowledgement of Work Not Performed by the Author 
The author acknowledges that Fasteris, a commercial company in Switzerland, carried out a 
series of sample preparation steps before performing high-throughput sequencing on RNA 
extracted from viper heart cells infected with BHP1-Lung (= Sunshine virus). The phylogenetic 
work  on  Sunshine  virus  was  performed  by  Dr  James  Wellehan.  The  gross  pathology  and 
histopathological findings associated with Sunshine virus infection were described by Dr Cathy 
Shilton. The reader will be reminded of these contributions in the relevant sections of this 
thesis. The rest of the work presented here was performed by the author. 1 | P a g e  
 
Chapter 1 – Purpose of Project and Outline of Thesis 
1.1  Purpose of Project 
This thesis defines an ongoing problem seen in Australian snakes and discusses the methods 
and results of an investigation into this problem. Australian snakes with neurorespiratory signs 
of disease have, for many years, been presented to veterinarians. Outbreaks of these signs 
involving  multiple  animals  have  been  seen  in  both  private  and  public  Australian  snake 
collections.  In  some  instances,  veterinarians  have  pursued  overseas  testing  to  look  for 
evidence  of  a  paramyxoviral  infection.  Many  of  these  affected  snakes  do  not  respond  to 
supportive  treatment  and  some  die  naturally  or  are  euthanased.  The  clinical  signs  and 
pathological findings, and the results of overseas diagnostic testing, have all been consistent 
with  an  infection  by  a  paramyxovirus.  However,  these  findings  should  not  be  viewed  as 
incontrovertible.  There  are  no  peer-reviewed  published  reports  that  definitively  confirm  a 
diagnosis of a viral infection in any of these snakes. 
 
The broad aims of this project are therefore: 
1.  To isolate and identify a virus from Australian snakes that could explain the clinical signs, 
pathological findings and overseas diagnostic test results that have been suggestive but 
not conclusive of a paramyxovirus infection. 
2.  To investigate if the association between the presence of this isolated virus and disease is 
causative. 
3.  To produce a diagnostic test that could rapidly screen Australian snakes for the presence of 
this virus. 
4.  To  apply  this  diagnostic  test  to  Australian  snake  samples  to  provide  clinically  useful 
information  about  the  biology  of  this  viral  infection  e.g.  shedding  patterns,  tissue 
predilections. 2 | P a g e  
 
1.2  Outline of Thesis 
This thesis describes an investigation of Australian snakes that resulted in the isolation and 
description of a novel paramyxovirus.  In Figure 1.1,  a chapter-by-chapter overview of this 
thesis is presented. This chapter provides an overview of the structure and content of each of 
the next seven chapters. Chapter two provides a critical review of the current and published 
literature that is relevant to the paramyxoviruses of snakes. This will equip the reader with the 
relevant information that is necessary to understand the methods that were subsequently 
utilised to screen Australian snake samples for the presence of a range of viruses, particularly 
paramyxoviruses.  In  chapter  three,  unpublished  data  in  the  form  of  clinical  signs, 
histopathology  reports  and  the  results  of  overseas  diagnostic  testing  are  presented  and 
critiqued. This chapter identifies the limitations of this data and provides the justification for a 
formal investigation of snakes affected with neurorespiratory signs, or other signs, considered 
consistent with a viral infection. 
 
Chapter four describes the suite of methods that were used to investigate Australian snake 
samples for the presence of viruses, mainly paramyxoviruses. This chapter also includes brief 
experiments that were performed on positive control material that aimed to optimise or adapt 
these methods to be more suitable to the samples that would be received. 
 
Chapter five describes the results of testing 463 Australian snake samples that were collected 
from  animals  suspected  of  harbouring  a  paramyxovirus.  The  testing  involved  screening 
samples  for  the  presence  of  haemagglutinating  agents  and  neuraminidase  activity.  Blood 
samples  were  screened  for  the  presence  of  anti-ferlaviral  antibodies.  Virus  isolation  and 
polymerase chain reaction were performed on swab and tissue samples. Nine viruses were 
eventually isolated from five snakes and, following this, further testing was performed on one 
of these isolates (BHP1-Lung) in an attempt to determine the family it belongs to. 
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Chapter six continues the investigation to determine the identity of this isolate. Analysis of the 
data  produced  from  high-throughput  sequencing  facilitated  the molecular  identification  of 
BHP1-Lung as a paramyxovirus. Partial characterisation of the six major open reading frames 
and phylogenetic analysis is described and revealed that this paramyxovirus was unique and 
did not cluster with either existing paramyxoviral subfamily. This novel paramyxovirus was 
named Sunshine virus after the geographical origin of the first isolate: the Sunshine Coast of 
Queensland, Australia. A set of polymerase chain reaction (PCR) primers was then designed to 
rapidly detect this virus in a range of clinical samples. 
 
Chapter  seven  describes the  results of  testing 141 samples  with  this  newly-designed  PCR. 
Animals infected with Sunshine virus could be identified and this allowed the clinical signs and 
histopathological findings that were associated with infection to be described. Finally, chapter 
eight provides a summarising discussion of the investigations performed. This final chapter 
provides a number of directions that future research on Sunshine virus can follow. 
 
For those reading this thesis electronically, the Table of Contents, List of Figures, List of Tables, 
cross-references  in  bold  type,  and  in-text  citations  have  been  inserted  as  hyperlinks.  This 
allows the reader to press the Ctrl (Control) key on their keyboard while left-clicking their 
mouse  on  the  hyperlink  to  be  taken  directly  to  the  relevant  section  of  the  thesis  or 
bibliography. 4 | P a g e  
 
 
Figure 1.1 Overview of the eight chapters presented in this thesis. 
Chapter One –Purpose of Project and Outline of Thesis
Chapter Two –Literature Review
• General information about paramyxoviruses
• General information about ferlaviruses
• Specific information about the disease that is associated with ferlavirus infection
• The diagnostic tests that are used to identify snakes that are, or once were, infected with ferlavirus.
Chapter Three –Paramyxoviruses in Australian Snakes
• Review of viral diseases described in Australian snakes
• A critical appraisal of paramyxoviruses being a possible explanation of the clinical signs, pathological findings and overseas 
diagnostic test results seen in some Australian snakes 
Chapter Four –Development and Validation of Methods
• The development and validation of the methods that would be used to screen Australian snake samples for the presence 
of a range of viruses, especially paramyxoviruses
Chapter Five –Sample Examination Leading to the Isolation of a Virus Named BHP1-Lung
• Screening swab and tissue samples for haemagglutination  and neuraminidase activity
• Screening blood samples for anti-ferlaviral antibodies
• Examining tissue samples by electron microscopy
• Screening swab and tissue samples by polymerase chain reaction
• Virus isolation attempts  from swab and tissue samples
• The isolation of viruses and further testing on these isolates
Chapter Six –Molecular Identification of BHP1-Lung as a Novel Paramyxovirus named 
Sunshine virus
• High-throughput sequencing leading to the discovery a novel paramyxovirus
• Partial characterisation of viral genome
• Naming the new virus Sunshine virus
• Phylogenetic analysis (work performed by Dr James Wellehan)
• Development of a set of polymerase chain reaction (PCR) primers to detect Sunshine virus
Chapter Seven –Diagnosing Sunshine virus
• PCR results of testing three sample submissions for the presence of Sunshine virus
• The clinical signs and pathological findings  (work performed by Dr Cathy Shilton) associated with Sunshine virus infection
Chapter Eight –Thesis Summary and General Discussion
• Thesis summary
• Future research directions5 | P a g e  
 
Chapter 2 – Literature Review 
2.1  Introduction 
A wide range of pathogenic viruses have been detected in snakes throughout the world and 
the interested reader is referred to  the comprehensive reviews by Wellehan and Johnson 
(2005),  Jacobson  (2007),  Marschang  (2011)  and  Ariel  (2011).    Paramyxoviruses  have  been 
detected in a diverse range of host species and have often been associated with significant 
morbidity  and  mortality  (Jacobson,  2007).  This  literature  review  will  provide  background 
information  on  the  paramyxoviruses,  concentrating  on  those  that  infect  snakes  (2.1  – 
Introduction); the clinical disease that they are capable of producing in snakes (2.2 – The 
Disease) and lastly; the specific laboratory tests that are available to detect, or suggest, the 
presence of these viruses in live and dead snakes (2.3 – Diagnostic Tests). 
2.1.1 General Information on Paramyxoviruses 
Members  of  the  family  Paramyxoviridae  are  currently  divided  into  two  subfamilies: 
Pneumovirinae  and  Paramyxovirinae  (Lamb  et  al.,  2005).  The  subfamily  Pneumovirinae 
includes  the  two  genera  Pneumovirus  (e.g.  Human  respiratory  syncytial  virus)  and 
Metapneumovirus  (e.g.  Avian  metapneumovirus),  while  the  subfamily  Paramyxovirinae 
currently contains seven genera: Respirovirus (e.g. Sendai virus), Morbillivirus (e.g. Measles 
virus), Rubulavirus (e.g. Mumps virus), Henipavirus (Hendra virus and Nipah virus), Avulavirus 
(e.g.  Newcastle  disease  virus),  Aquaparamyxovirus  (Atlantic  salmon  paramyxovirus)  and 
Ferlavirus (Fer-de-lance paramyxovirus) (ICTV, 2012). 
 
Paramyxoviruses are important viruses of animals. Newcastle disease virus, Nipah virus, Peste 
des  Petits  Ruminants  virus,  Rinderpest  virus  and  Turkey  rhinotracheitis  virus  are  all 
paramyxoviruses  that  cause  OIE  (Office  International  des  Epizooties)-Listed  Diseases  (OIE, 
2011). These five paramyxoviruses are joined by two more, Menangle virus and Hendra virus, 6 | P a g e  
 
and these seven viruses all feature on the Australian Government’s National Notifiable Animal 
Diseases List (Australia, 2011). 
 
All paramyxoviruses share a common structure consisting of a spiked envelope surrounding a 
negative sense, single-stranded, RNA genome, and various other functional proteins (Lamb and 
Parks,  2007).  Paramyxoviruses  are  often  spherical  but  can  be  filamentous  to  pleomorphic 
(Lamb and Parks, 2007). Sizes typically range from 150-350nm (Lamb and Parks, 2007). Figure 
2.1 illustrates the general appearance of a paramyxovirus. 
 
 
Figure  2.1  All  images  from  Lamb  and  Parks  (2007)  Left:  Schematic  representation  of  a  typical 
paramyxovirus.  RNP  =  RNA  nucleocapsid  phosphoprotein.  Top  right:  Negative  stain,  transmission 
electron microscopic (TEM) appearance of Parainfluenza virus type 5, a typical paramyxovirus showing a 
spiked  envelope  (226,280  X).  Bottom  right:  Negative  stain,  TEM;  disrupted  Sendai  viruses  showing 
typical  “herring-bone”  nucleocapsid  proteins.  Bar  represents  100nm.  The  unique  structure  of  the 
nucleocapsid is a key diagnostic feature of Paramyxoviridae. 
 
A typical and simplified life cycle of a paramyxovirus has been described by Lamb and Parks 
(2007).  The  major  antigenic  determinant  of  a  paramyxovirus  is  its  haemagglutinin-
neuraminidase  (HN)  protein  which  is  responsible  for  attachment  to the  host  cell’s  plasma 
membrane  and  the  in  vitro  haemagglutination  of  certain  vertebrate  erythrocytes.  Once 
attached, the viral fusion protein (F) facilitates entry into the host cell by fusing the viral 
envelope with the cell membrane of the host. The RNA genome of the virus is then transferred 
to the cytoplasm of the host cell where the viral RNA-dependent RNA polymerase (L, large) is 7 | P a g e  
 
used to replicate the virus’s genome and to create viral transcripts which code for, and initiate 
the  translation  of  the  viral  proteins.  The  nucleocapsid  (N)  protein  that  is  produced 
encapsulates the viral RNA, protecting it from nuclease digestion. The phosphoprotein (P) and 
cysteine-rich protein V (V) are the two proteins that can be synthesised by the polycistronic 
P/V gene. The phosphoprotein is a component of the polymerase complex, while the cysteine-
rich protein V (V) can be expressed to attempt to avoid host interferon defences. The matrix 
(M) protein is the most abundant structural protein and assembles between the envelope and 
nucleocapsid  core.  It  provides  an  anchor  point  for  the  F  and  HN  proteins.  Once  the  viral 
genome and its proteins have been assembled, they are released from the host cell through 
either cell lysis or by budding from the membrane. The viral envelope is formed from the 
plasma membrane of the host cell. 
 
More  detailed  reviews  about  paramyxoviral  genomes,  including  leader  sequences  and 
intergenic regions, have been published elsewhere (Lamb et al., 2005; Lamb and Parks, 2007). 
2.1.2 Ophidian Paramyxovirus or Ferlavirus 
The literature has not shown conformity in how it refers to snake paramyxoviruses. Since the 
first characterisation of a snake paramyxovirus that was named Fer de Lance Virus (FDLV) 
(Clark et al., 1979), the term ophidian paramyxovirus (often abbreviated to OPMV or oPMV) 
has also been used to describe the paramyxoviruses found in snakes  (Lloyd and Flanagan, 
1991; Homer et al., 1995; Jacobson et al., 1997; Manvell et al., 2000; Kindermann et al., 2001; 
Oros et al., 2001; Nogueira et al., 2002; Kolesnikovas et al., 2006). In 2009, a proposal was put 
forward by Kurath (2009) to the International Committee on Taxonomy of Viruses (ICTV) to 
create the new genus Ferlavirus with Fer-de-lance paramyxovirus (the same virus as FDLV) as 
its type species. Prior to the work presented in this thesis, all reptilian paramyxoviruses had 
clustered  together  within  the  Ferlavirus  genus  (Marschang  et  al.,  2009).  The  proposal  by 
Kurath has since been accepted by the ICTV and so Ferlavirus appears, for the first time, in the 
2011 release of Virus Taxonomy (ICTV, 2012). This thesis will therefore refer to the viruses of 8 | P a g e  
 
this proposed genus as “ferlaviruses”. The term “ophidian paramyxovirus” or “OPMV” will only 
be used where the relevant references have specifically referred to this virus as such and 
where  not  doing  so  would  create  confusion.  In  this  thesis,  the  discovery  of  a  new 
paramyxovirus of snakes, that is distantly related to the ferlaviruses, is described, and it is 
proposed that this new virus be named Sunshine virus after the geographical origin of the first 
isolate, the Sunshine Coast of Queensland. Therefore, the term “snake paramyxovirus” will 
encompass both the ferlaviruses that occur in snakes, and Sunshine virus. The term “reptilian 
paramyxovirus” will refer to all paramyxoviruses that have been reported in any reptile. 
2.1.3 Specific Information about Ferlaviruses 
In 1972, an outbreak of neurorespiratory disease in a Swiss serpentarium formed the basis for 
the first description of a paramyxovirus isolated from a snake (Folsch and Leloup, 1976). The 
physicochemical traits of this first isolate were then characterised and described by Clark et al. 
(1979). A personal communication mentioned by Kolesnikovas et al. (2006) states that the 
Brazilian lancehead vipers (Bothrops moojeni but incorrectly referred to as Fer-de-Lance vipers 
[B.atrox]  in  earlier  works)  in  the  Swiss  serpentarium  originated  from  Brazil.  No  further 
information is provided. 
 
The report by Folsch and Leloup (1976) may not have been the first recorded outbreak of a 
paramyxovirus in a collection of snakes. Lunger and Clark (1978) describe a 1970 study about 
an over-crowded collection of Japanese shim-hebi snakes (Elaphe quadrivirgata) that were 
being housed in a restaurant. A high mortality rate, clinical signs arising from the respiratory 
tract (respiratory distress, mucus secretions) and histopathological findings bearing a similarity 
to mammalian alveolitis were seen. Lunger and Clark (1978) speculate that this outbreak may 
have been caused by a viral pneumonia. However, even if this outbreak was proven to have a 
viral aetiology, it may not have been a paramyxovirus. 
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The entire genome of Fer-de-lance paramyxovirus (referred to as Fer-de-Lance Virus [FDLV] in 
this report) has been determined (Kurath et al., 2004). The genome was 15,378 nucleotides 
long  and  was  made  up  of  seven  distinct  genes:  3’  –  Nucleocapsid  (N)  –  Unknown  (U)  – 
Phosphoprotein/Protein V (P/V) – Matrix (M) – Fusion (F) – Haemagglutinin-Neuraminidase 
(HN) – RNA-Dependent RNA Polymerase (L). Six of these are common to most paramyxoviruses 
(section 2.1.1 – General Information on Paramyxoviruses) but a seventh, and novel, gene was 
also reported. This gene was designated (U) for “unknown” as its function was unidentified. 
Since this study, Marschang (2009) has found evidence of this gene in several more ferlaviral 
isolates, including isolates from lizard and chelonian hosts. Interestingly, a study published 
eight  years  before  Kurath  et  al.  (2004)  described  the  electrophoretic  separation  of  the 
radiolabelled proteins of ferlavirus-infected and uninfected cell culture (Richter et al., 1996). 
The  six  major  proteins  common  to  most  paramyxoviruses  were  identified  but  “other  less 
abundant proteins also were seen in infected cells and may represent truncated forms of 
structural proteins”. It is likely that one of these “other less abundant proteins” may have 
actually been encoded by the (U) gene that seems to be unique to the ferlaviruses. However, 
because  these  proteins  were  not  characterised  and  because the  Richter  et  al.  (1996)  and 
Kurath et al. (2004) studies investigated different ferlaviral isolates, it still remains possible 
that the (U) protein may only be found in some isolates of ferlavirus. 
 
In  2006,  Franke  et  al.  reviewed  the  paramyxoviral  fusion  protein  and  then  provided  a 
description of the sequence motifs of this protein in a ferlavirus. The fusion protein is thought 
to be made up of a precursor protein, named F0, that is cleaved by host cell enzymes into its 
active subunits: F1 and F2. In the case of the highly virulent (velogenic) strains of Newcastle 
disease virus (NCDV), a host cell protease named Furin cleaves the viral F0 protein into its 
subunits. Furin is found within the Golgi apparatus of a wide range of tissues and organs and 
this  is  believed  to  explain  why  infections  with  velogenic  strains  of  NCDV  involve  multiple 
organs.  Franke  et  al.  (2006)  demonstrated  that  ferlaviruses  have  a  fusion  protein  that  is 10 | P a g e  
 
cleaved by Furin. This may help explain the observations that ferlaviruses can cause severe 
illness (Folsch and Leloup, 1976; Jacobson et al., 1992) and be isolated (Clark et al., 1979), 
immunohistochemically  detected  (Homer  et  al.,  1995)  and  detected  by  polymerase  chain 
reaction (PCR) (Papp et al., 2010a), in a wide range of snake organs. 
 
The various isolates of ferlavirus have been assembled into phylogenetic trees to characterise 
the diversity within this proposed genus (Ahne et al., 1999b; Franke et al., 2001; Kindermann 
et al., 2001; Marschang et al., 2009; Papp et al., 2010a; Papp et al., 2010b; Abbas et al., 2011) 
(Figure 2.2 left). Results indicate that the isolates of ferlavirus can be placed into three groups 
(Ahne et al., 1999b): groups a and b form distinct groups, and it has been suggested that these 
form two distinct species, while the third group, i, is made up of various intermediate isolates. 
Broader phylogenetic comparisons between a ferlavirus and other paramyxoviral genera have 
also been reported (Junqueira de Azevedo et al., 2001; Kurath et al., 2004; Marschang et al., 
2009) (Figure 2.2 right). Junqueira de Azevedo et al. (2001) analysed a region of the F gene and 
found it was distantly related, although still most homologous, to Sendai virus and Human 
parainfluenza virus types 1 and 3. 
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Figure  2.2  Phylogenetic  trees  of  the  partial  (left)  and  complete  (right)  L  genes  of  ferlavirus.  Left 
Comparison  of  16  strains  of  ferlavirus  using  Sendai  virus  as  an  out-group  that  demonstrates  the 
clustering of ferlavirus into two groups (a and b) that are bridged by several intermediate isolates (Ahne 
et al., 1999b). Right Phylogenetic tree of the L gene showing the relatedness of ferlavirus (FDLV) to 
other paramyxoviruses (Kurath et al., 2004). Ebola virus is used as an out-group. Rubula = Rubulavirus. 
HPIV2 = Human parainfluenza virus 2. SV41 = Simian virus 41.  MuV = Mumps virus. Avula = Avulavirus. 
NDV = Newcastle disease virus. Henipa = Henipavirus. NiV = Nipah virus. HeV = Hendra virus. Morbilli = 
Morbillivirus. MeV = Measles virus. PDV = Phocine distemper virus. CDV = Canine distemper virus. TPMV 
= Tupaia virus. Respiro = Respirovirus. HPIV1 = Human parainfluenza virus 1. SeV = Sendai virus. BPIV3 = 
Bovine parainfluenza virus 3. HPIV3 = Human parainfluenza virus 3. EBOLA = Ebola virus. Pneumo = 
Pneumovirus. HRSV = Human respiratory syncytial virus. TiV = Tioman virus. 
 
The lack of serological relatedness of ferlaviruses to other paramyxoviruses has been reported 
by several authors (Clark et al., 1979; Potgieter et al., 1987; Blahak, 1995; Richter et al., 1996; 
Ahne et al., 1999b). Clark  et  al. (1979) titrated the antisera of 16 paramyxoviruses and 3 
orthomyxoviruses against a ferlavirus and then did the reverse by titrating ferlavirus antisera 
against these same 19 myxoviruses. It was concluded that ferlavirus was antigenically distinct 
from other myxoviruses. Like Clark et al. (1979), Richter et al. (1996) showed that the antisera 
specific for Parainfluenza virus types 1, 2 and 3 (presumed to be Human parainfluenza virus), 
Newcastle  disease  virus,  Respiratory  syncytial  virus  (presumed  to  be  Human  respiratory 
syncytial virus) or Canine distemper virus did not inhibit the haemagglutinating ability of three 
ferlaviral isolates. Ahne et al. (1999b) was also unable to demonstrate any cross-reactivity 
between  ferlaviral  antisera  and  a  range  of  paramyxoviruses:  Mumps  virus,  Measles  virus, 
Sendai virus and Newcastle disease virus. 
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In  contrast  to  these  findings,  serological  relationships  between  ferlavirus  and  other 
myxoviruses have been shown by other authors. Blahak (1995) demonstrated a serological 
relationship between ferlavirus and Avian paramyxovirus types 1 and 7 prompting Manvell et 
al. (2000) to classify two isolates of ferlavirus as “ophidian paramyxovirus type 1 (PMV-1) and 
ophidian  paramyxovirus  type  7  (PMV-7)”.  In  another  report,  Potgieter  et  al.  (1987)  used 
immunohistochemical staining to detect ferlavirus in a section of infected snake lung after the 
lung had been treated with the fluorescently-labelled antisera of Parainfluenza virus type 2. 
 
It  is  possible that  the  seemingly  contradictory  results  about the  serological  relatedness  of 
ferlaviruses to other paramyxoviruses are actually all valid and not contradictory. The disparity 
could  be  explained  if  the  various  ferlaviral  isolates  showed  diversity  in  their  serological 
relatedness to each other (Lloyd et al., 2005). If this were the case, then certain isolates of 
ferlavirus could show serological relatedness to some paramyxoviruses where others did not. 
But when all the findings in the literature are considered, it seems reasonable to conclude that 
the serological relatedness of the ferlaviruses to other paramyxoviruses is, at best, limited. 
 
The next two sections concern themselves with ferlaviral disease (2.2 – The Disease) and the 
tests that have been used to diagnose ferlaviral infection (2.3 – Diagnostic Tests). 
2.2  The Disease 
2.2.1 Clinical Signs and Differential Diagnoses 
Ferlaviral infections have been associated with highly pathogenic disease outbreaks (Folsch 
and  Leloup,  1976;  Jacobson  et  al.,  1980b;  Jacobson  et  al.,  1981;  Jacobson  et  al.,  1992; 
Kolesnikovas et al., 2006). Infection has been detected in several snake families: Colubridae, 
Elapidae, Viperidae, Crotalidae, Boidae
1 and Pythonidae  (Jacobson et al., 1997; Ahne et al., 
1999b; Oros et al., 2001). One report described the clinical signs associated with ferlaviral 
                                                           
1 It has not always been clear whether pythons are a subfamily (Pythoninae) of Boidae or are a family in 
their own right. However, recent molecular data suggest that pythons should form their own family, 
Pythonidae (Dong and Kumazawa, 2005; Noonan and Chippindale, 2006). 13 | P a g e  
 
infection  as  being  variable,  often  non-specific,  and  occasionally  subtle  (Sand  et  al.,  2004). 
When clinical signs can be attributed to a particular organ system, they are most commonly 
localised to the respiratory tract (Jacobson, 2007) but there are also reports about snakes 
suffering from neurological disease (Figure 2.3). Table 2.1 outlines the clinical signs reported 
by various authors. 14 | P a g e  
 
 
 
 
Figure 2.3 Burmese python (Python molurus bivittatus; top) (Bronson and Cranfield, 2006) and rock 
rattlesnake (Crotalus lepidus; middle) (Jacobson, 2007) showing abnormal posturing and an inability to 
right. Bottom: Aruba Island rattlesnake (Crotalus unicolor) with a haemorrhagic oral cavity (Jacobson, 
2007).15 | P a g e  
 
Clinical Sign  Reference 
Non-specific 
Anorexia  (Jacobson et al., 1992; Manvell et al., 2000; 
Kolesnikovas et al., 2006) 
Regurgitation (occasional)  (Jacobson et al., 1981; Jacobson et al., 1992; 
Kolesnikovas et al., 2006) 
Mucoid diarrhoea or malodorous stools  (Jacobson et al., 1981; Jacobson et al., 1992; 
Kolesnikovas et al., 2006) 
Lethargy/Moribund  (Folsch and Leloup, 1976; Ahne et al., 1987a) 
Sudden death  (Jacobson et al., 1981; Jacobson et al., 1997; Marschang 
et al., 2009; Papp et al., 2010a) 
Respiratory 
Not seen  (Jacobson et al., 1992; West et al., 2001) 
Not described further  (Kolesnikovas et al., 2006; Marschang et al., 2009) 
Brown to haemorrhagic discharge from 
nostrils and/or trachea or in oral cavity 
(Jacobson et al., 1981; Jacobson et al., 1997) 
Stridor and/or respiratory noise  (Manvell et al., 2000) 
Pneumonia  (Nogueira et al., 2002; Papp et al., 2010a) 
Clear mucus in mouth  (Potgieter et al., 1987) 
Clear nasal discharge  (Manvell et al., 2000) 
Mouth gaping  (Folsch and Leloup, 1976; Jacobson et al., 1981) 
Neurological 
Not described further  (Papp et al., 2010a) 
Complete flaccid paralysis  (West et al., 2001) 
Decreased cutaneous sensation  (West et al., 2001) 
Head tremors  (Jacobson et al., 1980b; Jacobson et al., 1992; 
Kolesnikovas et al., 2006) 
Abnormal posturing/disequilibrium i.e. 
opisthotonus (star gazing) or inability to right 
itself 
(Folsch and Leloup, 1976; Jacobson et al., 1980b; 
Jacobson et al., 1992; Kolesnikovas et al., 2006; Papp et 
al., 2010a) 
Table 2.1 Clinical signs of ferlaviral infection described in the literature. Only the references that report 
on original data are included here. 16 | P a g e  
 
In  1991,  Lloyd  and  Flanagan  described  the  clinical manifestations  of  ferlaviral  infection  as 
fitting  into  three  discrete  clinical  syndromes.  Firstly,  there  are  snakes  affected  acutely  or 
peracutely  who  usually  show  no  premonitory  signs  except  for  possibly  respiratory  and/or 
neurological compromise. The time from exposure to clinical disease can be six to ten (or 
more)  weeks.  The  second  category  involves  the  “poor  doers”.  Anorexia,  hypophagia  and 
regurgitation are often the first signs seen. It may be up to seven months before other signs 
are seen that may include reluctance to move, increased use of heat pads, emaciation and 
poor  muscle  tone.  These  snakes  often  have  high  anti-ferlaviral  antibody  titres  by 
haemagglutination  inhibition  but  viral  shedding  proceeds.  The  last  group  identifies  the 
clinically healthy animals that shed virus in the face of high antibody titres. These snakes may 
be carriers and be asymptomatic for up to ten months but eventually become chronic “poor 
doers”. These observations were based on clinical experience and were not from a controlled 
study. 
 
The clinical signs attributed to ferlaviral infection are variable and often non-specific. A long list 
of disease processes is associated with non-specific clinical signs but a shorter list exists for 
snakes  with  respiratory  and/or  neurological  signs  of  disease  (Table  2.2).  Anamnesis  and 
physical examination will exclude many of these diseases leaving only a few diagnoses that 
include respiratory and neurological disease. In these cases, ferlavirus infection should remain 
in the clinician’s mind until compelling evidence suggests otherwise. 
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Primary Differential Diagnoses 
Respiratory 
Viral: Inclusion body disease (IBD), reovirus 
Bacterial: Mycoplasma sp., Chlamydophila sp., Pasteurella sp.,  
Fungal: Mucor sp., Penicillium sp., Aspergillus sp., Candida sp. 
Parasitic: nematodes (e.g. lungworm), pentastomids, trematodes 
Infectious periodontal disease 
Nutritional: hypovitaminosis A, obesity 
Neoplasia 
Aspiration pneumonia 
Poor husbandry: too hot, topical irritants (e.g. disinfectant fumes)  
Ascites 
Neurological 
Viral: Inclusion body disease (IBD), reovirus, adenovirus 
Parasitic: visceral larval migrans (aberrant ascarid migration), protozoal 
Nutritional: hypovitaminosis B1, biotin deficiency, hypocalcaemia, ketoacidosis, hypoglycaemia 
Drug toxicities: ivermectin, insecticide 
Hepatoencephalopathy 
Renomegaly 
Head and/or spinal trauma 
Vestibular disease 
Table 2.2 Differential diagnoses for respiratory and neurological disease in snakes. Adapted from Girling 
and  Raiti  (2004)  and  Murray  (2006).  Secondary  and  tertiary  causes  of  neurological  and  respiratory 
disease (e.g. Pseudomonas sp. pneumonia) have been excluded for conciseness. 
 
There is only limited information available describing the signalments that have increased 
predilections for ferlaviral infection. During an outbreak of ferlaviral infection in a zoological 
collection of 438 snakes, all the snakes that died (35) were adults and both sexes were affected 
equally (Jacobson et al., 1981). The exact age of most of the 438 snakes in this collection was 
not known and the ages that were known were not presented in this report, so the average 
age at death could not be determined. The unsupported claim has been made that geriatric 
and young snakes are more likely to succumb to this disease (Ritchie, 2006). 
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Ritchie (2006) states that stress, shipping, temperature fluctuations and overcrowding may 
exacerbate subclinical infections. Ritchie (2006) also suggests that strain variation may dictate 
host specificity and similarly in cases where non-host adapted strains occur, wider outbreaks 
may be anticipated. In a more recent report, Papp et al. (2010a) investigated the strains of 
ferlavirus involved in disease outbreaks. Not only was it shown that several distinct strains 
could be found in an outbreak in a single collection but multiple distinct strains could also be 
found in a single snake. 
2.2.2 Gross Pathology 
Considering the clinical signs that are associated with ferlaviral infection, it is not surprising 
that any significant changes that are seen at necropsy are often localised to the respiratory 
system (Table 2.3 and Figure 2.4). It is important to note that more than one author has not 
detected any gross post mortem changes in snakes that were later identified to be infected 
with ferlavirus. 
  
Gross Pathology  Reference 
None  (Lloyd and Flanagan, 1991; Jacobson et al., 1997; Kolesnikovas et 
al., 2006) 
Pulmonary congestion or oedema  (Folsch and Leloup, 1976; Potgieter et al., 1987; Oros et al., 
2001; Kolesnikovas et al., 2006; Jacobson, 2007) 
Haemorrhagic pneumonia  (Jacobson et al., 1992; Jacobson et al., 1997; Oros et al., 2001; 
West et al., 2001) 
Blood in oral cavity or free in coelom  (Jacobson et al., 1997; Jacobson, 2007) 
White nodules on liver  (Jacobson et al., 1992) 
Mucoid or caseous exudate in the lung  (Jacobson et al., 1980b; Jacobson et al., 1981) 
Diffuse to focal accumulations of 
caseous necrotic debris in pulmonary 
tissue 
(Jacobson et al., 1992; Oros et al., 2001) 
Table 2.3 Gross pathological changes associated with ferlaviral infection 19 | P a g e  
 
 
 
Figure  2.4  Top:  Severe  haemorrhage  in  a  lung  from  an  Eastern  diamondback  rattlesnake  (Crotalus 
adamenteus) that was infected with ferlavirus (Jacobson, 2007). Bottom: Cut lung showing thickening 
and a frothy discharge (Bronson and Cranfield, 2006). 
 
It has been suggested by Lloyd and Flanagan (1991) that in the event of a snake’s death during 
a suspected outbreak of ferlavirus, samples should be collected in triplicate. One sample to be 
collected into formalin for histopathological assessment; a second to be collected into formalin 
for 48 hours and then transferred to 70% ethanol, which will facilitate any special staining that 
is required; and lastly, samples should be frozen down for virus isolation. Blood should also be 
taken  from  both  in-contact  and  adjacent  animals  for  anti-ferlavirus  antibody  detection. 20 | P a g e  
 
Although not mentioned in this report, tissue samples can also be used for the detection of 
nucleic acids by polymerase chain reaction and in situ hybridisation. 
2.2.3 Histopathology 
There are no histological signs that are pathognomonic for ferlaviral infection (Ritchie, 2006). 
Instead,  a  wide  range  of  histopathological  findings  have  been  reported  that  are  most 
commonly attributed to the respiratory and neurological systems (Table 2.4). Intranuclear or 
intracytoplasmic  viral  inclusions  may  be  seen  and  these  should  heighten  the  pathologist’s 
suspicions of ferlaviral infection (Jacobson, 2007). Ultrastructurally, these inclusions have been 
shown to consist of strands of viral nucleocapsid (Jacobson, 2007). Although less specific for 
ferlaviral infection than viral inclusions, proliferative pneumonia (Figure 2.5) and perivascular 
cuffing in the brain (Figure 2.6) are the changes most commonly reported in the literature. 
Jacobson  et  al.  (2001a)  has  noted  that  inclusion  body  disease  (IBD),  mycoplasmosis  and 
infection with reovirus form important rule-outs during an investigation of snakes affected 
with proliferative pneumonia. 
 
Through the use of immunohistochemistry, Homer et al. (1995) was able to localise pulmonary 
infections to the luminal surface and cytoplasm of faveolar epithelium. With a similar purpose, 
Sand et al. (2004) used in situ hybridisation to locate ferlavirus in a variety of infected organs. 
Virus was intranuclear in the brain while being intracytoplasmic in hepatocytes, Kupffer cells, 
pulmonary  alveolar  [faveolar]  macrophages,  respiratory  epithelial  cells  and  renal  tubular 
epithelial cells. 21 | P a g e  
 
Histopathological Change  Reference 
Respiratory 
Moderate to diffuse amounts of cellular debris 
and exudate filling airways 
(Jacobson et al., 1980b; Jacobson et al., 1981) 
Varying amounts of mixed inflammatory cells 
in the interstitium 
(Jacobson et al., 1980b; Jacobson et al., 1981; Potgieter 
et al., 1987; Jacobson et al., 1992; Jacobson et al., 
1997; Oros et al., 2001; West et al., 2001; Kolesnikovas 
et al., 2006; Jacobson, 2007) 
Gram negative micro-organisms seen  (Homer et al., 1995; Oros et al., 2001; Jacobson, 2007) 
Hyperplastic alveolar [faveolar] cells  (Homer et al., 1995; Jacobson et al., 1997; Oros et al., 
2001; Jacobson, 2007) 
Thickened pulmonary septae  (Homer et al., 1995; Jacobson et al., 1997; Jacobson, 
2007) 
Hyperplasia and often hypertrophied 
epithelium 
(Jacobson et al., 1981; Homer et al., 1995) 
Small numbers of pale eosinophilic 
intracytoplasmic (or not described) inclusions 
(Jacobson et al., 1981; Potgieter et al., 1987; Homer et 
al., 1995; Jacobson et al., 1997) 
Giant cell formation  (Homer et al., 1995; Kolesnikovas et al., 2006) 
Lesion severity decreases from cranial to 
middle to caudal lung area* 
(Jacobson et al., 1997) 
Neurological
§ 
Eosinophilic intracytoplasmic inclusion bodies  (West et al., 2001) 
Demyelination and degeneration of axon 
fibres 
(Jacobson et al., 1980b) 
Lymphohistiocytic neuritis of oesophagus  (West et al., 2001) 
Multifocal neuronal degeneration  (West et al., 2001) 
Moderate axonal sheath ballooning  (Jacobson et al., 1980b) 
Multifocal gliosis  (Jacobson et al., 1980b) 
Perivascular cuffing in the brain  (Jacobson et al., 1980b; West et al., 2001; Jacobson, 
2007) 
Other 
Pancreatitis and/or pancreatic necrosis and/or 
pancreatic fibrosis 
(Jacobson et al., 1980b; Jacobson et al., 1992; 
Kolesnikovas et al., 2006; Jacobson, 2007) 
Pancreatitic giant cell formation  (Kolesnikovas et al., 2006) 
Pyogranulomatous hepatitis  (Jacobson et al., 1992) 
Gram negative infections seen in many organs  (Jacobson et al., 1992) 
Table 2.4 Histopathological changes seen associated with ferlaviral infection. *These findings were in 
snakes that were experimentally infected with ferlavirus by endotracheal inoculation. 
§Brain was not 
examined histologically in Jacobson et al. (1981), Potgieter et al. (1987), Jacobson et al. (1992), Homer et 
al. (1995) or Jacobson et al. (1997). It is unclear whether the brain was examined in Oros et al. (2001) 
and Kolesnikovas et al. (2006). 22 | P a g e  
 
 
 
 
Figure 2.5 All images from Jacobson (2007). Top: Normal lung of a bush viper (Atheris squamiger). SM = 
smooth  muscle  bundle.  FV  =  faveolae  (airways).  Middle:  Normal  lung  of  a  western  diamondback 
rattlesnake (Crotalus atrox). SP = connective tissue septae. Bottom: Aruba Island rattlesnake (Crotalus 
unicolor) experimentally infected with ferlavirus. There are large amounts of debris and inflammatory 
cells in the airways. Thickened pulmonary septae are also noted. 23 | P a g e  
 
 
 
Figure 2.6 Perivascular cuffing (centre of image) in the brain of a rock rattlesnake (Crotalus lepidus) 
infected with ferlavirus (Jacobson, 2007). 
 
2.2.4 Non-Ferlaviral Microbiological Findings 
A number of authors have reported on the non-viral microbiological findings in snakes infected 
with ferlavirus. Gram negative bacterial pathogens have been cultured from various organs: 
Aeromonas,  Citrobacter,  Escherichia,  Enterobacter,  Morganella,  Proteus,  Providencia, 
Pseudomonas,  Salmonella  and  Serratia  (Folsch  and  Leloup,  1976;  Jacobson  et  al.,  1981; 
Jacobson  et  al.,  1992;  Homer  et  al.,  1995;  Oros  et  al.,  2001;  Kolesnikovas  et  al.,  2006; 
Jacobson, 2007). In one of these studies, fungal elements could not be cultured (Kolesnikovas 
et  al.,  2006).  It  has  been  suggested  that  ferlaviral  infections  may  be  immunosuppressive, 
possibly due to lymphoid depletion (Oros et al., 2001), allowing secondary bacterial invaders 
(Kolesnikovas et al., 2006). So while it is recommended that concurrent complicating bacterial 
infections be treated as early as possible (Jacobson et al., 1992; Kolesnikovas et al., 2006), 
antibiotic use may not provide any improvement in already affected snakes (Folsch and Leloup, 
1976; Jacobson et al., 1981). 
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Papp et al. (2010a) has described the isolation of reoviruses from various organs from four 
snakes that were positive by PCR for the presence of ferlavirus. In a second study, Abbas et al. 
(2011) simultaneously detected at least one atadenovirus, a reovirus and a ferlavirus in each of 
three corn snakes. One of these snakes, a juvenile, was vomiting and displayed dyspnoea 
before dying. These recent studies form the first reports of mixed viral infections in snakes 
infected with ferlavirus. 
2.2.5 Transmission 
Little  is  known  about  ferlaviral  transmission.  Koch’s  postulates  were  fulfilled  after  the 
successful infection and re-isolation of ferlavirus in a group of snakes (Jacobson et al., 1997). 
Ferlavirus was obtained from cell culture supernatant and then inoculated into the trachea of 
six naïve captive-bred Aruba Island rattlesnakes (Crotalus unicolor). Prior to viral challenge, 
anti-ferlaviral antibodies could not be detected by haemagglutination inhibition in any of these 
snakes. No further pre-infection testing was done, however, rapid detection using polymerase 
chain reaction did not become routine until effective primers were later published (Ahne et al., 
1999b). Once challenged, three snakes were euthanased at 4, 8 and 15 days post-inoculation 
(p.i.), respectively, while another two died at 19 and 22 days p.i. The sixth snake served as a 
control and was euthanased at day zero without viral inoculation. Another three snakes were 
sham-inoculated with uninfected cell culture supernatant. Ferlavirus was successfully isolated 
from the lungs of all the snakes that had been inoculated with virus and none of the sham-
inoculated snakes thus Koch’s postulates were satisfied. 
 
The  incubation  period  of  ferlavirus  in  naturally-acquired  infections  is  unknown.  It  is 
problematic to deduce the incubation period from the aforementioned study by Jacobson 
(1997) because this study experimentally inoculated a small number of animals (n=6) from one 
species with an amount of virus that is difficult to compare to a naturally-acquired infection. 
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as short as 21 days (Hernandez-Divers, 2006) but will generally exceed 90 days (Hernandez-
Divers, 2006; Ritchie, 2006). 
 
Pasmans et al. (2007) states that ferlavirus is easily transmitted through both aerosols and 
contact  and  terraria  for  individually  housed  snakes  provide  little  defence  against  the 
transmission of ferlavirus. Hernandez-Divers (2006) makes the unsupported claim that it can 
be transmitted from snake to snake by direct contact, respiratory secretions, fomites and 
ectoparasites (especially mites). Considering that ferlavirus has been isolated from the sputum 
of  a  rattlesnake  (Crotalus  durissus  terrificus)  (Nogueira  et  al.,  2002)  and  detected  by 
polymerase chain reaction (PCR) in both oral and cloacal swabs (Rachel Marschang, personal 
communication), it is reasonable to assume that ferlavirus can be transmitted between snakes 
by  both  oral  secretions  and  cloacal  excretions.  To  the  best  of  the  author’s  knowledge, 
ferlavirus has not been isolated, or detected by PCR, from fomites or ophidian ectoparasites. 
 
Jacobson  et  al.  (1980b)  describes  an  outbreak  of  ferlavirus  after  a  newly-introduced  rock 
rattlesnake (Crotalus lepidus) was placed into direct contact with eight snakes of the same 
species.  All  nine  of  these  snakes  died  but  several  colubrids  kept  in  the  same  room  were 
unaffected. It is possible that (1) this strain of ferlavirus did not affect the colubrids because it 
was not transmitted to the snakes that were not in direct contact; (2) that the colubrids were 
infected without being overtly affected; or (3) that this strain of ferlavirus was not infectious to 
colubrids. In an outbreak of ferlavirus in a collection of 446 snakes that were housed in three 
rooms, 87% of the snakes in one room died, 40% of the second room occupants died and all 
the snakes in the third room were unaffected (Folsch and Leloup, 1976). In the first two rooms, 
the snakes that were in the closest proximity to the rooms’ doors had the highest mortality 
rates. The third, and unaffected, room contained all the juvenile animals (defined in this study 
as ≤3yrs) so it is possible that age influenced resistance to overt clinical disease. So although 
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ferlaviral transmission within a collection is limited by snake proximity there are confounding 
variables, such as species and age, that would make this conclusion disputable. 
 
The shedding patterns of ferlavirus are unknown (Jacobson and Origgi, 2007). Although Lloyd 
and Flanagan (1991) state that some snakes are capable of shedding virus for an extended 
period  of  time,  this  claim  is  based  on  the  observation  that  some  snakes  have  significant 
haemagglutination inhibition (HI) antibody titres for five months or more while simultaneously 
“causing” seroconversion in cagemates throughout that time. However, it would be difficult to 
rule out an alternative explanation that all the snakes were infected and took variable amounts 
of time to seroconvert, especially considering that no screening tests for ferlavirus itself (e.g. 
virus  isolation)  were  mentioned.  Ritchie  (2006)  suggests  that  asymptomatic  seropositive 
snakes may be persistently-infected shedders while others may have mounted an appropriate 
immune response and cleared the infection. 
 
There are currently no reports concerning vertical transmission of ferlavirus (Pasmans et al., 
2007). 
2.2.6 Treatment and Prognosis 
No specific treatment has been identified as being effective against ferlavirus (Marschang and 
Chitty,  2004).  In  people,  the  antiviral  drug  ribavirin  (Virazole®)  is  sometimes  used  in  the 
treatment of Measles virus, Respiratory syncytial cell virus and Parainfluenza virus infections 
(Chakrabarti  et  al.,  2001;  Freeman  et  al.,  2004).  With  the  aid  of  computers,  the  three-
dimensional structure of the neuraminidase protein of an influenza virus was predicted, and 
based on this, oseltamivir (Tamiflu®) was synthesised as a high-affinity inhibitor of this enzyme 
(Alymova et al., 2005). Similar technology has been utilised for a drug named BCX 2798 that is 
capable of targeting paramyxoviral neuraminidase and it has been shown to decrease viral 
titres  in  mice  infected  with  a  recombinant  strain  of  Sendai  virus  whose  fusion  and 
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parainfluenza virus 3 (Alymova et al., 2005; Watanabe et al., 2009). None of these compounds 
have been tested against ferlavirus either in vitro or in vivo. 
  
Symptomatic  treatment  has  generally  been  provided  by  broad  spectrum  antibiotics 
(Kolesnikovas et al., 2006). These may be helpful because the isolation of secondary Gram 
negative bacteria from ferlavirus-positive snakes has been reported by several authors (Folsch 
and Leloup, 1976; Jacobson et al., 1981; Jacobson et al., 1992; Homer et al., 1995; Oros et al., 
2001; Kolesnikovas et al., 2006; Jacobson, 2007). Bronson and Cranfield (2006) have stated 
that the survival time of snakes infected with ferlavirus is improved by targeting secondary 
protozoal and bacterial infections.  
 
The onset of clinical signs, once seen, is usually progressive (Ritchie, 2006). The prognosis in 
affected snakes should be considered grave and the presence of neurological signs indicates a 
poorer prognosis (Ritchie, 2006). The anecdotal statement has been made that snakes that 
become severely lethargic, die within one week of the onset of signs (Bronson and Cranfield, 
2006). 
2.2.7 Prevention 
The methods that are commonly used to prevent the spread of contagions in other animals are 
used in the same way to control the spread of ferlavirus between snakes. The development of 
an inactivated (killed) ferlavirus vaccine was unsuccessful (Jacobson et al., 1991), so preventing 
infection is reliant on effective quarantine strategies. 
Quarantine 
To prevent the introduction of ferlavirus into a naïve collection it is recommended that new 
animals are only introduced after a period of quarantine (Ritchie, 2006). Pasmans et al. (2007) 
recommends that newly-acquired animals be kept in quarantine terraria that are in a separate 
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resident ones. It has also been recommended that the resident and quarantined animals are 
not attended to on the same day and that an entirely different person is used to attend to the 
resident and quarantined animals (Ritchie, 2006). Surrounding the quarantining period, cages 
and husbandry equipment should be disinfected (Pasmans et al., 2007). Marschang and Chitty 
(2004) recommend the use of any virucidal disinfectant. The efficacy of virucidal disinfectants 
against ferlavirus has not been reported but as a general rule, enveloped viruses are labile to a 
wide range of disinfectants (Heit and Riviere, 2009). 
 
During quarantine, specific antibody testing can be used to help determine if a snake has been 
exposed to ferlavirus (Bronson and Cranfield, 2006). Paired samples, taken at an eight-week 
interval, may reveal an increase in titre indicating a recent infection (Pasmans et al., 2007). 
Antibody testing is discussed in greater detail in section 2.3.6 – Haemagglutination Inhibition. 
 
The quarantine periods that have been recommended to prevent the introduction of ferlavirus 
into a collection vary between sources but overall, there is a general trend where modern 
recommendations  are  for  longer  periods  of  quarantine  (Table  2.5).  All  of  the 
recommendations are empirical due to the limited information that is available about ferlaviral 
transmission and environmental viability. Also, effective biosecurity necessitates that all the 
pathogens that can affect an animal’s health are considered. Choosing quarantine periods 
based on a single pathogen (in this case ferlavirus) is foolhardy. Quarantine periods should be 
determined by the pathogens with the longest incubation periods. In snakes, ferlavirus is just 
one infection that requires a lengthy quarantine period. Inclusion body disease (IBD) is another 
poorly understood infectious disease of snakes where quarantine periods have been reported 
of  at  least  six  months  (Keeble,  2004;  Schumacher,  2006)  and  six  months  to  a  year 
(Vancraeynest et al., 2006). 
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Quarantine Time  Reference 
At least 30 days  (Jacobson et al., 1980b) 
Minimum of 60 days  (Lloyd and Flanagan, 1991) 
Minimum of 60-90 days  (Bronson and Cranfield, 2006) 
Up to 90 days  (Gillespie, 2006) 
90 days  (Pasmans et al., 2007) 
Minimum of 90 days for animal raised in captivity  (Ritchie, 2006) 
Minimally 90 days in a clinically healthy collection  (Jacobson et al., 1992; Marschang and 
Chitty, 2004) 
At least two months since the last death in an affected 
collection. 
(Jacobson et al., 1992) 
Four months  (Hernandez-Divers, 2006) 
Six months or 180 days  (Keeble, 2004; Ritchie, 2006; Rossi, 2006) 
Table 2.5 The various quarantine periods that are recommended in the ferlaviral literature. 
 
Vaccination 
There have only been a few attempts to develop vaccines for reptiles. Yang  et al. (2007) 
successfully developed an orally-administered vaccine to protect against Aeromonas sobria in 
soft-shelled turtles (Trionyx sinensis). And during several outbreaks of Mycoplasma crocodyli in 
Nile crocodiles (Crocodylus niloticus), an autogenous vaccine was produced that was superior 
to  antibiotic  therapy  in  alleviating  clinical  manifestations  of  disease  (Mohan  et  al.,  1997; 
Mohan et al., 2001). But a vaccine that is both safe and effective against a reptilian virus 
remains an elusive goal for the researchers that have attempted to develop one (Jacobson et 
al., 1997; Marschang et al., 2001b; Origgi, 2007). In the only attempt to develop a ferlaviral 
vaccine, a sustained and significant concentration of circulating anti-ferlavirus antibodies could 
not be elicited (Jacobson et al., 1991). 
 
In this investigation by Jacobson et al. (1991), a black mamba (Dendroaspis polylepsis) isolate 
of ferlavirus was inactivated (killed) using 0.2% beta-propiolactone. This treatment effectively 
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hydroxide, an oil emulsion, or was left unchanged as a non-adjuvanted virus. Twenty-three 
western diamondback rattlesnakes (Crotalus atrox) were then divided into three groups of six 
and one group of five. Each of one group of six was injected intramuscularly with a single 
preparation of ferlaviral vaccine. Snakes in the group of five were inoculated with a control 
vaccine  of  Encephalomyocarditis  virus  (EMV)  that  was  inactivated  with  0.2%  beta-
propiolactone  and  adjuvanted  by  oil  emulsion.  At  the  time  of  this  study,  there  were  no 
effective reptile vaccines, so EMV was chosen as a control vaccine because it is known to 
produce antibody responses in mammals that can be detected by haemagglutination inhibition 
(HI). Vaccines were injected at days 0, 28 and 63. Blood was collected to determine antibody 
titres by HI at days: -56 (eight weeks prior to vaccination), 0, 14, 28, 42, 63, 84, 136, 176, 219, 
253 and 296 days after the first injection of vaccine was given. All pre-vaccination HI titres 
were  zero  and  a  positive  titre  was  defined  as  being  ≥20.  The  HI  titres  recorded  after 
vaccinations  were  variable,  unpredictable  and  could  only  be  detected  in  seven  of  the 
vaccinated  snakes  (Table  2.6).  Only  one  of  the  vaccinated  (oil-emulsion  adjuvant)  snakes 
produced a positive HI titre for greater than 200 days. No HI titre could be detected at any 
time point in the remaining 11 snakes that were vaccinated with ferlavirus or any of the five 
snakes that were vaccinated with EMV. A small number of snakes stopped eating during the 
trial but otherwise all remained healthy. 
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Snake 
Number 
  HI titre 
  d42  d63  d84  d136  d176  d219  d253  d296 
non-adjuvanted vaccine 
16    0  10  20  20  40-80  0  0  0 
21    20  40  40  10  10  10  0  0 
aluminium hydroxide adjuvant 
3    0  0  10  10  0  0  0  0 
23    0  0  10  10  0  0  0  0 
oil-emulsion adjuvant 
2    0  10  80  40  20  20  20  0 
7    0  0  20  20  20  10  10  0 
15    10  40  40  40  40  40  40  40 
Table 2.6 Adapted from Jacobson et al. (1997). Anti-ferlaviral titres (HI, haemagglutination inhibition) of 
western diamondback rattlesnakes (Crotalus atrox) after exposure to an inactivated ferlavirus vaccine. 
All snakes (n=16) and time  points (day  -56 to day 28) where an HI titre was not  detected are not 
presented and taken as zero. 
 
Protective immunity could not be demonstrated in this study because the vaccinated snakes 
were not challenged with unattenuated virus. The link between antibody titres and protective 
immunity has been the source of controversy in small animal medicine (Moore and Glickman, 
2004) and in reptiles there is a veritable dearth of information on this important link. The 
protective immunity against viruses is typically cell-mediated but can sometimes be an uneven 
contribution of cell-mediated and humoral responses (Wellehan and Johnson, 2005).  So the 
interpretation of haemagglutination inhibition titres as an appropriate surrogate marker for 
protective  immunity  in  this  investigation  should  not  be  automatically  assumed,  especially 
when  biologically  relevant  (protective)  antibody  titres  are  unknown.  Furthermore,  the 
secondary  immunological  response  in  reptiles  may  be  influenced  by  a  number  of  factors: 
inappropriate temperature, type of antigen used, antigenic dose, schedule of immunisation, 
route of immunisation, seasonal conditions and hormonal conditions (Jacobson et al., 1991). 
The effect that these variables had on the secondary immune response in this study is difficult 
to determine. So although Jacobson et al. (1991) concludes that future directions of reptile 
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such as enzyme-linked immunosorbent assays (ELISAs) that have greater sensitivities, there are 
many other considerations that should be investigated as well. 
 
Mayr et al. (2000) has suggested that cell culture-adapted ferlaviral isolates could be used in 
the production of live vaccines but in a brief and limited report of a vaccine trial using a 
modified-live isolate of ferlavirus, one snake died and another suffered severe illness (Lloyd 
and Flanagan, 1991). 
2.2.8 Ferlavirus in Non-Captive Free-Ranging Snakes 
Only  a  few  reports  have  described  ferlavirus  in  wild  snakes.  A  survey  of  10  free-ranging 
anacondas (Eunectes murinus) from Venezuela involved serological testing against a number of 
pathogens,  including  ferlavirus  (Calle  et  al.,  2001).  Ferlaviral-specific  antibody  titres  by 
haemagglutination inhibition (HI) were not detected in any snake. 
 
Allender et al. (2006) screened 20 endangered wild-caught eastern massasauga rattlesnakes 
(Sistrurus catenatus catenatus) from Illinois for the presence of anti-ferlavirus antibodies using 
two different isolates of ferlavirus in an HI assay. All the snakes were seropositive against both 
ferlaviral isolates with titres ranging from 20 to 640. In the absence of additional testing that is 
capable of detecting ferlavirus (as opposed to just anti-ferlaviral antibodies, e.g. virus isolation, 
polymerase chain reaction, in situ hybridisation or electron microscopy) the significance of 
these serological findings is uncertain. Despite this, the authors provide three possibilities to 
explain the HI results: the snakes were exposed to a non-ferlavirus paramyxovirus that cross-
reacts with the HI assay that was utilised; the positive results are false due to the presence of 
unidentified and non-specific inhibitors in the snakes’ sera; or, the snakes were exposed to 
ferlavirus but were not overtly ill because they had successfully mounted an adequate immune 
response against the virus. 
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The results of this report are further complicated by a subsequent serological survey of the 
same species of free-ranging snakes (Sistrurus catenatus catenatus) collected from the same 
area  two  years  later  (Allender  et  al.,  2008).  This  time,  plasma  was  submitted  to  three 
diagnostic laboratories for determination of anti-ferlaviral antibodies by HI using four different 
isolates of ferlavirus. From 26 snakes sampled, the number of snakes with positive HI titres 
against each isolate ranged from zero to 26. These results show the considerable disagreement 
that exists between the HI assays used in this study and the authors conclude that the inter-
laboratory variation of this assay makes it an unreliable indicator of infection or exposure to 
ferlavirus in this species. However, as was discussed earlier (2.1.3 – Specific Information about 
Ferlaviruses) the various isolates used in each HI assay may be serologically unrelated to each 
other and would then provide non-comparable results. In summary, using HI as a screening 
tool  to  determine  if  a  wild  reptile  has  been  exposed  to  ferlavirus  may  provide  equivocal 
results. 
2.2.9 Ferlavirus in Non-Snake Reptilian Hosts 
Chelonians 
In 1983, Jackson and Needham discovered anti-Sendai virus haemagglutination inhibition (HI) 
titres  of  up  to  256  in  34  tortoises  from  three  species:  Testudo  graeca,  T.hermanni  and 
Geochelone elegans. Seven of these 34 tortoises were showing signs of rhinitis at the time of 
blood sampling but there was little correlation between anti-Sendai virus HI titre and the 
presence of clinical signs. The authors did not attempt to isolate a paramyxovirus from any of 
these tortoises. In another study, a collection of Mediterranean tortoises (Testudo graeca and 
T.hermanni) was imported from Turkey to Switzerland and upon arrival many were found to 
have  a  viral  dermatitis  (Zangger  et  al.,  1991).  Light  microscopy  revealed  intracytoplasmic 
inclusions in the stratum germinativum and under electron microscopy; paramyxovirus-like 
particles were identified. 
 34 | P a g e  
 
In 1999, a ferlavirus was isolated from a Hermann’s tortoise (Testudo hermanni) suffering from 
pneumonia (Marschang et al., 2009). The identity of this ferlavirus was confirmed by sequence 
analysis but no further information is provided. In the most recent chelonian study, several 
different  ferlaviruses  were  detected  by  PCR  from  various  organs  of  a  leopard  tortoise 
(Geochelone pardalis babcocki) suffering from respiratory distress (Papp et al., 2010b). There 
were large amounts of mucopurulent discharge from its nares and mouth and on necropsy, the 
lungs were bilaterally consolidated and filled with thick exudate.  The viruses could not be 
isolated from a range of tissue samples into terrapene heart cells (TH-1) or viper heart cells 
(VH2). 
 
Based on these few reports it seems that paramyxoviruses are associated with disease in 
chelonians but it is rarely reported. 
Crocodiles 
Using electron microscopy, paramyxoviruses have been found in the faeces of Nile crocodiles 
(Crocodylus niloticus) (Huchzermeyer et al., 1994). These crocodiles had been fed chickens that 
were sourced from a farm  during an outbreak of Newcastle disease virus. This study also 
provided limited information about a paramyxovirus that was seen in the faeces of a crocodile 
not fed a diet of chickens. 
Lizards 
Most of the paramyxoviruses that have been described in lizards have not been associated 
with overt disease. A paramyxovirus was isolated from a false tegu (Callopistes maculatus) in 
1988 (Ahne and Neubert, 1991). This paramyxovirus was later identified as a ferlavirus by 
sequence analysis (Ahne et al., 1999b). Similarly, a paramyxovirus was isolated from the mouth 
of a healthy monitor lizard (Varanus prasinus) that was part of a reptile collection that had 
suffered an outbreak of ferlavirus in its snake population (Gravendyck et al., 1998). 
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In a serological survey of lizards, Gravendyck et al. (1998) collected 35 healthy free-ranging 
Honduran Island iguanas (Ctenosaura bakeri, C.similis and Iguana iguana rhinolopha) to look 
for evidence of paramyxoviral and reoviral infections. Using two reptilian paramyxoviruses as 
antigens, 41% of serum samples had antibodies that could be detected by virus neutralisation 
and 9% had haemagglutination inhibition (HI) antibody titres of ≥20 (maximum titre was 32). 
Sera could not be treated for non-specific haemagglutinins due to the small sample volume 
and  if  these  were  present,  they  could  have  potentially  decreased  the  final  HI  titres.  The 
authors could not isolate any viruses from pharyngeal and cloacal swabs from these lizards. In 
a  similar  study,  Marschang  et  al.  (2002)  tested  wild-caught  Mexican  lizards  (Xenosaurus 
grandis, X.platyceps and Abronia graminea) for exposure to paramyxovirus and reovirus. Anti-
ferlavirus  antibodies  were  detected  in  four  animals  representing  all  three  species  but 
significantly, a ferlavirus was isolated from the cloacal swab of X.platyceps. The results of this 
report  were  unable  to  clarify  the  clinical  significance  of  finding  ferlavirus  and  ferlaviral 
antibodies in these species. 
 
Lloyd et al. (2005) serologically tested the lizard population of a zoological park where the 
resident snake collection had a history of paramyxovirus-associated disease. In total, 59 lizards 
(from  12  families)  were  tested  for  the  presence  of  ferlavirus-specific  antibodies  by 
haemagglutination inhibition (HI). All the lizards, except one, were clinically normal. Seven 
lizards had HI titres that were considered positive (≥16) for exposure to ferlavirus. These seven 
positive animals were then retested 105 days later and six of them had either maintained or 
increased their antibody titres. The authors concluded that the six animals either had active 
infection, repeated antigen exposure or were in a carrier state. The authors did not comment 
on  the  possibility  that  the  HI  titres  might  be  falsely  positive.  In  another  study,  ferlavirus 
exposure was serologically assessed in 32 geckos (Gecko monarchus and Gehyra mutilata) that 
free-roamed the grounds of a zoological park (Kummrow et al., 2004). Blood was pooled from 
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HI. The authors speculate that the geckos may have a role as vectors for this virus but more 
detailed investigations would be necessary to elucidate this idea further. 
 
There are only two reports where a paramyxovirus was associated with mortality in a lizard 
(Jacobson et al., 2001a; Boyer et al., 2005). Three separate epidemics of ferlavirus were seen 
between 1998 and 1999 in caiman lizards (Dracena guianensis) that had been imported into 
the  USA  from  Peru  (Jacobson  et  al.,  2001a).  Many  individuals  were  found  dead  or  were 
anorexic upon arrival. Histopathology showed severe heterophilic and histiocytic pneumonia 
and ferlavirus was detected in tissue sections by immunohistochemistry. A virus was isolated 
using  viper  heart  cells  and  electron  microscopic  examination  of  cell  culture  supernatant 
confirmed the presence of a paramyxovirus. In the second report, paramyxovirus-like particles 
were seen by electron microscopy in the respiratory tract of a Thai water dragon (Physignathus 
concinus)  (Boyer  et  al.,  2005).  Histological  assessment  revealed  a  proliferative  interstitial 
pneumonia  and  eosinophilic  cytoplasmic  inclusions  of  the  pneumocytes  and  pancreatic 
ductular  epithelium.  DNA  probes  could  not  detect  a  reptilian  paramyxovirus  in  paraffin-
embedded sections. 
 
Only a small proportion of the reports about ferlavirus in non-snake reptiles show a strong 
association between disease and infection with this pathogen, but there is insufficient data to 
rule out the possibility that lizards, chelonians and maybe even crocodiles, play important roles 
as reservoir hosts for ferlavirus. This could have important implications when attempting to 
eradicate ferlavirus or prevent its introduction in collections that house snakes with non-snake 
reptiles. 
2.2.10   Zoonotic Potential 
Ahne  and  Mayr  (2000)  investigated  the  capability  of  ferlavirus  to  infect  human  blood 
mononuclear cell culture at the virus-permissive temperature of 28
0C. Viral replication could 
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isolate from a snake in BHK-21 hamster kidney cells at 37
0C but this study found that the 
highest haemagglutination titre, the greatest likelihood to grow in cell culture and the most 
significant cytopathic effects were seen when the isolate had been grown at 30
0C. Under the 
conditions described by other authors, it was found that ferlavirus did not replicate at 37
0C 
(Clark  et  al.,  1979;  Ahne  et  al.,  1999a;  Ahne  and  Mayr,  2000).  Clark  et  al.  (1979) 
comprehensively  investigated  the  susceptibility  of  mice  to  infection  with  ferlavirus.  Intra-
cerebral inoculation of ferlavirus into twenty 4-week-old and forty 24-hour-old mice failed to 
cause any sign of disease during observation for up to one year, nor were signs of histological 
lesions seen in the brains of animals as they were sacrificed at regular intervals throughout this 
year of observation. Ferlavirus that was inoculated intranasally or injected directly into the 
footpad of adult mice did not result in any clinical or histological evidence of disease. 
 
Based on this information it would seem unlikely that ferlavirus would pose a serious zoonotic 
risk  to  human  health.  Although  reptilian  paramyxoviruses  have  been  propagated  in  avian 
(Ahne et al., 1999a), piscine (Potgieter et al., 1987) and mammalian substrates (Mayr et al., 
2000), no species of paramyxovirus has been found that is capable of infecting two different 
vertebrate classes (e.g. reptiles and mammals) in vivo, so even the upper airways of a human 
(potentially providing a ferlavirus-permissive temperature) would be unlikely to be colonised 
or infected. 
2.3  Diagnostic Tests 
2.3.1 Virus Isolation 
For paramyxoviruses, virus isolation has traditionally been the “gold standard” diagnostic test 
that others are compared to (Quinn et al., 2002). The isolation of reptilian paramyxoviruses 
from clinical samples is reliant on intact virus proliferating in a biological substrate; commonly 
cultured  cells  or  embryonated  eggs  (Origgi  and  Pare,  2007).  Tissue  samples  and  oral  and 
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2004).  Table  2.7  provides  a  summary  of  the  techniques  that  have  been  used  to  isolate 
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Virus Isolation Techniques  Reference 
Successful attempts   
Sputum inoculated directly onto Vero cells  (Nogueira et al., 2002) 
Fulfilling Koch’s postulates: Vero cell-adapted ferlavirus was 
transmitted to naïve snakes and then lung homogenates were 
recovered at necropsy and used to reisolate ferlavirus onto Vero 
cells 
(Jacobson et al., 1997) 
Lung suspension inoculated onto fathead minnow skin cells (FHM, 
a piscine cell line), hamster kidney cells (BHK-21), swine testicular 
cells (ST), Vero cells and primary bovine turbinate cells (BTU) 
(Potgieter et al., 1987) 
Lung suspension inoculated into embryonated snake eggs and 
then subcultured onto nine reptilian and four mammalian cell 
lines 
(Clark et al., 1979) 
Pooled and/or individual snake organs inoculated onto 
monolayers of VH2 and/or IgH2 cells 
(Jacobson et al., 1980b; 
Jacobson et al., 1981; Ahne et 
al., 1987a; Homer et al., 1995; 
Kolesnikovas et al., 2006; Abbas 
et al., 2011) 
Various lizard organs inoculated onto VH2 and TH1 cells. After 
eight passages in TH1 cells, was adapted to Vero cells 
(Jacobson et al., 2001a) 
Ferlavirus replicating in VH2 cells adapted to Vero cells  (Richter et al., 1996; Mayr et 
al., 2000) 
Ferlavirus replicating in IgH2 cells adapted to Vero cells  (Richter et al., 1996; Mayr et 
al., 2000) 
Ferlavirus replicating in IgH2 cells adapted to chicken embryo 
fibroblasts (LSCC-H32) 
(Ahne et al., 1999a) 
Lung suspension inoculated into snake embryo fibroblasts  (Manvell et al., 2000) 
Unsuccessful attempts*   
Tortoise organ suspensions inoculated onto TH1 and VH2 cells  (Papp et al., 2010b) 
Pooled and/or individual snake organs inoculated onto monolayer 
of IgH2 cells 
(Jacobson et al., 1980b) 
Lung suspension inoculated into embryonated snake eggs and 
then subcultured onto three piscine cell lines 
(Clark et al., 1979) 
Lung suspension inoculated into the allantois of SPF embryonated 
chicken eggs and onto chicken embryo fibroblasts and Vero cells 
(Manvell et al., 2000) 
Lung suspension inoculated onto VH2 cells and feline kidney cells 
(CRFK) 
(Potgieter et al., 1987) 
 
Reptilian paramyxovirus replicating in fathead minnow cells 
subcultured into the allantois of SPF embryonated chicken eggs 
(Potgieter et al., 1987) 
 
Table  2.7  The  methods  that  have  been  reported  in  the  literature  to  isolate  paramyxoviruses  from 
reptiles. VH2 = viper heart cells. TH1 = terrapene heart cells. IgH2 = iguana heart cells. SPF = specific 
pathogen free. *Only those attempts where a paramyxovirus was successfully isolated using a different 
biological substrate are mentioned. This is to exclude the possibility that the unsuccessful attempt was 
because there was simply no virus in the inoculum. However, the possibility that the virus did grow in 
these cells but was not detected cannot be ruled out as further testing (e.g. polymerase chain reaction) 
was not performed. 40 | P a g e  
 
Cell Culture 
Monolayers of cultured cells can be used to isolate viruses (Origgi and Pare, 2007). A sample is 
processed for virus isolation and is then added to the cell culture media (the supernatant) of 
susceptible cells. Any viruses that are present in the sample are given the opportunity to 
propagate in the cultured cells. The cell types that have been used for the isolation of reptilian 
viruses are often immortal cell lines: viper heart cells (VH2; American Type Culture Collection 
[ATCC]-CCL 140)  which  are  fibroblasts  from  the  heart of  a  Russell’s  viper  (Vipera  russelli); 
iguana heart cells (IgH2; ATCC-CCL 108) which are epithelial cells from the heart of a green 
iguana (Iguana iguana); terrapene heart cells (TH-1; ATCC-CCL 50) which are epithelial cells 
from the heart of a box turtle (Terrapene carolina); or Vero cells (ATCC-CCL 81) which are 
epithelial cells from the kidney of an African green monkey (Cercopithecus aethiops) (Origgi 
and  Pare,  2007;  ATCC,  2011).  Ferlavirus  is  usually  isolated  using  reptilian  cell  lines  (most 
commonly viper heart cells) and in some cases has then been adapted to grow in Vero cells 
(Richter et al., 1996; Ahne et al., 1999a; Mayr et al., 2000; Jacobson et al., 2001a). In one 
report, a ferlavirus was isolated from the sputum of a South American rattlesnake (Crotalus 
durissus terrificus) directly into Vero cells (Nogueira et al., 2002).  
 
Cultured cells that are infected with a virus may display signs of their infection (Origgi and 
Pare, 2007). These signs are collectively termed the cytopathic effect (CPE). The cytopathic 
effect  associated  with  infection  from  reptilian  paramyxoviruses  has  been  described  by  a 
number of authors (Table 2.8). Syncytial cell formation and cell lysis are commonly reported 
(Figure 2.7). The time taken for CPE to emerge varies markedly between references: from only 
24 to 36 hours (Ahne et al., 1987a) to requiring serial passage (Jacobson et al., 1980b). 41 | P a g e  
 
Cytopathic Effect 
Cell line 
Viper heart 
cells (VH2) 
Terrapene 
heart cells 
(TH1) 
Vero cells 
Iguana heart 
cells (IgH2) 
Chicken 
embryo 
fibroblasts 
(LSCC-H32) 
Fathead 
minnow skin 
(FHM) 
Various
§ 
Syncytial/giant cell formation  (Abbas et al., 
2011)
ф (Jacobson 
et al., 1980b; 
Jacobson et al., 
1981; Blahak, 
1995; Homer et 
al., 1995; 
Jacobson et al., 
2001a) 
(Jacobson et al., 
2001a)
# 
(Richter et al., 
1996)
1 (Mayr et 
al., 2000)
2 
(Jacobson et al., 
2001a)
3 
(Ahne et al., 
1987a; Ahne et 
al., 1999b) 
(Ahne et al., 
1999a)
2 
(Potgieter et al., 
1987)* 
(Clark et al., 
1979) 
Cytoplasmic inclusion bodies  (Jacobson et al., 
1981) 
  (Mayr et al., 
2000)
2 
       
Cell lysis/monolayer 
destruction 
(Abbas et al., 
2011)
ф (Jacobson 
et al., 1981; 
Blahak, 1995; 
Homer et al., 
1995; 
Kolesnikovas et 
al., 2006) 
  (Mayr et al., 
2000)
2 
(Ahne et al., 
1987a; Ahne et 
al., 1999b) 
(Ahne et al., 
1999a)
2 
(Potgieter et al., 
1987)* 
(Clark et al., 
1979) 
Elongation of cell processes  (Homer et al., 
1995) 
           
Cell vacuolisation          (Ahne et al., 
1999a)
2 
   
Cell rounding  (Kolesnikovas et 
al., 2006) 
           
Table 2.8 The cytopathic effects of paramyxoviruses isolated from snakes and a lizard that have been described in the literature.
 §This isolate displayed CPE in nine 
reptilian and four mammalian cell lines after first being passaged through an embryonated snake egg. 
1Adapted from VH2 cells.
 2Adapted from IgH2 cells.
 3Adapted 
from TH1 cells. *Undescribed cytopathic changes were also seen when this isolate was propagated in hamster kidney cells (BHK-21), swine testicular cells (ST), Vero 
cells and primary bovine turbinate cells (BTU). 
#This isolate was obtained from a caiman lizard (Draecena guianensis). 
фTissue homogenates were inoculated onto 
VH2 and IgH2 cells but cell line that the isolate was successful isolated with is not specified. 42 | P a g e  
 
 
 
Figure 2.7 Both images from Mayr et al. (2000). Top: Normal Vero cells stained with haematoxylin and 
eosin. Bottom: Vero cells, five days after infection with ferlavirus. Massive syncytial cell formation, lysis 
of the monolayer and cell process elongation can be seen. 43 | P a g e  
 
Embryonated Eggs 
The successful isolation and/or propagation of reptilian paramyxoviruses using embryonated 
eggs has been reported (Clark et al., 1979; Ahne et al., 1999a). Similar attempts by other 
authors were unsuccessful (Potgieter et al., 1987; Manvell et al., 2000) (Table 2.7). Clark et al. 
(1979)  inoculated  lung  suspensions  into  a  site  near  the  embryo  of  three  25-day-old 
embryonated snake eggs (Cyclagras gigas). Each embryo died seven days after infection and 
the snake embryo was then frozen and processed for inoculation into several vertebrate cell 
lines and the allantoic and/or amniotic cavities of 7- to 8-day-old embryonated chicken eggs. A 
ferlavirus  was  isolated  that  had  a  haemagglutination  titre  of  1:32  (using  guinea  pig 
erythrocytes) after incubation in a snake egg. This  titre increased up to 1:512 after serial 
passage in chicken eggs. 
 
Ahne et al. (1999a) were able to adapt IgH2-grown ferlavirus to the allantoic cavity of 8-day-
old embryonated chicken eggs and obtain tissue culture infectious doses (TCID50) of 10
7.8-10
8.2 
mL
-1 after six days of incubation at 28
0C. The minimum infective dose was 0.1 TCID50. Using 
embryonated  chicken  eggs,  Manvell  et  al.  (2000)  attempted  to  isolate  a  ferlavirus,  and 
Potgieter  et  al.  (1987)  attempted  to  propagate  a  reptilian  paramyxovirus  that  had  been 
previously isolated using fathead minnow skin (FHM) cells. Both attempts were unsuccessful. 
Potgieter et al. (1987) was unable to detect haemagglutinating activity in the allantoic cavity of 
the  chicken  egg  and  Manvell  et  al.  (2000)  do  not  provide  a  basis  for  their  unsuccessful 
isolation.  
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2.3.2 Electron Microscopy 
Many  authors  have  utilised  transmission  electron  microscopy  (TEM)  to  identify  reptilian 
paramyxoviruses (Lunger and Clark, 1978; Clark et al., 1979; Jacobson et al., 1980b; Jacobson 
et al., 1981; Ahne et al., 1987a; Potgieter et al., 1987; Richter et al., 1996; Jacobson et al., 
1997; Manvell et al., 2000; Franke et al., 2001; Jacobson et al., 2001a; West et al., 2001). 
Ferlaviruses are medium-sized, have spiked envelopes and can be spherical to pleomorphic in 
morphology  (Jacobson  and  Samuelson,  2007)  (Figure  2.8).  The  nucleocapsid  of  a 
paramyxovirus forms the core of the virion and has a distinct “herring bone” appearance (Ahne 
and Mayr, 2000) (Figure 2.8 bottom). Spherical and filamentous forms of ferlavirus have been 
seen budding from infected cells (Jacobson et al., 1997) (Figure 2.9). 
 
Inclusion bodies have been identified under light microscopy in snake tissue infected with 
ferlavirus (Jacobson et al., 1981; Potgieter et al., 1987; Homer et al., 1995; Jacobson et al., 
1997;  West  et  al.,  2001).  Ultrastructural  assessment  has  shown  these  inclusions  to  be 
comprised of nucleocapsid strands (Jacobson et al., 1981; Jacobson et al., 1997) (Figure 2.10).45 | P a g e  
 
 
 
Figure 2.8 Transmission electron microscopic (negative staining) appearance of ferlavirus. Top: Spherical 
appearance of ferlavirus showing spiked envelope (Ahne et al., 1999b). Scale bar represents 100nm. 
Bottom: Disrupted ferlavirus releasing its characteristic “herring-bone” nucleocapsid protein (Ahne and 
Mayr, 2000). Scale bar represents 100nm. 46 | P a g e  
 
 
Figure 2.9 Transmission electron microscopic (positive staining) appearance of ferlavirus-infected cells. 
Hyperplastic type II epithelial cells from the lung of an Aruba Island rattlesnake (Crotalus unicolor) eight 
days  after  experimental  infection  with  ferlavirus  (Jacobson  et  al.,  1997).  Spherical  and  filamentous 
virions can be seen budding from the cell membrane (arrowheads). Scale bar of main picture represents 
2µm and scale bar of inset represents 200nm. 47 | P a g e  
 
 
 
Figure 2.10 Transmission electron microscopic (positive staining) appearance of ferlavirus-infected cells. 
Infected  Vero  cells  showing  virions  budding  from  the  cell  membrane  into  the  intercellular  spaces 
(arrows)  (Jacobson  et  al.,  1997).  IC  =  an  intracytoplasmic  inclusion  body  containing  nucleocapsid 
material. Scale bar represents 7µm. 48 | P a g e  
 
2.3.3 Haemagglutination and Haemadsorption Assays 
Haemagglutination (HA) assays rely on a sample containing the ability to cause the in vitro 
macroscopic  agglutination  of  erythrocytes  (Jacobson  and  Origgi,  2007).  In  virology,  the 
presence of haemagglutination suggests the presence of a haemagglutinating virus, such as a 
paramyxovirus,  (Jacobson  and  Origgi,  2007)  but  viruses  that  are  capable  of  in  vitro 
haemagglutination were only discovered decades after these traits had already been described 
in bacteria, such as staphylococci and campylobacter (Neter et al., 1954). 
 
Large quantities of virus are needed for macroscopic haemagglutination so this method is 
considered to be relatively insensitive (Quinn et al., 2002). In one study, ferlavirus-infected 
tissue  homogenates  did  not  haemagglutinate  chicken  erythrocytes  but  ferlavirus  could  be 
isolated onto viper heart cells and be detected by polymerase chain reaction (Kolesnikovas et 
al.,  2006).  Only  after  replication  in  viper  heart  cells,  could  haemagglutinating  activity  be 
detected.  Studies  comparing  the  lower  limits  of  detection  of  haemagglutination  to  other 
diagnostic tests, such as polymerase chain reaction, do not exist. 
 
Various  vertebrate  erythrocytes  were  compared  to  each  other  in  their  ability  to 
haemagglutinate  three  isolates  of  ferlavirus  (Richter  et  al.,  1996).  Chicken  and  guinea  pig 
erythrocytes  reliably  produced  high  titres  against  these  three  isolates  and  outperformed 
sheep,  human  type-O  and  rabbit  erythrocytes.  Haemagglutination  inhibition  is  offered 
commercially at several diagnostic laboratories as a serological test for ferlaviral exposure and 
many, if not all, of these laboratories utilise chicken or guinea pig erythrocytes as markers of 
ferlavirus-induced haemagglutination (Allender et al., 2008). 
 
In haemadsorption assays, erythrocytes attach themselves to the surface of a cell monolayer 
that is infected with a haemagglutinating virus (Mahy and Kangro, 1996). Haemadsorption of 49 | P a g e  
 
cells  infected  with  ferlavirus  has  not  been  reported  but  it  has  been  described  in  a 
paramyxovirus known to infect Atlantic salmon (Kvellestad et al., 2003). 
2.3.4 Neuraminidase Assay 
Neuraminidase (sialidase, receptor destroying enzyme) is a protein found on the surface of 
many myxoviruses (orthomyxoviruses and paramyxoviruses) that is capable of cleaving the 
glycosidic linkages of neuraminic acid (sialic acid) (Clark et al., 1979; Klenk and Herrler, 1997). 
Paramyxoviral neuraminidase serves two purposes. Firstly, during infection, the attachment 
protein of a paramyxovirus binds to a sialic acid residue on the surface of the host cell. But this 
bond can prevent the release of viral progeny from an infected cell so viral neuraminidase is 
used to cleave the sialic acid bond allowing the viral progeny to be released. This has the 
added benefit that progeny virions will not reattach themselves to previously infected cells 
allowing an infection to progress onto naive cells. Secondly, viral neuraminidase will cleave any 
sialic acid residues from viral proteins. This helps prevent viral aggregation. 
 
Using a substrate that is specifically cleaved by neuraminidase into an intensely fluorescent 
product (Yolken et al., 1980), significant neuraminidase activity was detected in three isolates 
of ferlavirus (Richter et al., 1996).  Clark  et al. (1979) also demonstrated the presence of 
neuraminidase  activity  in  a  ferlavirus.  After  haemagglutinating  chicken  and  guinea  pig 
erythrocytes  with  ferlavirus,  it  was  observed  that  these  erythrocytes  could  not  be  re-
agglutinated  by  ferlavirus,  implying  that  the  virus  had  a  receptor  destroying  enzyme 
(neuraminidase). 
2.3.5 Non-haemagglutination Inhibition Antibody Assays 
The detection of reptilian antibody responses to viruses has been reviewed by Jacobson and 
Origgi (2007). Serum (virus) neutralisation tests (SN, SNT, VN, VNT) are considered to be the 
“gold  standard”  antibody tests. These  tests  quantify  the  capability  of  serum  or  plasma to 
neutralise a particular pathogen’s infectivity of a biological substrate, such as a cell line. Serum 50 | P a g e  
 
neutralisation tests are labour-intensive and often have protracted turnaround times before 
results are available. In spite of this, SNT has been used for the detection of exposure to 
ferlavirus (Marschang et al., 2002). Enzyme-linked immunosorbent assay (ELISA) is a relatively 
modern technique that can also be used for the detection of antibodies (Jacobson and Origgi, 
2007).  It  is  highly  sensitive  but  requires  reagents  that  are  timely  to  create  (months)  and 
equipment  that  is  expensive  (up  to  US$10,000).  Like  SNT,  ELISA  has  been  used  for  the 
detection of ferlavirus exposure (Kania et al., 2000). 
2.3.6 Haemagglutination Inhibition 
In  contrast  to  serum  neutralisation  tests  (SNT)  and  enzyme-linked  immunosorbent  assays 
(ELISA), haemagglutination inhibition (HI) is a relatively simple, rapid and inexpensive test of 
humoral immunity (Quinn et al., 2002; Jacobson and Origgi, 2007). In this test, the ability of 
serum or plasma to inhibit viral haemagglutination is quantified (Jacobson and Origgi, 2007). 
Haemagglutination inhibition has been used widely as a serological test for the detection of 
exposure to ferlavirus (Jacobson et al., 1981; Potgieter et al., 1987; Jacobson et al., 1991; 
Jacobson et al., 1992; Brousset et al., 1994; Blahak, 1995; Richter et al., 1996; Jacobson et al., 
1997; Gravendyck et al., 1998; Manvell et al., 2000; Calle et al., 2001; Jacobson et al., 2001a; 
Marschang et al., 2002; Lloyd et al., 2005; Allender et al., 2006; Allender et al., 2008) and is 
offered commercially by several diagnostic laboratories (Table 2.9). 
 
Haemagglutination  inhibition  (HI)  titres  are  represented  as  the  reciprocal  of  the  greatest 
dilution of serum or plasma that inhibits macroscopic haemagglutination, so if the dilutions of 
1:2, 1:4, 1:8 and 1:16, but not 1:32, inhibited macroscopic haemagglutination, the HI titre 
would be 16 (Jacobson and Origgi, 2007). There is disagreement in the literature about the 
titres that should be considered positive for exposure to ferlavirus. Titres of greater than 10 
(Jacobson et al., 1992) and 16 (Pasmans et al., 2007) have been reported but it has also been 
suggested that less than 20 is negative, between 40 and 80 is suspect and greater than 80 is 
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Pasmans et al. (2007) makes the logical but unsupported claim that the presence of circulating 
anti-ferlavirus antibodies in a snake indicates the survival from infection but the animal may 
still be carrying latent virus. Pasmans et al. (2007) goes on to recommend that paired samples, 
eight weeks apart, be taken to determine if a snake has a rising antibody titre. A rising titre 
may indicate current exposure to ferlavirus, while a “positive” titre that does not increase may 
be indicative of previous exposure (Jacobson and Origgi, 2007). HI assays quantify the ability of 
serum  or  plasma  to  inhibit  macroscopic  haemagglutination  without  delineating  the 
contributions  to  this  inhibition  that  were  made  by  immunoglobulin  M  (IgM)  and  IgY  (the 
reptilian equivalent of IgG). Furthermore, controlled experiments that were able to identify the 
antibody  titres  at  several  time  points  during  and  after  antigen  exposure  do  not  exist.  So 
conclusions drawn from rising, falling or unchanged anti-ferlavirus HI titres may not always be 
reliable. Although it might be difficult to interpret HI titres, reports do exist that provide useful 
information about the HI titres that were seen during both a controlled transmission study and 
naturally occurring outbreaks of ferlavirus infection. 
 
The experimental transmission of ferlavirus in Aruba Island rattlesnakes (Crotalus unicolor) 
forms the only study where ferlavirus was inoculated into snakes under controlled conditions 
(Jacobson et al., 1997). In this study, HI titres were only assessed at the time of death. The last 
death  occurred  22  days  after  inoculation.  During  this  time,  no  snake  had  developed  an 
antibody response that could be detected by HI. 
 
In an outbreak of ferlavirus in a zoological collection, Jacobson et al. (1992) tested 31 snakes 
for  the  presence  of  anti-ferlavirus  antibodies  by  HI.  Twelve  snakes  showed  positive  titres 
(greater than 10) and these animals were then retested a number of times over the next year. 
Many cases showed high titres (5,120 to greater than 20,480) that decreased to low titres 
(below 100) over three to seven months. For example, the titre of a canebrake rattlesnake 52 | P a g e  
 
(Crotalus horridus) dropped from greater than 20,480 to 20 in a little over seven months and a 
gopher snake (Pituophis melanoleucus) had a titre that fell from greater than 20,480 to zero
2 in 
approximately one year. 
 
In another outbreak of ferlavirus in reptiles, this time a collection of caiman lizards ( Draecena 
guianensis), HI testing was performed on surviving animals several months after a ferlavirus 
had been isolated from dead animals (Jacobson et al., 2001a). From 17 animals tested, there 
were seven titres of less than or equal to 20 and ten titres were between 20 and 180. 
 
An HI titre is complicated by a long list of variables: the antibody’s affinity to the antigen, the 
integrity of the antigen being used, the availability of antibody in the serum, the preservation 
of  the  sample  and  lastly,  the  host’s  immune  response,  which  itself  is  influenced  by 
temperature,  the  season,  nutritional  status,  antigen  concentration,  route  of  inoculation, 
frequency  of  exposure  to  the  antigen  and  the  type  of  antigen  (Lloyd  et  al.,  2005).  The 
influences that these factors have on an HI titre have not been investigated in a controlled 
experiment and so the consideration that should be made to each of these factors can only be 
speculated. 
 
The time it takes for an animal to mount a detectable immune response to ferlavirus is another 
important consideration when testing animals by HI (Lloyd et al., 2005). From the results of a 
ferlavirus challenge study that were presented at a conference, it was concluded that naïve 
snakes  typically  take  six  to  eight  weeks  to  seroconvert  (Gaskin  et  al.,  1989).  It  has  been 
reported that some snakes will die prior to the development of a detectable (by HI) immune 
response (Ritchie, 2006). This suggests that testing live or dead snakes by HI shortly after 
exposure to ferlavirus may provide negative results. In the period before seroconversion, false 
                                                           
2 Considering the lower limit of detection of this assay is not known and because serum samples were 
initially diluted by a factor of ten, it is unlikely that a titre of zero is accurate. 53 | P a g e  
 
negatives are a legitimate concern and analysing paired serum samples may help to overcome 
this hurdle (Ritchie, 2006). 
 
According to Lloyd et al. (2005), if there is a serological unrelatedness between the ferlavirus 
that has been used as antigen in an HI assay and the ferlavirus the animal has been exposed to, 
negative HI results may occur. For this reason, other authors have recommended that two 
different viral isolates are used as the antigen source to accommodate serological differences 
that might exist between ferlavirus strains (Pasmans et al., 2007). In a study of 60 snake serum 
samples that were being tested by HI using two different strains of ferlavirus as antigens, 
considerable variation in HI titre was seen between the two antigens but most snakes that 
were considered to be positive, were positive using either antigen (Kania et al., 2000). 
 
In  contrast  to  the  findings  of  Kania  et  al.  (2000),  Allender  et  al.  (2008)  found  there  was 
considerable  variation  in  the  HI  titres  of  26  wild-caught  eastern  massasaugas  (Sistrurus 
catenatus  catenatus)  when  analysed  using  four  different  strains  of  ferlavirus  as  antigen. 
Against two antigens, 100 percent of plasma samples were positive, 56 percent were positive 
against the third and none were positive against the last. If all of the HI results that were 
presented in both the Kania et al. (2000) and Allender et al. (2008) studies were true, then the 
results may be explained simply by an unrelatedness of the antigens that were being used in 
the assays. But the possibility that some of these HI results were false cannot be excluded. 
Irrespective  of  whether either of  these explanations  is  true,  these  studies  provide  further 
evidence of the difficulties in interpreting HI titres. 
 
Only one investigation has compared HI to another test of humoral immunity: ELISA (Kania et 
al., 2000). Although there were titre differences between these two diagnostic tests, overall, 
there was agreement as to whether a sample was positive or negative. 
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While it seems as though rising or negative HI titres may provide some helpful information to a 
clinician about exposure to ferlavirus, the variables that confound these results have not yet 
been adequately studied and so the interpretation of single titres are problematic at best. 
Some zoological collections and private institutions require negative ferlavirus titres during 
quarantine before a snake is released into the main collection (Allender et al., 2008) and the 
difficulties  in  interpreting  HI  titres  places  the  decision-making  veterinarian  in  a  difficult 
position. 
2.3.7 Immunohistochemistry 
In this method, labelled anti-virus antibodies are used to detect the presence of viral antigen in 
various samples including formalin-fixed paraffin-embedded (FFPE) tissues (Quinn et al., 2002). 
Immunohistochemistry (IHC) can complement other diagnostic tests because a pathologist can 
compare the location of immunohistochemical staining to histological lesions. IHC requires the 
availability of animal-derived polyclonal or monoclonal antibodies that are specific to the virus 
under  investigation  (Sand  et  al.,  2004).  The  use  of  polyclonal  antibodies  makes  this  test 
difficult to standardise between laboratories (Homer et al., 1995). 
 
The detection of ferlavirus by IHC has been reported by various authors. Homer et al. (1995) 
inoculated rabbits with ferlavirus to produce a source of anti-ferlavirus polyclonal antibodies. 
These antibodies were then used to immunohistochemically identify ferlavirus antigen in FFPE 
tissues. This study demonstrated that standard formalin-fixation practices did not prevent the 
identification of ferlavirus in infected tissues, although fixation times are not always listed. 
Since this first report, IHC has been used to detect ferlavirus antigen in ferlavirus-infected Vero 
cells (Richter et al., 1996), five experimentally-inoculated Aruba Island rattlesnakes (Crotalus 
unicolor)  (Jacobson  et  al.,  1997),  a  caiman  lizard  (Draecena  guianensis)  (Jacobson  et  al., 
2001a), six snakes from the Canary Islands (Oros et al., 2001) and three pit vipers (Bothrops 
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2.3.8 In Situ Hybridisation 
This method uses a labelled sequence of nucleic acids, called a probe, to anneal, or hybridise, 
to  a  target  sequence  of  nucleic  acids  on  a  diagnostic  sample  (Johnson  et  al.,  2007).  An 
advantage that in situ hybridisation (ISH) has over IHC, is that biologically-derived polyclonal or 
monoclonal antibodies are not needed and that viral transcripts can be detected (Sand et al., 
2004). Like IHC, ISH can be used to temporally and spatially associate viruses with histological 
lesions. 
 
Using oligonucleotides as probes, Sand et al. (2004) were able to identify segments of the 
ferlavirus haemagglutinin-neuraminidase attachment gene (HN) in the tissue sections of 11 out 
of  14  snakes  that  had  histopathological  findings  that  were  consistent  with  a  ferlavirus 
infection. The 14 samples were then tested by reverse transcription polymerase chain reaction 
(RT-PCR)  and  the  same  11  samples  were  positive.  No  further  investigations  of  the  three 
negative results were reported. The detection of a transcript of a ubiquitous house-keeping 
gene (e.g. 18S rRNA, beta-actin) may have provided an internal control for all the samples. If a 
sample was negative for both ferlavirus and a house-keeping gene transcript, the integrity of 
the sample would become doubtful and the negative result for ferlavirus, by both ISH and RT-
PCR, would become equivocal. 
 
Only one other report describes the use of ISH for the detection of ferlavirus (West et al., 
2001). A generic avian paramyxovirus probe was used for the detection of ferlavirus in the 
brain  of  a  Boelen’s  python  (Morelia  boeleni)  with  neurological  signs.  Hybridisation  was 
observed even after increasing the stringency of the procedure. 
2.3.9 Polymerase Chain Reaction 
Polymerase chain reaction (PCR) involves the geometric amplification of target sequences of 
DNA using short sequences of synthetic DNA, called primers, such that femtogram (10
-15g) 
amounts of target DNA may be detected in microgram (10
-6g) amounts of total DNA (Johnson 56 | P a g e  
 
et al., 2007). RNA viruses, such as ferlavirus, can only be detected by PCR after the viral RNA 
has been reverse-transcribed into complementary DNA, known as cDNA. The detection of 
target RNA by PCR is known as reverse transcription-PCR (RT-PCR). 
 
As mentioned in the previous section on in situ hybridisation (ISH), Sand et al. (2004) used RT-
PCR to identify ferlaviral RNA in FFPE tissues. Primer sequences that target the attachment 
gene (HN) were designed that produce relatively small amplicons: 153 nucleotides. Targeting 
short amplicons increases the likelihood of detecting RNA that may have been degraded during 
formalin-fixation  (Antonov  et  al.,  2005).  Sand  et  al.  (2004)  amplified  and  then  sequenced 
appropriately-sized amplicons from 11 out of 14 cases that had histological findings consistent 
with ferlavirus infection.  
 
Although ISH offers an advantage over RT-PCR because histological lesions can be compared 
spatially to the presence of viral RNA, RT-PCR offers several advantages over other diagnostic 
tests, not just ISH. Unlike ISH, RT-PCR can be used on a diverse range of starting materials 
including blood, body cavity fluids, bronchial secretions/washings and other secretions. Sand 
et  al.  (2004)  reports  that  RT-PCR  also  has  some  important  advantages  compared  to 
haemagglutination-inhibition (HI): RT-PCR requires less time, reveals early stage of disease 
(prior  to  seroconversion)  and  does  not  require  paired  samples.  However,  RT-PCR  has 
important limitations that are not described by Sand et al. (2004). For example, RT-PCR is 
dependent on an adequate quantity and quality of viral RNA being present in the sample. In a 
hypothetical  example  where  a  cloacal  swab  is  being  tested  by  RT-PCR  and  the  swab  was 
collected from a snake infected with ferlavirus that is not shedding ferlavirus into its cloaca, 
the RT-PCR result will be negative. It is conceivable that evidence of this infection could still be 
obtained by HI. The shedding pattern of ferlavirus is not known (Jacobson and Origgi, 2007), so 
RT-PCR results that are negative may not be accurate representations of the animal’s disease 
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In 1999, primer sequences were designed and then successfully used for the detection of the 
polymerase (L) and attachment (HN) genes of ferlavirus (Ahne et al., 1999b). The L gene primer 
set has been used for nucleic acid detection by several authors (Ahne et al., 1999b; Nogueira et 
al., 2002; Marschang et al., 2009) and diagnostic laboratories (Table 2.9). In contrast to this, 
the haemagglutinin-neuraminidase (HN) gene has been targeted by other investigators (Sand 
et al., 2004; Kolesnikovas et al., 2006). Kurath et al. (2004) reported the order of conservation 
between paramyxoviral proteins (most conserved to least conserved): V-carboxy domain > L > 
M/F > N/HN > V > P. In agreement with this, Kindermann et al. (2001) found the L gene, from a 
selection of ferlaviruses, to be more conserved than the HN gene. 
 
In one study, a PCR targeting the HN gene was performed on 47 clinical samples (swabs, 
organs) that had previously been determined to be positive for ferlavirus by an L gene PCR 
(Papp et al., 2010a). Only 34% were positive when tested with the HN gene PCR. Because this 
study first screened samples with the L gene PCR, there was no opportunity that a sample 
could be discovered that was positive by the HN gene PCR and negative by the L gene PCR. In 
another study, Kolesnikovas et al. (2006) used an HN gene primer set (Ahne et al., 1999b) to 
successfully amplify ferlavirus from cell culture supernatant and infected tissues. Some tissue 
samples were negative using this primer set but these results were not pursued. The annealing 
temperature in this study was set at 50
0C but in the original study by Ahne et al. (1999b) the 
authors stated that the HN gene primer set was not always reliable and often the annealing 
temperature needed to be lowered to accommodate more difficult targets. Considering that 
every ferlaviral isolate tested so far by PCR, has been positive by an L gene PCR but some have 
escaped detection by an HN gene PCR (Ahne et al., 1999b; Franke et al., 2001; Marschang et 
al., 2009; Papp et al., 2010a), it seems reasonable to target the L gene in preference to the HN 
gene. 
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Not all authors have used the primer sets designed by Ahne et al. (1999b). In a retrospective 
study of 22 snakes from the Netherlands that died with histological findings consistent with 
ferlavirus infection, ten were positive for ferlavirus using newly designed primers (Kik et al., 
2004).  This  conference  abstract  did  not  provide  details  about  the  amplicon  size,  primer 
sequences or the region targeted by the primer set. Other studies have used novel degenerate 
primers to target the fusion (F) (Franke et al., 2006) and “unknown” (U) (Marschang et al., 
2009) genes of ferlavirus but neither primer set has been used diagnostically. 
2.3.10 Commercially Available Diagnostic Tests 
The diagnostic tests for ferlavirus that are available to the clinical practitioner are restricted to 
haemagglutination inhibition (HI), reverse transcription-polymerase chain reaction (RT-PCR) 
and virus isolation (Table 2.9). These tests are only offered on a commercial basis in Europe 
and the United States of America. For practitioners from Australia to gain access to these tests, 
various export permits are needed. For example, Australia has listed all 16 python species that 
are endemic to this country with the Convention on International Trade in Endangered Species 
(CITES, 2011). To  send  a sample  from  any  one of these  species  from  Australia  requires  a 
species-specific  permit  to  be  obtained  from  CITES.  Moreover,  some  of these  international 
diagnostic laboratories will need to have the relevant import permits in place before they can 
receive  samples  from  outside  their  country.  Negotiating  these  bureaucracies  can  be  time 
and/or cost-prohibitive. 
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Laboratory  Reference 
Haemagglutination Inhibition (HI) 
Hohenheim University, Germany  (Heard et al., 2004) 
Chemical and Veterinary Investigation Office (CVUA) of East 
Westphalia-Lippe (CVUA), Germany 
(R. Marschang, pers. comm.) 
Veterinary Laboratories Agency (VLA), UK  (Keeble, 2004) 
The University of Florida, USA  (Heard et al., 2004) 
The University of Tennessee, USA  (Heard et al., 2004) 
Texas State Diagnostic Laboratory, USA  (Ritchie, 2006) 
Reverse Transcription – Polymerase Chain Reaction (RT-PCR) 
Hohenheim University, Germany*  (R. Marschang, pers. comm.) 
Chemical and Veterinary Investigation Office  (CVUA) of 
East Westphalia-Lippe, Germany* 
(R. Marschang, pers. comm.) 
The University of Florida, USA*  (Heard et al., 2004) 
Virus Isolation 
Hohenheim University, Germany  (R. Marschang, pers. comm.) 
Chemical and Veterinary Investigation Office (CVUA) of East 
Westphalia-Lippe, Germany 
(R. Marschang, pers. comm.) 
Table 2.9 Diagnostic tests for ferlavirus that are commercially available. *Use the primer pairs designed 
by Ahne et al. (1999b) targeting the L-gene. 
 
In this chapter, the literature that concerns itself with ferlavirus has been reviewed. As will be 
shown in the following chapters, this information was drawn upon to make decisions about 
which diagnostic tests to pursue while attempting to discover a paramyxovirus in an Australian 
snake, the limitations of these tests and how to interpret test results. In the next chapter, a 
critical review of the information that has justified this investigation into the paramyxoviruses 
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Chapter 3 – Paramyxoviruses in Australian Snakes 
In the previous chapter, the peer-reviewed literature of the paramyxoviruses of snakes was 
reviewed. Compared to Europe and the USA, there is a relative dearth of information about 
the paramyxoviruses of Australian snakes. Even though currently-practising Australian reptile 
veterinarians have been seeing snakes display neurorespiratory signs of disease for the last 
two to three decades (Johnson, 2011), there have only been a few investigations (informal and 
formal) into the possible causes of disease. Historically, the tests available to the Australian 
practitioner to diagnose a viral infection in an Australian snake have either been nonexistent or 
only available through overseas laboratories. To send a sample to an overseas laboratory can 
be cost prohibitive, the turnaround times may be unacceptable, and the appropriate permits 
(e.g. CITES) may need to be in place before the samples can be submitted. As mentioned in the 
previous chapter, negotiating these bureaucracies can be cost and/or time-prohibitive. Partly 
because  of  these  diagnostic  hurdles,  Australian  reptilian  (not  just  snakes)  virology  has 
remained in its infancy. 
 
This  chapter  begins with a  short  review of the  peer-  and  non  peer-reviewed  reports  that 
describe  the  viruses  that  have  been  found  in  Australian  snakes.  This  is  followed  by  the 
unpublished results of overseas diagnostic testing that was performed on Australian snake 
samples. These are presented with the permission of the submitting veterinarians. Included 
with these results are summaries of a selection of Australian histopathological reports that 
show  justification  for  the  pursuit  of  overseas  diagnostic  testing.  The  recurring  anecdotal 
reports of snakes displaying neurorespiratory signs that do not respond to supportive care, 
that  sometimes  occur  in  outbreaks,  and  the  results  of  overseas  diagnostic  testing,  have 
collectively  provided  an  impetus  for  a  formal  investigation  of  Australian  snakes  for  the 
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3.1  Australian Snake Virology (excluding paramyxoviruses) 
In Australia, there are varying degrees of evidence to support the inclusion of iridoviruses, 
adenoviruses,  inclusion  body  disease  (IBD),  reoviruses  and  herpesviruses  as  endemic  viral 
diseases of native Australian snakes. The evidence for the presence of paramyxoviruses in 
Australian snakes will be reviewed in the next sections. 
 
In 1998, ten green tree pythons (Morelia viridis) were seized at an Australian international 
airport having been illegally imported from Indonesia. A ranavirus (family: Iridoviridae) was 
isolated  from  two  of  these  snakes  and  was  associated  with  rhinitis,  pharyngitis  and  liver 
necrosis (Hyatt et al., 2002). Although green tree pythons are endemic to Australia and the 
virus was isolated and identified in Australia, the snakes were of Indonesian origin and had 
been  isolated  in  quarantine  since  being  seized.  However,  this  paper  also  provides  the 
unsupported  claim that  an  erythrocytic  iridovirus  infection  has  been  detected  (details  not 
provided) in an Australian diamond python (Morelia spilota spilota). 
 
In 2011, an adenovirus (GenBank accession number: JN418933) was detected by the author 
using polymerase chain reaction (PCR) on pooled organs (kidney, liver and lung) from a captive 
Australian  death  adder  (Acanthophis  antarcticus)  with  lethargy,  flaccid  paralysis  and 
proliferative interstitial pneumonia (unpublished data). 
 
In 1998, Carlisle-Nowak et al. reported on inclusion body disease (IBD) in a diamond python 
(Morelia spilota spilota) and a north-west carpet python (Morelia spilota variegata). Diagnosis 
was based on non-specific and neurological clinical signs and  eosinophilic intracytoplasmic 
inclusion bodies that were seen histologically: both findings were consistent with IBD. The 
aetiological agent(s) that is responsible for IBD has not yet been definitively determined and so 
diagnosis  of  this  disease  is  defined  by  histopathology  (Chang  and  Jacobson,  2010).  In  the 
investigation by Carlisle-Nowak et al., there was no specific testing to attempt to rule out 63 | P a g e  
 
known viral diseases that could resemble the changes seen in these two snakes (e.g. reovirus 
or  paramyxovirus  infection).  The  two  cases  presented  in  this  paper  have  been  cited  as 
evidence of IBD in Australia (Oros et al., 1998; Jacobson et al., 2001b; Raymond et al., 2001; 
Huder  et  al.,  2002;  Chang  and  Jacobson,  2010)  but  until  more  specific  testing  becomes 
available, the presence of IBD in Australia should not be seen as irrefutable. An immunoassay 
capable of detecting a 67kD protein that is unique to cases of IBD (Chang and Jacobson, 2010; 
Chang et al., 2011), may allow a more definitive diagnosis of IBD to be made in the future. 
 
In a separate report about IBD, a group of 40 clinically-normal snakes being held at Taronga 
Zoo, New South Wales (NSW), on behalf of the NSW National Parks and Wildlife Service, were 
euthanased after two of these snakes were diagnosed with IBD (Rose and Humphreys, 2002). 
Electron microscopy had revealed C-type retroviral particles in the tissues from these two 
snakes. Ten of the 40 snakes were subject to post mortem examination and all had histological 
evidence of intra-cytoplasmic inclusion bodies within the central nervous system. 
 
Finally,  electron  microscopy  was  able  to  identify  reovirus  and  herpesvirus  particles  in  the 
brains of Australian snakes with neurological dysfunction (Rose et al., 2005). Further details 
are not provided. 
 
Prior to the findings presented in this thesis, there have been two levels of support for the 
presence of paramyxoviruses in Australian snakes. The first level of support consists of clinical 
signs and pathological findings that are consistent with paramyxovirus infection. These findings 
do  not  rule  out  the  infection.  The  next  level  of  support  consists  of  the  results  from 
haemagglutination  inhibition  assays  and  in  situ  hybridisation  that  are  suggestive  of 
paramyxovirus  infection.  These  findings  are  distinguished  from  those  that  are  consistent 
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3.2  Findings  Consistent  with  Paramyxovirus  Infection  in 
Australian Snakes 
There  have  been  several anecdotal reports  from  Australian  veterinarians, working  in  both 
private practice and with public collections, of snakes with neurological dysfunction such as 
the inability to right itself, opisthotonus, head tremors and ataxia (Figure 3.1). Respiratory 
clinical signs are reported less frequently. Mouth gaping is sometimes described (Figure 3.2) 
but it is unclear whether this suggests a neurological and/or respiratory sign of disease. If 
these cases were associated with paramyxovirus infections, the predominantly neurological 
signs being seen in Australia would be in contrast to those reported in overseas descriptions of 
ferlavirus infection: which most commonly are localised to the respiratory system and only 
occasionally  the  nervous  system  (Jacobson,  2007).  The  majority  of  these  snakes  seen  in 
Australia also have non-specific signs of disease such as regurgitation, weakness, lethargy and 
inappetence. Many of them do not respond to supportive care (e.g. fluid therapy, antibiotics, 
antiprotozoals  and  anthelmintics)  and  not  uncommonly,  in-contact  animals  are  similarly-
affected. A long list of differential diagnoses should be considered for a snake that has non-
specific signs of disease, neurological and/or respiratory signs of disease (Girling and Raiti, 
2004). So although the diagnosis of a paramyxovirus infection cannot be made on clinical signs 
alone, they are consistent with this infection. Together, the lack of response to the therapy 
that was targeted at other infectious aetiologies and the apparent transmissibility of illness, 
increase the likelihood of a viral infection. 
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Figure  3.1  Australian  pythons  with  neurological  signs  of  disease.  Top:  Wild  coastal  carpet  python 
(Morelia spilota mcdowelli) with neurological signs presented to Wildlife Warriors in Queensland. Photo 
courtesy of Dr Jon Hanger. Middle: Captive diamond python (Morelia spilota spilota) presented to a 
private practice in Victoria. Photo courtesy of Dr Tristan Rich. Bottom: Captive south-west carpet python 
(Morelia spilota imbricata) presented to the author in Western Australia. 66 | P a g e  
 
 
 
Figure 3.2 A captive spotted python (Antaresia maculosa) presented to a private practice in Queensland. 
An abnormal posture and inability to right itself (above) was seen along with open mouth breathing 
(below).  It  is  unclear  whether  the  open  mouth  breathing  was  representative  of  respiratory  and/or 
neurological disease (e.g. abnormal mouth gaping). Photo courtesy of Dr Bob Doneley. 67 | P a g e  
 
Some of these snakes have been submitted to pathology laboratories for further investigation. 
Only some of the pathology reports include gross pathological descriptions (Figures 3.3 and 
3.4).  Presumably,  this  is  because  only  tissue  samples  (as  opposed  to  whole  animals)  are 
submitted to pathology laboratories in the majority of cases. The limited information that is 
available about the gross pathology that is associated with these clinical presentations is non-
specific in all of the limited number of reports available to this review. This means that it is 
likely that gross pathology will not rule out a paramyxoviral infection. 
 
There are numerous histopathological reports of Australian snakes that support the tentative 
diagnosis of a paramyxoviral infection (Figure 3.5). As was mentioned in Table 2.2, inclusion 
body disease (IBD) and reovirus infection would be important differential diagnoses for snakes 
displaying clinical signs of neurorespiratory disease. The neurohistopathology that has been 
reported for IBD (Schumacher et al., 1994; Carlisle-Nowak et al., 1998; Jacobson et al., 2001b; 
Vancraeynest  et  al.,  2006)  overlaps  with  the  reports  described  in  Pathology  Reports  1-4 
(Figures 3.3-3.5). However, in cases of IBD, bright intracytoplasmic eosinophilic inclusions are 
often seen in the epithelial cells of a variety of tissues (Schumacher et al., 1994; Carlisle-Nowak 
et al., 1998; Chang and Jacobson, 2010), and these changes are not reported in Pathology 
Reports 1-4. Reovirus infection has been associated with neurological dysfunction in snakes 
(Vieler et al., 1994) but in this report the brain was not examined histologically as it was used 
exclusively for virus isolation. The author is not aware of any published reports about reovirus 
neurohistopathology in snakes. 
 
There are non-infectious explanations for the clinical signs, gross pathology and histological 
findings that have been reported for these Australian cases. While organophosphate toxicity 
and deficiencies in thiamine (Vitamin B1) and vitamin E may provide similar neurological clinical 
signs  and  neurohistopathology  (Maxie,  2007),  it  would  be  difficult  to  accept  that  dietary 
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distribution of disease that has been seen. Also, these particular non-infectious differential 
diagnoses do not explain the respiratory lesions seen, so other disease processes would need 
to be considered concurrently. 
 
In summary, the clinical signs, gross pathology and histopathological findings described in this 
chapter provide evidence that is consistent with the conclusion that paramyxovirus infection is 
present  in  Australian  snakes.  Paramyxoviral  infections  do  not  produce  pathognomonic 
histological  lesions  so  while  the  histological  findings  may  provide  the  most  specific,  and 
therefore compelling, evidence of paramyxovirus involvement so far, the assessment is not 
agent-specific and so the results should not be interpreted as being definitive. Some Australian 
clinicians have submitted samples to overseas laboratories for agent-specific testing and these 
are reviewed in the next section as findings that are suggestive of paramyxovirus infection in 
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Figure 3.3 Pathology report of a python (species unknown) which has been weak since a nephrectomy 
had been performed two years earlier. The histological findings are consistent with a paramyxoviral 
infection but the gross pathological changes are non-specific. NAD = no abnormalities detected. CBC = 
complete blood count. MBA = mixed bile acids. OPMV = ophidian paramyxovirus (ferlavirus). Sections of 
particular interest are highlighted in red. 
PATHOLOGY REPORT 1 
Euthanased Y/N: Yes, intracardiac barbiturate 
Hx: 1 kidney removed approx 2 years ago (granuloma), weak ever since. 
Body condition: Fair 
External examination: Blisters, now ruptured and dried along dorsum 
Body cavities: NAD 
Gastrointestinal: NAD, hair masses in rectum from recently digested meal 
Respiratory: NAD 
Musculoskeletal: Urate tophi at each intervertebral space along spine 
Urogenital: Urate visible in ureters and collecting ducts. Spherical 1.5cm diameter mass in kidney 
Neurological: NAD 
Cardiovascular: Damage from cardiac puncture (1. last week for CBC & MBA and 2. euthanasia). This 
damage could obscure other path? 
Reticuloendothelial: ?Unfamiliar 
Endocrine: ?Unfamiliar 
Tentative Dx: Renal failure, "spinal gout" could explain lethargy. 
 
GROSS PATHOLOGY: 
Multiple tissues including skull and anterior spinal column. One of the soft tissues contains a 15 mm 
diameter spherical well circumscribed tumour composed of pale semi-firm tissue. 
 
HISTOPATHOLOGY: 
In the brain, particularly in the brainstem region and spinal cord, there are marked degenerative and 
mild  inflammatory  changes.  These  are  characterised  by  spongiosis,  neuronal  necrosis,  axonal 
swelling  and  infiltration  by  macrophages  containing  ceroid  pigment,  these  tending  to  be 
concentrated  in  perivascular  locations.  Many  residual  nerve  cells  have  intracytoplasmic 
accumulation  of  similar  pigment.  A  solitary  eosinophilic  intranuclear  inclusion  body  is  detected 
within  an  astrocyte.  The  kidney  has  fibroplasia  and  cystic  tubular  dilation  with  intraluminal 
accumulation of urates. There is moderate diffuse interstitial infiltration by lymphocytes, histiocytes, 
plasma cells and heterophils. The abdominal tumour is an encapsulated accumulation of degenerate 
adipocytes. Examination of oesophagus, intestine and trachea is non-contributory. 
 
DIAGNOSES: 
1: Demyelinating encephalomyelitis consistent with paramyxoviral (OPMV) infection 
2: Chronic nephritis 
3: Mesenteric lipoma 
 
COMMENTS: 
1: The demyelinating nature of the encephalomyelitis and the detection of a typical inclusion body 
indicate paramyxoviral (OPMV) infection. 
2: In keeping with the previous finding of a renal granuloma, there is an end-stage kidney related to 
a chronic inflammatory process. 
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Figure  3.4  Pathology  report  of  a  python  (species  unknown)  with  neurorespiratory  signs.  In-contact 
snakes had been similarly affected and this snake did not respond to a course of enrofloxacin (“baytril”) 
and amoxicillin-clavulanic acid (“clav”). The necropsy identifies congestion and oedema in the lungs. The 
histopathology is consistent with ferlaviral (ophidian paramyxovirus) infection. Other possibilities are 
considered to explain the neuropathology. Sections of particular interest have been highlighted in red. 
OPMV = ophidian paramyxovirus (ferlavirus). CNS = central nervous system. 
PATHOLOGY REPORT 2 
HISTORY: 
Neuro signs and breathing difficulty approx. 1 month. Was treated by another vet with baytril and clav – no improvements. 
Strongly suspect OPMV. Owner has lost other snakes with similar signs recently. 
 
NECROPSY: 
One python carcass, approx. 2.2m body length was submitted for necropsy. The python was in excellent body condition, with 
abundant abdominal fat stores and good muscling. Moderately-sized testes confirmed the sex as male. The gastrointestinal 
tract was largely empty apart from scant hair and brown mucus in the stomach and scant liquid brown faeces in the distal 
intestine. The liver was pale brown with a slight zonal pattern (likely incidental physiological lipidosis). The lungs were bright 
red and wet on section, suggestive of congestion and oedema. There were no other notable gross abnormalities. 
Comment: The cause of death is not apparent from gross necropsy, although many diseases in snakes, including bacterial 
septicaemia and viral diseases often leave few gross lesions. A wide range of tissues, including brain and spinal cord, will be 
examined histologically for microscopic evidence of disease. A range of tissues has been stored frozen in the event further 
testing (eg. culture) is deemed necessary based on the histological findings. 
 
HISTOPATHOLOGY: 
Tissues are well preserved, except the intestine, which is moderately autolysed. 
Brain  and  spinal  cord:  In  the  brain,  involving  mainly  the  midbrain  and  medulla  oblongata,  there  is  marked  irregular 
vacuolation of the white matter, progressing to cystic cavitation in the most severely affected foci. There is moderate gliosis 
throughout the affected white matter, as well as the adjacent grey matter. The gliosis is most pronounced in the vicinity of 
blood vessels. Rare parenchymal blood vessels exhibit mural fibrinoid change, and many vessels are surrounded by clear 
space and/or eosinophilic protein droplets (oedema). There are occasional phagocytes containing globular golden-brown 
pigment in the parenchyma, and a cluster of these cells in the vicinity of a small focus of haemorrhage near the meninges. 
There is moderate meningeal infiltration with lymphocytes and plasma cells. The spinal cord exhibits similar changes of 
vacuolation of white matter, with phagocytes occasionally present within vacuoles, and gliosis of both white and grey matter. 
Lung:  The  lung  is  diffusely  congested.  There  is  diffuse  mild  infundibular  mononuclear  cell  infiltration.  The  columnar 
epithelium lining the major airway is moderately infiltrated with lymphocytes and there are scattered necrotic cells within the 
epithelium. The trachea is more mildly similarly affected. 
Spleen:  The  spleen  is  large  and  contains  a  markedly  active  lymphoid  population  consisting  primarily  of  solid  sheets  of 
lymphoblasts intermingled with lesser amounts of small lymphocytes and tingible body macrophages. 
Thymus:  Several  thymic  lobes  are  appreciable.  Lobes  lack  a  corticomedullary  distinction  and  are  well  populated  with 
lymphocytes. 
Kidney: There is moderate generalised global glomerulosclerosis with mild periglomerular and interstitial fibrosis. 
Liver: There is moderate diffuse hepatocellular lipidosis and small clusters of macrophages containing pale brown pigment 
scattered throughout the parenchyma. 
Heart: There is mild lymphoplasmacytic infiltration of the epicardium and myocardium. 
There are no notable findings in the stomach, thyroid (inactive), testis (active), adrenal gland, pancreas or intestine. 
 
Comment: The brain lesion of moderate nonsuppurative meningoencephalitis with marked white matter vacuolation is most 
suggestive  of  viral  infection.  Ophidian  paramyxovirus  is  the  most  likely  agent,  with  inclusion  body  disease  of  boids  (a 
retrovirus) a less likely alternative, based on the lack of typical inclusions. Either of these viruses may cause primarily CNS 
lesions  and  both  are  accepted  as  likely  being  in  Australia,  although  confirmatory  diagnostics  are  not  currently  readily 
available. Another possible aetiology for this CNS lesion is organophosphate toxicity (the likelihood of this would need to be 
judged  in  view  of  the  history  of  possible  exposure).  Finally,  and  least  likely,  thiamine  or  vitamin  E  deficiencies  could 
conceivably cause these CNS lesions (“thiamine” deficiency is usually either associated with fish-eating species or addition of 
sulphur to the diet, while vitamin E deficiency is associated with feeding spoiled or overly fatty feed and would normally have 
steatitis  as  an  accompanying  lesion).  The  other  findings  in  this  snake  of  moderate  nonsuppurative  bronchointerstitial 
pneumonia, mild nonsuppurative myocarditis, and possibly even the lymphoid hyperplasia, are also somewhat suggestive of a 
viral aetiology. The renal lesions are likely incidental and age or diet related. 
 
DIAGNOSIS: 
Glomerulosclerosis, lymphoid hyperplasia, mild interstitial pneumonia, nonsuppurative meningoencephalitis 
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Figure 3.5 Two histopathology reports of pythons (species unknown) with histories of neurorespiratory 
disease. In both cases, a demyelinating neuropathy and interstitial pneumonia was reported. These 
changes  are  consistent  with  paramyxoviral  infection.  Sections  of  particular  interest  have  been 
highlighted in red. 
PATHOLOGY REPORT 3 
HISTOPATHOLOGY: 
Brainstem and spinal cord have spongiosis, dystrophic axons, apoptotic necrosis of oligodendroglia, 
loss of glial cells, astrocytosis, microgliosis, macrophages containing ceroid pigment and eosinophilic 
intracytoplasmic inclusion bodies in neurons and astrocytes. Ceroid pigment is focally evident in the 
neuropil and within oligodendroglial cytoplasm. 
The  lung  has  congestion  and  oedema  together  with  interstitial  lymphocytic  infiltration. 
There is abundant bile pigment in renal tubular epithelium. Glomeruli have membranous expansion 
of mesangial matrix. In the liver, hepatocytes have diffuse fatty change and cholestasis is manifested 
by accumulation of bile  in hepatocyte cytoplasm, in canaliculi and in aggregations of sinusoidal 
macrophages.  The  spleen  has  mild  lymphoid  depletion.  Examination  of  heart,  intestine,  and 
stomach, pancreas and ovary is non-contributory. 
DIAGNOSIS: 
Demyelinating encephalomyelitis consistent with paramyxoviral (OPMV) infection 
COMMENTS: 
The demyelinating character of the encephalomyelitis and the inclusion bodies indicate OPMV. The 
interstitial pneumonia, glomerulonephritis, cholestatic hepatopathy, bilirubin nephrosis and splenic 
lymphoid depletion are quite typical. 
PATHOLOGY REPORT 4 
HISTOPATHOLOGY: 
The sections examined were liver, lung, brain, kidney, testicle, larynx, pancreas, heart, stomach and 
abdominal fat. 
Brain: Capillaries in the brain are congested and many are distended with serum. The grey matter of 
the brain, especially the medulla, and the spinal cord shows spongiosis with numerous swollen axons 
and a patchy gliosis. There is also demyelination and spongiosis of the spinal cord white matter with 
scattered dye gesturing chambers containing macrophages. Neurones in the medullary area are 
surrounded  by  and  sometimes  contain  vacuoles.  Eosinophilic  intranuclear  inclusion  bodies  are 
numerous. 
Lung: The lung is congested with proliferation of alveolar sites and thickening of  septae, which 
contain scattered heterophils and mononuclear inflammatory cells. Hyaline membranes are present 
on the surface of some alveoli. One corpora amylacea was seen and there are scattered pigmented 
bearing macrophages in the interstitium. 
Larynx: There is a fibrotic and centrally calcified nodule in the soft tissue adjacent to the larynx. In 
the  surrounding  connective  tissue  there  is  a  diffuse  infiltration  by  mixed  inflammatory  cells 
principally heterophils and macrophages. There is also some haemorrhage. 
No significant lesions were seen in the other organs examined. 
DIAGNOSIS: 
Demyelination and neuropathy associated with intranuclear inclusions 
Mild interstitial pneumonia -- consistent with ophidian paramyxovirus infection of snakes. 
COMMENTS: 
The  changes  in  the  CNS  and  lung  are  typical  of  paramyxovirus  infection  in  snakes.  The  chronic 
inflammatory nodule adjacent to the larynx is likely and incidental and probably associated with an 
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3.3  Findings  Suggestive  of  Paramyxovirus  Infection  in 
Australian Snakes 
The findings that are suggestive of a paramyxovirus infection in Australian snakes are being 
distinguished  from  those that  are  consistent with  infection  on the  basis  that  a  suggestive 
finding  involves  agent-specific  testing.  Some  Australian  veterinarians  have  pursued  agent-
specific  testing  by  submitting  serum  samples  to  the  Texas  Veterinary  Medicine  Diagnostic 
Laboratory  (TVMDL)  for  the  detection  of  anti-ferlavirus  antibodies  by  haemagglutination 
inhibition  (HI),  while  in  other  cases,  unstained  fixed  sections  have  been  submitted  to  the 
University of Georgia for the detection of a segment of the ferlaviral genome using in situ 
hybridisation (ISH). The methods of both tests have been published: the HI methods used by 
the TVMDL fall under the heading “Laboratory 1” in the report by Allender et al. (2008) and the 
ISH methods are described by Sand et al. (2004).  
Haemagglutination Inhibition 
From 2007 to 2008, 65 snakes from four Australian zoological collections (details anonymous), 
in which outbreaks of neurorespiratory disease were occurring, were tested for antibodies 
against  a  western  diamondback  rattlesnake  (Crotalus  atrox)  strain  of  ferlavirus  by 
haemagglutination inhibition (HI) (unpublished data). The results are summarised in Table 3.1. 
Thirteen  snakes  (20%)  had  titres  that  were  less  than  16  and,  according  to  the  diagnostic 
laboratory, were deemed to be negative for prior exposure to ferlavirus. The remaining 52 
snakes (80%) had titres ranging from 16 to 256, indicating prior exposure to ferlavirus. The 
percentage  of  animals  that  were  positive  was  reasonably  consistent  between  collections: 
collection 1 = 8/10 = 80%; collection 2 = 27/33 = 82%; collection 3 = 11/15 = 73%; collection 4 = 
6/7 = 86%. 
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HI 
Titre 
Laboratory 
Interpretation of 
Titre 
Number of Snakes 
Total  Collection 
1 
Collection 
2 
Collection 
3 
Collection 
4 
<16  Negative  2  6  4  1  13 
16  Very weak positive – 
previous exposure / non-
specific 
1  5  1  2  9 
32  Weak positive – previous 
exposure / non-specific 
2  9  4  3  18 
64  Positive – recent / current 
exposure 
3  5  0  1  9 
128  Strong positive – recent / 
current exposure 
2  5  5  0  12 
256  Very strong positive – 
recent / current exposure 
0  3  1  0  4 
Total    10  33  15  7  65 
Table 3.1 Results of 65 serum samples from four Australian zoological collections that were sent to 
Texas  Veterinary  Medicine  Diagnostic  Laboratory  for  the  detection  of  anti-ferlaviral  antibodies  by 
haemagglutination inhibition (HI). No titre exceeded 256. 
 
On the surface, these results are significant for two reasons. Firstly, there are 52 (out of 65) 
serum samples that this laboratory defines as being positive for the presence of significant 
concentrations (HI titre ≥ 16) of anti-ferlaviral antibodies, and furthermore, four of these 52 
samples have titres of 256 (“very strong positives”). If the positive predictive value of this assay 
is acceptable, then this is strong evidence for the presence of ferlavirus in Australian snakes. 
Secondly, if ferlaviruses are endemic to Australia, at least one endemic strain is serologically 
related to the antigen used in the TVMDL assay. This could facilitate the local detection of anti-
ferlaviral antibodies in Australian snakes if this isolate was made available to an Australian 
diagnostic laboratory. 
 
However, there are at least two reasons to question the significance of these results. Firstly, 
there  are  no  published  reports  that  these  HI  titres  have  been  correlated  with  virus 
neutralisation (VN) titres or experimental infections: the former is believed to provide a more 
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offered by the University of Florida has been validated with animals that were experimentally 
infected (Jacobson et al., 1997). So although the methods of the Texan laboratory have been 
subjected  to  peer-review  (Allender  et  al.,  2008),  the  author  is  unaware  of  any  published 
reports about the validation of their assay. Secondly, samples from the 52 Australian snakes 
with  significant  concentrations  of  anti-ferlaviral  antibodies,  were  not  scrutinised  for  the 
presence of ferlavirus using methods such as  PCR or virus isolation. Detection of the virus 
itself  would  not  only  definitively  answer  the  question  of  whether  paramyxoviruses  are 
endemic to Australian snakes but would also provide support for the significance of antibody 
titres performed in the future. 
In situ Hybridisation 
In 2009, formalin-fixed paraffin-embedded samples from 18 Australian snakes from Collection 
4  (Table  3.1)  that  died  with  clinical  signs  and  histopathological  findings  consistent  with  a 
paramyxoviral infection, were sent to the University of Georgia for detection of ferlavirus using 
in  situ  hybridisation  (ISH)  (unpublished  data).  The  lung  of  a  coastal  taipan  (Oxyuranus 
scutellatus scutellatus) and the gall bladder of a green tree snake (Dendrelaphis punctulata) 
were  positive  while  all  other  tissues  were  negative.  In  the  publication  that  describes  the 
methodology of this assay (Sand et al., 2004), a collection of samples were tested by both ISH 
and polymerase chain reaction (PCR): from 14 samples, 11 were positive by both ISH and PCR, 
and three were negative by both ISH and PCR. This provides support that this assay may have a 
high positive predictive value. 
 
   75 | P a g e  
 
3.4  The Status of Paramyxovirus in Australian Snakes Based 
on the Results of Others 
From the balance of information that has been reviewed in this chapter it would seem likely 
that paramyxoviruses are present in at least some Australian snakes. Ferlaviruses have been 
isolated from at least one green tree python (Morelia viridis) (Allender et al., 2006) and at least 
one carpet python (Morelia spilota) (Ahne et al., 1999b). This demonstrates the susceptibility 
of at least two Australian snake species to ferlaviral infection. Additionally, ferlaviruses have 
been found in a range of elapids, pythons and colubrids (Ahne et al., 1999b). These three 
families represent the majority of snake species found in Australia (Wilson and Swan, 2003). So 
there  is  strong  evidence  supporting  the  susceptibility  of  Australian  snake  species  to 
paramyxoviruses. 
 
As described earlier, Australian snakes have displayed clinical signs that are consistent with a 
paramyxovirus infection, and more importantly, pathological examination of the tissues from 
these affected animals has also supported the diagnosis of this infection. Agent-specific testing 
for anti-ferlaviral antibodies (by HI) and for the detection of sections of the ferlaviral genome 
on formalin-fixed paraffin-embedded tissues (by ISH), have both provided results that were 
suggestive of ferlaviral infection. In contrast to these findings, paramyxoviruses have not been 
detected in Australian snake samples by virus isolation, electron microscopy or sequenced PCR 
amplicons. 
 
Positive  control  material  was  needed  for  the  investigations  presented  in  this  thesis  and 
without the isolation of a paramyxovirus in Australia, isolates from overseas needed to be 
imported. Prior to the importation of a ferlavirus, the appropriate permits from the Australian 
Quarantine and Inspection Services (AQIS) needed to be in place. Ferlavirus had not previously 
been imported into Australia and so AQIS sought advice from Biosecurity Australia (BA), a unit 
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peer-reviewed  publications  describing  the  detection  of  ferlavirus  in  an  endemic  Australian 
snake, ferlavirus was considered to be exotic to Australia. 
 
From this review of the results specific to paramyxovirus infections in Australian snakes, a 
series of questions remain unanswered. Are paramyxoviruses found in Australian snakes? If so, 
are  these  paramyxoviruses  from  the  ferlavirus  genus?  Will  the  overseas  diagnostic  tests 
provide reliable results for Australian samples? Are other viruses, either on their own, or in 
combination with paramyxoviruses, contributing to at least some of these clinical cases? These 
questions formed the basis for the aims of the project that were presented on page 1. 
 
The following chapters outline the formal investigations that were performed on Australian 
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Chapter 4 – Development and Validation of Methods 
In  this  chapter,  the  materials  and  methods  are  discussed.  Some  of  the  generic  methods 
presented were developed further to accommodate the specific needs of this project. Any 
experiments that were performed on positive control material to validate these methods are 
presented in this chapter but the analysis of samples is reported in subsequent chapters. 
4.1  Sample Collection 
Samples were received in the form of swabs, blood or tissue (Figure 4.1). For swabs, oral and 
cloacal swabs were collected. For each swab, veterinarians were instructed to use a sterile 
cotton-tipped applicator pre-moistened with viral transport medium (= cell culture medium = 
minimum  essential  Eagle’s  medium  with  Earle’s  salts  *MEM,  Sigma,  cat.  no.  M5650+ 
supplemented with 5% (v/v) fetal bovine serum [FBS, GIBCO, cat. no. 10100-147], enrofloxacin 
[25µg/mL using Baytril® 2.5% Oral Solution, Bayer], amphotericin B [5µg/mL, GIBCO, cat. no. 
15290-018], penicillin G/streptomycin [50IU/mL and 0.5mg/mL respectively, Sigma, cat. no. 
P4333-20ML]  and  L-glutamine  [2mM,  GIBCO,  cat. no.  25030-149+),  Hartmann’s  solution or 
0.9% (w/v) isotonic saline to swab the oral cavity or the cloaca. For oral swabs, veterinarians 
were asked to ensure that the glottis was swabbed and if possible, also the endotracheal 
surface. An ear, nose and throat (ENT) swab was sometimes used to swab the trachea of small 
snakes. Swabs were then placed into small sterile containers such as a 1.5mL Eppendorf tube. 
0.7mL plain blood collection tubes were more readily available to some veterinarians and so 
were occasionally used. The swab was then submerged in Hartmann’s solution, isotonic 0.9% 
(w/v) saline or viral transport medium. 
 
Some snakes were sampled with three swabs: a combined cloacal and oral swab, a cloacal-only 
swab, and an oral-only swab. For these snakes, the cloacal-only swab was a swab of the distal 
cloaca and the oral-only swab was of one side of the mouth. The third swab (combined oral 78 | P a g e  
 
and cloacal swab) was performed on the other side of the mouth and a slightly more proximal 
area (i.e. further away from the vent) of the cloaca. 
 
For blood, whole blood, plasma or serum was submitted. For whole blood, the blood was 
spotted on filter paper and submitted for elution of antibodies. For serum, whole blood was 
allowed to clot and then centrifuged to allow retrieval of the cell-free supernatant. For plasma, 
whole blood was anti-coagulated in lithium heparin and then centrifuged to allow retrieval of 
the cell-free supernatant. 
 
For tissue, samples from various organs were collected aseptically into labelled sterile tubes 
e.g. urine sample containers. 
 
Samples  were  then  sent  to  the  author  by  express  couriers  using  either  Australia  Post  or 
privately-owned courier companies (e.g. TNT, Logical Freight Solutions). Some samples were 
sent frozen using dry ice, others were submitted in Eskies with ice bricks and occasionally 
samples were submitted under ambient conditions. 79 | P a g e  
 
 
Figure 4.1 Various sampling materials. From left to right: 1 = Minimum essential medium used as viral 
transport medium after supplementation with L-glutamine, foetal bovine serum and antimicrobials. 2 = 
formalin-fixed paraffin-embedded (FFPE) tissues. 3 = 1.5mL Eppendorf tube containing a rolled up 6µm 
section of the FFPE tissues. 4 = Ear, nose and throat (ENT) swab. Note the finer tip (compared to the 
cotton-tipped applicator [9]). 5 = 100mL bag of 0.9% (w/v) isotonic saline.  6 = small (1.3mL) blood 
collection  tube.  7  =  Packaging  cylinders  to  transport  the  sample(s).  The  closed  cylinder  shows  the 
International  Air  Transport  Association  (IATA)  packaging  label  for  biological  substances,  category  B 
(UN3373). The open cylinder shows the three layers of packaging. 8 = Urine sample container (70mL) 
sometimes  used  for  submitting  FFPE  sections  and  fresh  tissue  samples.  9  =  Sterile  cotton-tipped 
applicator used for swab collection. 
 
4.2  Virus Isolation and Propagation 
Cell culture was used to propagate viruses from viral stocks and to isolate viruses from primary 
samples. The allantoic cavities of embryonated chicken eggs were only used to propagate virus 
stocks. 
4.2.1 Cell culture 
For virus isolation, a number of methods were trialled but ultimately the methods described by 
Origgi and Pare (2007) were adapted for use as it was found that they provided the best 
balance between ease, speed and risk of contamination. Swabs and organ samples were used 
1
2
3
4
5
6
7
8
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for virus isolation. Oral and cloacal swabs were submitted in Hartmann’s solution, isotonic 
saline or viral transport medium (= cell culture medium). Each swab was vigorously vortexed in 
its media, the swab was removed and the media was then clarified (2,000g for 10 minutes at 
4
0C). The supernatant was collected and in some cases was then passed through a 0.45µm 
syringe-tip  filter  (Millipore,  Massachusetts)  to  remove  contaminating  bacterial  and  fungal 
elements. This supernatant was then ready to be pipetted onto cultured cells. 
 
Organ samples were collected from animals aseptically. The surface of the skin was cleaned 
with 70% (v/v) alcohol and the skin was incised using sterile instruments (e.g. forceps, scissors 
and/or scalpel blade). The instruments were then cleaned with 70% alcohol, dried with a paper 
towel and then flamed with a Bunsen burner. The coelomic cavity was then penetrated using 
these re-sterilised instruments. The instruments were sterilised again and used to retrieve the 
required organ samples. Organ samples (approximately 1cm
3) were individually placed into 
2mL aliquots of virus isolation media (minimum essential Eagle’s medium with Earle’s salts 
[MEM, Sigma, cat. no. M5650] supplemented with 5% (v/v) foetal bovine serum [FBS, GIBCO, 
cat. no. 10100-147], 2x enrofloxacin [25µg/mL using Baytril® 2.5% Oral Solution, Bayer], 2x 
amphotericin B [5µg/mL, GIBCO, cat. no. 15290-018], 5x penicillin G/streptomycin [50IU/mL 
and 0.5mg/mL respectively, Sigma, cat. no. P4333-20ML] and 1x L-glutamine [2mM, GIBCO, 
cat.  no.  25030-149]).  Samples  were  then  aseptically  and  finely  diced  using  sterile  scissors 
(Figure 4.2), vigorously vortexed and clarified (2,000g for 10 minutes at 4
oC). The supernatant 
was then ready to be pipetted onto cultured cells. 
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Figure 4.2 Left: A sample of lung being diced with sterile scissors in a petri dish. Right: A diced sample of 
organ in virus isolation media prior to clarification. 
 
Viper heart cells (VH2, ATCC CCL-140) (Figure 4.3), or rarely Vero cells (ATCC CCL-81) (Figure 
4.4), were grown in either 25cm
2 flasks or 6-well plates (9.6cm
2/well) at 30
0C and 5% CO2 using 
cell  culture  maintenance  media  (MEM  supplemented  with  5%  FBS,  1x  enrofloxacin 
[12.5µg/mL],  1x  amphotericin  B  [2.5µg/mL]  and  1x  L-glutamine  [2mM]).  At  80%-100% 
confluency,  the  culture  medium  was  removed,  the  cells  were  rinsed  with  1x  phosphate-
buffered saline (PBS, 130mM NaCl, 7mM KH2PO4, 3mM Na2HPO4.2H2O, pH 7.4) and 1mL (for 
25cm
2  flasks)  or  0.75mL  (for  9.6cm
2  wells)  of  the  clarified  supernatant  from  the  tissue 
suspension or swab, was added to the cells. Flasks and plates were left to incubate at room 
temperature for one hour. After the supernatant had been removed, the cells were rinsed 
several times with 1x PBS and then 5mL (for 25cm
2 flasks) or 3mL (for 9.6cm
2 wells) of virus 
isolation media was added. Flasks and wells were observed daily for cytopathic effects (CPE) 
using a polarising inverted microscope. Seven days after inoculation, flasks and wells were 
frozen and then left to thaw at room temperature. Media were clarified as above and a 0.75mL 
aliquot of supernatant was then used to replace the maintenance media of 75%-80% confluent 
cells growing in 6-well plates. Wells were left at room temperature for one hour and then 
2.5mL of maintenance media was then added to the 0.75mL of media in each well. For some 
virus isolation attempts, this freeze-thawing passage was repeated once more. 
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Two strains of ferlavirus, Fer-de-Lance virus (FDLV, ATCC VR-895) (Figure 4.3) and neotropical 
ophidian paramyxovirus  (ATCC VR-1408)
3 (Figure 4.4), served as positive controls for virus 
isolation and propagation experiments.  
                                                           
3 These two viruses  were imported from the  American  Type Culture  Collection (ATCC) through the 
ATCC’s exclusive Australian distributor, Cryosite. Cryosite arranged the permits necessary to allow the 
importation of these viruses into Australia. 83 | P a g e  
 
 
 
Figure 4.3 Uninfected Viper Heart cells (VH2) (above) and VH2 cells infected with Fer-de-Lance virus 
(bottom). Characteristic cytopathic effects (CPE) of ferlavirus can be seen as syncytial cell formation (red 
arrow pointing to cluster of nuclei in the centre of a syncytial cell) and detachment of the monolayer 
(blue arrow pointing to area of flask where cells were once attached). 84 | P a g e  
 
 
 
Figure  4.4  Uninfected  Vero  cells  (above)  and  Vero  cells  infected  with  neotropical  ophidian 
paramyxovirus  (bottom).  Characteristic  cytopathic  effects  (CPE)  of  ferlavirus  can  be  seen  as  small 
syncytial cell formation (two examples are outlined in red). 85 | P a g e  
 
Viral titre was determined using the Reed-Muench method as described by Mahy and Kangro 
(1996). Briefly, quintuplicate samples were added to host cells that had been grown in 96-well 
microtitre plates. Samples were usually added to cells in ten-fold serial dilutions but for viruses 
with  low  titres,  the  experiment  was  performed  using  three-fold  dilutions  to  improve  the 
resolution  of  the  assay  (Figure  4.5).  The  mathematically-derived  dilution  that  produced 
observable cytopathic effects (CPE) in fifty percent of wells was then recorded. The inverse of 
this dilution was then expressed per millilitre to produce the tissue culture infectious dose 
(TCID50).  Viral  concentration  was  also  estimated  by  the  haemagglutination  titre  of  the 
supernatant of infected culture flasks (Figure 4.6). 
 
 
Figure 4.5 Typical layout of 96-well plate for viral titre determination of both high-titre (left) and low-
titre (right) viruses. 
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Figure 4.6 The increasing haemagglutination titres of ferlavirus seen during incubation in cell culture. 
 
In addition to the methods described so far, the use of Ten Broeck (named after Thomas Ten 
Broeck)  tissue  grinders  to  make  tissue  suspensions  suitable  for  virus  isolation,  and  the 
establishment of a primary reptilian cell line to isolate viruses into, were also investigated. 
 
Ten  Broeck  tissue  grinders  have  successfully  been  used  by  others  for  the  isolation  of 
ferlaviruses from organ samples (Jacobson et al., 1980b; Jacobson et al., 1981; Jacobson et al., 
1992). They were not used routinely in this study for three main reasons: the adherence of 
tissue to the glass surfaces made it difficult to separate supernatant from tissue, they were 
messy and therefore more likely to attract contamination and, for lung tissues, would only 
compress the organ sample without macerating it (Figure 4.7). 
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Figure 4.7 A Ten Broeck tissue grinder showing a sample of lung adhering to the glass surfaces and 
almost overflowing out of the grinder. 
 
At  the  beginning  of  these  studies,  Vero  cells  were  available  for  virus  isolation  but  the 
successful isolation of reptilian paramyxoviruses using this mammalian cell line is limited to 
only two reports (Potgieter et al., 1987; Nogueira et al., 2002). A reptilian cell line would 
expand the number of substrates available to this project for virus isolation (see section 2.3.1 
– Virus Isolation, particularly Table 2.7, for a review of this subject). Although an established 
reptilian cell line (VH2) was eventually imported from the European Collection of Cell Cultures 
(ECACC, Cat. No. 90102539)
4, prior to this, attempts were made to establish a primary cell line 
of reptilian origin. A reptilian cell line that could be quickly developed in-house would avoid the 
considerable expense to import a cell line from Europe that required a CITES (Convention on 
International Trade in Endangered Species) permit. To establish a primary reptilian cell line, 
the explant method described by Clark et al. (1967; 1970; 1973) was used, which has produced 
three important cell lines: terrapene heart cells (TH-1, ATCC-CCL 50), viper heart cells (VH2, 
                                                           
4 This cell line  was  imported through the commercial  company Sigma. Sigma arranged the permits 
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ATCC CCL-140) and iguana heart cells (IgH2, ATCC-CCL 108). A large number of reptilian viruses 
have been isolated using these three reptilian cell lines (Jacobson, 2007). 
 
Briefly, organs were salvaged from reptiles that had been euthanased at a veterinary hospital 
or  from  reptiles  that  had  died  recently  due  to  road  trauma.  Animals  that  had  displayed 
antemortem neurorespiratory signs were excluded. Two main considerations dictated what 
organs would be retrieved from these animals. Firstly, this project would involve the analysis 
of samples that had been obtained from snakes that died with neurorespiratory disease, so 
samples of lung and brain were collected. Secondly, TH-1, VH2 and IgH2 are all from heart 
explants and so the heart became the third priority sample. Figure 4.8 outlines the series of 
steps to establish a primary reptilian cell line. Organ samples were recovered aseptically, using 
the methods described previously for virus isolation. Organs were then cut into small pieces 
(approximately 1-3mm
3) and explanted into 25cm
2 tissue culture flasks. A small amount of cell 
culture media (1mL) was added and the explants were incubated at 30
0C and 5% CO2. Flasks 
were examined daily and, one to three days later, an additional 1mL of media was added being 
careful  not  to  dislodge  the  explants.  This  process was  repeated  until  the  total  volume  of 
culture media was 5mL. 89 | P a g e  
 
 
Figure 4.8 Establishment of a primary cell line using an explant method. The organ (heart) is collected 
aseptically, minced, suspended in a small volume of cell culture media and then seeded into a culture 
flask.90 | P a g e  
 
In most cases, explants adhered to the culture flask but often cells did not propagate from the 
explants. Only in a few cases was significant cell growth seen and only in one case, a lung 
explant from a tiger snake (Notechis scutatus) (Figure 4.9), did the monolayer reach confluency 
(Figure 4.10). But even these cells could not be passaged. The cells remained adhered despite 
exposure to trypsin and so a cell scraper was used to dislodge the cells from the culture flask. 
Only a small percentage of these dislodged cells adhered to a new culture flask and after two 
weeks, the cell population had remained relatively unchanged. After several months and many 
attempts, the decision was made to abandon the goal of establishing a primary reptilian cell 
line. Instead, a reptilian cell line (VH2) was imported from overseas. 91 | P a g e  
 
 
 
Figure 4.9 Attempt to establish a primary reptilian cell line using a sample of lung from a tiger snake 
(Notechis  scutatus).  Eight  days  after  explantation.  Top:  Cells  can  be  seen  propagating  around  the 
explant. Scale bar represents 1mm. Bottom: Cell morphology eight days after explantation. Scale bar 
represents 100µm. 92 | P a g e  
 
 
Figure 4.10 Attempt to establish a primary reptilian cell line using a sample of lung from a tiger snake 
(Notechis scutatus). 14 days after explantation. The flask has reached confluency. These cells could not 
be passaged. Scale bar represents 1mm. 
 
4.2.2 Embryonated chicken eggs 
Cell culture has been the main substrate used for the isolation of reptilian paramyxoviruses 
(Table  2.7).  Only  two  reports  describe  attempts  to  isolate  reptilian  paramyxoviruses  into 
embryonated vertebrate eggs. Clark et al. (1979) successfully isolated Fer-de-Lance virus using 
embryonated snake eggs and Manvell  et al. (2000) was unable to isolate a ferlavirus into 
embryonated chicken eggs. In the studies presented in this thesis, embryonated chicken eggs 
were used mainly for the propagation of viruses that were already established in cell culture. 
The positive control ferlaviruses, neotropical ophidian paramyxovirus (ATCC VR-1408) and Fer-
de-Lance virus (FDLV, ATCC VR-895), were propagated after they had been adapted to this new 
substrate. 
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8- to 12-day-old specific pathogen free (SPF) embryonated chicken eggs were kindly donated 
by the Department of Agriculture and Food Western Australia (DAFWA). The relevant anatomy 
of an embryonated chicken egg is illustrated in Figure 4.11. The series of steps involved in 
propagating  viruses  in  embryonated  chicken  eggs  are  depicted  in  Figure  4.12.  Eggs  were 
candled to ensure the embryo was viable. This was defined by a rich supply of blood vessels 
(Figure 4.12) or movement of the embryo. The surface of an egg was then sprayed with 70% 
(v/v) ethanol, which was left to evaporate. Next, an engraver weakened a point on the surface 
of the egg that was approximately 30 degrees from the top of the egg. Using a 23G 1½ inch 
needle attached to a 1mL syringe, a 0.2mL aliquot of virus stock was inoculated into each 
allantoic cavity by inserting the needle through the weakened area of the egg to a depth of 
about 25mm. A small amount of air trailed the inoculum to accommodate for the needle’s 
dead space. Molten candle wax was used to seal the hole in the egg. Eggs were then left to 
incubate at virus permissive temperature (30
0C). After incubation (3-7 days), any surviving 
embryos were euthanased by placing the eggs into a refrigerator for several hours. The surface 
of an egg was then sprayed with 70% alcohol and sterile scissors were used to aseptically 
dissect away the top of the egg to expose its contents. The egg was tilted slightly and a 1mL 
pipette tip was used to move the embryo against gravity to allow the allantoic fluid to pool on 
one side of the egg. A second 1mL pipette tip was used to collect the allantoic fluid being 
careful not  to break the yolk sac. Approximately 3-9mL was obtained from each egg. The 
allantoic fluid was clarified (2,000g for 10 minutes at 4
0C) to remove organic debris and then 
haemagglutination  assays  were  used  (section  4.3  -  Haemagglutination)  to  quantify  the 
amount of virus. 
 
It  was  found  that  cell  culture-adapted  ferlaviruses  required  at  least  one  passage  in 
embryonated chicken eggs before significant increases in viral concentration were seen and 
inoculating  the  allantoic  cavity  with  0.2mL  of  virus  stock  seemed  to  produce  higher 
concentrations of virus than inoculums of 1mL or 0.5mL (Figure 4.13). However, the variation 94 | P a g e  
 
in virus concentration between the allantoic cavities of different embryonated chicken eggs 
that had been inoculated with the same amount of virus, showed a variation that was larger 
than the difference between the various inoculum volumes (Figure 4.14). 
 
 
Figure 4.11 Anatomy of a 10-day-old embryonated chicken egg showing the embryo, the air sac and the 
extra-embryonic membranes (1998). 
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Figure 4.12 Using embryonated specific pathogen free (SPF) chicken eggs to propagate ferlaviruses. The 
egg is candled to assess the viability of the embryo. The air sac can be seen at the top of the egg (green 
arrow). An engraver is used to weaken an area of the egg. Virus stock is injected into the allantoic space. 
Molten candle wax is used to seal the plug (red arrows) before eggs are left to incubate at a viral 
permissive temperature. After incubation, the top of the egg is removed to gain access to the allantoic 
fluid. The yolk sac is still prominent (purple arrow). 96 | P a g e  
 
 
 
Figure  4.13  Haemagglutination  titres  of  ferlavirus  after  incubation  in  embryonated  chicken  eggs. 
Significant  haemagglutination  activity  cannot  be  detected  in  any  of  four  eggs  inoculated  with  cell 
culture-adapted ferlavirus after five days of incubation (above). The allantoic fluid from all four eggs was 
collected  and  pooled  and  then  three  different  volumes  were  inoculated  into  four  more  eggs.  The 
relationship between haemagglutination titre and the volume that is inoculated into the allantoic cavity 
of embryonated chicken eggs was recorded (bottom).  
 
 
Figure 4.14 Haemagglutination titres of two strains of ferlavirus (neotropical ophidian paramyxovirus 
and Fer-de-Lance virus) grown in the allantoic cavities of six embryonated chicken eggs. The aliquots of 
each strain of virus that were inoculated into each egg were identical. 
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4.3  Haemagglutination Activity 
Haemagglutination assays were performed on various sample types, each sample needing to 
be processed by a specific method (Figure 4.15). Oral and cloacal swabs were submitted in 
Hartmann’s solution, isotonic saline or viral transport medium (= cell culture medium). Swabs 
were vigorously vortexed in their media before aliquots were collected. To test cell culture 
flasks, either an aliquot of supernatant was taken without any further processing or the entire 
flask was frozen and then left to thaw at room temperature. If the latter, the thawed contents 
of the flask were clarified at 2,000g for ten minutes at 4
0C to pellet cellular debris. Aliquots of 
this clarified medium were then collected. Prior to the haemagglutination assay, the clarified 
contents of some frozen-and-thawed flasks were concentrated by either polyethylene glycol 
(PEG) precipitation or ultracentrifugation. 
 
For PEG precipitation, 10mL of clarified supernatant was made up to 100mL using phosphate 
buffered  saline  (PBS).  Sodium  chloride  (NaCl)  and  PEG  (MW  ~6,000)  were  added  to  final 
concentrations of 2.2% (w/v) and 6% (w/v) respectively and the solution stirred continuously 
with magnetic stirrers for two hours at 4
0C. The solution was then clarified at 2,000g for 20 
minutes at 4
0C. Supernatant was removed to reduce the volume by a factor of 100. Sodium 
acetate (50mM, pH 4.8) was then added to create a volume of 10.4mL. The solution was 
stirred again for 1 hour at 4
0C and then clarified as before. This time, the supernatant was 
retained and the pellet was discarded. The supernatant was then poured onto a frozen 2.6mL 
20% (w/v, dissolved in water) sucrose cushion in a 16mm x 76mm Beckman® Ultra-Clear tube 
and then ultracentrifuged at 148,000g for two hours at 4
0C. Supernatant was discarded and 
the pellet was resuspended in 100µL of PBS. 98 | P a g e  
 
 
Figure 4.15 Processing various sample types for use in a haemagglutination assay. Left: Swab tips in 
saline (left) or viral transport medium/cell culture medium (right). Right: Cell culture supernatant and 
cell lysate. 
 
Whole blood was prepared for use in a haemagglutination assay using the methods reported 
by Raidal et al. (1993). Whole blood was collected from the jugular vein of either a guinea pig 
or a chicken and then mixed with an equal volume of Alsever’s solution (0.42% [w/v] sodium 
chloride,  2.05%  [w/v]  glucose,  0.8%  [w/v]  trisodium  citrate,  0.055%  [w/v]  citric  acid 
monohydrate, pH 7.4). Alsever’s solution is both an anticoagulant and a blood preservative. 
Erythrocytes  were  then  carefully  washed.  The whole  blood-Alsever’s  solution  mixture  was 
centrifuged at 300g for 10 minutes at 4
0C, the supernatant was discarded and the erythrocyte 
pellet was then resuspended in phosphate-buffered saline (PBS). This process was repeated 
until the supernatant was clear. Pelleted erythrocytes were then added to PBS to create a 
working solution with a concentration of 0.5% (v/v) e.g. 65µL of erythrocytes to 13mL of PBS. 
 
With the samples processed and the erythrocytes prepared, the haemagglutination assay was 
then  set  up  (Raidal  et  al.,  1993).  Samples  and  positive  and  negative  controls  were  each 
assigned to a row of a 96-well microtitre plate (Figure 4.16). Next, 50µL of PBS was added to all 
the wells in each row. 50µL of processed sample, or control, was then added to the well in the 
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first column and mixed with the 50µL of PBS already there. 50µL of the 100µL in this first well 
was then mixed with the 50µL of PBS in the second well. This was repeated for each well in the 
row creating doubling dilutions of the sample from the first well (1:2) to the twelfth well 
(1:4,096). The 50µL of surplus from the twelfth well was discarded. 50µL of washed chicken or 
guinea pig erythrocytes (0.5% v/v in PBS) were then added. The plate was then left to incubate 
for  approximately  one  to  three  hours,  at  either  room  temperature  or  4
0C,  to  allow  the 
erythrocytes to settle at the bottom of the well. Haemagglutination titres were read as the 
reciprocals of the greatest dilutions that resulted in complete haemagglutination (Figure 4.16). 
Two strains of ferlavirus, Fer-de-Lance virus (FDLV, ATCC VR-895) and neotropical ophidian 
paramyxovirus  (nOPMV,  ATCC  VR-1408),  served  as positive  controls  for  haemagglutination 
assays  (Figure  4.16)  and  for  PEG-precipitation  experiments  (Figure  4.17).  Prior  to  the 
importation of ferlavirus, attenuated human influenza virus was used as a positive control for 
haemagglutination assays. 
 
Figure 4.16 The first three rows of a microtitre plate showing a typical layout of positive and negative 
controls for a haemagglutination assay. 
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Figure 4.17 Concentration of positive control ferlavirus by polyethylene-glycol precipitation (PEG-P). Fer-
de-Lance virus (FDLV) and neotropical ophidian paramyxovirus (nOPMV) were used as controls. Negative 
control was performed on a second plate and performed as expected. 
 
4.4  Haemadsorption 
Haemadsorption was assessed using the methods outlined by Mahy and Kangro (1996). Briefly, 
culture media was removed from a flask and the cell monolayer was rinsed with PBS. Chicken 
or  guinea  pig  erythrocytes  0.5%  (v/v  in  PBS)  were  then  added  to  the  flasks  to  cover  the 
monolayer. Flasks were then left to incubate at room temperature for 30 minutes and then 
carefully examined while gently agitating the flask to look for firmly attached erythrocytes. 
Unattached erythrocytes were decanted and the monolayer examined again during gentle 
agitation.  Finally,  the  monolayer  was  gently  rinsed  with  PBS  and  examined  once  more. 
Uninfected viper heart cells (VH2) and VH2 cells infected with ferlavirus served as negative and 
positive controls respectively for this assay. 
4.5  Haemagglutination Inhibition 
Testing for anti-ferlavirus antibodies was performed using haemagglutination inhibition (HI). 
Samples were submitted as plasma, serum or as whole blood dried onto a disc of filter paper (= 
dried  blood  spots  =  DBS)  (Whatman  number  3  filter  paper,  Whatman  International  Ltd., 
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Maidstone, England). For plasma or serum, the methods reported by Jacobson et al. (1992) 
were followed. Some “serum” samples that had been submitted frozen and then allowed to 
thaw contained variable amounts of haemolysis (Figure 4.18) and fibrin clots (Figure 4.19) due 
to incomplete clotting followed by inadequate separation of the supernatant from the cellular 
pellet.  For  these  samples,  the  “serum”  was  centrifuged  at  580g  for  10  minutes  at  room 
temperature to pellet cellular debris, and a wooden applicator was used to remove any clots 
from the sample. 
 
300µL aliquots of serum or plasma were then heated at 56
0C for 30 minutes to inactivate heat-
labile  non-specific  inhibitors  of  haemagglutination.  Non-specific  haemagglutinators  were 
removed  by  haemadsorbing  the  serum  aliquots to  10µL  of  pelleted  chicken  or  guinea  pig 
erythrocytes during an overnight incubation at 4
oC (Figure 4.20). 
 
Figure 4.18 Frozen-thawed samples submitted as “serum” containing decreasing amounts of haemolysis 
from left to right. Good quality erythrocyte-free sample on far right.  102 | P a g e  
 
 
Figure 4.19 Blood clots (blue arrow) and haemolysis-free fibrin clots (green arrow) that were removed 
from “serum” samples. 
 
 
Figure 4.20 Haemadsorbing serum samples to remove non-specific haemagglutinators. Normal settling 
of erythrocytes in a sample free of haemagglutinators (left) contrasted to a haemagglutinated sample, 
rich in haemagglutinators (right). 103 | P a g e  
 
As  for  the  haemagglutination  assay  mentioned  earlier,  rows  were  assigned  to  controls  or 
samples, and then 50µL of PBS was added to each well. Processed serum (or plasma) was then 
added to the first well and then pipetted across the row to create two-fold dilutions (1:2 to 
1:4,096 [for 12 columns] or 1:256 [for 8 columns]). 50µL (titrated to 4-8 haemagglutination 
units) aliquots of neotropical ophidian paramyxovirus (ATCC VR-1408) were then added to 
each  well.  Next,  the  mixture  of  serum/plasma  and  virus  was  left  for  one  hour  at  room 
temperature. Inhibition of viral haemagglutination was measured by the addition of 50µL of 
0.5% (v/v) chicken erythrocytes to each well. HI titres were read as the greatest dilution that 
completely  inhibited  haemagglutination  (Figure  4.21).  PBS  was  used  as  a  negative 
serum/plasma control and serum from a western diamondback rattlesnake (Crotalus atrox) 
with  an  HI  titre  of  >256  /  50µL,  kindly  donated  by  Dr  Rachel  Marschang  (University  of 
Hohenheim, Germany), served as a positive control. 
 
Figure 4.21 Controls for a haemagglutination inhibition assay. Top row: Positive control consisting of 
serum from a western diamondback rattlesnake (Crotalus atrox) with previous exposure to ferlavirus. HI 
titre  =  16/50µL.  Middle  row:  Two-fold  serial  dilutions  of  virus  (neotropical  ophidian  paramyxovirus 
[ATCC VR-1408]) to determine the number of haemagglutinating units in each 50µL aliquot. HA titre = 
4/50µL. Bottom row: PBS negative control. HI titre <2/50µL. 
 
4.5.1 Eluting Anti-ferlaviral Antibodies from Filter Paper 
For  dried  blood  spots  (DBS),  a  short  experiment  was  designed  to  compare  four  different 
methods of antibody elution. A standard hole-punch was used to obtain a sample from each 
disc of filter paper (Figure 4.22). 400µL from two positive control serum samples (HI titres of 
>256 / 50µL) was added to two 38.5cm
2 discs of filter paper (keeping each serum sample 
separate). For the first elution method, a hole punch of filter paper from each positive control 
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sample was added to the first eluant (0.3% [v/v] Tween 20, 0.1% [w/v] sodium azide dissolved 
in phosphate-buffered saline [PBS]) and then sonicated in a water bath (Ultrasonicator FX-10, 
Unisonics, Sydney) for 15 minutes (Jafri et al., 1998). For method two, hole punch samples 
were left overnight at 4
0C in the second eluant (5% [w/v] skim milk powder and 5% [v/v] 
Tween 20 dissolved in water) (Helfand et al., 2001). For method three, hole punch samples 
were added to the third eluant (0.05% [v/v] Tween 20, 1% [w/v] bovine serum albumin [BSA], 
0.5% [w/v] gelatin dissolved in [PBS]) and mixed in a Thermomixer (Eppendorf Asia-Pacific) at 
1,200rpm for two hours at room temperature before the eluant was passed through a 0.45µm 
filter (Yu et al., 2007). For the last method, hole punch samples were added to PBS and left at 
4
0C overnight. 
 
Figure 4.22 Whole blood from a diamond python (Morelia spilota spilota) dried onto a disc of Whatman 
filter paper. A hole punch is used to obtain a sample of blood from the filter paper. Ruler = 1cm major 
increments and 1mm minor increments. 
 
Each eluted sample was then tested for anti-ferlaviral antibodies using both guinea pig and 
chicken  erythrocytes  as  described  above  (Figure  4.23).  The  second  and  third  methods 
appeared to perform better than a simple elution into PBS (the fourth method) but overall, 
only small differences were seen between the four different elution methods. 105 | P a g e  
 
 
Figure  4.23  Comparison  of  four  methods  to  elute  anti-ferlaviral  antibodies  from  filter  paper.  Each 
method was tested using two different positive controls and two different erythrocytes (RBCs) (chicken 
and  guinea  pig).  Haemagglutination  inhibition  (HI)  titres  were  recorded  one  hour  after  adding  the 
erythrocytes to each well but photos were taken several hours later. As such, it is difficult to determine 
the HI titre in some rows from this image and so angled double yellow lines have been added after the 
well that showed complete inhibition of haemagglutination. Two double lines are used when it was 
difficult to determine the titre. 
 
This short experiment provides evidence that at least four methods are able to elute anti-
ferlaviral antibodies from snake serum that had previously been dried onto filter paper, but it 
does not show the number of anti-ferlaviral antibodies that were eluted as a percentage of 
those that there dried onto the filter paper. This “elution efficiency” should be investigated in 
future studies. In a study by Helfand et al. (2001), it was shown that there was concordance in 
the titres of anti-measles virus antibodies that were eluted off filter paper compared to those 
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in  serum.  Similarly,  Jafri  et  al.  (1998)  showed  there  was  no  significant  decrease  in  the 
sensitivity of dried blood spot samples compared to serum samples during a serosurvey of 
cysticercosis. Drying whole blood onto filter paper allows these samples to be transported and 
stored under conditions that are less stringent than those needed for serum samples (McDade 
et al., 2007). Only a small amount of whole blood is needed to create a dried blood spot that 
can be tested for the presence of antibodies and this will benefit reptile studies where animals 
can be small and/or difficult to collect larger volumes of blood from. So utilising dried blood 
spots for reptilian serodiagnostics could prove worthwhile. 
4.5.2 Concentrating Anti-ferlaviral Antibodies by Ultrafiltration 
In  another  short  experiment,  the  ability  to  concentrate  anti-ferlaviral  antibodies  by 
ultrafiltration was tested. Ultrafiltration is used to concentrate macromolecules in solutions by 
filtering and retaining molecules above a certain nominal molecular weight limit (NMWL e.g. 
50,000  Daltons  [Da])  using  centrifugation.  The  flow-through  is  discarded  and  the  retained 
molecules are then extracted by inverting the filter prior to a second centrifugation. In this 
experiment,  positive  control  serum  (known  to  contain  anti-ferlaviral  antibodies)  was 
concentrated using a YM-100 Microcon ultrafilter (Millipore, Massachusetts, NMWL = 100kDa). 
In snakes, a low-molecular-weight immunoglobulin (Ig) with a sedimentation coefficient of 7-9 
svedbergs (S) is likely to be equivalent to avian IgY and mammalian IgG and a high-molecular-
weight immunoglobulin (19.6-20.5S) is likely to be equivalent to mammalian and avian IgM 
(Origgi, 2007). Avian IgY and mammalian IgG have molecular masses of approximately 180kDa 
(Origgi,  2007;  Tizzard,  2009)  and  avian  and  mammalian  IgM  have  molecular  masses  of 
approximately 900kDa  (Tizzard, 2009). This means that the 100kDa NMWL of the  YM-100 
Microcon ultrafilter would be likely to retain the snake equivalents of IgG and IgM. 
 
Two 500µL aliquots of positive control serum were placed on top of two YM-100 Microcon 
ultrafilters which were then placed into microcentrifuge tubes and centrifuged at 14,000g for 
12 minutes at room temperature. The pass-through that collected in the microcentrifuge tube 107 | P a g e  
 
was kept. The ultrafilters were then inverted and placed into new microcentrifuge tubes to 
collect  the  eluate.  The  volumes  of  the  eluants  were  then  adjusted  to  create  two 
concentrations: 16-fold and 22-fold. These two concentrated samples, along with the pass-
through were then tested for the presence of anti-ferlaviral antibodies by haemagglutination 
inhibition (HI) as described earlier (Figure 4.24). 
 
Figure 4.24 Detection of anti-ferlaviral antibodies by haemagglutination inhibition after concentration 
using ultrafiltration. Positive control material was concentrated by factors of ~16 and ~22. The flow-
through was also tested to ensure that no antibodies could be detected by this assay. 
 
This  short  experiment  showed  that  anti-ferlaviral  antibodies  could  be  concentrated  using 
ultrafiltration.  By  utilising  this  method,  lower  quantities  of  anti-ferlaviral  antibodies  could 
become detectable in an HI assay. 
4.5.3 Unusual Clumping of Erythrocytes 
Unusual  clumping  of  red  cells  was  seen  in  some  haemagglutination  (HA)  and 
haemagglutination inhibition (HI) assays (Figure 4.25). To try and determine the cause, several 
of the steps of an HI assay were investigated (Table 4.1). 
Positive control:
unconcentrated
Positive control:
~16x concentration
2 4 8 16 32 64 128 256 512 1,024 2,048 4,096
HI titre
(/50µL)
16
256
512 Positive control:
~22x concentration
Flow-through
Negative control:
PBS
<2
<2108 | P a g e  
 
 
Figure 4.25 Haemagglutination inhibition (HI) assay showing unusual clumping of erythrocytes. * An HI 
positive control was not yet available at this time. 
 
Only one of the methods in Table 4.1 reduced the incidence of abnormal erythrocyte clumping 
(data not shown). April Childress from the University of Florida (the largest reptilian diagnostic 
laboratory in America) made the suggestion that the working suspension of erythrocytes (0.5% 
v/v) should be vortexed prior to use. This small modification to the procedure provided far 
more reliable results (Figure 4.26). 
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Haemagglutination Inhibition Assay 
Erythrocyte Processing 
  Adding 0.1% (w/v) bovine serum albumin (BSA) to the PBS that is used as a diluent for the 
erythrocytes. This is believed to reduce red cell autoagglutination (Jacobson and Origgi, 
2007) 
  Passing the PBS (red cell diluent) through a 0.45µm syringe-tip filter to remove non-
filterable bacterial and fungal elements from the diluent 
  Ensuring that the red cells used in the assay were fresh (less than a few hours old). It has 
been reported that the whole blood of chickens can be stored in an equal volume of 
Alsever’s solution at 4
0C for up to two weeks prior to use in HA and HI assays for psittacine 
beak and feather disease (Raidal et al., 1993) 
  Use a commercial Alsever’s solution (Sigma) rather than one made “in-house” 
  Using erythrocytes sourced from guinea pigs rather than chickens 
  Increase number of erythrocyte washes from three to five 
  Vortexing the 0.5% (v/v) erythrocyte suspension prior to use (April Childress, University of 
Florida, personal communication) 
Antigen Source 
  Using cell culture derived antigen rather than antigen from the allantoic fluid of 
embryonated chicken eggs. Normal allantoic fluid of chickens has been shown to contain 
haemagglutination inhibitors of influenza virus and the GDVII strain of mouse 
encephalomyelitis virus (Tamm and Tyrrell, 1954) 
  Using original antigen stocks (from ATCC) rather than antigen that has been propagated 
“in-house” 
  Increased the concentration of antigen used in each well from 4 HA / 50µL to 8 HA / 50µL 
  Clarify antigen immediately prior to use 
Sample Processing 
  Use fresh plasma/serum samples rather than samples eluted off filter paper 
  Omit the haemadsorption of the serum/plasma 
  Omit the heat inactivation (removes heat labile non-specific inhibitors of 
haemagglutination) of the serum/plasma 
  Use kaolin (Raidal et al., 1993), receptor-destroying enzyme (RDE, Denka Seiken, Tokyo, 
Japan), dextran sulfate (Liebhaber, 1970; Monath et al., 1970), trypsin-periodate (Boliar et 
al., 2006) or heparin-MnCl2 (Liebhaber, 1970) rather than heat to remove non-specific 
inhibitors of haemagglutination 
Antigen-antibody Reaction 
  Incubating the virus solution with the antibody sample at both 4
0C and at room 
temperature 
Unbound antigen-erythrocyte Reaction 
  After the addition of red cells to detect the presence (or inhibition) of haemagglutination, 
allowing the incubation to occur at both 4
0C and at room temperature 
Table 4.1 Steps of a haemagglutination inhibition assay that were altered to determine the cause of 
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Figure 4.26 Comparison of two methods of erythrocyte preparation. The method used early in these 
studies (“old method”) did not involve vortexing the working suspension of erythrocytes whereas the 
later method (“new method”) did. Cleaner haemagglutination can be seen with the new method. PBS = 
phosphate-buffered saline. 
 
The impact that haemolysis and blood clotting had on a ferlaviral haemagglutination inhibition 
assay was assessed. Two 50µL aliquots of positive control serum (known to contain detectable 
levels of anti-ferlaviral antibodies) from a western diamondback rattlesnake (Crotalus atrox) 
were diluted three-fold with two 100µL aliquots of fresh whole blood from a black-headed 
python (Aspidites melanocephalus). The first 150µL mixture was frozen and allowed to thaw. 
After centrifugation (500g x 5min), the supernatant was collected. This sample was to emulate 
a “serum” sample with significant haemolysis that still contained clotting factors. The second 
150µL mixture was centrifuged immediately to pellet the erythrocytes and the supernatant 
was  collected.  This  sample  was  to  emulate  a  “serum”  sample  that  still  contained  clotting 
factors.  Both  of  these  “serum”  samples  formed  clots  that  were  removed  with  wooden 
applicators as described above. To control this experiment, an aliquot of fresh whole blood 
from the black-headed python was added to lithium heparin, anticoagulated and centrifuged 
positive control:
ferlavirus
negative control:
PBS
ferlavirus:
Vero cells
2 4 8 16 32 64 128 256
ferlavirus:
viper heart cells
positive control:
ferlavirus
negative control:
PBS
ferlavirus:
Vero cells
ferlavirus:
viper heart cells
HA titre (/50µL)
NEW 
METHOD
OLD 
METHOD111 | P a g e  
 
before the supernatant (plasma) was collected. A second aliquot of fresh whole blood was left 
to clot and then centrifuged before the supernatant (serum) was collected. Samples were then 
tested by HI for the presence of anti-ferlaviral antibodies using the methods described earlier 
(Figure 4.27). Although this experiment was limited to only one positive control sample spiked 
into the fresh whole blood of only one snake and no further replicates were performed, the 
experiment was able to demonstrate that the presence of a clot, and its subsequent removal 
with  a  wooden  applicator,  did  not  prevent  the  detection  of  anti-ferlaviral  antibodies.  The 
sample  in  this  experiment  required  several  hours  to  fully  clot.  The  remarkable  contrast 
between the ex vivo clotting times of mammalian blood and reptilian blood might explain why 
the  University  of  Florida 
(http://www.vetmed.ufl.edu/college/departments/sacs/documents/HAIProtocol.pdf)  requires 
plasma, rather than serum samples for their haemagglutination inhibition assay. As expected, 
the  presence  of  haemolysis  obscured  the  observer’s  ability  to  detect  haemagglutination 
inhibition but did not appear to significantly affect the assay in other ways. 
 
Figure  4.27  Impact  that  haemolysis  and  blood  clots  have  on  haemagglutination  inhibition  titres. 
Hyperimmune serum served as a positive control (HI titre 16/50µL, row 1) and was spiked into healthy 
snake blood (HI titre <2/50µL, rows 3 and 4) that contained clots (denoted as “serum”) with (row 5, HI 
titre 4/50µL) or without (row 6, HI titre 4-8/50µL) significant amounts of haemolysis. 
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4.6  Neuraminidase Activity 
In 1996, Richter et al. described the successful adaptation of the methods reported by Yolken 
et al. (1980) to detect neuraminidase activity in three ferlaviral isolates. These methods were 
applied to the viral isolates used in this study. Using flat-bottom microtitre plates, an 80µL 
sample  of  cell  culture  supernatant  or  allantoic  fluid  was  mixed  with  an  equal  volume  of 
neuraminidase  substrate: 2’-(4-methylumbelliferyl)-α-D-N-acetylneuraminic  acid  sodium  salt 
hydrate (Sigma, Cat. No. M8639) dissolved in a phosphate buffer solution (0.1M phosphate 
buffer  [8mM  Na2HPO4.2H2O,  92mM  NaH2PO4.2H2O],  1mM  CaCl2,  pH  5.8)  to  a  final 
concentration of 0.1mM. The mixture was left to incubate at 30
0C. After excitation at 355nm, 
the  emission  at 480nm was  quantified  using  a  fluorometer  (Titertek®  Fluorskan,  EFLABoy, 
Finland) at various times after the substrate had been added to the viral solution (e.g. 30 
minutes, 90 minutes, 3 hours and 24 hours). Attenuated human influenza virus (kindly donated 
by Dr Cassie Berry) and ferlavirus (ATCC VR-1408) were used as positive controls and media 
that  the  viruses  were  grown  in  (allantoic  fluid  or  cell  culture  supernatant)  were  used  as 
negative controls. 
 
To investigate the robustness of this assay, different diluents, incubation times and sample 
dilution rates were assessed (Table 4.2). Although the virus permissive temperature of human 
influenza virus is 37
0C, the virus was incubated with the neuraminidase substrate at 30
0C. This 
was done to mimic the incubation temperature that would be used for any reptilian isolates. 
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Sample  Emission at 480nm 
Experiment One (effect of diluent)     
Incubation time  1hr  2hr 
hIV – phosphate buffer  257  310 
hIV – PBS  237  309 
hIV – cell culture medium  197  245 
Uninfected phosphate buffer  -5  -4 
Uninfected PBS  -2  -3 
Uninfected cell culture medium  -11  -11 
Experiment Two (effect of sample dilution)     
Incubation time  2hr 
hIV – 1 in 8 dilution  314 
hIV – 1 in 16 dilution  341 
hIV – 1 in 20 dilution  278 
hIV – 1 in 25 dilution  287 
hIV – 1 in 27 dilution  272 
hIV – 1 in 40 dilution  280 
hIV – 1 in 80 dilution  200 
Uninfected allantoic fluid (five replicates)  35, 36, 36, 37, 35 
Table 4.2 The amount of neuraminidase (NA) activity of an attenuated human influenza virus (hIV, 
512HA  /  50µL)  compared  to  various  uninfected  culture  substrates.  The  NA  substrate  (2’-(4-
methylumbelliferyl)-α-D-N-acetylneuraminic acid) is exposed to the virus for certain lengths of time to 
produce  a  fluorescent  substrate.  The  emission  at  480nm  provides  an  estimate  of  NA  activity.  For 
experiment one, hiV was propagated in the allantoic cavity of embryonated chicken eggs and then NA 
activity was assessed after dilution in three different diluents. For experiment two, uninfected allantoic 
fluid was mixed with allantoic-derived hIV to seven dilution rates.  
 
4.7  Electron Microscopy 
Electron microscopy was used on a number of samples to search for viruses. Transmission 
electron microscopy (TEM) was used to search for viruses in cell culture media and infected 
cells while scanning electron microscopy (SEM) was used on occasion to visualise viruses on 
the surface of haemagglutinated chicken erythrocytes. 
4.7.1 Transmission Electron Microscopy 
A variety of sample types were processed in a number of ways and then negatively stained 
with  phosphotungstic  acid  before  examination  by  transmission  electron  microscopy  (TEM) 114 | P a g e  
 
(Figure  4.28,  top  panel).  Clarification,  polyethylene  glycol  (PEG)  precipitation  and 
ultracentrifugation  were  performed  as  previously  described  (section  4.3  – 
Haemagglutination). After sample processing,  2µL aliquots of each sample were absorbed 
onto formvar-coated copper mesh grids for ten minutes. Excess liquid was removed using a 
small piece of filter paper. The surface of the formvar-coated grid was then negatively stained 
for three minutes using a 2µL aliquot of phosphotungstic acid (PTA, 1% v/v in Tris-buffered 
water, pH 7.3). Excessive liquid was again removed with filter paper. Grids were examined 
using  a  Philips  CM100  Biotwin  transmission  electron  microscope  (Philips/FEI  Corporation, 
Eindhoven, The Netherlands). Attenuated human influenza virus (kindly donated by Dr Cassie 
Berry) (Figure 4.29) and Nelson Bay orthoreovirus (Figure 4.30) served as positive controls.115 | P a g e  
 
 
 
 
Figure 4.28 Transmission electron microscopic (TEM) examination of several different sample types. 
Top: Cell culture media and infected cells were processed in various ways for examination by TEM after 
negative staining. Bottom: Infected cells and histological sections (in this case, inclusion bodies in a 
section of snake brain) were positively stained prior to examination by TEM. PEG = polyethylene glycol.
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Figure 4.29 Transmission electron microscopic view of two negatively stained human influenza virions 
(red arrows). The spiked envelope can be seen on the surface of each virion (a section of envelope has 
been bordered by two blue lines). 
 
 
   
Figure 4.30 Transmission electron microscopic view of Nelson Bay orthoreovirus after negative staining. 
Top: Two intact virions. Bottom Left: Double capsid structure can be seen in this partially digested 
virion. Bottom Right: A typical empty shell. 117 | P a g e  
 
Infected  cells  from  cell  culture  and  histological  sections  were  positively  stained  prior  to 
examination by TEM (Figure 4.28, bottom panel). For infected cells from cell culture, media 
was removed, the monolayer was rinsed with PBS and cells were then trypsinised and pelleted 
(580g  x  10  minutes).  Trypsin  was  removed  and  the  cells  were  then  resuspended  in  5% 
glutaraldehyde (v/v in Sörensen’s phosphate buffer *12.9mM KH2PO4, 53.1mM Na2HPO4, pH 
7.4])  and  left  for  two  hours  at  4
0C  for  fixation.  Cells  were  pelleted,  glutaraldehyde  was 
removed and the cells were resuspended in Sörensen’s phosphate buffer to remove residual 
glutaraldehyde. Cells were again pelleted, supernatant removed, and cells were resuspended 
in a drop of molten agarose (2% w/v in water). Immediately afterwards, cells were pelleted at 
full speed on a bench top centrifuge (~20,000g x 1 minute). Cells were moved to a refrigerator 
and once the agarose had solidified (approximately 10 minutes), the agarose plug was carefully 
removed from its tube and the cell pellet was dissected away from the rest of the agarose. The 
agarose-encased  and  glutaraldehyde-fixed  cell  pellet  was  then  processed  before  being 
positively stained. 
 
First, the cell pellet was submerged in Dalton’s chrome osmic acid (1% w/v osmium tetroxide 
[OsO4], 1% w/v K2Cr2O7, 0.85% w/v NaCl, pH 7.2) for one hour at 4
0C. The Dalton’s chrome 
osmic acid was decanted away and the sample was dehydrated. The sample was washed three 
times, each for two minutes, with each of four concentrations (v/v) of ethanol: 70%, 90%, 95% 
and 100%. The sample was then washed twice, each for two minutes, with 100% propylene 
oxide. After the propylene oxide had been removed, the sample was then infiltrated with a 
60:40 mix of propylene oxide and EPON (24.6% w/v dodecenyl succinic anhyride hardener 964, 
47.1% w/v Taab 812 resin, 28.2% w/v methyl nadic anhydride) and left to incubate at 4
0C for 
one hour. The propylene oxide-EPON mixture was removed and EPON was used to cover the 
sample which was then left to incubate on a slow moving rotor (approximately 1-5 rpm) at 
room temperature for 12 hours. The EPON and sample were then transferred to an embedding 
capsule and the EPON resin was left to polymerise during a 24 hour incubation at 60
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the resin plugs were removed from the embedding capsules and semi-thin sections were cut 
(1µm) and stained with a toluidine blue solution (1% w/v toluidine blue and 0.5% w/v sodium 
tetraborate [borax]). Semi-thin sections were assessed by light microscopy for their suitability 
as ultra-thin sections (70-90nm). If the sample quality was adequate, several ultra-thin sections 
were then cut and placed onto copper grids. Ultra-thin sections were then ready for positive 
staining.  Sections  were  incubated  in  a  drop  of  saturated  uranyl  acetate  for  five  to  seven 
minutes.  Uranyl  acetate  was  cleared  by  submerging  the  sections  in  distilled  water.  After 
drying, the sections were stained with 0.1%-0.4% (w/v) lead citrate for four minutes, which 
was then washed away in distilled water. After drying, the grids containing the sections were 
coated in formvar before being examined by TEM. 
 
For histological sections, areas of interest (usually inclusion bodies) were identified. Coverslips 
were then removed by soaking the slide in xylene at 60
0C. The slide was then placed into fresh 
xylene  at  room  temperature  for  five  minutes.  Next,  the  slide  was  transferred  to  a  50:50 
solution of xylene and propylene oxide for five minutes, and then a solution of pure propylene 
oxide  for  a  further  five  minutes.  The  slide  was  covered  in  a  25:75  solution  of  EPON  and 
propylene oxide for one hour. An embedding capsule was filled with EPON and then placed 
over the area of interest of the slide and left to polymerise for 24 hours at 60
0C. The slide was 
then attached to the embedding capsule and the slide and capsule were immersed in liquid 
nitrogen where the slide separated away from the capsule leaving the section embedded in 
the  capsule’s  EPON.  Finally,  ultra-thin  sections  were  cut,  placed  onto  copper  mesh  grids, 
positively stained as previously described, coated in formvar and viewed under TEM. 
4.7.2 Scanning Electron Microscopy 
Only  haemagglutinated  chicken  erythrocytes  were  examined  under  a  scanning  electron 
microscope  (SEM).  Haemagglutinated  erythrocytes  were  fixed  in  glutaraldehyde  and  then 
pelleted.  After  removing  excess  glutaraldehyde,  the  fixed  erythrocytes  were  incubated  in 
Dalton’s chrome osmic acid at 4
0C for two hours. The sample was then washed in several 119 | P a g e  
 
changes of 30% (v/v) ethanol until no more osmic acid washed away. Next, the sample was 
washed twice, each time for five to ten minutes, with each of five concentrations (v/v) of 
ethanol: 50%, 70%, 80%, 90% and 95%. After three ten-minute washes in 100% ethanol, the 
sample was then left on a specimen stub to air-dry causing the cells to adhere to the stub. The 
sample was then splattered (coated) with gold and then stored in a desiccator until it was 
viewed in a Philips XL 20 scanning electron microscope (Philips/FEI Corporation, Eindhoven, 
The  Netherlands).  Two  viruses  with  high  haemagglutination  titres  were  used  as  positive 
controls: human influenza virus (2,048HA/50µL) and ferlavirus (256HA/50µL) (Figure 4.31). 
  
 
Figure  4.31  Myxovirus-induced  haemagglutination  of  chicken  erythrocytes.  Human  influenza  virus 
(2,048HA/50µL) (top right) and ferlavirus (256HA/50µL) (bottom right) are compared to a published 
report that used human influenza virus (Tawara et al., 1976) (left). Red arrows point to the bridging that 
is responsible for the macroscopic haemagglutination that is observed. 
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4.8  Polymerase Chain Reaction 
Many  different  sample  types  were  processed  for  the  detection  of  a  range  of  viruses  by 
polymerase chain reaction (PCR)  (Figure 4.32). The objective of sample processing was to 
extract the nucleic acid (RNA and/or DNA) from a diverse range of sample types: cell culture, 
swabs, fresh tissue samples and formalin-fixed tissue samples. 
 
 
Figure  4.32  Various  sample  types  that  were  processed  for  the  detection  of  a  range  of  viruses  by 
polymerase chain reaction 
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200-400µL aliquots of unprocessed media and frozen-thawed, clarified cell lysate were taken 
from infected and uninfected flasks. Total nucleic acid (RNA and DNA) was extracted from each 
using  the  MagMAX™  Viral  RNA  Isolation  Kit  (Ambion,  Austin,  Texas,  cat.  no.  AM1939) 
according to the manufacturer’s protocols. For freeze-dried vaccines, lysis/binding solution 
from the Ambion extraction kit was added to the vaccine vial to dissolve the contents. From 
there,  total  nucleic  acid  extraction  proceeded  in  accordance  with  the  manufacturer’s 
recommendations. 
 
For combined oral-cloacal swabs, a cotton-tipped applicator was pre-moistened in isotonic 
saline (or Hartmann’s solution) and then the inside of the snake’s mouth (especially the glottis) 
and cloaca were swabbed. Oral-only and cloacal-only swabs were also taken from a subset of 
the snakes. All swab tips were broken off into sterile containers, submerged in isotonic saline 
(or  Hartmann’s  solution).  Containers  that  contained  immersed  swab  tips  were  vigorously 
vortexed for at least 30 seconds and then a 200µL aliquot of the saline or Hartmann’s solution 
was  used  for  total  nucleic  acid  extraction  using  the  Purelink
TM  Viral  RNA/DNA  Mini  Kit 
(Invitrogen, Victoria, cat. no. 12280-050) according to the manufacturer’s instructions. 
 
Fresh tissues were submitted in isotonic saline or Hartmann’s solution, while freshly-frozen 
tissues were submitted in small sterile containers without media. A small (1-3mm
3) piece of 
tissue was collected from each organ sample and using the MELT
TM Total Nucleic Acid Isolation 
System (Ambion, Texas, cat. no. AM1983), total nucleic acid was extracted from the sample in 
accordance with the manufacturer’s instructions. For formalin-fixed paraffin-embedded (FFPE) 
samples, sections (4-10µm) were cut with a fresh microtome blade that was wiped with xylene 
between sections. Total nucleic acid was recovered as per the methods described for fresh and 
freshly-frozen tissues, but with minor modification. Samples were first deparaffinised in two 
washes of xylene. Each wash consisted of adding 1mL of xylene to a microcentrifuge tube that 
contained the sections from each sample being processed. The tube was then vortexed and 122 | P a g e  
 
incubated for three minutes at 50
0C. After centrifugation at ~20,000g for two minutes, the 
supernatant was removed. This xylene wash was repeated once more and then the xylene was 
cleared with two washes of ethanol. An ethanol wash consisted of adding 1mL of 100% ethanol 
to the deparaffinised sections, vortexing the tube, pelleting the tissue at ~20,000g for two 
minutes  and  then  removing  the  supernatant.  Deparaffinised  tissues  were  then  digested 
overnight at 50
0C in the digestion cocktail provided with the Ambion kit. After this extended 
digestion, the sample was treated identically to a fresh tissue that was being processed with 
the same extraction kit. 
 
Total nucleic acid was always eluted into 30µL of elution buffer. For the detection of RNA 
viruses, the RNA in extracted total nucleic acid was reverse transcribed into complementary 
DNA (cDNA). For this, 13.5µL of total nucleic acid was added to 1µL of random hexamers 
(100ng/µL) (except some reovirus PCRs, see later) and 1µL of dNTPs (10mM) and incubated at 
65
0C for five minutes. 0.5µL of Superscript® III reverse transcriptase (200 units/µL, Invitrogen, 
Victoria, cat. no. 18080-044) and 4µL of 5x buffer were then added to make a final volume of 
20µL which was then incubated at 25
0C for five minutes, 45
0C for 45 minutes and 70
0C for 15 
minutes. For PCR amplification, 1µM (final concentration) of each primer was added to 1µL of 
cDNA and then Platinum PCR Supermix© (Invitrogen, Victoria, cat. no. 11306-016) was used to 
bring the final reaction volume to 20µL. 
 
Thermocycling  always  started  with  a  two  minute  incubation  at  94
0C  to  remove  anti-taq 
antibodies. Various cycling conditions followed that were dictated by the recommendations 
published for each particular primer set. Where primers were designed in house, denaturation 
was always at 94
0C for 20 seconds. The annealing temperature was set at 3-5
0C below the 
lowest melting temperature (Tm) of the primer set and incubation at this temperature lasted 
for 20-45 seconds. The extension temperature was always 72
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seconds to one minute depending on the anticipated amplicon size. Each PCR continued for 40 
cycles. 
 
Several different primer sets were used for the detection of reoviruses (Table 4.5) and for all 
except those described by Landolfi et al. (2010) and Wellehan et al. (2009), random hexamers 
were used to reverse transcribe RNA into cDNA. When using the primer sets published by 
Landolfi et al. (2010) and Wellehan et al. (2009), both primers from the first round of the PCR 
were used as gene specific primers in the reverse transcription of RNA. Gene-specific primers 
were added (0.5µL of 30-80µM) to the RNA template along with dNTPs before the mixture was 
incubated at 94
0C for two minutes, and then chilled rapidly to 4
0C using ice water. After the 
addition of reverse transcriptase and its buffer, the solution was then incubated at 45
0C for 45 
minutes  and  70
0C  for  15  minutes.  Prior  to  the  addition  of  the  labile  enzyme  reverse 
transcriptase, RNA templates are often incubated at 60
0C to remove secondary structure but in 
the  case  of  double-stranded  RNA  (dsRNA)  viruses  like  reoviruses,  not  only  was  a  higher 
temperature used (94
0C) to denature the dsRNA into single strands (Davis and Boyle, 1990) but 
gene specific primers that target both strands of the viral genome were used. When using the 
PCR  primers  reported  by  Landolfi  et  al.  (2010)  and  Wellehan  et  al.  (2009)  on  reovirus 
templates, specific amplicons could only be detected when using gene specific primers, and 
not random hexamers, to reverse transcribe the RNA.  
 
The  PCR  primers  that  were  tested  on  the  nucleic  acid  that  had  been  extracted  from  cell 
culture, vaccines and tissues, are listed in Tables 4.3 – 4.5. Primers were either designed in-
house or carefully selected from published reports. For published primer sequences, primers 
with the demonstrated ability to detect a diverse range of viruses within a particular group 
were chosen. For primers designed in-house, primers were either designed manually or with 
the aid of computer software (Primer Premier®, Version 5, PREMIER Biosoft International). The 
investigative nature of this project meant that the identity of the virus (or viruses) was not 124 | P a g e  
 
known, so primers that could theoretically detect all the members of a particular genus or 
family were designed. To do this, a conserved region of the viral genome was selected. The 
polymerase  gene  has  been  consistently  chosen  for  ferlaviruses  (Ahne  et  al.,  1999b), 
paramyxoviruses (Tong et al., 2008), adenoviruses (Wellehan et al., 2004) and herpesviruses 
(VanDevanter et al., 1996), and so efforts were focussed on this gene. Next, sequences from 
several viruses in a particular group (e.g. ferlaviruses, orthoreoviruses) were downloaded from 
GenBank  (National  Center  for  Biotechnology  Information,  Bethesda,  Maryland)  and  then 
aligned  using  ClustalW  (Thompson  et  al.,  1994).  Nucleic  acid  sequences  were  aligned  for 
closely related viruses (e.g. ferlaviruses) but amino acid sequences were aligned for more 
distantly related viruses (e.g. paramyxoviruses). Highly conserved areas were identified and 
primers were designed to anneal to these areas. Primers were chosen based on numerous 
criteria: minimal predicted hairpin, dimer and cross-dimer formation; weak annealing to other 
areas  of  the  virus  genome  (false-binding);  BLASTN  (Basic  Local  Alignment  Search  Tool  for 
Nucleotides,  http://blast.ncbi.nlm.nih.gov/Blast.cgi)  failed  to  find  similar  sequences  in  the 
GenBank  database;  and  for  primer  pairs,  the  melting  temperatures  were  similar  for  each 
primer. 
 
For some PCRs, the stringency was lowered by decreasing the annealing temperature. The 
positive controls used for paramyxovirus, ferlavirus, reovirus, herpesvirus and adenovirus PCRs 
were  canine  distemper  virus  (Protech  C3,  Fort  Dodge,  Auckland),  a  neotropical  strain  of 
ferlavirus  (ATCC  VR-1408),  Nelson  Bay  orthoreovirus  (kindly  donated  by  Professor  Graham 
Wilcox), equine herpesvirus (G. Wilcox) and canine adenovirus type 2 (Protech C3) respectively. 
 
PCR products were separated using 2% agarose gel (w/v dissolved in Tris-Acetate-EDTA buffer) 
electrophoresis at 80 Volts for 80 minutes and visualised using 0.005% SYBR® safe (v/v in the 
agarose-Tris-Acetate-EDTA  gel;  Invitrogen,  Mulgrave,  Victoria,  cat.  no.  S33102)  and  a 
transilluminator (DR88M Dark Reader non-UV Transilluminator; Clare Chemical Research Inc., 125 | P a g e  
 
Dolores, Colorado). Bands of correct size were excised from the gel using a sterile scalpel 
blade, purified using the Purelink
TM Quick Gel Extraction Kit (Invitrogen, Mulgrave, Victoria, cat. 
no. K210012) and then directly sequenced on an ABI 3730xl DNA Analyser (Applied Biosystems, 
Foster City, California). Primer sequences were excluded from the amplicons, which were then 
compared to the GenBank database (www.ncbi.nlm.nih.gov/Genbank/index.html).  126 | P a g e  
 
Virus  Genome region 
Primers (5’ → 3’), amplicon size 
Reference 
First round  Second round 
Paramyxoviridae  Polymerase (L)  S2 (TTATGAGATACTACAGAAAGGACA) 
AS1 (AGGAATTGCAGCATGATT), 154bp 
Single round only  Designed in-house 
   
S2 
AS3 (CATAGTCTGGAAGGAAGCA), 107bp 
Single round only  Designed in-house 
   
S4 (GATTATGAGATACTACAGAAAGGACA) 
AS5 (TGGGAGATAATGCCTTGTC), 274bp 
Single round only  Designed in-house 
   
S7 (GGACAAGGCATTATCCCC) 
AS6 (ATTTCTTTCTCCTTGAGACTATA), 223bp 
Single round only  Designed in-house 
   
qS2 (GTTATGGCAAATCATGCTGCGATACCTTA) 
qAS2 (CTGATGGGAGATAATGCCTTGTCCTTCAT), 157bp 
Single round only  Designed in-house 
   
DegenParamyxoS (GGIGGKATWGAAGGWTWITGYCAAAAAMTRTGGAC) 
DegenParamyxoAS (TKAYTGCWATTGMTTGATTGTCWCC), 109bp 
Single round only  Designed in-house 
   
L5 (GCAGAGATTTTCTCTTTCTT) 
L6 (AGCTCTCATTTTGTATGTCAT), 627bp 
L7 (TAGAGGCTGTTACTGCTGC) 
L8 (CATCTTGGCAAATAATCTGCC), 566bp 
(Ahne et al., 1999b) 
   
PAR-F1 (GAAGGITATTGTCAIAARNTNTGGAC) 
PAR-R (GCTGAAGTTACIGGITCICCDATRTTNC), 662bp* 
PAR-F2 (GTTGCTTCAATGGTTCARGGNGAYAA) 
PAR-R, 584bp* 
(Tong et al., 2008) 
   
PAR-F2 
PAR-R, 584bp* 
Single round only  (Tong et al., 2008) 
   
PNE-F1 (GTGTAGGTAGIATGTTYGCNATGCARCC) 
PNE-R (GTCCCACAAITTTTGRCACCANCCYTC), 488bp
# 
PNE-F2 (ACTGATCTIAGYAARTTYAAYCARGC) 
PNE-R, 264bp
# 
(Tong et al., 2008) 
   
PNE-F2 
PNE-R, 264bp
# 
Single round only  (Tong et al., 2008) 
   
pmxF (TACTGCCTNAATTGGAGATATGA) 
pmxR (CCTTCTATACCCCCTCTAGGATA), 224bp
@ 
Single round only  (Yong et al., 2008) 
   
PMV14610F (TTTGCNAAAATGACNTACAAAATGAG) 
PMV15353R (GAAGGNTATTGNCAGAAGNTATGGAC), 744bp 
Single round only  (Nollens et al., 2008) 
Table 4.3 Primers used for the detection of the polymerase gene (L) of paramyxoviruses, especially ferlaviruses. R = A or G; Y = C or T; W = A or T; K = G or T; M = A or 
C; D = A, G or T; N = A, C, G or T; I=inosine. *
#@Information not provided in original manuscript but estimated from binding sites in *Fer-de-Lance virus (FDLV), see 
Figure 6.9, 
# Bovine respiratory syncytial cell virus (BRSV), see Figure 6.9 or 
@ human parainfluenza virus (GenBank accession number: FJ455842.2) 127 | P a g e  
 
 
 
 
Virus  Genome region 
Primers (5’ → 3’), amplicon size 
Reference 
First round  Second round 
Ferlavirus  Haemagglutinin - Neuraminidase (HN)  S2 (TATGGAGGACTGATGACACC) 
AS1 (GCACCCCGCCTAATG), 247bp 
Single round only  Designed in-house 
  S2 
AS3 (AGAAATACCCTATTAGTTGATTACT), 109bp 
Single round only  Designed in-house 
  HN1 (AAATCCTGCAGTACCGTGGCA) 
HN2 (AGATATCTGTGTAAACTCCTG), 679bp 
HN3 (GCACTCTACCCCAGTGTTGG) 
HN4 (TTCTATCCAGCTTATTCTTAT), 399bp 
(Ahne et al., 1999b) 
Table 4.4 Primers used for the detection of the haemagglutinin-neuraminidase gene (HN protein) of ferlaviruses. 128 | P a g e  
 
 
Virus  Genome region 
Primers (5’ → 3’), amplicon size 
Reference 
First round  Second round 
Reoviridae  Polymerase (L1)  ReoS (AACAACAGCACGATGATGAA) 
ReoAS1 (ACCATTATCCCATCATCACC), 137bp 
Single round only  Designed in-house 
 
ReoA-F (GCNTGYGAYGCNWSNATHACN) 
ReoB-R (RTTRTTNGCNGTRTGYTCNGT), 324bp 
Single round only  Designed in-house 
   
ReoA-F 
ReoC-R (NCCRTCRTCNCCYTGRCANACRTARTT)*, 447bp 
ReoA-F 
ReoB-R, 324bp 
Designed in-house 
   
ReoA-F 
ReoD-R (RTANARYTTNARRTAYTCNGC)*, 594bp 
ReoA-F 
ReoB-R, 324bp 
Designed in-house 
   
ReoA-F 
ReoD-R, 594bp 
ReoA-F 
ReoC-R, 447bp 
Designed in-house 
   
ReoA-F 
ReoD-R, 594bp 
ReoB-F (ACNGARCAYACNGCNAAYAAY) 
ReoC-R, 123bp 
Designed in-house 
   
ReoA-F 
ReoD-R, 594bp 
ReoB-F 
ReoD-R, 270bp 
Designed in-house 
   
ReoA-F 
ReoD-R, 594bp 
ReoC-F (AAYTAYGTNTGYCARGGNGAYGAYGGN) 
ReoD-R, 147bp 
Designed in-house 
   
ReoB-F 
ReoC-R, 123bp 
Single round only  Designed in-house 
   
ReoB-F 
ReoD-R*, 270bp 
ReoB-F 
ReoC-R, 123bp 
Designed in-house 
   
ReoB-F 
ReoD-R, 270bp 
ReoC-F 
ReoD-R, 147bp 
Designed in-house 
   
ReoC-F 
ReoD-R, 147bp 
Single round only  Designed in-house 
   
L1.rv5 (GCATCCATTGTAAATGACGAGTCTG) 
L1.rv6 (CTTGAGATTAGCTCTAGCATCTTCTG)*, 416bp 
L1.rv7 (GCTAGGCCGATATCGGGAATGCAG) 
L1.rv8 (GTCTCACTATTCACCTTACCAGCAG), 344bp 
(Leary et al., 2002) 
   
L1.rv5m (CTGCATCCATTGTAAATGACGAGTC) 
L1.rv4m (GCTATGTCATATTTCCATCCGAATTC)*, 455bp 
L1.rv6 
L1.rv7, 374bp 
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1607F (CARMGNCGNSCHMGHTCHATHATGCC) 
2608R (TAVAYRAAVGWCCASMHNGGRTAYTG), 1,053bp 
2090F (GGBTCMACNGCYACYTCBACYGAGCA) 
2334R (CDATGTCRTAHWYCCANCCRAA), 292bp 
(Wellehan et al., 2009) 
   
1607F 
2608R, 1,053bp 
1607F 
2334R, 775bp 
(Wellehan et al., 2009) 
   
1607F 
2608R, 1,053bp 
2090F 
2608R, 570bp 
(Wellehan et al., 2009) 
   
1607F 
2334R, 775bp 
2090F 
2334R, 292bp 
(Wellehan et al., 2009) 
   
2090F 
2608R, 570bp 
2090F 
2334R, 292bp 
(Wellehan et al., 2009) 
   
2090F 
2334R, 292bp 
2090F 
2200R (CCRTCRTCWCCYTGRCAKAYRTARTT), 162bp 
(Landolfi et al., 2010) 
 
σA capsid protein 
(S1, S2) 
PAF (ACTTCTTYTCTACGCCTTTCG) 
PAR (ATYAAWDCWCGCATCTGCTG), 598bp 
Single round only  (Zhang et al., 2006) 
 
Inner coat protein 
(S6) 
AQ1 (AWSCCKTAYATCTATGGCTT) 
AQ2 (TTRGAGACGAAMAKNGASGC), 443bp 
Single round only  (Seng et al., 2004) 
Herpesviridae  Polymerase  Forward 1: DFA (GAYTTYGCNAGYYTNTAYCC), 735bp# 
Forward 2: ILK (TCCTGGACAAGCAGCARNYSGCNMTNAA), 
479bp# 
Reverse 1: KG1 (GTCTTGCTCACCAGNTCNACNCCYTT) 
TGV (TGTAACTCGGTGTAYGGNTTYACNGGNGT) 
IYG (CACAGAGTCCGTRTCNCCRTADAT), 232bp# 
(VanDevanter et al., 
1996) 
Adenoviridae  Polymerase  AdenopolRouter (GTDGCRAANSHNCCRTABARNGMRTT) 
AdenopolFouter (TNMGNGGNGGNMGNTGYTAYCC), ~553bp 
AdenopolRinner (CCANCCBCDRTTRTGNARNGTRA) 
AdenopolFinner (GTNTWYGAYATHTGYGGHATGTAYGC), 
~320bp 
(Wellehan et al., 2004) 
Table  4.5  Primers  used  for  the  detection  of  the  genes  that  code  for  the  polymerase,  σA  capsid  and  inner  coat  proteins  of  Reoviridae,  orthoreoviruses  and 
aquareoviruses respectively. Primers used for the detection of the polymerase genes of herpes- and adenoviruses are also included. R = A or G; Y = C or T; W = A or T; 
K = G or T; S = C or G; H = A, C or T; M = A or C; D = A, G or T; V = A, G or C; B = G, C or T; N = A, C, G or T. * First round PCR products were electrophoresed looking for 
appropriately-sized amplicons. # Amplicon size influenced by species of herpesvirus. Estimates provided here are for human herpesvirus 1 (GenBank number: 
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4.9  In situ Hybridisation 
In situ hybridisation (ISH) has been used for the sensitive detection of ferlaviral RNA from 
archival sections of formalin-fixed paraffin-embedded (FFPE) tissues (West et al., 2001; Sand et 
al., 2004). In both publications, DNA oligonucleotides were used as probes. West et al. (2001) 
used probes that had been designed for the detection of avian paramyxoviruses, while the 
probes  published  by  Sand  et  al.  (2004)  were  specifically  designed  for  the  detection  of 
ferlaviruses. For the studies presented in this thesis, the oligonucleotide sequences reported 
by Sand et al. (2004) were used. In 2002, Jones described the steps needed to detect mRNA 
with  digoxigenin-labelled  DNA  oligonucleotide  probes  and  this  protocol was followed.  The 
process can be divided into four sections: probe labelling, sample preparation, hybridisation 
and detection. 
 
One  hundred  picomoles  of  each  DNA  oligonucleotide  was  labelled  at  the  3’  end  with 
digoxigenin  using  the  DIG  Oligonucleotide  Tailing  Kit,  2
nd  Generation  (Roche,  Mannheim, 
Germany, cat. no. 03 353 583 910), according to the manufacturer’s instructions. The final 
concentration of labelled probe was 100pmol/22µL (4.55µM, or approximately 20-40ng/µL, 
depending on the molecular weight of the particular oligonucleotide). 
 
For sample preparation, six micron (6µm) sections were cut from FFPE tissues, placed onto 
silanised slides and left unstained. Sections were deparaffinised in two three-minute washes of 
xylene. Tissues were then hydrated after two one-minute washes in 100% and then 95% (v/v) 
ethanol that were followed by two three-minute immersions in pure water. Slides were then 
immersed in 2x standard saline citrate (SSC) buffer (300mM NaCl, 30mM trisodium citrate, pH 
7) at 70
0C for ten minutes. Following this, slides were placed into pure water for five minutes. 
Tissue sections were then covered with 100µL of a proteinase K solution (20µg/mL in Tris-
buffered saline [50mM Tris, 150mM NaCl, pH 7.6]) and left to incubate at 37
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Slides were then twice immersed in pure water at 4
0C for five minutes. Next, slides were 
transferred  into  0.4%  paraformaldehyde  (w/v  dissolved  in  1  x  phosphate-buffered  saline 
[130mM NaCl, 7mM KH2PO4, 3mM Na2HPO4.2H2O, pH 7.4]) and left to incubate at 4
0C for 20 
minutes before being immersed in pure water for five minutes. 
 
For hybridisation, each section was first covered in 50µL of pre-hybridisation solution (600mM 
NaCl, 0.1% w/v sodium pyrophosphate, 0.2% w/v polyvinylpyrrolidone [MW 40,000], 0.2% w/v 
Ficoll  [MW  40,000],  EDTA  5mM,  Tris-HCl  50mM,  10%  w/v  dextran  sulphate,  31.5%  v/v 
formamide, dissolved in water) and incubated at 37
0C for one hour. After adding 50µL of 
hybridisation solution (0.5µL [approximately 10-20ng] of each probe made up to 50µL with 
pre-hybridisation solution) to each section, coverslips were applied and the sections were then 
left  to  incubate  overnight  at  37
0C.  The  next  day,  the  coverslips  were  removed  and  the 
hybridisation solution was rinsed with 2x SSC before slides were twice immersed in 2x SSC at 
37
0C for ten minutes. 
 
For  detection,  sections  were  covered  in  100µL  of  a  600-fold  dilution  of  anti-digoxigenin 
alkaline  phosphatase  conjugate  (Anti-Digoxigenin-AP  Fab  fragments,  150  units  in  200µL, 
Roche, Mannheim, Germany, cat. no. 11 093 274 910, diluted in Tris-buffered saline) and left 
to incubate for 30 minutes. Sections were then rinsed in two five-minute washes of Tris-
buffered saline. Next, sections were washed in alkaline phosphatase substrate buffer (100mM 
Tris-HCl, 100mM NaCl, 50mM MgCl2) for five minutes. After covering slides in 200µL of an 
alkaline  phosphatase  substrate-levamisole  solution  (196µL  of  BM  Purple  AP  Substrate, 
precipitating, Roche, Mannheim, Germany, cat. no. 11 442 074 001, and 4µL Levamisole® 
32g/L, Western Stock Distributors, Perth, Australia), sections were left in the dark to incubate 
overnight. Slides were then examined for hybridisation before they were rinsed under running 
water for five minutes. Slides were exposed to a 30 second immersion in a bluing solution and 132 | P a g e  
 
then stained with Brazilin for two minutes. Residual stain was cleared with pure water and a 
coverslip was mounted using Apathy’s mountant, an aqueous mountant. 
 
Alkaline phosphatase activity is found in many different tissue types and levamisole has the 
ability to block endogenous alkaline phosphatase (except intestinal sources) while sparing the 
activity  of  exogenous  alkaline  phosphatase  (Ponder  and  Wilkinson,  1981).  To  analyse  the 
endogenous  alkaline  phosphatase  activity  in  various  snake  tissues,  a  one-off  bench-top 
experiment on duplicate sections was performed. A section consisting of snake brain, lung and 
liver was exposed to 200µL of alkaline phosphatase substrate solution containing levamisole 
(see above for solution compositions), while a second section from the same snake tissues was 
exposed to the substrate solution without levamisole. In the section stained in the absence of 
levamisole,  non-specific  staining  of  the  liver  was  noted,  particularly  in  areas  of  high  fat 
content. There was a moderate amount of staining in the lung but none could be detected in 
the brain. In the presence of levamisole, very little staining could be seen. This was taken as 
meaning  that  the  snake  sections  examined  contained  significant  amounts  of  endogenous 
alkaline phosphatase activity that could be quenched with levamisole. 
 
Primers were designed for the detection of 18S ribosomal RNA (rRNA) (18S rRNA antisense: 5’ 
AAACCATCCAATCGGTAGTAGC; 18S rRNA sense: 5’ CCAGTAAGTGCGGGTCATAAGC). Using these 
primers, 18S rRNA was detected by PCR in formalin-fixed paraffin-embedded (FFPE) snake 
tissue  (data  not  shown).  To  control  for  the  ISH  methodology  described,  100pmol  of  each 
primer was labelled with digoxigenin and used as a probe to hybridise to 18S rRNA in a variety 
of FFPE snake tissues. Snake sections known to be infected with ferlavirus were not available 
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Chapter 5 – Sample  Examination  Leading  to  the  Isolation  of  a 
Virus Named BHP1-Lung 
This chapter describes the snake samples that were sourced from around Australia and the 
tests that were performed on them that ultimately lead to the isolation of a virus, initially 
referred to as BHP1-Lung. The chapter is divided into four main sections. In the first section 
(5.1 – Sample Collection), samples are tabled according to type (e.g. swab, tissue, blood etc) 
and what tests were performed on them. Some of the tests were selected for their abilities to 
detect  paramyxoviruses  (e.g.  polymerase  chain  reaction  [PCR],  haemagglutination  and 
neuraminidase assays) while others were selected for their capabilities to detect a broader 
range  of  viruses  (e.g.  virus  isolation  and  electron microscopy).  The  second section  of  this 
chapter (5.2 – Screening Samples for Viruses) describes the results of the sample testing. 
Eventually, a virus was isolated in cell culture and the third section of this chapter (5.3 – 
Laboratory  Investigations  of  BHP1-Lung)  describes  the  tests  that  were  performed  on  this 
isolate to try and determine the family that it belongs to. The final section (5.4 - Chapter 
Summary) summarises the results of sample testing and the more specific testing that was 
performed on BHP1-Lung. 
5.1  Sample Collection 
From the period of May 2007 to October 2009 various snake samples were received from 
veterinarians for virus screening (Table 5.1). In total, 463 samples were collected from 192 
snakes  from 36  reptile  collections  from  five  Australian  states or  territories.  Samples were 
received from all states and territories except Tasmania and the Australian Capital Territory 
(ACT). All samples were provided by veterinarians that worked  with privately (e.g. private 
practitioners)  or  publicly-owned  (e.g.  zoological  gardens)  snake  collections.  In  all  cases, 
samples  were  from  snakes  that  had  histories,  clinical  signs,  diagnostic  test  results  and/or 
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in-contact  (either  directly  [e.g.  cagemate]  or  indirectly  [e.g.  same  room])  with  the 
aforementioned snakes. 
 
Three sample types were received: swabs, blood and tissue (section 4.1 – Sample Collection). 
Swabs were either cloacal or oral. For oral swabs, veterinarians were asked to preferentially 
sample the glottis and if possible, the trachea. “Blood” samples were serum, plasma or whole 
blood. Tissue was either fresh, freshly frozen or formalin-fixed and paraffin-embedded (FFPE). 
 
Samples  were  predominantly  screened  for  certain  viruses  using  four  different  methods: 
haemagglutination (HA) assay, haemagglutination inhibition (HI) assay, virus isolation (VI) and 
polymerase chain reaction (PCR). A small selection of samples (five cloacal swabs) was also 
screened  by  a  neuraminidase  (NA)  assay  (section  5.2.2  –  Neuraminidase  Activity).  Some 
samples  were  screened  by  more  than  one  test.  From  463  samples  collected,  217  were 
screened by HA, 86 by HI, 161 by VI and 50 by PCR. 
 
Typically, swabs were first screened with HA because it was rapid, reasonably selective for 
paramyxoviruses of interest (e.g. known ferlaviruses) and cost-effective to test large batches. 
Some swabs were additionally screened for viruses by VI and PCR. Tissue samples were usually 
screened by VI because it was thought that these samples would be more likely to contain 
intact virus. At the time, PCR was considered to be an expensive and time consuming test, 
especially  when  it  was  not  yet  known  what  virus,  or  viruses,  were  likely  to  be  present. 
However, the sensitivity and the existence of broadly-reactive primer sets mean that PCR was 
an under-utilised tool at this stage of the investigation. 135 | P a g e  
 
  Haemagglutination 
Assay (HA)* 
Haemagglutination 
Inhibition Assay (HI) 
Virus Isolation (VI) 
Polymerase Chain 
Reaction (PCR)
# 
Sampling Data         
Period of Sampling 
May-2007 to 
September-2008 
May-2007 to 
August-2008 
May-2007 to 
October-2009 
May-2007 to 
October-2009 
States/Territories Sampled  NSW, Qld, WA, Vic  NSW, Qld, WA, Vic  NSW, Qld, WA, SA, NT  NSW, Qld, WA, Vic, SA, NT 
Collections Sampled  19  12  14  18 
Snakes Sampled  106  86  47  35 
Sample Type         
Cloacal and Oral Swabs  204  0  12  23 
Blood  0  86  0  0 
Tissue  13  0  149  23 
Formalin-fixed paraffin-
embedded (FFPE) 
0  0  0  4 
Table 5.1 Snake samples screened for viruses from May-2007 to October-2009. In total, 463 samples were collected from 192 snakes from 36 reptile collections 
from six Australian states or territories. *A second swab taken from the same snake at a different time counts as two samples from one snake. If a sample was 
tested by HA first and VI second, and then a sample of cell culture supernatant (from the VI attempt) was retested for HA activity, this counts as one HA sample and 
one VI sample. 
#Samples that were tested for multiple viruses by PCR, were still only recorded as one sample. NSW = New South Wales, Qld = Queensland, WA = 
Western Australia, Vic = Victoria, SA = South Australia, NT = Northern Territory. Samples received after PCR primers had been designed to screen for Sunshine virus 
by PCR (August-2010) are not included in this table. Samples were not received between October-2009 and August-2010 as efforts were focussed on determining the 
identity of BHP1-Lung.  136 | P a g e  
 
5.2  Screening Samples for Viruses 
5.2.1 Haemagglutination Assays 
From 463 samples collected for virus screening, 217 (204 cloacal or oral swabs and 13 tissue 
samples) were tested for the presence of a haemagglutinating agent (Table 5.1) using the 
methods described earlier (section 4.3 – Haemagglutination). In addition to the 217 samples, 
cell  culture  supernatant  from  attempts  at  virus  isolation  was  sometimes  tested  with  this 
haemagglutination  (HA)  assay.  Many  months  after  this  initial  HA  screening,  viruses  were 
eventually isolated using virus isolation (Table 5.3) and the testing of these isolates for HA 
activity is discussed later (section 5.3.2 – Haemagglutination and Haemadsorbing Activity).  
 
Out of the 217 samples that were tested for HA activity, it was detected in the swabs from two 
snakes that were collected from a zoological collection in Queensland in 2007 (Figure 5.1). 
Some snakes from this collection were occasionally displaying neurorespiratory or non-specific 
(e.g.  lethargy)  signs  of  disease.  Sporadic  deaths  occurred  in  both  symptomatic  and 
asymptomatic animals and in these cases, histopathological assessment was consistent with a 
paramyxoviral  infection.  Furthermore,  significant  levels  of  anti-ferlaviral  antibodies 
(haemagglutination inhibition titres up to 512/50µL) had been detected in serum samples 
submitted to an overseas diagnostic laboratory. With respect to the owner’s wishes, more 
specific details are excluded in an attempt to retain the anonymity of this collection. The first 
HA positive was detected in the cloacal swab of a seemingly-healthy 10 year old female black-
headed  python  (Aspidites  melanocephalus)  from  sampling  performed  in  early  May-2007 
(sample 3) while the second positive was detected in the cloacal swab of a seemingly-healthy 
four year old female scrub python (Morelia amethistina) from sampling performed in late-June 
2007 (sample 7). 137 | P a g e  
 
 
 
Figure 5.1 Swabs of nine snakes (samples 1-9) from a zoological collection in Queensland. Top: Cloacal 
swabs from six snakes sampled in early May-2007. Bottom: Cloacal and mouth swabs from three snakes 
sampled in late June-2007. In both assays, an attenuated strain of human influenza virus and phosphate-
buffered saline (PBS) were used as positive and negative controls respectively. Clear haemagglutination 
can be seen in Sample 3 and Sample 7 - Cloaca but not in any other samples. 
Positive Control:
influenza virus
Negative control:
PBS
Sample 1
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2 4 8 16 32 64 128 256 512 1,024
HA titre
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256
<2
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8-16
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Positive control:
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Sample 9 – mouth
Sample 9 – cloaca
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For  both  of  these  samples  (sample 3  [a  cloacal  sample]  and  sample  7  –  cloaca  also),  the 
haemagglutination was still present after passing the sample through a 0.45µm syringe-tipped 
filter (Figure 5.2). It has been shown that some bacterial haemagglutinins are not able to be 
separated  from  the  cell  wall  (Neter  et  al.,  1954)  and  filtration  should  prevent 
haemagglutination  whereas  haemagglutinating  viruses  (e.g.  paramyxoviruses)  and  secreted 
bacterial  haemagglutinins  would  be  expected  to  only  be  minimally  affected  by  filtration. 
However,  the  significance  of  this  result  is  uncertain  because  cell  wall-associated  bacterial 
haemagglutinins could still potentially be filterable if the cell wall had been disrupted and viral 
haemagglutinins may be excluded by filtration if the pore size was exclusive of the virus. 
 
The increase in HA titre seen with Sample 7 – cloaca (32 → >256) that was observed post-
filtration could be explained if the hemagglutinins in the swab sample were unevenly adsorbed 
to the other components of the sample (e.g. urates), potentially making each aliquot unique 
and therefore the inter-assay HA titres would not always be repeatable. 
 
 
Figure 5.2 Swabs from two snakes (sample 3 (top) and sample 7 – cloaca (bottom), see Figure 5.1) after 
passing the sample through a 0.45µm filter. In both assays, an attenuated strain of human influenza 
virus and phosphate-buffered saline (PBS) were used as positive and negative controls respectively. 
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In the both cases, repeat sampling and testing of each of these two snakes at a later stage 
could not demonstrate the persistence of detectable haemagglutinating activity (Figure 5.3) 
indicating either the first result was a false positive (discussed later) or the haemagglutinating 
agent was no longer present in the mouth or cloaca in amounts detectable by this assay. 
 
 
Figure 5.3 Repeat sampling from two snakes (sample 3 (top) and sample 7 (bottom), see Figure 5.1) 
Top: Mouth and cloacal swabs were collected from this snake in the morning and afternoon 56 days 
after the original sample was collected. Despite some unusual red cell clumping in one sample (cloaca 
+56d (am)), no compelling evidence of haemagglutination can be seen.  Bottom: Mouth and cloacal 
swabs  were  taken  five  and  seven  days  after  the  original  sample  was  collected.  In  both  assays,  an 
attenuated strain of human influenza virus and phosphate-buffered saline (PBS) were used as positive 
and negative controls respectively. 
2 4 8 16 32 64 128 256
Positive control:
influenza virus
Negative control:
PBS
Sample 3:
mouth +56d (am)
cloaca +56d (am)
mouth +56d (pm)
cloaca +56d (pm)
HA titre
(/50µL)
128
<2
<2
<2?
<2
<2
Positive Control:
influenza virus
Negative control:
PBS
Sample 7:
Mouth +5d
2 4 8 16 32 64 128 256
HA titre
(/50µL)
512
<2
<2
<2
<2
<2
Cloaca +5d
Mouth +7d
Cloaca +7d140 | P a g e  
 
The significance of the two positive HA titres remains undefined. A study by Khalesi et al. 
(2005) on Psittacine beak and feather disease virus (PBFDV, a parrot circovirus), concluded that 
six  feather  samples  with haemagglutinating  activity  up  to  320  HA  units  /  50µL of  feather 
suspension were false-positive results because PFBDV could not be detected by polymerase 
chain reaction (PCR) and the HA activity could not be neutralised by anti-PBFDV antibodies and 
was removed by filtration through a 0.22µm filter. The HA activity of the two snake cloacal 
samples presented here (Figure 5.1) was not removed by filtration through a 0.45µm filter. 
Interestingly,  neuraminidase  activity  could  also  be  detected  in  both  of  these  samples, 
consistent with a myxovirus (section 5.2.2 – Neuraminidase Activity). However, testing for 
anti-ferlaviral antibodies (section 5.2.3 – Haemagglutination Inhibition) and PCR testing for 
ferlavirus (section 5.2.6  – Polymerase Chain Reaction), and later Sunshine virus (data not 
shown), was negative. 
5.2.2 Neuraminidase Activity 
Only cloacal swab samples from the Queensland zoological collection discussed earlier (page 
136)  were  selected  for  quantitation  of  neuraminidase  activity.  Activity  was  measured  by 
assessing  the  amount  of  a  neuraminidase  substrate  (2’-(4-methylumbelliferyl)-α-D-N-
acetylneuraminic acid) that was cleaved into a fluorescent product by the sample. Methods 
described earlier were followed (section 4.6 – Neuraminidase). An attenuated strain of human 
influenza virus (Table 4.2) and a ferlaviral isolate were used as positive controls, while cell 
culture medium (the medium the swabs were transported in) served as a negative control. All 
five cloacal swabs that were tested produced emissions at 480nm that were below those of 
the positive controls but above those of the negative control (Table 5.2). 
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Sample (HA titre [HAU / 50µL])  Emission at 480nm 
Influenza virus (1,024)  324 
Ferlavirus (64)  268 
Sample 1 (< 2)  114 
Sample 2 (< 2)  24 
Sample 3 (16)  177 
Sample 4 (< 2)  141 
Sample 7 (32)  137 
Cell culture medium (three replicates)  5.8, 5.8, 5.5 
Table 5.2 The neuraminidase (NA) activity present in five snake cloacal swabs collected from a zoological 
collection in Queensland. An attenuated strain of human influenza virus and a ferlavirus were used as 
positive controls while the medium that the swabs were stored in (cell culture medium) was used as a 
negative control. The NA substrate (2’-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid) was exposed 
to the sample for 18 hours at 30
0C. The emission at 480nm provides an estimate of the amount of NA 
substrate that has been cleaved into a fluorescent product. HAU = Haemagglutinating units. 
 
This experiment was adversely affected by the unsuitability of the negative control that was 
used. A more suitable control would have been cloacal swabs from seemingly healthy snakes. 
Statistical analysis may then have been needed to help demarcate significant from insignificant 
levels of NA activity. Steps were not taken to identify a suitable negative control and because 
of this, the results in this experiment cannot be validated. 
 
It was initially thought that a limitation of this assay was that NA activity (even if filterable) 
could be explained by neuraminidase-secreting species of bacteria (O'Toole et al., 1971). It was 
therefore decided that this test was unsuitable for screening primary samples and would be 
reserved for samples suspected to be free of bacteria (e.g. virus isolates). In hindsight and with 
further consultation with the literature, it has been shown that mammalian and bacterial NA 
activity  can  be  differentiated  from  viral  NA  activity  through  the  use  of 
ethylenediaminetetraacetic acid (EDTA) (Yolken et al., 1980). If this method was demonstrated 
to be applicable to snake cloacal swabs then this may have provided further insight into the 
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5.2.3 Haemagglutination Inhibition 
Blood  samples  (plasma,  serum  or  whole  blood)  were  submitted  from  12  Australian  snake 
collections for quantitation of anti-ferlaviral antibodies using a haemagglutination inhibition 
(HI) assay described earlier (section 4.5 – Haemagglutination Inhibition). Each collection had 
reason to suspect the presence of a ferlavirus (e.g. clinical signs, histopathology). In total, 86 
samples were tested but no titre exceeded 8 (defined as the greatest dilution that completely 
inhibited  haemagglutination).  This  included  serum  samples  that  were  submitted  from  the 
zoological  collection  in  Queensland  that  had  produced  two  cloacal  swabs  with 
haemagglutinating activity (page 136). Although there is disagreement within the literature as 
to where the specific cut-off between a positive and negative HI titre should be, titres that do 
not exceed 8 have always been considered negative  (Jacobson et al., 1992;  Jacobson and 
Origgi, 2007; Pasmans et al., 2007). 
 
The results of these HI assays were marred by non-repeatable and unusual red cell clumping 
(Figure 4.25) and many of these assays were performed before a positive control (serum from 
a western diamondback rattlesnake with an HI titre of > 256 / 50µL) was obtained from Dr 
Rachel Marschang in Germany, and so the results presented here should be viewed cautiously. 
Delays in obtaining the positive control serum were caused by the time needed to obtain the 
necessary  importation  permits.  When  the  positive  control  serum  became  available  for  HI 
testing, it performed reliably (Figure 4.21) but the unusual red cell clumping continued to 
occur in many samples (but never the positive control) until a new method of processing red 
cells was adopted (Table 4.1 and Figure 4.26). So while it may be tempting to conclude that 
this assay had the ability to detect a truly positive sample (the positive control) and therefore 
all the samples that were tested were negative, the sample results presented here should be 
considered equivocal until the negative predictive value of this assay is confirmed as being 
acceptable. 
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5.2.4 Electron Microscopy 
Unlike  haemagglutination  (HA),  neuraminidase  (NA)  and  haemagglutination  inhibition  (HI) 
assays, electron microscopic examination of samples can potentially identify a wide range of 
viruses. Transmission electron microscopy (TEM) can evaluate the size and morphology of a 
virus and if examining infected cells, also the site of replication (intranuclear, intracytoplasmic 
or both) (Jacobson and Samuelson, 2007). More specific identification of a virus is often reliant 
on molecular methods such as the sequenced products of polymerase chain reaction. 
 
The use of electron microscopy to directly examine clinical samples has been limited to only 
certain viruses e.g. adenoviruses in dragon cloacal washes (Jacobson and Samuelson, 2007). 
Identification of viral particles by electron microscopy is reliant on a number of factors: an 
experienced and patient pathologist (and/or electron microscopist) and an adequate quantity 
of virus in the specimen being examined (Jacobson and Samuelson, 2007). For these reasons, 
electron microscopic examination of samples that were submitted to the present study was 
restricted to sample types where a virus was likely to be present in high numbers.  
 
Consideration was given to the ultrastructural examination of the surface of erythrocytes that 
had been haemagglutinated by cloacal swab samples (Figure 5.1) but a preliminary study using 
positive control material concluded that the haemagglutination titres of these samples (8-16 
and 32 HA / 50µL) would be far too low to allow visualisation of viral particles (section 4.7.2 – 
Scanning Electron Microscopy). Furthermore, even if viral particles were found, the limited 
magnification  and  the  inability  to  assess  the  internal  structures  of  the  viruses  would  be 
inadequate to identify the family that the virus belongs to. Consequently, this idea was not 
pursued. 
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The ultrastructural assessment of inclusion bodies identified by light microscopy has been used 
to characterise the contents of the inclusion (Jacobson et al., 1997; Jacobson and Samuelson, 
2007). Samples were selected that had inclusion bodies that could be convincingly identified 
under light microscopy (Figures 5.4 and 5.5). Samples were processed for positive staining 
transmission electron microscopy (TEM) according to the methods described earlier (section 
4.7.1 – Transmission Electron Microscopy). 145 | P a g e  
 
 
Figure 5.4 Section of brain from a Stimson’s python (Antaresia stimsoni) displaying neurological signs. 
Stained  with  haematoxylin  and  eosin  (H&E).  Top:  low-power  view  (40x).  Bottom:  Eosinophilic 
intranuclear inclusion bodies (arrows) can be seen in a large number of ependymal cells lining a ventricle 
(1,000x). 
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Figure 5.5 Section of brain from a south-west carpet python (Morelia spilota imbricata) displaying subtle 
neurological signs. Stained with haematoxylin and eosin (H&E). Top: low-power view (40x). Bottom: 
Massive number of eosinophilic intranuclear inclusion bodies (arrows) can be seen throughout the brain 
(400x).147 | P a g e  
 
No convincing viral particles could be detected within any inclusion body that was examined by 
TEM; only what appeared to be amorphous material could be seen (Figure 5.6). 
 
    
 
Figure 5.6 Transmission electron microscopic (TEM) view of an inclusion body in the brain of a Stimson’s 
python  (Antaresia  stimsoni)  displaying  neurological  clinical  signs  (top).  A  published  image  of  an 
intracytoplasmic  inclusion  body  (IC)  in  a  viper  heart  cell  infected  with  a  ferlavirus  is  provided  for 
comparison  (Jacobson  et  al.,  1997)  (bottom);  the  authors  state  that  the  inclusion  body  contains 
nucleocapsid material. Scale bar = 7µm. Top Left: Low power view of the nucleus of an ependymal cell 
showing the central inclusion body.  Right: Higher power view of  the inclusion body revealing  what 
appears to be amorphous material. 
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For some viruses, the contents of its associated inclusion body can be reliably anticipated. For 
example,  the  viral  inclusions  associated  with  measles  virus  infection  consistently  contain 
nucleocapsid material (Ghadially, 1988). But this is not always the case as some viral inclusions 
are made of amorphous material (Geisbert and Jahrling, 1995). In the present study, there was 
no  clear  evidence  that  the  inclusion  bodies  examined  contained  viral  proteins  (e.g. 
paramyxoviral nucleocapsids), but the possibility that the inclusions were still viral in nature 
should not be excluded. However, inclusion bodies have been seen in other reptiles that were 
considered  to  be  non-viral  in  origin.  For  example,  the  ultrastructural  appearance  of  the 
intranuclear  and  intracytoplasmic  inclusions  in  the  liver  of  a  Deckert’s  rat  snake  (Elaphe 
obsoleta deckerti) was most consistent with a type of storage material (possibly lysosomal in 
origin) (Jacobson et al., 1979). And in two more reports, non-viral inclusions were detected in 
the lung of a desert tortoise (Gopherus agassizii) (Jacobson and Samuelson, 2007) and the liver 
of a king snake (Lampropeltis getula) (Jacobson et al., 1980a). This means that the possibility 
that the inclusion bodies examined in the present study were non-viral in origin should also be 
considered. 
 
Electron microscopic examination of samples is usually performed to determine the family that 
a virus belongs to. This information can then be utilised in molecular methods to facilitate 
more specific and definitive identification of the virus. Considering the equivocal results that 
had been obtained from electron microscopy, no further attempts to identify viral particles 
were made. 
5.2.5 In situ Hybridisation 
In situ hybridisation is a method that has allowed the detection of ferlaviral-specific nucleic 
acids in formalin-fixed paraffin-embedded (FFPE) samples (West et al., 2001; Sand et al., 2004). 
Despite numerous attempts by the author to establish a method that would reliably detect 
abundant housekeeping genes (e.g. 18S rRNA) in FFPE snake sections (section 4.9 – In situ 
Hybridisation),  only  irregular  staining  could  be  achieved  inconsistently.  Considering  that 149 | P a g e  
 
reliable detection of ubiquitous housekeeping genes could not be validated and moreover, 
that  ISH  requires  prior  knowledge  of  the  nucleic  acid  sequence  of  the  virus  of  interest, 
screening samples by ISH was not performed. 
 
It was decided that only when a viral sequence had been determined from at least one of the 
snake  samples  being  screened  for  viruses,  would  this  test  be  revisited.  When  this  finally 
occurred (approximately four years later), ISH was not performed due to time-constraints. It is 
intended that ISH will be used in future studies to detect Sunshine virus in FFPE material. 
5.2.6 Polymerase Chain Reaction 
In total, 50 samples were assessed by polymerase chain reaction (PCR) for the presence of a 
selection of viruses. These samples consisted of swabs (23), tissue samples (23) and formalin-
fixed  paraffin-embedded  (FFPE)  material  (4).  Samples  were  submitted  from  snakes  with 
histories, clinical signs, diagnostic test results and/or pathological findings that were consistent 
with a virus (or viruses) that affected the neurorespiratory systems. More specifically, anti-
ferlaviral  antibodies  (Table  3.1)  and  demyelinating  encephalopathies  with  interstitial 
pneumonias (Figures 3.3-3.5) had been detected in some of these snakes. This meant that a 
paramyxovirus was of the greatest interest. However, reoviruses and retroviruses (possibly the 
aetiological agent of inclusion body disease (IBD) (Chang and Jacobson, 2010)) needed to be 
considered  as  well  (discussed  in  greater  detail  on  page  67).  Due  to  the  challenges  in 
differentiating  endogenous  from  exogenous  retroviruses
5  and the complexities in linking  
retroviruses to snake disease (Huder et al., 2002; Vancraeynest et al., 2006), it was decided to 
initially  delay  investigations  of  a  retrovirus.  Testing  for  reoviruses  would  become  more 
important if a paramyxovirus could not be detected. 
 
                                                           
5 The interested reader is directed to the article by Hofacre and Fan (2010) that reviews the endogenous 
and exogenous forms of Jaagsiekte sheep retrovirus (JSRV). 150 | P a g e  
 
In summary, PCR was primarily used to screen samples for ferlaviruses (genus-level detection) 
and more broadly, for paramyxoviruses (family-level detection). The primer sets that were 
used in this study were selected from published reports or were designed by the author. Each 
primer  set  would  theoretically  be  able  to  detect  a  broad  range  of  ferlaviruses  and/or 
paramyxoviruses (Tables 4.3 and 4.4). 
 
A filterable haemagglutinating agent with neuraminidase activity had been detected in two 
Queensland  swab  samples  (Figures  5.1  and  5.2,  Table  5.2).  During  the  PCR  testing  for 
paramyxoviruses, particular attention was paid to these two samples. After extensive testing, 
none  of  the  paramyxovirus  primers  designed  in-house  (eight  single-round  PCRs)  nor  the 
primers designed by Ahne et al. (1999b) (two nested PCRs) (Tables 4.3 and 4.4) yielded an 
amplicon of the expected size. 
 
Of the rest of the submitted samples, only occasionally was an amplicon produced that was 
near to the expected size. In these situations, the PCR products were sequenced but in all 
cases,  the  Basic  Local  Alignment  Search  Tool  for  nucleotides  (BLASTN, 
http://blast.ncbi.nlm.nih.gov/Blast.cgi)  did  not  identify  any  similarities  to  the  sequences  in 
GenBank  (National  Center  for  Biotechnology  Information,  Bethesda,  Maryland).  Therefore, 
sequencing could not confirm that these products were of viral origin. 
 
Samples were sometimes examined for reoviruses using the primers published by Wellehan et 
al.  (2009).  Only  samples  that  were  highly  suspicious  of  harbouring  a  paramyxovirus  or  a 
reovirus (based on history, clinical signs and pathological findings), and previous testing for a 
paramyxovirus was negative, were tested for the presence of a reovirus. No amplicons of the 
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5.2.7 Virus Isolation 
For  virus  isolation,  161  samples  were  examined  (12  cloacal/oral  swabs  and  149  tissue 
samples). Swab and tissue samples were processed and then inoculated onto susceptible cells 
(sometimes Vero cells but usually viper heart (VH2) cells) using the methods described earlier 
(section 4.2 – Virus Isolation and Propagation). Virus isolation was not attempted on the two 
cloacal  swabs  mentioned  earlier  (page  136).  After  the  swabs  had  been  used  for  2-3 
haemagglutination assays, a neuraminidase assay and polymerase chain reaction, insufficient 
sample  volume  remained  for  virus  isolation.  For  virus  isolation  attempts,  uninfected  cells 
served as negative controls while two strains of ferlavirus, Fer-de-Lance virus (FDLV, ATCC VR-
895) (Figure 4.3) and neotropical ophidian paramyxovirus (ATCC VR-1408) (Figure 4.4), served 
as positive controls. Although some curious changes to cellular morphology were seen in some 
virus  isolation  attempts  (Figure  5.7),  the  findings  were  never  repeatable,  and  after 
consultation with other virologists, these cells were not investigated further for the presence 
of viruses. 
 
 
Figure 5.7 Unusual cell morphology seen in a flask of viper heart (VH2) cells. After several days, the cells 
became indistinguishable from the background population. Scale bars = 100µm. 
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Sample  Submission  One  –  an  Outbreak  of  Neurorespiratory  Disease  in  a  Private 
Collection from the Sunshine Coast of Queensland 
In July 2008, a private breeder of birds and reptiles from Queensland acquired seven jungle 
carpet pythons (Morelia spilota cheynei) as a breeding loan to add to their collection of 70 
Australian  pythons  (Antaresia  sp.,  Morelia  spilota  ssp.  and  Aspidites  sp.).  Prior  to  the 
acquisition of these snakes, all the snakes in the main collection had been eating well, were in 
good body condition and were not displaying any overt signs of illness. Five of the seven 
recently-acquired snakes were emaciated, had dysecdysis (including retained spectacles) and 
were burdened with moderate mite infestations. For biosecurity reasons, these five snakes 
were humanely euthanased on the day they arrived. The remaining two snakes also had mite 
burdens and were treated with topical ivermectin (5mg/L). The main snake collection and the 
remaining two snakes (an adult male and an unsexed juvenile) that had been recently-acquired 
were all individually housed in a single room with the recently-acquired snakes kept separate 
from the main collection by several metres. Husbandry equipment was not shared between 
the newly-acquired snakes and the snakes in the main collection. The two groups were never 
attended to on the same day. A timeline of the events that unfolded in this collection are 
presented in Figure 5.8. 
 
Approximately 90 days after the newly-acquired snakes arrived, while they were still being 
kept separate to the main collection, it was noticed that approximately one quarter of the 
main collection had mite infestations and were treated with ivermectin. Twenty one days later 
the  apparently  healthy,  newly-acquired  adult  male  was  released  into  the  main  collection. 
Approximately 40 days later, there was a thermostat failure that coincided with cold weather 
(minima of <15
0C). Seven snakes started to show neurorespiratory clinical signs consisting of a 
mild discharge of clear viscous fluid from the mouth, stomatitis, dyspnoea and lethargy. These 
snakes were treated with enrofloxacin (5mg/kg IM sid x 21 days). After an initial improvement, 
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antibiotics.  Clinical  signs  consisted  of  opisthotonos,  inability  to  right,  head  tremors, 
independent movement of the cranial and caudal halves of the body, mild discharge of clear 
viscous fluid from the mouth, dyspnoea and lethargy. The most severely affected individual 
(M.s.cheynei from the main collection) died a few days later. A necropsy revealed congested 
lung  tissue  but  was  otherwise  unremarkable.  Histopathology  revealed  demyelinating,  non-
suppurative encephalitis with prominent eosinophilic intranuclear inclusion bodies and rare 
intracytoplasmic inclusions. A section of lung revealed prominent congestion and oedema. 
 
Several days later, the second newly-acquired snake (M.s.cheynei, while still in quarantine) 
developed acute neurorespiratory clinical signs and died two days later. Gross pathology and 
histopathological  findings  were  similar  to  the  first  death.  Approximately  seven  days  later, 
another seven snakes started to display similar neurorespiratory clinical signs. The previously 
affected  snakes  were  continuing  to  display  mild  chronic  neurorespiratory  clinical  signs. 
Approximately another seven days later, the decision was made to depopulate, so the 70 
remaining snakes were humanely euthanased. 
 
Samples were retrieved from 17 snakes (selection was based on clinical signs and/or which 
snakes they had been in direct contact with). The brain and a portion of lung, liver and kidney 
were collected from 16 of these snakes. Half of the organ sample was frozen immediately and 
the  other  half  was  placed  into  4%  (v/v)  formalin.  The  brain  was  not  submitted  from  the 
seventeenth snake but the rest of the organ samples were collected identically. Blood was 
collected from 13 of these 17 snakes, and serum was then frozen down. Frozen organ samples 
and serum were submitted (on dry ice, using an overnight courier) to the author for further 
testing. After 24 hours of fixation, formalin was decanted from the “wet” formalin-fixed organ 
samples and the samples were submitted to the author using regular postage. 154 | P a g e  
 
 
Figure 5.8 Timeline of events of a private collection of pythons from the Sunshine Coast in Queensland starting from the acquisition of seven jungle carpet pythons 
(Morelia spilota cheynei) and finishing when the entire collection was humanely euthanased several months later. 
Day 1
Main collection = 70 snakes (Antaresiasp., Morelia
spilotaspp., Aspidites sp.)
Seven jungle carpet pythons (M.s.cheynei) 
acquired. Five euthanased due to ill-health
Days 1-21
Tworemaining newly acquired jungle 
carpet pythons (M.s.cheynei) treated with 
topical ivermectin for mite infestation
Days 90-111
Mite infestation detected in 
approximately 25% of main collection. 
Treated with topical ivermectin
Day 110
First of the newly acquired snakes released 
into main collection (adult male)
Day 183
First death (M.s.cheyneifrom main collection). Gross necropsy revealed congested 
lung tissue but otherwise was unremarkable. Histopathology revealed 
demyelinating, non-suppurative encephalitis with prominent eosinophilic 
intranuclear inclusion bodies and rare intracytoplasmic inclusions. Section of lung 
revealed prominent congestion and oedema.
Day 186
Second death (M.s.cheyneiwhile still being held in quarantine). Gross and 
histopathological assessment similar to first death
Days 186-193
Seven more snakes show neurorespiratory clinical signs. All clinically affected 
snakes continue to show chronic mild signs
Day 200
Entire collection humanely euthanased
Days 146-150
Thermostat failure coinciding with four days of cold weather
Day 150
Seven individuals show neurorespiratory signs (mild discharge of clear 
viscous fluid from mouth, stomatitis, dyspnoea and lethargy)
Thermostats repaired
Days 150-171
Three week treatment of the seven affected snakes with enrofloxacin
Days 170-180
After initial improvement, the seven affected snakes show further 
development of clinical signs (opisthotonus, inability to right, head tremors, 
independent movement of cranial and caudal halves of body, mild discharge 
of clear viscous fluid from mouth, dyspnoea and lethargy)
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Sample Submission Two – Samples collected by Dr Cathy Shilton from the Berrimah 
Veterinary Laboratories (BVL) in Darwin, Northern Territory 
From 2005 to 2008, Dr Cathy Shilton, an anatomical veterinary pathologist from the Northern 
Territory (NT), identified nine snakes from four separate NT locations that had histories, clinical 
signs and/or pathological findings that were considered consistent with a viral (potentially 
paramyxoviral) infection. Formalin-fixed paraffin-embedded (FFPE) material was available from 
all nine snakes. Additionally, samples from three brains and two lungs were collected from 
four snakes, representing one of these sources. These samples were stored at -80
0C before 
being submitted on dry ice to the author. 
Cytopathic Effects 
In total, virus isolation was attempted on 161 samples (12 swabs and 149 tissue samples), 76 
of which were from Sample Submissions One and Two (67 and nine samples respectively). 
Samples  were  processed  and  then  inoculated  onto  viper  heart  (VH2)  cells  as  previously 
described (section 4.2 – Virus Isolation and Propagation). The kidney and liver samples from 
each snake from Sample Submission One (Sunshine Coast, Queensland) were pooled to save 
time and reagents. After the clarified tissue suspensions from clinically-affected snakes had 
been inoculated onto VH2 cells, the cells were examined daily for cytopathic effects (CPE). Of 
the 161 samples that were examined by virus isolation, CPE was detected in nine samples from 
five snakes (Table 5.3). All five snakes were from Sample Submissions One or Two. In all cases, 
CPE was characterised by extensive formation of multinucleate giant cells (Figures 5.9 and 
5.10). Very little cell lysis was noted irrespective of the method of blind passage (freeze-thaw 
or trypsinisation) or the length of time (up to three weeks) that the cells were left to incubate 
after the emergence of CPE (data not shown). During these experiments, cell rounding, cell 
detachment and perinuclear granulation were not significant hallmarks of this virus’s CPE. 
Cytoplasmic vacuolation was seen occasionally (Figure 5.10). 156 | P a g e  
 
Species: Abbreviation  Sample Origin  Clinical History 
Virus Isolation 
(first appearance of CPE) 
Brain  Lung 
Kidney-
Liver 
Jungle carpet python (Morelia 
spilota cheynei): JCP1Qld 
Sunshine Coast, 
Queensland 
Subtle neurological signs. Shared enclosure with snake 
that died acutely 
+ (p2d2)  -  + (p3d3) 
Black-headed python (Aspidites 
melanocephalus): BHP1 
Sunshine Coast, 
Queensland 
Low  grade  respiratory  disease  and  stomatitis.  Shared 
enclosure with two snakes (one after the other) that died 
acutely 
+ (p2d2)  + (p2d2)  + (p2d1) 
Jungle carpet python 1: JCP1NT  Northern Territory  Several snakes from  this  collection showed dysecdysis, 
anorexia, neurological signs and/or   death over several 
weeks. This snake was euthanased while still relatively 
active 
+ (p1d5)  + (p1d4)  n.s. 
Jungle carpet python 2: JCP2NT  Northern Territory  Died naturally  -  + (p1d4)  n.s. 
Jungle carpet python 3: JCP3NT  Northern Territory  Moribund  + (p1d6)  n.s.  n.s. 
Table  5.3  Positive  virus  isolation  results  from  snakes  from  a  source  of  samples  submitted  from  the  Sunshine  Coast,  Queensland  and  Berrimah  Veterinary 
Laboratories, Northern Territory. Positive virus isolation was defined by characteristic cytopathic effects (CPE) (large syncytium with minimal cell lysis). - = negative. + 
= positive. n.s. = not sampled. pXdY = the passage number and days since the last passage. The day of cell inoculation = p1d1.  157 | P a g e  
 
 
 
Figure 5.9 Uninfected viper heart (VH2) cells (above) and VH2 cells infected with the supernatant of a 
lung  suspension  from  a  black-headed  python  (Aspidites  melanocephalus)  that  died  with 
neurorespiratory signs of disease (bottom). Extensive formation of multinucleate giant cells can be seen 
in the infected culture. Scale bars = 100µm. 158 | P a g e  
 
 
 
Figure 5.10 Viper heart (VH2) cells infected with the supernatant of a brain suspension from a jungle 
carpet  python  (Morelia  spilota  cheynei)  that  died  with  neurorespiratory  signs  of  disease.  Extensive 
formation of multinucleate giant cells and a cell with a large amount of intracytoplasmic vacuolation 
(arrow) can be seen. Scale bar = 100µm. 
 
Supernatant from viper heart (VH2) cells that were infected with a lung suspension from a 
black-headed  python  from  the  Sunshine  Coast  (BHP1-Lung,  Table  5.3)  was  selected  for 
additional testing in an effort to further characterise this isolate. This isolate was selected 
because it produced widespread CPE and was from a snake that was positive by virus isolation 
in all organ samples tested. The selection of the isolate from the lung, as opposed to the brain 
or kidney-liver, was arbitrary. 
 
Three passages of BHP1-Lung (p1 → p4) in viper heart cells demonstrated that the CPE could 
be observed repeatedly (Figure 5.11). The viral titre of BHP1-Lung (at the fourth passage) was 
calculated  using  the  Reed-Muench  method  as  previously  described  (section  4.2  –  Virus 
Isolation and Propagation). The tissue culture infectious dose (TCID50) was calculated as 10
2.75 159 | P a g e  
 
mL
-1.  This virus  was  sent to  the  veterinary virology  laboratory  at  the  Berrimah  Veterinary 
Laboratories (BVL) in the Northern Territory for archiving and continuing investigation. In the 
hands of one of the virologists at this laboratory, a viral titre (TCID50), using the same VH2 cell 
line, of at least (further serial dilutions not performed) 10
5 mL
-1 was obtained (Richard Weir, 
pers. commun.). So it is possible that this virus does not inherently replicate at a low viral titre 
but instead may be sensitive to its growth conditions. 160 | P a g e  
 
 
 
Figure 5.11 Uninfected viper heart (VH2) cells (top image) compared to BHP1-Lung throughout three 
passages (bottom two rows). The third day of the second passage (p2d3) shows early cytopathic effects 
(CPE) in the form of syncytial cell formation. Three days later (p2d6), further progression of CPE can be 
seen. Syncytial cells are larger and there is considerable cytoplasmic clearing around a central cluster of 
nuclei. Similar CPE can be seen during the next two passages (p3d7 and p4d8). Scale bars = 100µm.
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Once the CPE could be reliably anticipated, a short experiment was set up to compare two 
different methods of viral passage: trypsinisation and freeze-thawing. For trypsinisation, the 
virus was passaged by  trypsinising and splitting infected cells (one to three split). For the 
freeze-thaw  method,  the  virus  was  passaged  by  freezing,  thawing,  clarifying  and  then 
inoculating infected cell lysate onto uninfected cells. For each of these two methods, the viral 
passage was performed at two different intervals. For the short interval, once CPE could be 
seen in 10% of the monolayer (four days), the virus was passaged, and then again two days 
later. For the long interval, the virus was passaged two days later than the short interval (six 
days). 
 
Passaging the virus using the trypsinisation method appeared to outperform the freeze-thaw 
method as it clearly augmented the percentage of the monolayer that was displaying CPE 
(Table 5.4 and Figure 5.12). However, this experiment did not involve several passages, was 
not repeated, did not use any replicates for each passage method and only crudely assessed 
viral  titre  by  using  CPE  as  a  surrogate  marker.  So  although  there  appears  to  be  a  clear 
advantage  by  passaging  the  virus  by  splitting  the  infected  cells,  the  results  of  this  short 
experiment  should  not  be  over-interpreted.  This  experiment  was  not  able  to  provide  an 
optimal passage interval or an optimal splitting ratio (e.g. 1:2, 1:3, 1:4 etc). 
 
It  has  been  shown  that  Fer-de-Lance  virus  contains  a  fusion  gene  that  is  expressed  as  a 
precursor protein (F0) which is then cleaved by the ubiquitous host cell enzyme, furin, into 
active subunits (Franke et al., 2006). In 1996, Richter et al. described the use of trypsin to 
improve the in vitro infectivity of three strains of ferlavirus. It was presumed that the improved 
infectivity was caused by trypsin cleaving the inactive fusion protein precursor into its active 
subunits. The trypsinisation method seemed to improve the infectivity of BHP1-Lung and this 
may have been attributable to the presence of trypsin. 
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Passage method 
Days since start of experiment 
0  4  5  6  7  8  11  23 
Freeze-thaw: short interval  0%  10%  1%  1%  0%  0%  1%  10% 
Freeze-thaw: long interval  0%  10%  10%  5%  1%  0%  1%  10% 
Trypsinisation: short interval  0%  10%  60%  50%  30%  20%  20%  20% 
Trypsinisation: long interval  0%  10%  15%  15%  10%  25%  20%  20% 
Table  5.4  Percentages  of  viper  heart  (VH2)  cell  monolayers  displaying  cytopathic  effect  following 
inoculation of BHP1-Lung. Four methods of viral passage are compared. Viral passages are underlined 
and displayed in bold type and for these days, the percentage is representative of the CPE of the 
monolayer before the passage. 163 | P a g e  
 
 
 
Figure 5.12 Viper heart (VH2) cells infected with BHP1-Lung. Above: Two days after BHP1-Lung-infected 
VH2 cells were split 1:3 (10% of monolayer was showing cytopathic effects [CPE] before this split). 
Approximately 50% of the monolayer is displaying CPE in the form of syncytial cell formation (arrows). 
Below: Two days after BHP1-Lung-infected cells (CPE was also 10%) were frozen, thawed, clarified and 
then the supernatant was inoculated onto uninfected VH2 cells. Only about 1% of the monolayer is 
displaying subtle signs of CPE. A small multinucleate cell can be seen (arrow). Scale bars = 100µm.164 | P a g e  
 
A brief attempt was made to assess the infectivity of BHP1-Lung in a second cell line. BHP1-
Lung was inoculated onto Vero cells using the methods described earlier for a freeze-thaw 
passage. Briefly, viper heart (VH2) cells infected with BHP1-Lung were frozen, thawed, clarified 
and then the supernatant was inoculated onto Vero cells. Inoculated cells were assessed daily 
for cytopathic effects (CPE) and after two weeks, a freeze-thaw passage was repeated. CPE 
could not be detected in Vero cells. Many paramyxoviruses are known to have a broad in vitro 
host range (Lamb et al., 2005) and ferlaviruses, for example, are capable of replication in Vero 
cells (Mayr et al., 2000) (Figure 4.4). This experiment was performed before it was shown that 
BHP1-Lung seemed to produce more widespread CPE when passaged using the trypsinisation 
method. Future experiments that aim to define the in vitro host range of BHP1-Lung should 
consider using a method that includes exposure to trypsin. This short study was not pursued as 
physicochemical  investigations  that  might  have  been  able  to  provide  insight into  the  viral 
family that BHP1-Lung belongs to were seen as higher priorities. 
 
After attempting virus isolation from 161 samples, a virus (or viruses) had been isolated into 
viper  heart  (VH2)  cells  that  repeatedly  produced  cytopathic  effects  (CPE)  in  the  form  of 
widespread syncytial cell formation with minimal cell lysis. Based on the CPE seen, it was 
considered most likely that BHP1-Lung would be a member of one of four families of syncytial 
cell-forming  viruses:  reovirus,  paramyxovirus,  retrovirus  or  herpesvirus.  Reovirus  and 
paramyxovirus  infections  and  inclusion  body  disease  (potentially  caused  by  a  retrovirus 
(Schumacher  et  al.,  1994))  have  all  been  implicated  in  neurorespiratory  disease  in  snakes 
(Marschang and Chitty, 2004; Ritchie, 2006; Jacobson, 2007). Although a herpes-like virus was 
isolated from a green iguana (Iguana iguana) that caused syncytial cell formation in cell culture 
(Clark and Karzon, 1972), the histories, clinical signs and pathological findings of the five snakes 
(Table 5.3) that a virus (including BHP1-Lung) was isolated from, were inconsistent with a 
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5.2.8 Summary of Sample Testing 
To this point, testing 217 samples by HA, 5 by NA, 86 by HI and 50 by PCR had produced only 
two interesting results: two cloacal swabs that each contained a filterable haemagglutinating 
agent and also possessed NA activity. Examination of inclusion bodies by TEM had also failed 
to identify a virus. Screening 161 samples by VI had produced (by far) the most compelling 
results: nine viruses were isolated that all produced similar CPE. One of these isolates was 
selected  for  further  testing,  BHP1-Lung,  and  this  additional  testing  is  discussed  in  the 
remainder of this chapter. 
5.3  Laboratory Investigations of BHP1-Lung 
5.3.1 Electron Microscopic Examination 
Examination of the ultrastructure of BHP1-Lung could potentially allow identification of the 
viral family it belongs to. BHP1-Lung had repeatedly shown the ability to cause syncytial cell 
formation and this suggested that it was most likely to be a reovirus, paramyxovirus, retrovirus 
or herpesvirus. These four viruses all have characteristic ultrastructural appearances (Table 
5.5).  Images  can  be  reviewed  elsewhere:  for  ferlaviruses  see  Figure  2.8;  for  reptilian 
orthoreoviruses and a mammalian orthoreovirus (Nelson Bay orthoreovirus, NBV), see Ahne et 
al.  (1987b)  and  Figure  4.30  respectively;  for  retroviruses,  see  Linial  et  al.  (2005);  and  for 
herpesviruses, see Davison et al. (2005). 
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Characteristic  Orthoreovirus  Ferlavirus  Retrovirus  Herpesvirus 
Morphology  icosahedral (but 
can appear 
spherical), spiked 
at the vertices, 
“cygnet ring” 
appearance, 60-
80nm 
pleomorphic, 
spiked, “herring 
bone” appearance 
to nucleocapsid 
protein, 30-500nm 
spherical, small 
surface 
projections, 80-
100nm 
characteristic 
appearance, 
spherical, ~200nm 
Buoyant density  1.36g/cm
3 in CsCl  1.13-1.18g/cm
3 in 
sucrose 
1.16-1.18g/cm
3 in 
sucrose 
1.22-1.28g/cm
3 in 
CsCl 
Table 5.5 Descriptions of the ultrastructural appearances of orthoreoviruses (Chappell et al., 2005), 
ferlaviruses (Richter et al., 1996), retroviruses (Linial et al., 2005) and herpesviruses (Davison et al., 
2005). 
 
Being able to visualise reptilian viruses by transmitting electron microscopy (TEM) requires a 
skilled and patient pathologist and the likelihood of success will be improved if the virus is 
abundant  (Jacobson  and  Samuelson,  2007).  Prior  to  visualisation  by  electron  microscopy, 
viruses can be concentrated by ultracentrifugation. Additionally, the virus can also be purified 
by ultracentrifuging the virus in a density gradient of either caesium chloride (for isopycnic 
centrifugation) or sucrose (for rate-zonal centrifugation) (Mahy and Kangro, 1996). Viruses will 
equilibrate into specific areas along this gradient and this point can be used to help determine 
the viral identity (Table 5.5). 
 
Several different sample types of BHP1-Lung were examined by TEM. Unprocessed, clarified, 
clarified/PEG-precipitated and clarified/ultracentrifuged culture media, and clarified frozen-
thawed cell lysate were all examined by TEM after negative staining with phosphotungstic 
acid. TEM was also used to examine intact infected cells after positive staining with uranyl 
acetate and lead citrate. Using the trypsinisation method (page 161 and Figure 5.12), cells 
exhibiting  extensive  cytopathic  effects  (CPE)  could  be  examined.  The  methods  for  sample 
processing and staining were described earlier (section 4.7 – Electron Microscopy). 
 
For all samples of BHP1-Lung that were examined by positive or negative staining TEM, no viral 
particles could be confidently identified after extensive searches. The most interesting image 167 | P a g e  
 
of a “virus-like” particle is presented in Figure 5.13. Unprocessed cell culture supernatant from 
a flask infected with JCP1NT-Brain (jungle carpet python 1 (Northern Territory) – brain) (Table 
5.3) was also extensively examined and no viral particles could be detected. 
    
   
Figure 5.13 A virus-like particle from a sample of BHP1-Lung (top row), viewed under TEM after negative 
staining  with  phosphotungstic  acid,  is  compared  to  two  published  images  that  show  ferlaviruses 
(bottom row). The size (~175nm), shape (spherical) and “spiked” surface of the “virus-like” particle are 
all  consistent  with  a  paramyxovirus  but  the  characteristic  “herring  bone”  appearance  of  the 
nucleocapsid protein (seen in a disrupted ferlavirus, bottom left (Ahne and Mayr, 2000)) cannot be 
seen. The staining pattern of the “virus-like” particle implies that it is hollow (compare to the intact 
ferlavirus, bottom right (Marschang et al., 2002)) and there is no evidence that the “membrane” was 
disrupted. Ferlaviral scale bars = 100nm 
 
Electron microscopy generally requires a high viral titre. The low viral titre achieved in this 
study (Tissue Culture Infectious Dose (TCID50) = 10
2.75 mL
-1) may help explain why viral particles 
could not be found. In anticipation of this concern, samples of BHP1-Lung were concentrated 
using several methods and the supernatant of a separate sample (JCP1NT-Brain) of infected 
viper heart cells were examined but viral particles continued to elude detection. 168 | P a g e  
 
 
As mentioned earlier, identification of viral particles by electron microscopy is reliant on a 
number of factors: an experienced and patient pathologist (and/or electron microscopist) and 
an adequate quantity of virus in the specimen being examined  (Jacobson and  Samuelson, 
2007). To this end, the failure to identify any viral particles in samples infected with BHP1-Lung 
may have been attributable to the relative inexperience of the author in electron microscopy. 
Outsourcing positively-staining grids of infected cell culture and negatively-stained grids of cell 
culture supernatant to more experienced electron microscopists (e.g.  Dr Alex Hyatt at the 
Australian Animal Health Laboratories [AAHL]) may have been helpful. 
5.3.2 Haemagglutination and Haemadsorbing Activity 
BHP1-Lung had repeatedly shown the ability to cause syncytial cell formation in cell culture 
and  this  suggested  that  it  was  most  likely  to  be  a  reovirus,  paramyxovirus,  retrovirus  or 
herpesvirus.  
 
Ferlaviruses  (all  previously  discovered  reptilian  paramyxoviruses)  have  the  capability  to 
haemagglutinate a selection of vertebrate erythrocytes (Richter et al., 1996; Kolesnikovas et 
al., 2006), however, many paramyxoviruses outside of the proposed ferlavirus genus have not 
shown  any  haemagglutinating  activity  (Lamb  et  al.,  2005).  All  reoviruses  that  have  been 
detected in reptiles have been tentatively assigned to the genus Orthoreovirus (Marschang, 
2011) and although some mammalian orthoreoviruses have demonstrated haemagglutination 
capabilities (e.g. Mammalian orthoreovirus 1) (Chappell et al., 2005), no reptilian orthoreovirus 
has shown this trait (Ahne et al., 1987b; Vieler et al., 1994; Lamirande et al., 1999; Chappell et 
al., 2005). Retroviruses have not been shown to have any haemagglutinating activity. Feline 
and canine herpesviruses have been shown to possess haemagglutination activity (Gillespie 
and Judkins, 1974; Xuan et al., 1990) but the author was unable to find any investigations 
trying  to  identify  the  ability of reptilian  herpesviruses  to  haemagglutinate erythrocytes.  In 
summary,  if  BHP1-Lung  was  found  to  have  haemagglutinating  activity,  it  would  raise  the 169 | P a g e  
 
suspicion that BHP1-Lung was a paramyxovirus (likely ferlavirus) and reduce the likelihood that 
it was a reovirus, retrovirus or herpesvirus. 
 
The  haemagglutinating  ability  of  BHP1-Lung  was  investigated  by  (1)  assessing  the  in  vitro 
macroscopic haemagglutination (HA) of guinea pig and chicken erythrocytes under various 
conditions and (2) assessing the haemadsorbing (Hd) traits of viper heart cells infected with 
BHP1-Lung. 
 
Previously, samples were screened for the presence of a haemagglutinating agent using only 
chicken erythrocytes but to broaden the scope of this assay, the choice of erythrocyte was 
reviewed. For ferlaviruses at least, the reliability of haemagglutination has been dependent on 
what erythrocytes were used (Richter et al., 1996). The decision was made to use guinea pig 
and chicken erythrocytes because these are the two species that have been used in HA and 
haemagglutination inhibition (HI) assays for ferlaviruses both in diagnostic laboratories and in 
the published literature. Guinea pig erythrocytes are used by the Texas Veterinary Medical 
Diagnostic Laboratory and have also been used by various authors (Clark et al., 1979; Richter et 
al., 1996; Allender et al., 2006). Chicken erythrocytes are used by the University of Florida in 
the USA and Honhenheim University in Germany. They were also selected by several authors 
of published reports (Clark et al., 1979; Jacobson et al., 1980b; Jacobson et al., 1981; Potgieter 
et al., 1987; Jacobson et al., 1991; Jacobson et al., 1992; Blahak, 1995; Richter et al., 1996; 
Jacobson et al., 1997; Gravendyck et al., 1998; Franke et al., 2001; Jacobson et al., 2001a). 
 
Three samples from a flask of viper heart (VH2) cells infected with BHP1-Lung were assessed 
for  haemagglutination  (HA)  activity.  These  assays were  performed  in  accordance  with  the 
methods  described  previously  (section  4.3  –  Haemagglutination).  Untreated  supernatant 
formed the first sample and HA activity was assessed using chicken erythrocytes (Figure 5.14). 
The next two samples were taken from clarified frozen-thawed cell lysate, one of which was 170 | P a g e  
 
additionally concentrated by polyethylene glycol (PEG) precipitation (Figure 5.15). These three 
samples were then added to chicken and/or guinea pig erythrocytes and assessed for HA 
activity.  Untreated  ferlavirus,  and  ferlavirus  that  had  been  concentrated  using  PEG-
precipitation (Figure 4.17), served as positive controls for this assay. Phosphate-buffered saline 
(PBS) was used as a negative control. 
 
Other samples were also analysed. In addition to BHP1-Lung, the unprocessed supernatants of 
VH2 cells that were infected with samples from Queensland and the Northern Territory (Table 
5.3) were also assessed for HA activity (Figures 5.14 and 5.16). 
 
 
Figure 5.14 Haemagglutination activity of the supernatant from four flasks of viper heart (VH2) cells with 
syncytial cell formation. Isolates were at the fourth day of their second passage. PBS = Phosphate-
buffered saline. Abbreviations for each sample are defined in Table 5.3. 
 
 
 
Figure 5.15 Haemagglutination (HA) activity of BHP1-Lung after concentration using polyethylene glycol 
(PEG)-precipitation. Both guinea pig and chicken erythrocytes (RBCs) were used as indicators of HA 
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activity. This experiment was performed before a new erythrocyte processing method (Figure 4.26) was 
being used routinely and so although the first two wells of BHP1-Lung using the guinea pig erythrocytes 
appear to represent clumped red cells (Figure 4.25), they could be displaying haemagglutination. 
 
 
Figure 5.16 Haemagglutination activity (using guinea pig erythrocytes) of the supernatant from eight 
flasks of viper heart (VH2) cells with syncytial cell formation. Supernatant was collected at the end of the 
first (p1) and second (p2) passage. PBS = Phosphate-buffered saline. Abbreviations for each sample are 
defined in Table 5.3. 
 
HA activity of BHP1-Lung could not be detected by these assays. If present, it was below the 
lower limit of detection of this assay (<2 HA units / 50µL) and even after concentration with 
PEG-precipitation, HA activity could not be confidently detected. Other concentration methods 
could have been used (e.g. ultrafiltration, ultracentrifugation), and for each method, different 
vertebrate erythrocytes and different incubation conditions (e.g. room temperature or 4
0C) 
could  have  been  trialled,  but  the  experiments  presented  here  do  not  provide  compelling 
evidence that BHP1-Lung contains any HA activity. 
 
For haemadsorption (Hd), a flask of viper heart cells infected with BHP1-Lung was assessed 
using the methods described earlier (section 4.4 – Haemadsorption). A flask of Vero cells 
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infected with ferlavirus was used a positive control and a flask of uninfected viper heart cells 
was used as a negative control. Only minimal erythrocyte attachment was seen with the Vero 
cells that were infected with ferlavirus and no erythrocytes could be seen that were attached 
to the monolayer of BHP1-Lung-infected or uninfected viper heart cells. 
 
Overall,  these  experiments  were  unable  to  demonstrate  that  BHP1-Lung  contained  any 
haemagglutinating (either HA or Hd) activity. It may have been helpful to determine the lowest 
infectious dose (TCID50) that could be detected using this HA assay. This may have shown that 
the concentration of BHP1-Lung (previously determined by its infectious dose (TCID50) of 10
2.75 
mL
-1) was below the lower limit of detection for the HA assay and as a result the assay would 
be unable to detect the HA activity of BHP1-Lung even if it was present. Determining a tissue 
culture infectious dose utilises virus replication and as such its sensitivity can be superior to 
methods such as haemagglutination assays where a very large number of particles are needed 
to  produce  the  observable  effect  (Mahy  and  Kangro,  1996).  Clearly,  the  lower  limit  of 
detection  of  the  HA  assay  (expressed  as  a  TCID50)  cannot  be  determined  for  BHP1-Lung 
(because HA activity could not be detected) and so a virus with haemagglutinating activity that 
could be reliably detected would need to be used (e.g. ferlavirus). However, the correlation 
between HA activity and TCID50 for a particular ferlavirus may not be the same for BHP1-Lung 
(if it had HA activity), so care would be needed when extrapolating from the chosen ferlavirus 
to BHP1-Lung. So in summary, it could not be shown that BHP1-Lung contained any HA or Hd 
activity but this should not be interpreted to mean that it was absent. Without phenotypic 
evidence for the haemagglutinating activity of BHP1-Lung, molecular identification of this trait 
would be needed (section 6.2 – Partial Genome Characterisation). 
 
Had  it  been  shown  that BHP1-Lung  was  a  haemagglutinating  virus;  neuraminidase  activity 
could have been tested by assessing the haemagglutination of erythrocytes that had been 
previously  exposed  to  BHP1-Lung.  If  BHP1-Lung  contained  a  receptor  destroying  enzyme 
(neuraminidase), erythrocytes would not be able to be haemagglutinated for a second time 173 | P a g e  
 
(Clark  et  al.,  1979).  But  because  HA  activity  could  not  be  detected  in  BHP1-Lung,  this 
experiment could not be attempted. 
5.3.3 Neuraminidase Activity 
As mentioned previously, BHP1-Lung had repeatedly shown the ability to cause syncytial cell 
formation  in  cell  culture  and  this  suggested  that  it  was  most  likely  to  be  a  reovirus, 
paramyxovirus, retrovirus or herpesvirus. Amongst viruses, neuraminidase activity is unique to 
orthomyxoviruses and paramyxoviruses (Kawaoka et al., 2005; Lamb et al., 2005). Although 
neuraminidase  activity  has  not  been  detected  in  paramyxoviruses  from  the  subfamily 
Pneumovirinae  (e.g.  Avian  metapneumovirus)  or  the  genera  Morbillivirus  (e.g.  Rinderpest 
virus
6, Canine distemper virus) and Henipavirus (e.g. Hendra virus, Nipah virus) (Lamb et al., 
2005),  all  ferlaviral  isolates  tested  so  far  have  demonstrated  neuraminidase  activity 
(Marschang, 2011). The presence of neuraminidase activity in BHP1-Lung would suggest that it 
was a paramyxovirus (likely ferlavirus) and not a reovirus, retrovirus or herpesvirus. 
 
The neuraminidase activity of BHP1-Lung was investigated in two experiments by assessing the 
amount of a neuraminidase substrate, 2’-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid, 
that was cleaved into a fluorescent product by the supernatant of infected viper heart cells. To 
do this, methods described earlier were followed (section 4.6 – Neuraminidase). A ferlaviral 
isolate were used as positive controls, while uninfected culture substrate served as a negative 
control.  In  the  first  experiment,  BHP1-Lung  and  ferlavirus  were  left  to  incubate  with  the 
neuraminidase substrate for either 30 minutes or one hour (Table 5.6). The second experiment 
was the same as the first except that the second incubation time was doubled to two hours 
(Table 5.6). Previously it had been shown that a longer incubation time produced a greater 
emission at 480nm (Table 4.2). 
                                                           
6 Like all members of the genus Morbillivirus, the attachment protein of Rinderpest virus is classified as 
an H protein (as compared to an HN protein) as it is not considered to have significant neuraminidase 
activity (Lamb et al., 2005). However, in the presence of a highly specific substrate, bovine submaxillary 
mucin, neuraminidase activity has been detected (Langedijk et al., 1997). 174 | P a g e  
 
 
Sample  Emission at 480nm [first replicate, second replicate 
(average reading)] 
Experiment One     
Incubation time  30mins  1hr 
Ferlavirus  297, 314 (305.5)  312, 332 (322) 
Uninfected allantois  0, 0 (0)  0, -5 (-2.5) 
BHP1-Lung  22, 25 (23.5)  20, 22 (21) 
Uninfected cell culture supernatant  3, 9 (6)  2, 8 (5) 
Experiment Two     
Incubation time  30mins  2hrs 
Ferlavirus  300, 320 (310)  297, 313 (305) 
Uninfected allantois  0, -3 (-1.5)  0, -3 (-1.5) 
BHP1-Lung  17, 21 (19)  16, 20 (18) 
Uninfected cell culture supernatant  0, 6 (3)  -1, 5 (2) 
Table 5.6 The emission at 480nm of a strain of allantoic-derived ferlavirus (ATCC VR-1408, 128HA / 
50µL) and cell culture-derived BHP1-Lung after exposure to the neuraminidase (NA) substrate 2’-(4-
methylumbelliferyl)-α-D-N-acetylneuraminic acid for 30 minutes, one hour or two hours. The emission 
at 480nm provides an estimate of each isolate’s NA activity. Uninfected allantoic fluid and uninfected 
cell culture supernatant were used as negative controls. HA = haemagglutination. 
 
These two experiments demonstrated that under these conditions the neuraminidase activity 
of BHP1-Lung was less than a ferlaviral isolate and that the amount of neuraminidase product 
did not increase after a two hour incubation period. 
 
To investigate the possibility that the relatively (compared to a ferlavirus isolate) low level of 
detectable neuraminidase activity (if any at all) might be due to the low titre of BHP1-Lung 
(TCID50 = 10
2.75 mL
-1), attempts were made to determine the lower limit of detection of this 
assay. To do this, a ferlaviral isolate was serially diluted and maximum incubation periods were 
extended from two hours to 24 hours (Figure 5.17). For the ferlaviral isolate, there was an 
almost-geometric decrease in the emission at 480nm as the dilution increased from undiluted 
to a 15,625 dilution. And this was observed for each time point: 50m, 2h20m, 3h40m and 20h. 
Additionally, starting at the 25-fold dilution and continuing to the 15,625-fold dilution, longer 
incubation periods were associated with higher 480nm emissions. In brief, Figure 5.17 shows 175 | P a g e  
 
that ferlaviral emission signals were positively correlated with incubation time but negatively 
correlated with isolate dilution. 
 
In  contrast  to  these  findings,  the  emission  signals  from  all  concentrations  of  BHP1-Lung 
actually slightly decreased with increasing incubation times. This finding is not consistent with 
neuraminidase  activity  in  BHP1-Lung.  The  ferlaviral  isolate  had  an  initial  dilution  of  128 
haemagglutinating units per 50 µL (128HA/50µL) and so if neuraminidase activity was truly 
detected at the greatest dilution, 1:15,625, than this would suggest that a ferlaviral isolate 
with an HA titre of less than 0.008HA/50µL can be detected by this assay. This would make the 
lower limit of detection at least 250-times lower than a haemagglutination assay (2HA/50µL 
divided by 0.008HA/50µL). However, these methods have not been able to detect influenza 
virus below an infectious dose (TCID50) of 10
3 mL
-1 (Yolken et al., 1980), which is still greater 
than the TCID50 of BHP1-Lung (10
2.75 mL
-1). So it remains unclear whether the concentration of 
BHP1-Lung  exceeded  the  lower  limit  of  detection  of  this  assay  and  therefore,  the 
neuraminidase activity inherent to BHP1-Lung remains uncertain. 
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Figure 5.17 The amount of neuraminidase (NA) activity of five-fold serial dilutions of BHP1-Lung compared to a strain of ferlavirus (ATCC VR-1408, 128HA / 50µL). 
The NA substrate (2’-(4-methylumbelliferyl)-α-D-N-acetylneuraminic acid) is exposed to each isolate for a certain length of time (50 minutes [50m], two hours and 20 
minutes [2h20m], three hours and 40 minutes [3h40m] or 20 hours and 20 minutes [20h]) to produce a fluorescent substrate. The emission at 480nm provides an 
estimate of each isolate’s NA activity. 
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A solid-phase neuraminidase assay with a sensitivity that provides a 100-fold improvement on 
the methods utilised here has been described (Yolken et al., 1980). It is a modified enzyme-
linked immunosorbent assay (ELISA) and was not used in this project due to the difficulty and 
expense in obtaining the necessary reagents. Another neuraminidase assay that utilises a 1,2-
dioxetane derivative of sialic acid (neuraminic acid) has been described that provides a 67-fold 
reduction in the lower limit of detection of NA activity when compared against methods that 
utilise the neuraminidase substrate used in this project (Buxton et al., 2000). Although these 
methods have not been validated for the detection of ferlaviral neuraminidase, future studies 
should consider them. 
 
As mentioned earlier, the attachment protein of paramyxoviruses from the genus Morbillivirus 
(H) has been thought to only possess haemagglutinating activity (Lamb et al., 2005). However, 
neuraminidase activity has been demonstrated in Rinderpest virus (a morbillivirus) but only 
when exposed to bovine submaxillary mucin (Langedijk et al., 1997). The implication of this 
finding is that even if sensitive methods of detecting neuraminidase activity were applied to 
higher titres of BHP1-Lung in the future, a result that does not demonstrate the presence of 
neuraminidase activity should be cautiously interpreted. 
 
This short phenotypic study had failed to unequivocally detect neuraminidase activity in BHP1-
Lung and so the presence of this enzyme would be reliant on molecular identification. 
5.3.4 Haemagglutination Inhibition 
BHP1-Lung was collected from a privately-owned snake collection in Queensland during an 
outbreak of neurorespiratory disease (page 152). Serum was collected from 13 of these snakes 
and was available for testing for anti-ferlaviral antibodies using a haemagglutination inhibition 
(HI) assay. The HI assay was performed in accordance with the methods previously described 
(section  4.5  – Haemagglutination  Inhibition). Many  samples contained  haemolysis (Figure 
4.18) and clots (fibrin and whole blood, Figure 4.19). Consequently, these samples required 178 | P a g e  
 
extra processing that was described earlier (section 4.5 – Haemagglutination Inhibition). It 
was previously shown that the affect on HI titre that these changes had was increasing the 
difficulty in assessing the settling of erythrocytes in “serum” samples containing large amounts 
of haemoglobin (Figure 4.27). 
 
Using a neotropical strain of ophidian paramyxovirus (ATCC VR-1408) as antigen, no HI titre 
exceeded 8 (Figure 5.18). 
 
Figure 5.18 Haemagglutination inhibition (HI) assay of serum samples collected from a privately-owned 
collection of snakes that produced the isolate BHP1-Lung (sample 7 in this figure). The inadequate 
separation of erythrocytes from serum prior to freezing has provided varying shades of red in some 
wells. No HI titre exceeded eight. HA = haemagglutination. 
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In 2008, Allender et al. used serum samples from 26 eastern massasaugas (Sistrurus catenatus 
catenatus, a North American pit viper) to demonstrate the considerable variability in ferlaviral 
HI  antibody  testing  that  existed  between  three  American  diagnostic  laboratories.  Many 
variables contribute to inter-laboratory variation in HI titre (e.g. the strain of virus and the 
number of haemagglutinating units of antigen). A more detailed discussion of the variables 
that influence HI titre in reptiles was described earlier on page 52. The serum samples in the 
present study were tested against an American isolate of ferlavirus (ATCC VR-1408) but it has 
been  shown  that  not  all  ferlaviruses  are  serologically  related  to  each  other.  It  has  been 
suggested  that  at  least  some  European  isolates  may  be  serologically  unrelated  to  some 
American isolates (Lloyd et al., 2005). It was for this reason that these serum samples were 
tested against the second isolate of ferlavirus available to this study (Fer-de-Lance virus, ATCC 
VR-895, a European isolate). Results of this second assay were uninterpretable because of 
abnormal red cell clumping (similar in appearance to Figure 4.25). The assay was not repeated. 
 
Various titres have been used to demarcate previous ferlaviral exposure from no previous 
exposure (Lloyd and Flanagan, 1991; Gravendyck et al., 1998) but the titres in this report (≤8) 
are generally considered to be non-specific. The present study is limited by the lack of paired 
serum samples (where the second sample is collected at an interval that exceeds the period of 
convalescence). Theoretically, the single sample point tested in this study may have been 
taken before a detectable antibody response could be measured. A second sample may have 
been able to demonstrate a rising titre suggesting active infection. So although this testing 
could not demonstrate the presence of anti-ferlaviral antibodies, a number of confounding 
variables mean the results presented here should not be over interpreted. 
5.3.5 Chemical Experiments 
Chemical  experimentation  of  BHP1-Lung  would  assess  the  changes  to  viral  titre  after  the 
isolate  was  exposed  to  chloroform  and  ether;  a  DNA  synthesis  inhibitor;  and  an  acidic 
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BHP1-Lung had repeatedly shown the ability to cause syncytial cell formation in cell culture 
and  this  suggested  that  it  was  most  likely  to  be  a  reovirus,  paramyxovirus,  retrovirus  or 
herpesvirus. These four viruses all have a unique panel of chemical traits. These include, but 
are  not  limited  to,  the  ability  to  haemagglutinate  vertebrate  erythrocytes,  neuraminidase 
activity, the presence or absence of a lipid envelope and an RNA or DNA genome. At the same 
time as an investigation of the chemical traits of BHP1-Lung, several polymerase chain reaction 
(PCR)  primer  sets  would  be  tested  against  this  isolate  (section  5.2.6  –  Polymerase  Chain 
Reaction). Although a sequenced PCR product would be more likely to specifically identify the 
viral family that BHP1-Lung belongs to, investigation of its chemical traits does not require any 
prior knowledge. A summary of the chemical traits of the orthoreoviruses (all known reptilian 
reoviruses), ferlaviruses (all known reptilian paramyxoviruses), retroviruses and herpesviruses 
is presented in Table 5.7. This is followed by a discussion of each characteristic. 
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Characteristic  Orthoreovirus  Ferlavirus  Retrovirus  Herpesvirus 
Lipid envelope  No but can bud 
from a cell and 
transiently have an 
envelope 
Yes  Yes  Yes 
Haemagglutination  Species-dependent 
but absent in 
reptilian 
orthoreoviruses 
Yes but genus-
dependent for other 
paramyxoviruses 
No  Species-dependent 
but not reported for 
reptilian 
herpesviruses 
Neuraminidase  No  Yes but genus-
dependent for other 
paramyxoviruses 
No  No 
DNA / RNA 
genome 
dsRNA, 
segmented 
ssRNA(-), 
unsegmented 
reverse 
transcribing. 
Genomic nucleic 
acid is subfamily-
dependent: dsDNA 
for 
Spumaretrovirinae 
and ssRNA(+) for 
Orthoretrovirinae 
dsDNA 
Table 5.7 The chemical characteristics of orthoreoviruses (Chappell et al., 2005), ferlaviruses (Richter et 
al., 1996), retroviruses (Linial et al., 2005) and herpesviruses (Davison et al., 2005). Unique traits are 
bolded and underlined. 
 
Enveloped  viruses,  as  a  general  rule,  are  more  environmentally  labile  than  unenveloped 
viruses  and  this  difference  in  lability  has  been  exploited  experimentally  to  suggest  the 
presence  or  absence  of  a  viral  envelope.  Such  experiments  include  exposure  to 
detergents/lipid solvents (e.g. chloroform), high temperatures (e.g. 56
0C) and acidic conditions 
(e.g. pH 3). Of the four viral groups mentioned in Table 5.7, only reoviruses are unenveloped
7 
so it would be expected that the viral titre of a reovirus would be the least affected after 
exposure to these adverse conditions. 
 
Of the four viruses listed in Table 5.7, only herpesviruses and the Spumaretrovirinae subfamily 
of  the  retroviruses  have  DNA  genomes  and  only  orthoreoviruses  have  double-stranded 
segmented RNA genomes. The ability of a DNA or reverse transcribing (e.g. retrovirus) virus to 
                                                           
7 Reoviruses can sometimes be released from the host cell through the process of budding. In this event, 
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replicate will theoretically be impaired in the presence of a DNA synthesis inhibitor (e.g. 5’ 
bromo-3’  deoxyuridine  *BUDR+),  whereas  the  replication  of  non-reverse  transcribing  RNA 
viruses  will  be  unaffected.  However,  the  situation  in  retroviruses  may  not  be  so  straight 
forward. As an example, syncytial cell formation associated with Bovine leukemia virus  was 
observed despite the presence of a DNA synthesis inhibitor (Graves and Jones, 1981). But in 
summary, if the viral titre of BHP1-Lung was unaffected by the presence of a DNA synthesis 
inhibitor, this would be consistent with a reovirus or a paramyxovirus. 
 
Reoviruses,  unlike  paramyxoviruses,  retroviruses  and  herpesviruses,  have  a  segmented 
genome  that  can  be  electrophoretically  (e.g.  polyacrylamide  gel  electrophoresis  [PAGE]) 
separated into a unique arrangement of segments (Giordano et al., 1997). This method has 
been utilised to positively identify reptilian reoviruses (Ahne et al., 1987b; Vieler et al., 1994; 
Lamirande et al., 1999). 
 
Acridine orange is a histological stain that stains green in the presence of double-stranded 
nucleic acid and stains red in the presence of single-stranded nucleic acid (McMaster and 
Carmichael, 1977) and so green cytoplasmic staining would suggest the presence of a reovirus 
(Ahne  et  al.,  1987b).  Double  stranded  viral  genomes  will  also  exist  for  herpesviruses  and 
retroviruses but in these two cases, the replication cycle predominantly occurs in the nucleus 
(Davison  et  al.,  2005;  Linial  et  al.,  2005)  and  so  cytoplasmic  staining  would  be  minimal. 
Although  not  performed  on  cells  infected  with  a  reptilian  paramyxovirus,  acridine  orange 
would be expected to stain red in both the cytoplasm and the nucleus (Lamb et al., 2005). 
 
Many of these chemical tests have been applied to the reptilian viruses of interest: ferlaviruses 
(Richter et al., 1996; Marschang et al., 2002), snake reoviruses (Ahne et al., 1987b; Vieler et al., 
1994; Blahak, 1995) and herpesviruses (but only in chelonians) (Marschang et al., 2001a). As 
expected, snake reoviruses showed resistance to lipid solvents and a DNA synthesis inhibitor; 183 | P a g e  
 
ferlaviruses were resistant to a DNA synthesis inhibitor but susceptible to lipid solvents; and 
chelonian herpesviruses were susceptible to both DNA synthesis inhibitors and lipid solvents. 
The author could not find similar investigations assessing reptilian retroviruses, but a report 
does exist for a retrovirus-like virus in salmon that surprisingly was resistant to both DNA 
synthesis inhibitors and lipid solvents (Oh et al., 1995). 
 
In summary, utilising a series of chemical experiments can provide several opportunities to 
obtain valuable biological data about a viral isolate of unknown identity. To this end, BHP1-
Lung was analysed using some of these methods. 
Effect of Chloroform and Ether 
BHP1-Lung was exposed to several adverse conditions and after exposure to each, any change 
in viral titre was recorded (Table 5.8). Equine herpes virus (EHV), an enveloped DNA virus 
grown in a rabbit kidney cell line (RK-13, American Type Culture Collection [ATCC] CCL-37), and 
Nelson Bay orthoreovirus (NBV), an unenveloped RNA reovirus grown in a porcine squamous-
equine kidney cell line (PSEK), were used as positive controls. By using these two viruses as 
controls, these investigations would have the potential to reveal two biological traits about 
BHP1-Lung: the presence or absence of a lipid envelope and the presence of a DNA or RNA 
genome. 
 
For each of the following experiments, four to six replicates of each viral isolate were treated 
and an additional four to six replicates were left untreated. 
 
All  three  isolates  (EHV,  NBV  and  BHP1-Lung)  were  exposed  to  chloroform  at  a  final 
concentration  of  33%  (v/v)  (i.e.  one  part  chloroform  to  two  parts  viral  isolate)  at  room 
temperature for ten minutes. Solutions were then centrifuged at 2,000g for ten minutes at 
room  temperature  and  the  aqueous  phase  (the  supernatant)  was  collected.  Nitrogen  was 
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were then assessed for viral titre (Table 5.8, experiment one) using the Reed-Muench method 
described earlier (section 4.2.1 – Cell culture). Aliquots of NBV, EHV and BHP1-Lung were left 
untreated to serve as negative controls. 
 
Unexpectedly, the viral titre of NBV was reduced by a factor of 631. This is inconsistent with 
the results of other reovirus studies where the infectivity of snake reoviruses was resistant to 
the effects of chloroform (Ahne et al., 1987b; Vieler et al., 1994; Blahak, 1995). However, the 
effect on viral titre was not quantified in these studies leaving the definition of “resistant” to 
be  subjectively  interpreted.  Further  investigation  of  the  literature  revealed  that  some 
reoviruses  are  sensitive  to  the  effects of  chloroform  (possibly  due  to  denaturation  of  the 
protein coat) (Feinstone et al., 1983) but are reliably resistant to the effects of ether (Engler 
and Broome, 1969). For this reason, treatment of BHP1-Lung and further treatment of NBV 
and EHV involved exposure to diethyl ether and a lower concentration of chloroform (10% 
compared to 33%). 
 
NBV and EHV were exposed to 10% (v/v) chloroform  (i.e. one part chloroform to nine parts 
viral isolate) and all three isolates were treated with 20% (v/v) diethyl ether  (i.e. one part 
ether to four parts viral isolate). BHP1-Lung was not exposed to the second concentration of 
chloroform because it would be unlikely to provide additional information due to the low titre. 
Exposure to 10% chloroform and 20% ether was for ten minutes at 4
0C and overnight at 4
0C 
respectively. As before, lipid solvents were removed by clarification and bubbling nitrogen gas 
through each solution. Viral titres were then calculated (Table 5.8, experiments one and two). 
Effect of Acid 
Each isolate was exposed to an acidic environment by mixing one part of virus solution with 
nine  parts  of  acidified  cell  culture  media  (pH  =  3,  using  hydrochloric  acid)  at  4
0C.  After 
incubation at room temperature for 30 minutes, the pH was returned to neutral (according to 
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determined for each of the three isolates (Table 5.8, experiment one). Several hours after the 
virus solutions were inoculated onto their respective cell lines, it was noticed that the phenol 
red pH indicator in each flask was yellowy-orange, indicating that the media was acidic. 
 
Unexpectedly, the viral titre of EHV decreased by a factor of 10 (by comparison the titre of the 
unenveloped  virus,  NBV  decreased  by  a  factor  of  126).  Consultation  with  the  literature 
revealed that Pacheco’s disease virus (PDV-1, an avian herpesvirus) is relatively resistant to 
acidic environments (TCID50 decreased by a factor of 6.3 after exposure to pH = 3) (Cho and 
McDonald, 1980), while pseudorabies virus (a porcine herpesvirus) is more labile to extreme 
acidic environments (no infectivity detected at pH = 3) (Zhu et al., 2011). For experiment two 
(Table 5.8), isolates were exposed to acid (pH = 3) overnight at 4
0C and afterwards, cell culture 
media was alkalinised to a pH of 8.5 (using sodium hydroxide and a pH meter). 
Effect of a DNA synthesis Inhibitor 
For DNA synthesis inhibition, 5’ bromo-3’ deoxyuridine (BUDR; Sigma-Aldrich, cat. no. B5002-
100MG; reconstituted in water), was added to cell culture medium at a final concentration of 
100µg/mL and left overnight at 4
0C to incubate. Viral titre was then determined as before. 186 | P a g e  
 
Virus  Untreated  Chloroform  Ether (20% v/v)  Acid (pH = 3)  5’ Bromo-3’ deoxyuridine 
(BUDR, 100µg / mL) 
Experiment One    33% (v/v)  X-fold decrease    X-fold decrease    X-fold decrease    X-fold decrease 
Equine herpes virus  10
6.3  < 10
2.1  > 15,849  n.d.  N/A  10
5.3  10  < 10
2  > 19,952 
Nelson Bay 
orthoreovirus  10
6.3  10
3.5  631  n.d.  N/A  10
4.2  126  10
5.3  10 
BHP1-Lung  10
2.7  < 10
2.1  > 4  < 10
3.5  N/A  < 10
3  N/A  10
2.7  0 
Experiment Two    10% (v/v)  X-fold decrease    X-fold decrease    X-fold decrease    X-fold decrease 
Equine herpes virus  10
5.1  < 10
2.1  > 1,000  < 10
2.2  > 794  10
4.2  8  < 10
2.1  > 1,000 
Nelson Bay 
orthoreovirus  10
7.1  10
4.8  200  10
6.5  4  10
5.4  50  10
3.6  3,162 
Table 5.8 Effect of ether, acid, a DNA synthesis inhibitor and two concentrations of chloroform on the viral titre (TCID50) of Equine herpes virus (EHV), an enveloped 
DNA virus, Nelson Bay orthoreovirus (NBV), an unenveloped RNA virus and BHP1-Lung. Experiment One: All three isolates were exposed to 33% (v/v) chloroform. 
One part of virus solution was exposed to nine parts of cell culture media with a pH of 3 and then returned to a neutral pH. The DNA synthesis inhibitor, 5’ bromo-3’ 
deoxyuridine (BUDR), was added to each isolate to a final concentration in the flask of 100µg/mL. Only BHP1-Lung was exposed to ether. Experiment Two: Only NBV 
and EHV were analysed in this experiment. These two viruses were exposed to a lower concentration of chloroform (10% v/v), ether (20%), acid (pH = 3) and the DNA 
synthesis inhibitor (BUDR) using the methods of experiment one. 187 | P a g e  
 
Discussion of Results of Chemical Experiments 
In this series of experiments, a number of unexpected results emerged: (1) the infectivity of 
Equine herpes virus (EHV, an enveloped virus,), was found to be more resistant to treatment 
with an acidic solution than Nelson Bay orthoreovirus (NBV, an unenveloped virus); (2) when 
these  two  isolates  were  exposed  to  a  DNA  synthesis  inhibitor,  the  infectivity  of  EHV 
consistently fell below the lower limit of detection but in the second experiment only, the 
infectivity of NBV decreased by a factor of 3,162, inconsistent with the presence of an RNA 
genome; (3) the infectivity of EHV was substantially reduced after exposure to chloroform and 
diethyl ether while for NBV, the infectivity was reduced after exposure to chloroform but was 
relatively unaffected by exposure to ether. Although these results were found to be initially 
surprising, all the observations (with the exception of the decrease in infectivity of NBV after 
the second exposure to BUDR) have been reported elsewhere in the literature (see earlier). 
 
These  experiments  were  only  able  to  provide  a  limited  amount  of  information  about  the 
biological traits of BHP1-Lung. While the infectivity of BHP1-Lung was reduced after exposure 
to chloroform, the untreated viral titre was not high enough to assess the full extent of this 
decrease. The infectivity of BHP1-Lung after exposure to diethyl ether could not be assessed 
because residual ether (not completely eliminated by nitrogen gas) affected the viper heart 
cells even at dilutions that were greater than the untreated viral titre. Put another way, due to 
the effects that diethyl ether had on the viper heart cells, only titres (TCID50) of BHP1-Lung that 
exceeded 10
3.5 mL
-1 would be detectable. The untreated TCID50 of BHP1-Lung was 10
2.75 mL
-1. 
Similarly, the effect that treating the isolate with acid had on the viper heart cells limited the 
lower limit of detection to a TCID50 of 10
3 mL
-1, again greater than the untreated TCID50 of 
BHP1-Lung. 
 
Future  studies  that  investigate  the  chemical  resistance  of  BHP1-Lung  should  attempt  to 
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chloroform, ether and acid are removed before exposure to host cells. As mentioned earlier 
(page 158), in the hands of another virologist, a TCID50 for BHP1-Lung of at least 10
5 mL
-1 was 
seen. Attempts to adapt BHP1-Lung to an alternate cell line may have yielded a greater viral 
titre.  In  other  species  of  virus,  viral  titres  have  been  increased  through  the  use  of  serial 
passage (Churchill et al., 1969; Petkova et al., 1986).  
  
In contrast to these findings, the infectivity of BHP1-Lung was unaffected by the presence of a 
DNA synthesis inhibitor (BUDR). Although NBV showed a significant decrease in infectivity after 
exposure to BUDR in the second experiment (Table 5.8), it was still detectable. In contrast, the 
infectivity  of  EHV  fell  below  the  lower  limit  of  detection  in  both  experiments.  These 
experiments are consistent with BHP1-Lung containing an RNA genome. Retroviruses rely on 
reverse transcribing their RNA genome into proviral DNA (Linial et al., 2005) and so it would be 
theoretically expected that the infectivity of these viruses would be eliminated (or at least 
considerably reduced) by a DNA synthesis inhibitor. However, experimental data on Bovine 
leukemia virus and a retrovirus-like virus, suggests this may not be a reliable trait inherent to 
all retroviruses (Graves and Jones, 1981; Oh et al., 1995). 
 
There are physical experiments and other chemical experiments that could have been utilised 
in these studies. As an example of a physical experiment, the effect of filtration on viral titre 
could have been analysed. Observing cytopathic effects after passing a solution of BHP1-Lung 
through a syringe-tip filter (e.g. 0.45µm, 0.2µm and/or 0.1µm pore-size diameters) may have 
shown that BHP1-Lung contained a filterable agent consistent with a virus (as opposed to 
other non-filterable microbes) but based on the low titre of BHP1-Lung and the variability in 
size  of  the  four  syncytium-forming  viruses  (reoviruses,  retroviruses,  herpesviruses  and 
especially paramyxoviruses) it was unlikely to be of any further benefit and is not commonly 
reported in the literature. In 1995, Blahak reported that the haemagglutinating ability and 
infectious titre of a ferlaviral isolate was significantly decreased after exposure to 56
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susceptibility to heat would form another physicochemical experiment that could have been 
performed on BHP1-Lung. In contrast to ferlaviruses, orthoreoviruses (all currently described 
reptilian reoviruses) are able to withstand extremes in heat (up to 55
0C) (Chappell et al., 2005). 
However, in light of the low titre of BHP1-Lung, this test was not pursued. 
 
Examining cells infected with BHP1-Lung under a fluorescent microscope after staining with 
acridine  orange  could  have  provided  some  further  insight  into  the  genome  of  this  virus. 
Attempts were made to do this with BHP1-Lung-infected viper heart cells but in the author’s 
hands, the stain rapidly deteriorated after exposure to fluorescent light, preventing accurate 
assessment of the monolayer (data not shown). Staining iguana heart (IgH2) cells infected with 
a snake orthoreoviruses with acridine orange has been used with success by other authors 
(Ahne et al., 1987b). 
 
Extractions  of  dsRNA  from  samples  of  BHP1-Lung  could  have  been  electrophoretically 
separated  in  an  attempt  to  visualise  a  segmented  genome  that,  amongst  reoviruses, 
herpesviruses,  retroviruses  and  paramyxoviruses,  is  unique  to  the  reoviruses.  The 
electropherotype of reptilian orthoreoviruses has been identified by other authors (Ahne et 
al., 1987b; Vieler et al., 1994; Blahak, 1995) and attempts to identify it in this study should 
have been made. Again, the low titre of BHP1-Lung may have prevented identification. 
 
Finally, taking aliquots of BHP1-Lung, ultracentrifuging those through a density gradient of 
sucrose or  caesium  chloride  and  then  testing  the  viral  titre of  sequential  fractions  of  the 
various densities may have provided an insight into the buoyant density of the isolate. Specific 
densities have been reported for the four virus groups of interest (Table 5.5). 
 
In summary, the results of the chemical experiments performed on BHP1-Lung were mostly 
equivocal and this was best explained by the low viral titre. The presence of a DNA synthesis 190 | P a g e  
 
inhibitor did not affect the viral titre of BHP1-Lung and this suggests the presence of an RNA 
genome. 
5.3.6 Polymerase Chain Reaction 
BHP1-Lung  was  tested  by  an  assortment  of  methods  (e.g.  haemagglutination  and 
neuraminidase activity, electron microscopic examination etc) but the most time and effort 
was  committed  to  testing  BHP1-Lung  by  polymerase  chain  reaction  (PCR).  Although  PCR 
required background knowledge about BHP1-Lung, its lower limit of detection may have been 
able  to  overcome  the  low  viral  titre  that  had  questioned  many  of  the  results  previously 
obtained. PCRs were performed in accordance with the methods described earlier (section 4.8 
– Polymerase Chain Reaction). 
 
Initially,  efforts  were  primarily  focussed  on  screening  BHP1-Lung  with  a  wide  variety  of 
ferlavirus primers (Tables 4.3 and 4.4). No amplicons of the expected size were generated. 
Next, primers that had the capability  to detect a broader range of paramyxoviruses were 
tested  on  BHP1-Lung  (Table  4.3).  The  hemi-nested  pan-Pneumovirinae  PCR  primer  set 
published by Tong et al. (2008) (PNE-R, PNE-F1 and PNE-F2) produced an amplicon close to the 
expected  size  but  sequencing  and  searching  GenBank  (National  Center  for  Biotechnology 
Information,  Bethesda,  Maryland)  using  BLASTN  (Basic  Local  Alignment  Search  Tool  for 
Nucleotides, http://blast.ncbi.nlm.nih.gov/Blast.cgi) could not confirm that the PCR product 
was viral in origin. No other paramyxoviral PCR primer set produced an amplicon near to the 
expected size. 
 
As more and more results emerged from the other experiments being concurrently performed 
on BHP1-Lung, increasing validity was given to the possibility that BHP1-Lung may represent a 
reovirus. A reptilian reovirus would be explanatory, or at least consistent, with (1) the low 
grade respiratory disease and stomatitis seen in the host (a black-headed python) during an 
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apparent absence of haemagglutinating and neuraminidase activity, (4) the inability to detect 
anti-ferlaviral antibodies in the host and (5) the negative PCR results for the presence of a 
paramyxovirus. For these reasons, PCR primers were selected from the literature, and others 
were designed in-house, that could theoretically detect a wide range of reoviruses (Table 4.5). 
Some of these primer sets contained primers that could be used in various permutations to 
provide additional opportunities to detect a reovirus. The reovirus primers designed by the 
author (A-F, B-F, C-F, B-R, C-R and D-R) and the primer sets published by Wellehan et al. 
(2009), Landolfi et al. (2010) and Leary et al. (2002) were used in every permutation that 
would  theoretically  generate  an  amplicon.  Despite  these  attempts,  no  amplicons  of  the 
expected size were produced. 
 
Investigating the possibility that BHP1-Lung was a retrovirus was to be initially postponed for 
reasons already mentioned (section 5.2.6 – Polymerase Chain Reaction). Briefly, it would be 
difficult to differentiate an endogenous from an exogenous retrovirus and the link between 
retroviruses and snake disease has not always been clear (Huder et al., 2002; Vancraeynest et 
al., 2006; Chang and Jacobson, 2010; Hofacre and Fan, 2010). 
 
The  histories,  clinical  signs  and  pathological  findings  of  the  animals  in  the  Queensland 
collection  that  produced  BHP1-Lung  were  inconsistent  with  an  adenovirus  or  herpesvirus 
infection but broadly-reactive PCRs for the detection of these two virus families were available 
(Table  4.5).  Remaining  open  to  a  serendipitous  discovery,  BHP1-Lung  was  tested  for  the 
presence of these two virus families but in both cases the results were negative
8. 
 
Months spent testing BHP1-Lung for the presence of paramyxoviruses and reoviruses had 
failed to identify a virus within this sample. Although the author had access to, and utilised, 
                                                           
8 During the adenovirus testing of BHP1-Lung, samples from lizards with histopathology consistent with 
an adenovirus infection were screened using the primer set described by Wellehan et al. (2004) and 
adenoviruses  were  detected.  These  results  were  published  as  the  first  detection  of  reptilian 
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positive control material for these PCRs (section 4.8 – Polymerase Chain Reaction), an ongoing 
concern was that the negative testing of BHP1-Lung could be attributed to technical reasons 
i.e. were negative results true or false? To this end, the Jacobson Laboratory at the University 
of Florida and Dr Rachel Marschang at the University of Hohenheim were both approached 
about testing BHP1-Lung for ferlavirus and reovirus by PCR using the methods utilised in their 
diagnostic services. While the importation of these samples into the United States of America 
was bureaucratically prohibitive, importing the samples into Germany was likely to be possible. 
Before pursuing this any further it was decided to analyse BHP1-Lung using high-throughput 
sequencing (section 6.1 – High-throughput Sequencing). 
5.4  Chapter Summary 
Snake  samples  were  received  from  most  Australian  states  and  territories.  Samples  were 
submitted  if  there  was  a  suspicion  that  the  snake  was  infected  with  a  pathogenic  virus. 
Samples  were  obtained  from  snakes  with  histories,  clinical  signs,  overseas  diagnostic  test 
results and/or pathological findings that were consistent with a viral infection affecting the 
neurorespiratory  systems.  Some  submissions  were  from  snakes  that  were  in-contact  with 
affected  snakes.  In  total,  463  samples  were  received  and  217  were  analysed  for 
haemagglutination activity, 5 for neuraminidase activity, 86 for the presence of anti-ferlaviral 
antibodies using a haemagglutination inhibition assay, 50 were tested by polymerase chain 
reaction and 161 were inoculated onto cell culture in an effort to isolate a virus. In addition to 
this, a small selection of samples were analysed by electron microscopy. 
 
Some of these tests were complicated by confounding variables but ultimately, virus isolation 
provided an important result. Viruses were isolated from nine samples from five snakes. In all 
cases, the cytopathic effects seen in cell culture consisted primarily of syncytial cell formation 
in the absence of significant cell lysis and based on this, it was decided that these viruses were 
most  likely  to  be  from  one  of  four  families:  Paramyxoviridae,  Reoviridae,  Retroviridae  or 193 | P a g e  
 
Herpesviridae.  The  virus  obtained  from  the  lung  suspension  of  a  black-headed  python 
(Aspidites melanocephalus) was named BHP1-Lung and was tested by several methods in an 
effort  to  determine  the  virus  family  it  belongs  to.  Results  of  some  of  these  tests  were 
complicated by the low viral titre of this isolate. However, it seemed likely that BHP1-Lung 
possessed an RNA genome. Extensive testing by polymerase chain reaction for the presence of 
a paramyxovirus, reovirus, adenovirus and herpesvirus was unable to identify the virus family 
that BHP1-Lung belongs to. 
 
The next chapter describes how high-throughput sequencing was employed to determine the 
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Chapter 6 – Molecular  Identification  of  BHP1-Lung  as  a  Novel 
Paramyxovirus Named Sunshine virus 
This chapter describes the use of high-throughput sequencing to identify BHP1-Lung as a novel 
paramyxovirus. BHP1-Lung was named Sunshine virus as homage to the geographical origin of 
the first isolate: the Sunshine Coast of Queensland, Australia. The chapter is divided into six 
sections. In the first section (6.1 - High-throughput Sequencing), the justification for using 
high-throughput sequencing is explained followed by the series of steps that were taken to 
analyse the considerable volume of sequence data. This section concludes after BHP1-Lung 
had been confidently identified as a paramyxovirus. In the next section (6.2 - Partial Genome 
Characterisation), the open reading frames of BHP1-Lung are analysed and compared to other 
paramyxoviruses. Particular attention is focussed on the attachment gene in an effort to clarify 
the ambiguous test results obtained from earlier phenotypic testing (e.g. haemagglutination 
and neuraminidase assays). 
 
The first two sections confirm that BHP1-Lung is a unique paramyxovirus and so the third 
section (6.3 – Proposing the Name Sunshine virus for BHP1-Lung) justifies the name that was 
selected for it. In the fourth section (6.4 - Sunshine virus Phylogeny), the phylogenetic work of 
Dr Jim Wellehan is reproduced that places Sunshine virus within the family Paramyxoviridae 
but outside of the two existing subfamilies. In section five (6.5 – Development and Validation 
of  a  Sunshine  virus  Polymerase  Chain  Reaction  Primer  Set),  the  primers  that  were  used 
unsuccessfully for the detection of a paramyxovirus in BHP1-Lung are retrospectively analysed 
for their suitability to detect Sunshine virus. They were found to be unsuitable and so new 
primers were designed with the capability to screen various sample types for the presence of 
Sunshine  virus.  The  chapter  concludes  with  a  summary  of  the  findings  presented  in  the 
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6.1  High-throughput Sequencing 
At this point of the project, at least one virus had been isolated from five snakes (Table 5.3) 
but extensive testing on one of these isolates, BHP1-Lung, by polymerase chain reaction (PCR) 
had failed to reveal the identity of the virus. The decision was then made to test this sample by 
high-throughput sequencing. Unlike PCR, which relies on primers annealing to complementary 
areas  on  a  target  sequence,  high-throughput  sequencing  does  not  depend  on  any  prior 
knowledge about the target sequences. This gives it a distinct advantage compared to PCR. 
Unbiased  sequence-independent  detection  has  the  ability  to  detect  novel  viruses  and  has 
already  been  used  successfully  in  several  species  of  veterinary  significance:  pigs,  parrots, 
turtles, minks, bees, bats and monkeys (Kreuze et al., 2009). After some preliminary enquiries, 
a Swiss commercial company, Fasteris, was found that could tailor their processing methods to 
the requirements of this sample. 
 
Once it was decided that high-throughput sequencing would be utilised, the next decision that 
needed  to  be  made  was  whether  RNA  or  DNA  would  be  submitted  to  Fasteris.  The  titre 
(TCID50) of BHP1-Lung had remained unchanged in the presence of a DNA synthesis inhibitor 
(BUDR,  see  Table  5.8)  suggesting  the  presence  of  an  RNA  genome  (e.g.  paramyxovirus, 
reovirus). Selecting RNA as the template for high-throughput sequencing would be a necessity 
for  non-reverse  transcribing  RNA  viruses  (because  DNA  is  not  synthesised  during  their 
replication) but it would also be able to detect the viral transcripts and genome of reverse 
transcribing RNA viruses (e.g. retroviruses) (Nakamura et al., 2009) and the viral transcripts of 
DNA viruses (e.g. herpesviruses) (Nakamura et al., 2009; Ma et al., 2011). 
 
To process RNA samples obtained from cellular extracts, Fasteris usually removes abundant 
ribosomal RNA (rRNA) from total RNA by selectively extracting polyadenylated RNA species 
(e.g.  mRNA)  using  oligo(dT)  purification.  It  has  been  estimated  that  rRNA  constitutes 
approximately  90%  of  all  cellular  RNA,  so  removing  it  would  improve  the  likelihood  of 197 | P a g e  
 
detecting viral RNA  (He et al., 2010). But considering some viruses, such as paramyxoviruses, 
are not polyadenylated at the 3’ end of their genome (Lamb et al., 2005), this purification step 
would  need  to  be  skipped.  After  processing,  Fasteris  would  then  perform  Illumina® 
sequencing. 
 
Figure 6.1 provides an overview of the extraction of total RNA from viper heart cells (VH2) 
infected with BHP1-Lung, to the submission to Fasteris for further processing, and finally, to 
the de novo assembly of unique contigs. 
RNA Extraction from BHP1-Lung-infected VH2 Cells 
Briefly, RNA was extracted from a 25cm
2 flask of BHP1-Lung-infected VH2 cells, which was 
displaying extensive cytopathic effects (CPE). Media was removed and the monolayer was 
rinsed with phosphate-buffered saline (PBS, 130mM NaCl, 7mM KH2PO4, 3mM Na2HPO4.2H2O, 
pH 7.4). 1mL of Trizol® LS (Invitrogen, Mulgrave, Victoria, cat. no. 10296-028) was added to the 
flask, mixed thoroughly with the cell lysate that it created, and then transferred to a new tube. 
333µL of chloroform was added, the tube was vortexed and then left at room temperature for 
five  minutes.  The  contents  of  the  tube  were  then  transferred  to  a  phase  lock  gel  heavy 
separator  tube  and  centrifuged  at  12,000g  for  15  minutes  at  4
oC.  The  volume  of  clear 
supernatant was then quantified and mixed with 100% ethanol to a final ethanol concentration 
of 33% (v/v). This mixture was then added to an RNeasy® spin column (Qiagen, Doncaster, 
Victoria, cat. no. 74104) and centrifuged at 8,000g for one minute. Flow through was discarded 
and  the  remaining  washes  were  performed  in  accordance  with  the  manufacturer’s 
instructions. RNA was eluted into 60µL of RNase-free water. Ribosomal RNA (rRNA) was then 
twice removed from total RNA using the Ribominus™ Eukaryote Kit (Invitrogen, Mulgrave, 
Victoria,  cat.  no.  A10837-02).  The  concentration  and  purity  of  RNA  was  determined 
spectrophotometrically  (NanoDrop  ND-1000  Spectrophotometer,  Thermo  Scientific, 
Wilmington,  Delaware):  249ng/µL,  260nm  :  280nm  absorbance  =  2.14,  260nm  :  230nm 
absorbance = 2.30. rRNA-depleted RNA was then adsorbed to the silica membrane of a spin 198 | P a g e  
 
column from the Ribominus™ Concentration Module (Invitrogen, Mulgrave, Victoria, cat. no. 
K1550-05). This column was then stored under ambient conditions for one week before being 
eluted.  Repeat  analysis  by  spectrophotometry  ensured  there  had  not  been  any  significant 
deterioration during storage. This extraction procedure (now validated) was then repeated on 
another  flask  of  BHP1-Lung-infected  cells  and  the  rRNA-depleted  RNA  was  adsorbed  to 
another  silica  membrane  before  being  sent  to  Fasteris  in  Switzerland,  under  ambient 
conditions, for elution and further processing. 
Processing, Sequencing and de novo Assembly Performed by Fasteris 
Fasteris cleaved the RNA into small pieces (size not specified) using zinc. Single strand cDNA 
(i.e.  RNA:cDNA  hybrids)  was  then  synthesised  using  reverse  transcriptase  and  random 
hexamers. This was followed by second strand cDNA synthesis using DNA polymerase and 
RNase H. Overhangs were converted to blunt ends using T4 DNA polymerase and Klenow DNA 
polymerase. The exonuclease activity of these enzymes removes 3’ end overhangs and the 
polymerase activity fills in the 5’ overhangs. The 3’ ends were then polyadenylated to create 
binding sites for oligonucleotide adaptors, which were ligated to the cDNA fragment ends. 
cDNA was then purified and size-enriched (200bp +/- 25bp) using agarose gel electrophoresis 
followed by gel extraction. cDNA was amplified using two primers that annealed to the end 
adaptors. The cDNA library was then sequenced using a Genome Analyser GAIIx (Illumina®). In 
total, 10,544,936 reads (each 38 nucleotides long) were sequenced and de novo assembly 
produced 5,818 unique contigs. 199 | P a g e  
 
 
Figure 6.1 Sequencing and assembling the rRNA-depleted total RNA from viper heart (VH2) cells infected 
with BHP1-Lung.  Total RNA  was extracted from infected cells and then depleted of  ribosomal RNA 
(rRNA). From this, 10,544,936 reads were sequenced and from these, 5,818 unique contigs could be 
assembled. An assembled contig that is 69 nucleotides long is provided as an example. The minimum 
coverage of this 69-nucleotide contig is one, the maximum coverage is all 36 contigs, the mean coverage 
is 19.8 and the standard deviation of coverage is 12.5. 
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Analysis of Data 
Figure 6.2 outlines the next series of steps that were performed to analyse these unique 
contigs.  The  Basic  Local  Alignment  Search  Tool  (BLASTN; 
http://blast.ncbi.nlm.nih.gov/Blast.cgi) was used to try and determine the identity of these 
unique sequences. Batch searches were performed and the results downloaded. Results were 
then searched for the word “virus”. From the 5,818 unique contigs, 326 had BLAST hits for the 
word “virus”. The viral family was then determined for each BLAST hit and viruses not known 
to  occur  in  vertebrates  were  excluded.  This  excluded  host  DNA  (e.g.  virus  receptors)  and 
viruses  of  algae,  invertebrates,  plants,  protozoa  and  fungi.  This  left  212  unique  contigs 
representing 25 classified families and one unclassified virus (Salterprovirus). Next, ORF Finder 
(http://www.ncbi.nlm.nih.gov/projects/gorf/) was used to identify open reading frames (ORFs) 
and  then  search  the  protein  database  of  GenBank  (National  Center  for  Biotechnology 
Information,  Bethesda,  Maryland)  for  similarities.  Only  one,  an  11,709  nucleotide  contig, 
showed strong similarity to a virus. This sequence had one ORF with a predicted amino acid 
sequence that was similar to the fusion glycoprotein superfamily and a second that was similar 
to paramyxovirus RNA-dependent RNA-polymerase. 201 | P a g e  
 
 
Figure 6.2 Analysis of 5,818 unique assembled contigs to identify a single contig with strong similarity to 
a paramyxovirus. By searching all 5,818 unique contigs with the Basic Local Alignment Search Tool for 
Nucleotides (BLASTN), 326 were identified with search results that contained the word “virus”. 114 were 
excluded on the basis that they were viruses that occur in non-vertebrates (algae, plants, invertebrates, 
fungi and protozoa) or were of host DNA origin (e.g. virus receptors). Only one of the remaining contigs 
contained  open  reading  frames  (ORFs)  that  showed  strong  similarity  to  a  virus,  in  this  case,  a 
paramyxovirus. BLASTP = Basic Local Alignment Search Tool for Proteins. 
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The raw sequencing data (the 10,544,936 reads) were then reassembled “in-house” using CLC 
Genomics  Workbench®  software  (CLC  Bio©)  to  look  for  additional  sequence  information 
belonging to the putative paramyxoviral genome. A 17,187 nucleotide contig was assembled 
from 292,587 reads (2.77% of total reads) that extended the 11,709 nucleotide contig, that 
had been assembled by Fasteris, by an additional 5,478 nucleotides at the 3’ end of the viral 
genome. These additional nucleotides contained ORFs with strong similarities to paramyxoviral 
matrix (M) and nucleocapsid (N) ORFs. The mean coverage of this 17,187 nucleotide contig was 
648 reads with a standard deviation of 605 reads. There was a minimum of one read and a 
maximum of 4,647 reads over the length of the contig (Figure 6.1 provides an example to 
clarify the definitions of these terms). The first 21 nucleotides from the 3’ end had 16 or fewer 
reads, while the last four nucleotides at the 5’ end, had four or fewer reads. The remaining 
17,162 nucleotides (of the 17,187 nucleotide contig) had 20 or more reads contributing to 
each nucleotide of this contig. 
 
This data showed strong evidence for the presence of a paramyxovirus in viper heart cells 
(VH2) infected with BHP1-Lung. This result was also explanatory for the cytopathic effects 
(CPE) seen in this flask (primarily syncytial cell formation). At this point, it was apparent that 
two lines of investigation were needed. Firstly, what  was this new paramyxovirus? Was it 
another ferlavirus, or was it unique amongst the paramyxoviruses? Further characterisation of 
the genome and phylogenetic placement of this virus would be used in an attempt to answer 
these  questions.  Secondly,  what  is  the  significance  of  this  finding?  Cost  restraints  had 
prevented the analysis of an RNA sample of uninfected VH2 cells so the possibility that this 
paramyxovirus was endogenous to the VH2 cells that had been used in this project, could not 
be excluded. To investigate this possibility, PCR primers were designed that could screen tissue 
samples  and  uninfected  cells  for  this  paramyxovirus.  The  next  four  sections  concern 
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for it, phylogenetically placing it in the paramyxovirus family and designing and using PCR 
primers to investigate the significance of this new virus. 
 
6.2  Partial Genome Characterisation 
Figure 6.3 maps the paramyxovirus genome that is present in the 17,187 nucleotide contig. 
The predicted amino acid sequences from four paramyxoviral open reading frames (ORFs) 
were detected by BLASTP (Basic Local Alignment Search Tool for Proteins): nucleocapsid (N), 
matrix (M), fusion (F) and polymerase (L). The order of conservation between paramyxoviral 
proteins  has  been  previously  described  (Kurath  et  al.,  2004)  (most  conserved  to  least 
conserved): V-carboxy domain > polymerase (L) > matrix (M) / fusion (F) > nucleocapsid (N) / 
attachment (HN) > zinc binding protein (V) > phosphoprotein (P); so identifying N, M, F and L 
from the 17,187 contig using BLASTP was not unexpected. Three other ORFs were present but 
they could not be identified by BLASTP. 204 | P a g e  
 
 
Figure 6.3 Map of genomic RNA (3’ to 5’) of a 17,187 nucleotide length of sequenced genome from viper heart cells infected with BHP1-Lung. Numbers represent 
nucleotide lengths. ORF = open reading frame. Where GenBank similarity could not be validated, putative annotation has been used based on the ORF that is 
positioned at the corresponding position of other paramyxoviruses. 
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The Putative Attachment Protein 
Between the fusion and polymerase genes, lies an ORF, 2,031 nucleotides in length. In all 
paramyxoviruses, except the Pneumovirus genus, this is the location of an ORF that codes for 
the attachment protein (H, HN or G). GenBank searches using BLASTN (Basic Local Alignment 
Search  Tool  for  Nucleotides)  and  BLASTP  did  not  provide  any  meaningful  results  so  the 
(putative) attachment protein was aligned with those of 18 paramyxoviruses: two from each of 
the  seven  currently  accepted  genera  (Respirovirus,  Rubulavirus,  Avulavirus,  Morbillivirus, 
Henipavirus, Pneumovirus and Metapneumovirus), one from each of the two newly-proposed 
genera (Ferlavirus and Aquaparamyxovirus) and two unclassified paramyxoviruses (Menangle 
virus  and  Beilong  virus).  Other  authors  have  presented  the  relatedness  of  paramyxoviral 
attachment proteins in a phylogenetic tree (Li et al., 2006) but these proteins do not align as 
well as other paramyxoviral proteins and so a tree may not accurately depict relatedness 
(section 6.4 – Sunshine virus Phylogeny). Amino acid sequences were aligned using CLUSTALW 
(http://www.genome.jp/tools/clustalw/) (Thompson et al., 1994) and the results of pairwise 
alignment are presented in Table 6.1. The putative attachment protein of BHP1-Lung was the 
only  paramyxovirus  that  showed  weak  alignment  (<15%)  to  all  other  attachment  proteins 
analysed. 206 | P a g e  
 
 
BHP1-
Lung 
FDLV 
Atlantic 
salmon 
PMV 
Sendai 
Human 
PIV 
Menangle 
Porcine 
RV 
Mumps  NCDV 
Avian 
PMV2 
Rinderpest  Measles  Hendra  Nipah  Beilong 
Human 
RSV 
Bovine 
RSV 
Human 
MPV 
Avian 
MPV 
Genus  Unclass.  Ferla.  AquaPMV  Respiro  Respiro.  Unclass.  Rubula.  Rubula.  Avula.  Avula.  Morbilli.  Morbilli.  Henipa.  Henipa.  Unclass.  Pneumo.  Pneumo.  MPV  MPV 
Attachment 
protein 
?  HN  HN  HN  HN  HN  HN  HN  HN  HN  H  H  G  G  G  G  G  G  G 
Protein 
length (AA) 
676  564  576  575  572  595  576  582  577  583  609  617  604  602  734  299  257  219  585 
Avian MPV  9.91  10.28  10.07  9.74  9.96  9.23  10.59  10.82  10.05  9.78  11.97  11.28  10.42  9.57  10.60  17.39  15.95  24.20   
Human MPV  13.69  12.78  13.70  15.52  15.07  12.78  14.61  14.15  13.70  13.70  14.15  11.87  13.70  13.70  12.78  15.98  13.24    24.20 
Bovine RSV  14.39  12.06  12.06  12.06  14.40  13.62  12.45  12.84  11.28  12.45  12.06  10.89  13.23  11.67  12.06  29.18    13.24  15.95 
Human RSV  11.37  13.71  13.38  12.71  13.71  13.38  11.71  12.71  13.04  11.37  11.71  11.37  13.04  13.04  11.37    29.18  15.98  17.39 
Beilong  9.32  31.56  27.78  24.87  22.73  11.93  16.84  19.93  20.80  16.30  12.31  12.97  17.55  18.27    11.37  12.06  12.78  10.60 
Nipah  10.63  19.33  20.31  20.17  18.01  12.94  14.76  11.68  14.04  12.52  13.95  12.79  78.74    18.27  13.04  11.67  13.70  9.57 
Hendra  11.09  18.44  19.44  18.26  17.13  11.43  14.06  11.86  12.48  10.80  13.08  12.58    78.74  17.55  13.04  13.23  13.70  10.42 
Measles  11.51  12.41  11.98  13.22  12.76  10.08  10.59  11.34  11.78  11.15  58.78    12.58  12.79  12.97  11.37  10.89  11.87  11.28 
Rinderpest  11.00  13.47  11.11  12.87  13.29  10.08  12.15  11.17  11.44  10.63    58.78  13.08  13.95  12.31  11.71  12.06  14.15  11.97 
Avian PMV2  9.09  19.33  18.06  18.43  16.78  15.78  27.60  25.26  32.41    10.63  11.15  10.80  12.52  16.30  11.37  12.45  13.70  9.78 
NCDV  9.88  24.29  19.44  20.35  20.45  15.94  28.99  29.12    32.41  11.44  11.78  12.48  14.04  20.80  13.04  11.28  13.70  10.05 
Mumps  9.97  19.68  21.18  16.52  18.71  18.9  39.93    29.12  25.26  11.17  11.34  11.86  11.68  19.93  12.71  12.84  14.15  10.82 
Porcine RV  9.90  24.64  20.66  19.13  20.98  17.19    39.93  28.99  27.60  12.15  10.59  14.06  14.76  16.84  11.71  12.45  14.61  10.59 
Menangle  11.60  13.65  14.06  12.87  12.59    17.19  18.90  15.94  15.78  10.08  10.08  11.43  12.94  11.93  13.38  13.62  12.78  9.23 
Human PIV  10.66  34.04  36.01  44.75    12.59  20.98  18.71  20.45  16.78  13.29  12.76  17.13  18.01  22.73  13.71  14.40  15.07  9.96 
Sendai  10.61  37.06  37.21    44.75  12.87  19.13  16.52  20.35  18.43  12.87  13.22  18.26  20.17  24.87  12.71  12.06  15.52  9.74 
Atlantic 
salmon PMV 
11.11  37.59    37.21  36.01  14.06  20.66  21.18  19.44  18.06  11.11  11.98  19.44  20.31  27.78  13.38  12.06  13.70  10.07 
FDLV  11.17    37.59  37.06  34.04  13.65  24.64  19.68  24.29  19.33  13.47  12.41  18.44  19.33  31.56  13.71  12.06  12.78  10.28 
BHP1-Lung    11.17  11.11  10.61  10.66  11.60  9.90  9.97  9.88  9.09  11.00  11.51  11.09  10.63  9.32  11.37  14.39  13.69  9.91 
Table 6.1 Pairwise alignments of the attachment proteins of 19 paramyxoviruses using CLUSTALW. Numbers represent percentage similarities. The similarities of the 
attachment proteins of viruses from the same genera are in adjacent columns and highlighted in red. BHP1-Lung has the only attachment protein that has less than a 
15%  similarity  to  each  of  the  other  18  proteins.  FDLV  =  Fer-de-Lance  virus  (GenBank  accession  number:  NC_005084).  Atlantic  salmon  PMV  [Paramyxovirus] 
(EF646380). Sendai virus (NC_001552). Human PIV [Parainfluenza virus] (NC_003461). Menangle virus (NC_007620). Porcine RV [Rubulavirus] (NC_009640). Mumps 
virus  (NC_002200).  NCDV  =  Newcastle  disease  virus  (NC_002617).  Avian  PMV2  [Paramyxovirus  2]  (HM159993).  Rinderpest  virus  (NC_006296).  Measles  virus 
(NC_001498). Hendra virus (NC_001906). Nipah virus (NC_002728). Beilong virus (NC_007803). Human RSV [Respiratory syncytial virus] (NC_001781). Bovine RSV 
[Respiratory Syncytial virus]  (NC_001989). Human MPV [Metapneumovirus] (NC_004148). Avian MPV [Metapneumovirus] (NC_007652). HN = Haemagglutinin-
Neuraminidase. H = Haemagglutinin. G = Glycoprotein. AA = Amino acid. Unclass. = Unclassified. Ferla. = Ferlavirus. AquaPMV = Aquaparamyxovirus. Respiro = 
Respirovirus. Rubula. = Rubulavirus. Avula. = Avulavirus. Morbilli. = Morbillivirus. Henipa. = Henipavirus. Pneumo. = Pneumovirus. 207 | P a g e  
 
Despite  this  analysis,  the  putative  attachment  protein  of  BHP1-Lung  remains  poorly 
characterised.  Both  haemagglutination  (HA)  and  neuraminidase  (NA)  activity  could  not  be 
convincingly  detected  phenotypically  (sections  5.3.2  –  Haemagglutination  and 
Haemadsorbing  Activity  and  5.3.3  –  Neuraminidase  Activity)  and  the  pairwise  protein 
alignments were also non-contributory. While it may therefore be tempting to claim that this 
protein is a G (glycoprotein) attachment protein (i.e. possesses neither HA or NA activity), the 
experiments presented in this thesis do not provide enough evidence to support this. Future 
studies that attempt to clarify the identity of this attachment protein could have direct clinical 
significance.  For  example,  the  other  snake  paramyxoviruses,  the  ferlaviruses,  have  HN 
attachment proteins which can be used in haemagglutination inhibition (HI) assays to detect 
anti-ferlaviral  antibodies  (section  2.3.6  –  Haemagglutination  Inhibition).  To  detect  the 
humoral response to paramyxoviruses with G attachment proteins, HI assays cannot be used. 
Virus neutralisation and/or ELISA (enzyme-linked immunosorbent assay) assays are often used 
instead (Lamb and Parks, 2007). Analysis of the predicted three-dimensional structure of this 
uncharacterised protein may provide further insight into its form and function (Langedijk et al., 
1997). 
The Putative Phosphoprotein and a 540-nucleotide Open Reading Frame 
A 1,677 nucleotide ORF can be seen 3’ to the matrix (M) ORF. In all paramyxoviruses this is the 
location for a phosphoprotein (P). A GenBank search using BLASTP and BLASTN was unable to 
confirm the identity of this putative phosphoprotein. Further analysis of this protein was not 
pursued. 
 
Additionally, between this putative phosphoprotein (P) and N, lies a 540 nucleotide (179 amino 
acids) ORF. Only paramyxoviruses from the proposed genus Ferlavirus (all previously described 
reptilian paramyxoviruses) are known to translate a protein, named “U” for unknown, in this 
region (Kurath et al., 2004; Marschang et al., 2009). A GenBank search using BLASTP and 
BLASTN was unable to confirm the identity of this possible ORF. A pairwise alignment of the 208 | P a g e  
 
amino acid sequences of the U proteins of Fer-de-Lance virus (FDLV, 167 amino acids, GenBank 
accession  number:  NP_899655)  and  another  ferlavirus  (GonoGer85,  167  amino  acids, 
AY534644) showed an 88.6% similarity to each other but when aligned with the 179 amino 
acid predicted protein sequence from BHP1-Lung, the pairwise similarities were only 13.2% 
and  12.6%  respectively.  Kurath  et  al.  (2004)  used  electrophoretic  separation  of  ferlaviral 
proteins to discover that the U ORF translated into a protein. Applying this technique to BHP1-
Lung could reveal whether this 540 nucleotide ORF is a protein coding region of the genome. 
Sunshine  virus  and  the  ferlaviruses  are  not  closely  related  (section  6.4  –  Sunshine  virus 
Phylogeny), there is little sequence similarity and therefore no reason to expect that these 
ORFs are orthologous. 
 
Future  characterisations  of  the  Sunshine  virus  genome  could  consider  analysing  the 
untranslated and intergenic regions (UTRs and IGRs) to look for sequence similarities to other 
paramyxoviruses. This has been done for other paramyxoviruses (Wang et al., 2000; Li et al., 
2006) and may provide some further insight into the biology of Sunshine virus. 
 
In all known paramyxoviruses, the nucleocapsid gene (N) is nearest to the 3’ end and the 
polymerase gene (L) is nearest to the 5’ end, so it is likely that the sequence information 
generated from this investigation includes all of the coding regions of this new virus. The depth 
of coverage from the Illumina® high-throughput sequencing is shallow at both the 3’ and 5’ 
end of the contig. Therefore, the 17,187 nucleotide contig may not represent the complete 
genome. 5’ or 3’ rapid amplification of cDNA ends (RACE) may help in defining the terminal 
ends of this genome (Kurath et al., 2004). The 17,187 nucleotide contig is not divisible by six 
but without the certainty that this contig represents the complete genome of Sunshine virus, it 
cannot be concluded whether this new genome conforms to the “rule of six”. The “rule of six” 
is  where  the  total  number  of  nucleotides  in  the  viral  genome  is  a  multiple  of  six 209 | P a g e  
 
(polyhexameric) and is a unique feature of all members of the Paramyxovirinae subfamily but 
not the Pneumovirinae subfamily (Kolakofsky et al., 2005; Lamb et al., 2005). 
 
The 17,187 nucleotide contig has been deposited into GenBank under the accession number 
JN192445. 
6.3  Proposing the Name Sunshine virus for BHP1-Lung 
The Basic Local Alignment Search Tool for Proteins (BLASTP) had revealed four proteins (N, M, 
F and L) with strong similarity to other paramyxoviruses. Open reading frames (ORFs) that 
presumably  coded  for  the  phosphoprotein  (P)  and  the  attachment  protein  could  not  be 
confidently aligned with other paramyxoviruses. These findings supported the conclusion that 
BHP1-Lung was unique among paramyxoviruses and should be provided with its own name. 
 
Formal recognition of new viral taxa can only be provided by the International Committee on 
Taxonomy of Viruses (ICTV, 2010). Proposals must be submitted to the ICTV with a justification 
as to why the new virus should be taxonomically independent of its closest relatives. This has 
not been done but as the discoverer of this new virus and for the purposes of clarity when 
discussing this new virus, a name was suggested. 
 
The  rules  of  orthography  are  listed  on  the  ICTV  website 
(http://ictvonline.org/codeOfVirusClassification_2002.asp).  For  BHP1-Lung,  it  was  important 
that its name did not create confusion with the existing cluster of snake paramyxoviruses; the 
ferlaviruses. Further constraints were that the name should be euphonious (pleasing to the 
ear). Several names were considered that did not seem appropriate before the name Sunshine 
virus was chosen (Table 6.2). 
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Possible names for a new 
paramyxovirus in Australian snakes  Comments 
Snake neurorespiratory paramyxovirus   Considers the host, predominant clinical signs and virus 
family. 
 Does not adequately differentiate it from the ferlavirus 
group. 
Reptilian neurorespiratory 
paramyxovirus 
 As above but allows for a greater diversity of future hosts 
but could be confusing if it is never found in non-snake 
reptiles. 
Ophidian paramyxovirus (OPMV)   More concise but would cause great confusion with the 
published literature that refers to ferlaviruses as ophidian 
paramyxoviruses (OPMV). 
Aspidites virus   Like Fer-de-Lance virus (FDLV, the type species of the 
proposed genus Ferlavirus and named after the Fer-de-
Lance viper mentioned in the first report of this virus), 
would be homage to the first species (in this case genus) that 
the virus was isolated from. 
Australian snake paramyxovirus   Considers the geographical origin of the first isolate, the 
host and the virus family. 
Australian reptile paramyxovirus   As above but allows for a greater diversity of future hosts 
but could be confusing if is never found in non-snake 
reptiles. 
Mortalivirus   A variation of an existing paramyxoviral genus, 
Morbillivirus. 
 Future epidemiological data may conclude that the name 
misleadingly implies a high mortality rate. 
 Name is not very descriptive. 
 Breaks the rules of orthography because the word “virus” 
must be included in the final word of the species name 
which itself must be more than one word. 
Sunshine virus   Euphonious and memorable. 
 Refers to the geographical origin of the first isolate which 
follows a precedent already set by other paramyxoviruses 
e.g. Menangle virus, Hendra virus, Nipah virus, Sendai 
virus, Newcastle disease virus, Beilong virus, Mossman 
virus, Tioman virus and Salem virus. 
 Name could be considered facetious. 
Table  6.2  Names  that  were  considered  for  the  new  Australian  snake  paramyxovirus.  Ultimately, 
Sunshine virus was chosen. 
 
Sunshine  virus  follows  a  precedent  of  several  other  paramyxoviruses  whose  names  were 
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6.4  Sunshine virus Phylogeny 
The phylogenetic analysis of Sunshine virus was performed by Dr James Wellehan (DVM, MS, 
PhD,  DipACZM,  DipACVM)  from  the  University  of  Florida  and  formed  part of  a  submitted 
manuscript of this work. Dr Wellehan has published more than 65 papers predominantly on 
the infectious diseases of a wide range of animals and his phylogeny methods have been 
accepted for publication in many journals. 
 
In this section (6.4 - Sunshine virus Phylogeny) work is presented in text boxes that was not 
performed by the author of this thesis. It is included here nevertheless so that this thesis can 
contain the most complete account of the current knowledge on Sunshine virus. 
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Open  reading  frames  (ORFs)  were  identified  using  a  web-based  translator 
(http://www.vivo.colostate.edu/molkit/translate/index.html).  Large ORFs were identified by 
sequence homology to known paramyxoviruses in GenBank (National Center for Biotechnology 
Information,  Bethesda,  Maryland),  EMBL  (Cambridge,  United  Kingdom),  and  Data  Bank  of 
Japan  (Mishima,  Shizuoka,  Japan)  databases  using  BLASTP  (Altschul  et  al.,  1997),  and  by 
location in the genome. 
 
The  predicted  homologous  amino  acid  sequences of  mononegaviral  proteins  were  aligned 
using MAFFT (Katoh and Toh, 2008).  Bayesian analyses of each alignment were performed 
using MrBayes 3.1 (Ronquist and Huelsenbeck, 2003) with gamma distributed rate variation 
and a proportion of invariant sites, and amino acid substitution model jumping. Four chains 
were run and statistical convergence was assessed by looking at the standard deviation of split 
frequencies  as  well  as  potential  scale  reduction  factors  of  parameters.    The  first  10%  of 
1,000,000 iterations were discarded as a burn in, based on examination of trends of the log 
probability vs. generation. Two independent Bayesian analyses were run to avoid entrapment 
on local optima. 
 
Maximum likelihood (ML) analyses of each alignment were performed using PHYLIP (Phylogeny 
Inference  Package,  Version  3.66)  (Felsenstein,  1989),  running  each  alignment  using  the 
program Proml with amino acid substitution models JTT (Jones et al., 1992), PMB (Veerassamy 
et al., 2003), and PAM (Kosiol and Goldman, 2005) further set with global rearrangements, five 
replications of random input order, gamma plus invariant rate distributions, and unrooted.  
The values for the gamma distribution were taken from the Bayesian analysis. Nyamanini virus 
(GenBank accession number NC012703) was used as the outgroup for the  N and L genes, 
Bornavirus  (NC_001607)  was  used  as  the  outgroup  for  the  M  gene,  and  Atlantic  salmon 
paramyxovirus (EF646380) was designated as the outgroup for the F gene.  The alignment was 
then  used  to  create  data  subsets  for  bootstrap  analysis  to  test  the  strength  of  the  tree 213 | P a g e  
 
topology (200 re-samplings)  (Felsenstein, 1985), which was analyzed using the amino acid 
substitution model producing the most likely tree in that alignment. 
 
Bayesian phylogenetic analysis of the predicted N and M proteins found that the WAG model 
of amino acid substitution was most probable with a posterior probability of 1.000 (Whelan 
and Goldman, 2001). The predicted F protein analysis found the CpRev model to be most 
probable (posterior probability=1.000), and the predicted L protein analysis found the Blosum 
model to be most probable (posterior probability=1.000) (Henikoff and Henikoff, 1992; Adachi 
et al., 2000). Bayesian trees including posterior probabilities of clades are shown (Figures 6.4 - 
6.7).214 | P a g e  
 
 
 
 
Figure 6.4 Bayesian phylogenetic tree of predicted 1,711-2,331 amino acid sequences of mononegaviral 
RNA-dependent-RNA  polymerase  based  on  MAFFT  alignment.  Bayesian  posterior  probabilities  of 
clusters  as  percentages  are  in  bold,  and  ML  bootstrap  values  for  clusters  are  given  to  the  right. 
Nyamanini virus (GenBank accession number NC012703) was used as the outgroup.  Sunshine virus is 
bolded. Thick brackets demarcate viral families, medium brackets indicate paramyxoviral subfamilies, 
and  thin  brackets  demarcate  paramyxoviral  genera.    Sequences  retrieved  from  GenBank  include 
Bornavirus  (GenBank  accession  #  NC_001607),  Nyamanini  (NC_012703),  Duvenhage  (EU293119), 
Flanders  (AAN73288),  Lake  Victoria  Marburg  (YP_001531159),  Sudan  Ebola  (YP_138527),  Newcastle 
disease virus (NC_002617), Avian Paramyxovirus 2 (HM159993), Avian Paramyxovirus 6 (NC_003043), 
Human  Parainfluenzavirus  2  (NC_003443),  Simian  Parainfluenzavirus  5  (NC_006430),  Mapuera 
(NC_009489), Porcine Rubulavirus (NC_009640), Mumps (NC_002200), Menangle (NC_007620), Tioman 
(NC_004074), Beilong (NC_007803), J Virus (NC_007454), Canine Distemper Virus (NC_001921), Dolphin 
Morbillivirus (NC_005283), Measles (NC_001498), Rinderpest (NC_006296), Peste des Petits Ruminants 
Virus  (NC_006383),  Mossman  (NC_005339),  Nariva  (FJ362497),  Tupaia  Paramyxovirus  (NC_002199), 
Hendra  (NC_001906),  Nipah  (NC_002728),  Bovine  Parainfluenzavirus  3  (NC_002161),  Human 
Parainfluenzavirus  1  (NC_003461),  Human  Parainfluenzavirus  3  (NC_001796),  Sendai  (NC_001552), 
Atlantic  Salmon  Paramyxovirus  (EF646380),  Ferlavirus  (NC_005084),  Avian  Metapneumovirus 
(NC_007652), Human Metapneumovirus (NC_004148), Bovine Respiratory Syncytial Virus (NC_001989), 
Human Respiratory Syncytial Virus (NC_001781) and Pneumonia Virus of Mice (NC_006579). 
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Figure 6.5 Bayesian phylogenetic tree of predicted  529-662 amino acid sequences of paramyxoviral 
fusion proteins based on MAFFT alignment. Bayesian posterior probabilities of clusters as percentages 
are in bold, and ML bootstrap values for clusters are given to the right. Atlantic salmon paramyxovirus 
(EF646380)  was  used  as  the  outgroup.    Sunshine  virus  is  bolded.  Medium  brackets  indicate 
paramyxoviral  subfamilies,  and  thin  brackets  demarcate  paramyxoviral  genera.  Sequences  retrieved 
from GenBank are from the same genomes as the L genes used in Figure 6.4. 
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Figure 6.6 Bayesian phylogenetic tree of predicted 142-377 amino acid sequences of mononegaviral 
matrix proteins based on MAFFT alignment.  Multifurcations are marked with arcs. Bayesian posterior 
probabilities of clusters as percentages are in bold, and ML bootstrap values for clusters are given to the 
right.    Bornavirus  (NC_001607)  was  used  as  the  outgroup.  Sunshine  virus  is  bolded.  Thick  brackets 
demarcate  viral  families,  medium  brackets  indicate  paramyxoviral  subfamilies,  and  thin  brackets 
demarcate paramyxoviral genera. Sequences retrieved from GenBank are from the same genomes as 
the L genes used in Figure 6.4. 
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Figure 6.7 Bayesian phylogenetic tree of predicted 370-738 amino acid sequences of mononegaviral 
nucleoproteins based on MAFFT alignment. Bayesian posterior probabilities of clusters as percentages 
are in bold, and ML bootstrap values for clusters are given to the right. Nyamanini virus (GenBank 
accession  number  NC012703)  was  used  as  the  outgroup.  Sunshine  virus  is  bolded.  Thick  brackets 
demarcate  viral  families,  medium  brackets  indicate  paramyxoviral  subfamilies,  and  thin  brackets 
demarcate paramyxoviral genera. Sequences retrieved from GenBank are from the same genomes as 
the L genes used in Figure 6.4. 
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ML analyses of the predicted N, M, and L proteins found the most likely tree resulted from the 
JTT model of amino acid substitution, and analysis of the predicted F protein found that the 
most likely tree resulted from the PMB model.  These parameters were used for bootstrap 
analysis. Bootstrap values from ML analysis are shown on the Bayesian trees (Figures 6.4 - 6.7). 
 
None of the analyses found that Sunshine virus clustered within either currently recognized 
subfamily of the paramyxoviruses.  The predicted L gene analysis found that Sunshine virus 
clustered within the Paramyxoviridae with 100% posterior probability and 100% ML bootstrap 
value (Figure 6.4).  The M gene analysis, while supporting recognized genera as monophyletic, 
was  not  able  to  resolve  deeper  level  relationships,  including  not  forming  a  distinct 
monophyletic  cluster  from  the  Avulavirus/Rubulavirus  and 
Respirovirus/Henipavirus/Morbillivirus clades in the subfamily Paramyxovirinae.  Similarly, the 
N gene analysis did not resolve deeper level relationships with strong confidence, and actually 
had weak support for paraphyly of the family Paramyxoviridae, with support in the Bayesian 
(but not ML) analysis for a clade containing Rhabdoviridae/Paramyxovirinae/Sunshine virus.  
The M gene analysis found support for genera and subfamilies, but homologous genes are not 
present in other members of the Mononegavirales to examine deeper level relationships. 
 
We  chose  to  examine  amino  acid  alignments  because  of  concerns  regarding  non-lineage 
factors on viral nucleotide composition bias outweighing the true phylogenetic signal. The 
paramyxoviruses are divergent to the point that the phosphoproteins and attachment proteins 
cannot be reliably aligned, and this indicates that the phylogenetic signal from synonymous 
sites  is  likely  to  be  significantly  weakened  by  homoplasy.  While  it  has  been  shown  that 
nucleotide alignments may be moderately more informative than amino acid alignments when 
looking at vertebrate genes (Townsend et al., 2008), viral evolutionary events such as host 
switches  may  cause  differential  biases  in  different  lineages.    In  the  genus  Atadenovirus, 
squamate reptiles appear to be the endemic hosts.  These viruses appear to have jumped into 219 | P a g e  
 
birds  and  mammals  in  at  least  two  separate  events,  and  in  both  cases,  host  jumps  were 
associated  with  a  large  AT  bias  (Wellehan  et  al.,  2004).    Experimental  cross-species 
transmission of a feline lentivirus was shown to have a major impact on nucleotide bias (Poss 
et al., 2006).  Host nucleotide composition and host switches also appear to have a significant 
impact on astrovirus composition (van Hemert et al., 2007). 
 
Dr Wellehan produced phylogenetic trees based on the entire amino acid sequences of the L, 
F, M and N paramyxoviral proteins (Figures 6.4 - 6.7). These trees all show that Sunshine virus 
should be clustered within the family Paramyxoviridae but outside existing subfamilies. All four 
trees also show that Sunshine virus is related to ferlavirus only at a family level. Previous to the 
discovery  of  Sunshine  virus,  all  known  reptilian  paramyxoviruses  had  clustered  within  the 
proposed genus ferlavirus (Kurath et al., 2004). The paramyxoviruses show considerable host 
diversity by utilising salmonid, reptilian (birds, snakes, lizards and tortoises), and mammalian 
hosts, and there is no evidence of host-virus codivergence over large-scale paramyxovirus 
evolution.  Ferlaviruses have been found to infect snakes, lizards and tortoises (Marschang et 
al., 2009). The use of snake hosts by Sunshine virus is likely an independent event from the use 
of snake hosts by ferlaviruses. 
 
High-throughput  sequencing  had  generated  enough  Sunshine  virus  sequence  data  to 
determine that it is a paramyxovirus and subsequent phylogenetic analysis had demonstrated 
its uniqueness within this family. With the sequence information available, polymerase chain 
reaction (PCR) primers could be designed that would allow the rapid identification of Sunshine 
virus in a variety of sample types.  
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6.5  Development  and  Validation  of  a  Sunshine  virus 
Polymerase Chain Reaction Primer Set 
Illumina®  high-throughput  sequencing  had  allowed  the  identification  of  a  unique 
paramyxovirus that was subsequently named Sunshine virus. Several PCR primers that had 
been designed for the detection of a broad range of paramyxoviruses (Tables 4.3 – 4.4) failed 
to detect Sunshine virus. With the benefit of hindsight, this was not surprising considering the 
partial  genome  characterisation  (section  6.2  –  Partial  Genome  Characterisation)  and 
phylogenetic  assessment  (section  6.4  –  Sunshine  virus  Phylogeny)  of  Sunshine  virus  both 
concluded that it was a unique species of paramyxovirus. However, with the recently-available 
Sunshine virus sequence data, the suitability of these paramyxoviral primers could be analysed 
in greater detail. It was still possible that the failure of these primers to detect Sunshine virus 
was  technical  and  not  theoretical.  Two  primer  sets  of  particular  interest  were  chosen  for 
further analysis. Firstly, the L gene primer set described by Ahne et al. (1999b) was chosen 
because it is used in at least two diagnostic laboratories (University of Florida and University of 
Hohenheim, Germany) and every ferlaviral isolate that has been tested with these primers has 
been detected (Marschang et al., 2009). It would be valuable to know if this primer set is 
unable to detect all known reptilian paramyxoviruses (i.e. all ferlaviruses and Sunshine virus). 
The second primer set of particular interest was described by Tong et al. (2008) and had been 
carefully  designed  to  detect  all  known  members  from  each  of  the  two  paramyxoviral 
subfamilies: Paramyxovirinae and Pneumovirinae. With Sunshine virus being phylogenetically 
placed between these two subfamilies (Figures 6.4 – 6.7) it would be interesting to see if it 
could theoretically be detected by either a pan-Paramyxovirinae or pan-Pneumovirinae set of 
primers. 
 
To be able to assess the binding sites of the Ahne primers in the ferlavirus and Sunshine virus 
genomes, the L genes of a ferlaviral isolate, Fer-de-Lance virus (FDLV), and Sunshine virus, 
were translationally aligned. To do this, the L gene of both viruses was translated into an 221 | P a g e  
 
amino acid sequence and aligned with CLUSTALW (Thompson et al., 1994). The alignment was 
cross-referenced with the alignment produced by MUSCLE (Edgar, 2004). Next, the nucleotides 
from the original gene were reinserted in place of the amino acids. The primer binding sites 
were found for FDLV, and the analogous region of the Sunshine virus genome was located. 
These sites were then checked for similarity to the primer sequence (Figure 6.8). The number 
of bases in the primer that matched with the binding site on the viral genome, both in total, 
and at the 3’ end of the primer, are presented in Table 6.3. This process was repeated for the 
primers described by Tong et al. (2008) using the L genes of FDLV and bovine RSV as controls 
(Figure 6.9 and Table 6.3). 222 | P a g e  
 
 
Figure 6.8 Assessment of the binding affinity of the Ahne L-gene PCR primer set (Ahne et al., 1999b) to 
Sunshine virus and Fer-de-Lance virus (FDLV). A translational alignment was performed where the L 
gene nucleotide sequences were translated into amino acid sequences which were then aligned using 
CLUSTALW  (cross-referenced  with  MUSCLE)  and  finally,  nucleotides  were  reinserted  in  place  of  the 
amino acids. The four PCR primers (Ahne 5-8) were then positioned into their binding sites to assess 
their similarity to the corresponding area of the Sunshine virus genome. * = complementary sequence.
xxx√√xx√xx√xx√xx√xxx______ 
Sunshine virus (3’: 1108-1139) GATAGGTGCGACTTGATTGCACTTGAGAAATG 
Ahne 5 (5’ → 3’) ______GCAGAGATTTTCTCTTTCTT______ 
FDLV (3’: 1036-1067) GAAATATCAGAGATTTTCTCTTTCTTCAGATC 
______x√√√√√√√√√√√√√√√√√√√______ 
 
______√√√√√x√xxx√xx√x√√√√√x______ 
Sunshine virus (3’: 1714-1746) GCAAAAATGACTTGTGACTTAAGAGCATGTCAA 
Ahne 6* (3’ → 5’) ______ATGACATACAAAATGAGAGCT______ 
FDLV (3’: 1642-1674) GCCAAGATGACATACAAAATGAGAGCTGCACAA 
______√√√√√√√√√√√√√√√√√√√√√______ 
 
______√x√x√√xxxxxxxx√√√xx______ 
Sunshine virus (3’: 1151-1181) CTATATTGGGGGTGAGAGAGGCTATTTTAAA 
Ahne 7 (5’ → 3’) ______TAGAGGCTGTTACTGCTGC______ 
FDLV (3’: 1079-1109) CCGTCCTAGAGGCTGTTACTGCTGCTGATAA 
______√√√√√√√√√√√√√√√√√√√______ 
 
______√xx√√√x√x√√√√√x√√x√√√______ 
Sunshine virus (3’: 1696-1728) ACCTCTGCTAGACTCTTTGCAAAAATGACTTGT 
Ahne 8* (3’ → 5’) ______GGCAGATTATTTGCCAAGATG______ 
FDLV (3’: 1624-1656) CAAGCGGGCAGATTATTTGCCAAGATGACATAC 
______√√√√√√√√√√√√√√√√√√√√√______ 223 | P a g e  
 
 
Figure 6.9 Assessment of the binding affinity of the Tong L-gene PCR primer set (Tong et al., 2008) to 
Sunshine virus, Fer-de-Lance virus (FDLV) and Bovine respiratory syncytial virus (RSV). A translational 
alignment was performed using the same method described in Figure 6.8. The six PCR primers (PAR-F1, 
PAR-F2, PAR-R, PNE-F1, PNE-F2, PNE-R) were then positioned into their binding sites to assess their 
similarity to the corresponding area of the Sunshine virus genome. * = complementary sequence. 
√√x√√√√√√xxx√√√√√√√x√√√√x√___ 
Sunshine virus (3’: 2146-2177) ATAGAGGGGTATCAACAAAAAGAATGGTCAGC 
PAR-F1 (5’ → 3’) ___GAAGGITATTGTCAIAARNTNTGGAC___ 
FDLV (3’: 2200-2231) ATTGAGGGATACTCACAAAAAATGTGGACTAT 
______√√x√√√√√x√xx√√√√√√√√√√√√√√___ 
 
√xxx√√√√x√√x√√√√√√√√√√√√√√___ 
Sunshine virus (3’: 2224-2254) ATTGCCCCTTCTATTGTTCAAGGAGATAACCA 
PAR-F2 (5’ → 3’) ___GTTGCTTCAATGGTTCARGGNGAYAA___ 
FDLV (3’: 2278-2309) AGAGTCTCCGCAGTTATCCAAGGAGACAATCA 
______√√xx√xx√√x√xx√x√√√√√√√√√√√___ 
 
______x√xx√√√√√x√√√√xx√x√x√√√√√xxx__ 
Sunshine virus (3’: 2781-2812) CCAACGCATTGATGATGTACTGACTTCCAGTA 
PAR-R* (3’ → 5’) __GNAAYATHGGIGAICCIGTAACTTCAGC__ 
FDLV (3’: 2835-2866) GCGTAATATCGGGGATCCTTTAGTAGCGGCAT 
______√√√√√√√√√√√√√√√√√x√√xxxx√x√√__ 
 
xxxxx√x√√√√x√x√√√√√√√xxxx√x√__ 
Sunshine virus (3’: 1695-1726) AACCTCTGCTAGACTCTTTGCAAAAATGACTT 
PNE-F1 (5’ → 3’) ___GTGTAGGTAGIATGTTYGCNATGCARCC__ 
Bovine RSV (3’: 1860-1891) TAGTGTAGGTAGGATGTTTGCAATGCAGCCAG 
______√√√√√√√√√√√√√√√√√√√√√√√√√√√√__ 
 
_√√√√√√x√√xx√√√√√x√xx√xx√xx __ 
Sunshine virus (3’: 1912-1943) ACTACTGATTTGGTTAAGTACTGTTTAAGATG 
PNE-F2 (5’ → 3’) ___ACTGATCTIAGYAARTTYAAYCARGC __ 
Bovine RSV (3’: 2083-2114) ATCACTGATCTTAGCAAGTTCAATCAGGCATT 
______√√√√√√√√√√√√√√√√√√√√√√√√√√ __ 
 
√√√√√√√xxxxx√√√√√√xxx√√√xxx__ 
Sunshine virus (3’: 2147-2177) TAGAGGGGTATCAACAAAAAGAATGGTCAGC 
PNE-R* (3’ → 5’) __GARGGNTGGTGYCAAAAITTGTGGGAC__ 
Bovine RSV (3’: 2321-2351) TAGAAGGTTGGTGTCAAAAATTGTGGACTAT 
______√√√√√√√√√√√√√√√√√√√√√√√√xxx__ 224 | P a g e  
 
Primer (bases)  Virus, Primer matches (%) 
Virus, Primer matches (√) or 
mismatches (x) for the six bases at the 
3’ end of the primer (5’ → 3’) 
Ahne 5 (20)  FDLV, 19 (95) 
Sunshine virus, 6 (30) 
FDLV, √√√√√√ 
Sunshine virus, xx√xxx 
Ahne 6 (21)  FDLV, 21 (100) 
Sunshine virus, 13 (62) 
FDLV, √√√√√√ 
Sunshine virus, x√√√√√ 
Ahne 7 (19)  FDLV, 19 (100) 
Sunshine virus, 7 (37) 
FDLV, √√√√√√ 
Sunshine virus, x√√√xx 
Ahne 8 (21)  FDLV, 21 (100) 
Sunshine virus, 15 (71) 
FDLV, √√√√√√ 
Sunshine virus, √√√xx√ 
PAR-F1 (26)  FDLV, 22 (85) 
Sunshine virus, 20 (77) 
FDLV, √√√√√√ 
Sunshine virus, √√√√x√ 
PAR-F2 (26)  FDLV, 18 (69) 
Sunshine virus, 21 (81) 
FDLV, √√√√√√ 
Sunshine virus, √√√√√√ 
PAR-R (28)  FDLV, 22 (79) 
Sunshine virus, 17 (61) 
FDLV, √√√√√√ 
Sunshine virus, √√xx√x 
PNE-F1 (28)  Bovine RSV, 28 (100) 
Sunshine virus, 15 (54) 
Bovine RSV, √√√√√√ 
Sunshine virus, xxx√x√ 
PNE-F2 (26)  Bovine RSV, 26 (100) 
Sunshine virus, 16 (62) 
Bovine RSV, √√√√√√ 
Sunshine virus, √xx√xx 
PNE-R (27)  Bovine RSV, 24 (89) 
Sunshine virus, 16 (59) 
Bovine RSV, √√√√√√ 
Sunshine virus, √√√√√√ 
Table  6.3  Comparison  of  the  primer  binding  sites  on  either  Fer-de-Lance  virus  (FDLV)  or  bovine 
respiratory syncytial virus (RSV) compared to Sunshine virus for each of ten primers. The number of 
bases that are identical to the primer sequence are presented, as are the similarities that exist at the 3’ 
end of the primer. 
 
From this data, it can be seen that there was near perfect similarity between all four Ahne L 
gene primers and FDLV but for Sunshine virus, there are a large number of mismatches. Only 
Ahne 6 has five consecutive matches at its 3’ end with Sunshine virus. Similarly, with the Tong 
primers, only PAR-F2 and PNE-R showed strong 3’ end similarities with Sunshine virus. Ahne 6 
(a reverse primer) is upstream from PAR-F2 (a forward primer) and so would not generate an 
amplicon. Equally, PNE-R (a reverse primer) is also upstream from PAR-F2 and so this primer 
pair would not produce an amplicon either. 
 
By analysing the primer binding sites of various paramyxoviral primers to Sunshine virus using 
these methods, it could be seen that they would not be anticipated to amplify a segment of 
the viral genome. Even with the few primers that would be assumed to bind (Ahne 6, PAR-F2 
and PNE-R), they cannot be used in concert due to their respective binding sites. However, this 225 | P a g e  
 
method of primer binding analysis could prove useful in designing primers or using existing 
primers (from different published sets) to be able amplify Sunshine virus. It would be even 
more advantageous if primers could be designed that could amplify both ferlaviruses and 
Sunshine virus in a way that produced amplicons that were different sizes for each virus. This 
would allow both viruses to be screened with only one primer set. The divergent sequences of 
these two viruses could allow this possibility. 
 
Although this analysis had shown potential in identifying primers that could amplify Sunshine 
virus, it was ultimately shown that it was unlikely that technical reasons (e.g. number of cycles, 
annealing temperature, concentration of magnesium chloride, primer concentration, amount 
of starting template etc) explained the inability of these primers to amplify a segment of 
Sunshine  virus.  It  was  therefore  concluded  that  new  primers  should  be  designed  for  the 
detection of Sunshine virus. 
 
Sunshine  virus  had  been  discovered  as  a  novel  paramyxovirus  but  several  questions  still 
remained about its significance. 
 
1.  Could this virus be detected in uninfected VH2 cells? 
2.  Could this virus be detected in BHP1-Lung (the tissue sample)? 
3.  Could this virus be detected in the tissue samples of other snakes that produced the 
same cytopathic effects (CPE) in cell culture? 
4.  Could this virus be detected in the tissues of seemingly healthy snakes? 
5.  Could this virus be detected in formalin-fixed paraffin-embedded (FFPE) samples? 
 
A set of PCR primers that was specifically designed for Sunshine virus would provide a rapid, 
sensitive and specific means to detect this virus in a range of samples, allowing many of these 
questions  to  be  answered.  Using  the  paramyxoviral  sequence  information  that  had  been 226 | P a g e  
 
generated from high-throughput sequencing, non-degenerate primers were designed based on 
the RNA-dependent RNA-polymerase gene. This gene was selected as it has been shown to be 
one of the most conserved regions between different paramyxoviruses (Kurath et al., 2004), 
and,  for  snake  paramyxoviruses,  between  different  ferlaviruses  (Marschang  et  al.,  2009). 
Targeting the polymerase gene would hopefully facilitate the future detection of other strains 
of  Sunshine  virus.  100  primer  sequences  were  produced  by  a  computer  program  (Primer 
Premier®, Version 5, PREMIER Biosoft International) and from these, four primers were chosen 
(Table 6.4) for several reasons: similar melting temperatures; minimal predicted hairpin, dimer 
and cross-dimer formation; weak annealing to other areas of the Sunshine virus genome (false-
binding); BLASTN (Basic Local Alignment Search Tool for Nucleotides) failed to find similar 
sequences in the GenBank database; the ability to be used in different combinations (Figure 
6.10); and at least some of these primers would produce amplicons small enough to detect 
Sunshine virus in wax-embedded archival material. 
 
Primer set (number of nucleotides from 3’ end of polymerase gene)  PCR product size (bp) 
SunshineS1 (2444): 5’GGAAAGGGAGGTCTATG 
SunshineAS1 (2596): 5’ATTCAACATCTGGGGTC 
153 
SunshineS2 (2240): 5’TTCAAGGAGATAACCAGG 
SunshineAS2 (2469): 5’CGGGATTCCCATAGAC 
230 
SunshineS2 (2240): 5’TTCAAGGAGATAACCAGG 
SunshineAS1 (2596): 5’ATTCAACATCTGGGGTC 
357 
Table 6.4 Primer sequences, and anticipated amplicon size, for the detection of Sunshine virus. PCR = 
polymerase chain reaction. bp = base pairs. 
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Figure  6.10  Four  primers  designed  for  the  detection  of  Sunshine  virus:  S1,  S2,  AS1  and  AS2.  Each 
amplicon (represented as rectangles) starts and finishes with the number of bases from the 3’ end of the 
polymerase gene. Primers can be used as three separate primer pairs (S1-AS1 = 153bp product; S2-AS2 = 
230bp product; S2-AS1 = 357bp product) or in two heminested polymerase chain reactions (S2-AS1 
followed by S1-AS1; or S2-AS1 followed by S2-AS2). bp = base pairs. 
 
These primers were then used with various templates to answer the five questions mentioned 
earlier. 
Experiment one – infected versus uninfected viper heart cells 
Detecting this paramyxovirus in infected but not uninfected VH2 cells would suggest that this 
virus was from the tissue sample (BHP1-Lung) that was inoculated onto the VH2 cells and was 
not a contaminant or a virus endogenous to this cell line. To investigate this, attempts were 
made to detect Sunshine virus in uninfected cells using all three Sunshine virus primer pairs 
(AS1-S1, AS2-S2 and AS1-S2). Infected cells served as positive controls. 
 
RNA was extracted and cDNA was synthesised from viper heart cells according to the methods 
described earlier (section 4.8 – Polymerase Chain Reaction) All Sunshine virus PCRs used the 
same cycling conditions: 94
0C x 2 minutes, followed by 40 cycles of 94
0C x 20 seconds, 45
0C x 
45 seconds and 72
0C x 30 seconds. Sunshine virus could be detected in two flasks of viper 
heart cells that had been infected with BHP1-Lung and JCP1NT-Brain (abbreviations defined in 
S2 AS2 AS1 S1
RNA-dependent RNA-polymerase (L)
5’ 3’ S2 AS2
2240 2596
S1 AS1
2444 2596
2444 2596 153bp
153bp
357bp
AS1 S1
2469
2240 2596
AS2 S2
2469 2240
2240 230bp
230bp
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Table  5.3)  respectively  (Figure  6.11).  All  three  primer  pairs  yielded  an  amplicon  of  the 
appropriate size  in  infected  cells  and  did  not  produce  any  amplicons  using the  RNA  from 
uninfected cells as a template. DNA was extracted from agarose gel and sequenced directly as 
previously  described  (section  4.8  –  Polymerase  Chain  Reaction).  Sequenced  PCR  products 
were  compared  to  the  relevant  section  of  the  Sunshine  virus  genome  that  had  been 
determined by high-throughput sequencing. 
 
 
Figure 6.11 Polymerase chain reaction amplicons of uninfected and infected viper heart cells. Infected 
cells  had  either  been  inoculated  with  BHP1-Lung  or  JCP1NT-Brain.  Lanes  1-3  =  primer  pair  AS1-S1 
(153bp); lane 1 = uninfected cells, lane 2 = BHP1-Lung, lane 3 = JCP1NT-Brain. Lanes 4-6 = primer pair 
AS2-S2 (230bp); lane 4 = BHP1-Lung, lane 5 = JCP1NT-Brain, lane 6 = uninfected cells, Lane 7 = molecular 
ladder. 100bp increments from 100-1,000bp, brightest band is 500bp, largest band is 1,500bp. Lanes 8-
10 = primer pair AS1-S2 (357bp); lane 8 = BHP1-Lung, lane 9 = JCP1NT-Brain, lane 10 = uninfected cells. 
 
Experiment two – infected versus uninfected tissue samples 
Detecting Sunshine virus in viper heart cells infected with BHP1-Lung and JCP1NT-Brain, and not 
in uninfected viper heart cells, suggested that Sunshine virus was not endogenous to this cell 
line and the origin of the virus was from the tissue samples that been inoculated onto these 
cells. However, it was still conceivable that Sunshine virus was a contaminant that infected 
some (but not all) VH2 cells during virus isolation attempts. To explore this possibility, the 
original tissue sample, BHP1-Lung, was tested for Sunshine virus by PCR. In addition, a sample 
of BHP1-Lung that had previously been formalin-fixed and paraffin-embedded (FFPE) was used 
to  see  if  Sunshine  virus  (if  present)  could  be  detected  in  archival  samples.  To  serve  as  a 
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negative  control,  “unaffected” snake tissue  was  used.  The  pathology  archives  of Murdoch 
University were searched for snake submissions where the cause of death had been attributed 
to a non-viral aetiology (e.g. road trauma or neoplasia). RNA was extracted from FFPE and 
fresh-frozen  tissue  samples  according  to  the  methods  described  earlier  (section  4.8  – 
Polymerase Chain Reaction). For reverse transcription, cDNA was synthesised using random 
hexamers  or  gene-specific  primers  (GSP).  cDNA  synthesis  using  random  hexamers  was 
performed  as  previously  described  (section  4.8  –  Polymerase  Chain  Reaction).  For  gene-
specific primers, the same method was employed but instead of 1µL of random hexamers 
(100ng/µL), 0.5µL of each primer (~1µM final concentration) was used. 
 
For  PCR,  10µL of  SYBR  GreenER
TM  SuperMix  (Invitrogen,  Victoria, cat.  no. 11762-100)  was 
combined with each primer (AS1-S1, 153bp amplicon) to a final concentration of 1µM and 
made up to a final volume of 19µL using PCR-grade water. To this, 1µL of cDNA was added. The 
PCR  was  performed  in  a  Rotor-Gene  thermocycler  (RG-3000,  Corbett  Research,  Sydney, 
Australia) using cycling conditions previously described for this primer pair. Sunshine virus 
could be detected in both the freshly-frozen and FFPE samples of BHP1-Lung, but not in the 
tissue of a snake that was unlikely to be infected with Sunshine virus (6.12). Virus was detected 
irrespective of the method of cDNA synthesis but when synthesised with gene-specific primers, 
the cycle threshold (Ct value) was approximately 1-2 cycles lower than cDNA that had been 
amplified using random hexamers (data not shown). The linear range of quantitation of this 
real-time PCR had not been established and so these results should not be over-interpreted. 
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Figure 6.12 Polymerase chain reaction of tissue samples of BHP1-Lung. Lanes 1-7 = primer pair AS1-S1 
(153bp); lane 1 = positive control (viper heart cells infected with BHP1-Lung), lane 2 = tissue sample 
BHP1-Lung – random hexamers, lane 3 = tissue sample BHP1-Lung – gene-specific primers (GSP), lane 4 
= formalin-fixed paraffin-embedded (FFPE) BHP1-Lung – random hexamers, lane 5 = FFPE BHP1-Lung – 
GSP, lane 6 = FFPE negative control (“unaffected” snake tissue) – random hexamers, lane 7 = FFPE 
negative control – GSP, lane 8 = molecular ladder. 100bp increments from 100-1,000bp, brightest band 
is 500bp, largest band is 1,500bp. 
 
From these two simple experiments, numerous conclusions could be drawn: 
  Sunshine virus does not appear to be a virus that is endogenous to the viper heart cell line, 
  Sunshine virus was only found in tissue samples that produced cytopathic effects in cell 
culture consistent with a paramyxovirus, 
  Sunshine virus could not be found in the tissues of a snake unlikely to have been infected 
with Sunshine virus, and 
  Using the methods described, Sunshine virus could be detected in FFPE material.  
 
With these preliminary experiments completed, these primers could be applied to a range of 
samples to further investigate the link between Sunshine virus and disease. 
6.6  Chapter Summary 
This chapter describes the molecular identification of BHP1-Lung as a novel paramyxovirus that 
was then named Sunshine virus. High-throughput sequencing was performed on RNA from 
viper heart cells infected with BHP1-Lung and more than 10 million reads were sequenced 
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(each 38 nucleotides long). From these, 5,818 unique contigs were assembled but only one 
was confirmed to be viral in origin. The translated sequence of this contig contained open 
reading frames (ORF) that showed strong similarity to the nucleoprotein (N), matrix (M), fusion 
(F) and polymerase (L) proteins found in paramyxoviruses. BLASTN and BLASTP (Basic Local 
Alignment Search Tool for Nucleotides [BLASTN] / Proteins [BLASTP]) searches could not find 
any similarities in the GenBank database to the putative attachment protein or the putative 
phosphoprotein of BHP1-Lung. In the case of the putative attachment protein, it showed a 
similarity of less than 15% to 18 other paramyxoviral attachment proteins. All these results 
confirmed BHP1-Lung as a novel paramyxovirus and it was named Sunshine virus, after the 
geographical origin of the first isolate: the Sunshine Coast of Queensland, Australia. Work 
performed  by  Dr  Jim  Wellehan  phylogenetically  placed  Sunshine  virus  within  the  family 
Paramyxoviridae but outside of both existing subfamilies. 
 
Two paramyxovirus primer sets (Ahne et al., 1999b; Tong et al., 2008) were analysed for their 
appropriateness  to  detect  Sunshine  virus.  The  results  of  this  analysis  supported  the 
experimental work performed in the previous chapter that had suggested that these primers 
may be unsuitable for the detection of Sunshine virus. Because of this, new primers were 
designed that were able to demonstrate that Sunshine virus: (1) was not endogenous to the 
viper heart cell line, (2) could be detected in the BHP1-Lung tissue sample and, (3) could not be 
found in “unaffected” snake tissue. These primers were also able to detect Sunshine virus in 
formalin-fixed paraffin-embedded (FFPE) archival material. 
 
In  the  next  chapter,  the  clinical  signs  and  pathological  findings  that  are  associated  with 
Sunshine virus are discussed. The results of PCR testing on a number of samples are also 
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Chapter 7 – Diagnosing Sunshine virus 
In  chapter  three  (Paramyxoviruses  in  Australian  Snakes),  background  information  on  an 
ongoing problem in Australian snakes was outlined. Snakes were dying with neurorespiratory 
signs of disease, and pathological findings and overseas testing indicated that at least some of 
these snakes were likely to have been infected with one, or a combination of, a small selection 
of pathogenic viruses. A paramyxovirus provided the soundest explanation for these initial 
findings but a reovirus or a retrovirus could not be excluded either. The purpose of the present 
project was to search for these viruses in Australian snakes with neurorespiratory clinical signs. 
After  analysing  463  snake  samples,  using  a  variety  of  methods,  a  paramyxovirus  was 
discovered (Chapter 5 – Sample Examination Leading to the Isolation of a Virus Named BHP1-
Lung). Significantly, this paramyxovirus was the first to be isolated from a reptile that did not 
belong to the proposed genus Ferlavirus (Chapter 6 – Molecular Identification of BHP1-Lung 
as a Novel Paramyxovirus Named Sunshine virus). This virus was named Sunshine virus after 
the geographical origin of the first isolate: the Sunshine Coast of Queensland, Australia. It was 
determined  that  existing  paramyxovirus  primers  would  probably  be  inadequate  to  screen 
samples for Sunshine virus by polymerase chain reaction (PCR). New primers were designed 
and promising test results on positive control material provided a justification to use these 
primers on clinical samples. 
 
The  first  section  of  this  chapter  (7.1  –  Results  of  Polymerase  Chain  Reaction  Testing  for 
Sunshine virus) describes the PCR testing for Sunshine virus that was performed on a range of 
clinical samples (swabs, tissues and formalin-fixed paraffin-embedded tissues). PCR results that 
were positive provided a means to identify snakes that were infected with Sunshine virus. This 
then allowed the clinical signs and pathological findings that were associated with Sunshine 
virus infection to be reported. This clinical data is presented in the next three sections (7.2 – 234 | P a g e  
 
Clinical Signs, 7.3 – Gross Pathology, and 7.4 – Histopathology). The final section summarises 
the findings presented in this chapter (7.5 – Chapter Summary). 
7.1  Results  of  Polymerase  Chain  Reaction  Testing  for 
Sunshine virus  
From  October-2010  to  August-2011,  141  samples  from  three  separate  submissions  were 
tested for Sunshine virus by PCR (Table 7.1). The first two sample submissions were described 
earlier (section  5.2.7 –  Virus Isolation)  but will  also  be  mentioned  here  briefly.  The  third 
submission is presented below for the first time. 
Sample  Submission  One  –  an  Outbreak  of  Neurorespiratory  Disease  in  a  Private 
Collection from the Sunshine Coast of Queensland 
In  2008,  all  the  snakes  (70  Australian  pythons)  in  a  private  collection  were  humanely 
euthanased in response to an outbreak of neurorespiratory disease. A more detailed history of 
this outbreak may be found starting on page 152. In total, samples from 17 livers, kidneys and 
lungs, 16 brains and 13 serum samples were collected from 17 snakes. Snakes were selected 
for sample collection based on clinical signs and/or which snakes they had been in direct 
contact  with.  Half  of  each  organ  sample  was  submitted  frozen  and  the  other  half  was 
submitted fixed in formalin. 
 
Five viruses were isolated from frozen tissue samples (Table 5.3) and one of these, a lung 
sample from a black-headed python (BHP1-Lung), was identified as Sunshine virus using high-
throughput sequencing and a set of newly-designed PCR primers
9 (Figures 6.11 and 6.12). 
Besides BHP1-Lung, 79 frozen samples (samples from 17 livers and kidneys, 16 lungs and brains 
and 13 serum samples) from this collection were tested for the presence of Sunshine virus by 
PCR. 
                                                           
9 Of the five viruses isolated from Sample Submission One and the four viruses isolated from Sample 
Submission Two, only two were identified as Sunshine virus by PCR and sequencing: BHP1-Lung and 
JCP1NT-brain. However, all the tissue samples that were used to isolate these viruses, were tested by 
PCR and sequencing to confirm the presence of Sunshine virus. 235 | P a g e  
 
Sample Submission Two – Samples collected by Dr Cathy Shilton from the Berrimah 
Veterinary Laboratories (BVL) in Darwin, Northern Territory 
From 2005 to 2008, Dr Cathy Shilton, an anatomical veterinary pathologist from the Northern 
Territory (NT), identified nine snakes from four separate NT locations that had histories, clinical 
signs and/or pathological findings that were considered consistent with a viral (potentially 
paramyxoviral) infection. Formalin-fixed paraffin-embedded (FFPE) material was available from 
all nine snakes. Additionally, freshly-frozen samples from three brains and two lungs were 
available from four of these snakes. 
 
Four viruses were isolated using viper heart cells (Table 5.3) and one of these, JCP1NT-Brain, 
was later confirmed to be Sunshine virus by PCR
9 (Figure 6.11). Only formalin-fixed paraffin-
embedded samples were tested for the presence of Sunshine virus using PCR. 
Sample  Three  –  An  Outbreak  of  Neurological  Disease  in  a  Queensland  Zoological 
Collection10 
In 2011, a collection of 32 snakes (24 Australian and exotic non-venomous snakes and eight 
venomous  snakes)  was  afflicted  by  sporadic  cases  of  neurological  disease  and  other  non-
specific signs of disease (inappetence, lethargy and regurgitation). Cloacal and oral swabs were 
opportunistically sampled on multiple occasions. From some of these animals, three swabs 
were collected: an oral-only swab, a cloacal-only swab and a combined oral-cloacal swab. 
Methods for swabbing were described earlier (section 4.1 – Sample Collection). In total, 41 
combined oral-cloacal swabs, three oral-only and three cloacal-only swabs from 22 snakes 
were tested for Sunshine virus by PCR. In addition, a sample of brain, lung, liver and kidney 
from one of these snakes was also tested.  
                                                           
10 It should be noted that this is the sixth zoological collection mentioned in this thesis. In Chapter 3, 
four  Australian  zoological  collections  were  mentioned  that  had  pursued  testing  for  anti-ferlaviral 
antibodies at an overseas laboratory. The Queensland zoological collection mentioned in Chapter 5 that 
produced the haemagglutinating samples (samples 3 and 7) was one of these four Australian zoological 
collections. The final mention of a zoological collection, described in this chapter for the first time, is 
distinct from all others previously mentioned. These collections have been ambiguously named to retain 
their anonymity. 236 | P a g e  
 
 
Sample Submission One 
Private Collection, Sunshine 
Coast, Queensland 
Sample Submission Two 
Berrimah Veterinary Laboratories 
(BVL), Northern Territory 
Sample Submission Three 
Queensland Zoological Collection 
Sampling Data       
Period of Sampling  2008  2005 to 2008  2011 
Collections Sampled  1  4  1 
Snakes Sampled  17  9  22 
Virus isolation results  Five isolates from two snakes, one 
confirmed to be Sunshine virus 
Four isolates from two snakes, one 
confirmed to be Sunshine virus 
No previous testing 
Samples       
Brain  16  3  1 
Lung  17  2  1 
Liver  17  0  1 
Kidney  17  0  1 
Various formalin-fixed 
paraffin-embedded tissues 
17  9  0 
Serum  13  0  0 
Combined oral-cloacal swabs  0  0  41 
Cloacal-only swabs  0  0  3 
Oral-only swabs  0  0  3 
Total Samples Tested by 
PCR 
81*  9
#  51 
Table 7.1 Samples that were tested for the presence of Sunshine virus by polymerase chain reaction. *Only one formalin-fixed paraffin-embedded (FFPE) sample was 
tested (Figure 6.12), the remaining 80 samples consisted of freshly frozen tissue samples and serum. #Only FFPE material was tested by PCR. 237 | P a g e  
 
RNA  was  extracted  and  then  reverse  transcribed  into  cDNA  with  random  hexamers,  from 
swabs, freshly-frozen tissue samples and FFPE material as previously described (section 4.8 – 
Polymerase Chain Reaction). The primer set SunshineS1-SunshineAS1 (153bp amplicon, Table 
6.4) was always used for FFPE material but for other samples, SunshineS2-SunshineAS1 (357bp 
amplicon, Table 6.4) was usually used. Cycling conditions for the PCR were described earlier 
(section 6.5 – Development and Validation of a Sunshine virus Polymerase Chain Reaction 
Primer Set, Experiment one, page 227). Sequencing of PCR products was in accordance with 
previously described methods (section 4.8 – Polymerase Chain Reaction). For all snakes that 
were PCR tested for Sunshine virus using swab samples, the combined oral-cloacal swab was 
tested  first.  If  a  snake tested  positive,  and  individual  swabs were  available,  the  individual 
swabs were then tested to determine whether the oral-only and/or the cloacal-only swabs 
were positive. 
7.1.2 PCR Testing on Tissue Samples and Serum, Including a Comparison to Virus 
Isolation Results 
Results of PCR testing on tissue samples were compared to the relevant virus isolation results. 
Positive results are presented in Table 7.2. 238 | P a g e  
 
Species 
Sample 
Submission 
Clinical History 
Polymerase Chain Reaction (PCR)  Virus Isolation 
Brain  Lung  Liver  Kidney  Serum  Brain  Lung  Ki-Li 
Jungle carpet python 1  1  Clinical respiratory disease  +  -  -  +  -  -  -  - 
Jungle carpet python 2   1  Slight head tremor  +  +  +  +  n.s.  -  -  - 
Jungle carpet python 3   1  Slight head tremor  +  +  +  +  -  -  -  - 
Jungle carpet python 4   1  Subtle neurological signs. Shared enclosure with snake that died acutely  +  -  +  +  -  +  -  + 
Black-headed python 1  1  Low grade respiratory disease and stomatitis. Shared enclosure with two 
snakes (one after the other) that died acutely 
+  +  +  +  -  +  +  + 
Black-headed python 2   1  Asymptomatic. Mated to snake that later died acutely  +  -  -  -  -  -  -  - 
Woma python  1  Chronic respiratory signs and periods of neurological dullness  +  +  +  +  -  -  -  - 
Spotted python 2  3  Weakness and lack of coordination  +  +  -  +  n.s.  n.t.  n.t.  n.t. 
Total positive / total samples tested  8/8  5/8  5/8  7/8  0/6       
      PCR*   
Jungle carpet python 1   2A  Several  snakes  from  collection  A  showed  dysecdysis,  anorexia, 
neurological signs, death over several weeks. This snake was euthanased 
while still relatively active 
+  +  +  n.s. 
Jungle carpet python 2   2A  Died naturally  -  -  +  n.s. 
Jungle carpet python 3   2A  Moribund  +  +  n.s.  n.s. 
Carpet python  2A  Neurological signs and dyspnoea  +  n.s.  -  n.s. 
Carpet python 1   2B  Neurological signs  +  n.s.  n.s.  n.s. 
Carpet python 2   2B  Delayed righting reflex, incoordination, gaping mouth  +  n.s.  n.s.  n.s. 
Carpet python 3   2B  Opisthotonus, loss of righting reflex, anorexia of 2-3 months duration  +  n.s.  n.s.  n.s. 
Total positive / total samples tested    4/10  3/10  2/7 
Table 7.2 PCR and virus isolation results from snakes that were positive for Sunshine virus by either test. Positive virus isolation was defined by a characteristic cytopathic effect 
(large syncytium with minimal cell lysis). - = negative. + = positive. n.s. = not sampled. n.t. = not tested. Ki-Li = combined kidney-liver sample. BVL = Berrimah Veterinary Laboratory. 
2A/2B represents separate collections. *PCR performed on pooled formalin-fixed paraffin-embedded (FFPE) organs that included at least brain and lung. All individual organ 
samples were submitted fresh or freshly-frozen. Jungle carpet python = Morelia spilota cheynei. Black-headed python = Apidites melanocephalus. Woma python = Aspidites 
ramsayi. Spotted python = Antaresia maculosa. Carpet python = Morelia spilota. The “Spotted python 2” in this table is the same snake as the “Spotted python 2” mentioned in 
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The results in Table 7.2 show that Sunshine virus has been detected in fresh-frozen tissues and 
formalin-fixed paraffin-embedded (FFPE) sections from a range of Australian pythons. 
 
In this investigation, there were eight snakes that were PCR positive in at least one of the four 
freshly-frozen organs. Seven snakes were PCR positive in more than one of organs sampled. A 
sample of brain was PCR positive in all eight cases (8/8). Samples of kidney (7/8), liver (5/8) 
and lung (5/8) were also commonly positive by PCR. The data presented here are exploratory 
and are limited by a small number of samples that were PCR positive but it would seem 
reasonable that sampling the brain during a necropsy should form a priority sample during an 
investigation of suspected Sunshine virus infection. Similarly, taking a sample of (in order of 
preference) kidney, liver and lung from a live animal may be useful when screening for this 
virus. 
 
Within this group of eight snakes, all snakes had been identified to be infected with Sunshine 
virus by PCR but Sunshine virus was isolated in only two of these animals. Furthermore, more 
freshly-frozen organ samples were positive by PCR (25/32 = 78%) than virus isolation (5/21 = 
24%).  No  sample was  positive  by virus  isolation  and  negative  by  PCR.  To standardise  this 
comparison further, spotted python 2 can be excluded from this group of eight snakes because 
it was not tested by virus isolation and PCR, and the PCR testing on kidney and liver samples 
can be combined (if either kidney or liver was positive by PCR, the “combined” sample is 
considered positive). After this data standardisation, PCR was still positive (17/21 = 81%) more 
often than virus isolation (5/21 = 24%). 
 
Two other papers have compared PCR to virus isolation in detecting reptilian paramyxoviruses. 
Both papers refer to the ferlaviruses. In a study by Kolesnikovas et al. (2006), using organ 
samples from three snakes infected with ferlavirus, both virus isolation (six positives out of 
seven samples) and PCR (three positives out of three samples) were able to detect infection in 240 | P a g e  
 
all three snakes. In a second study with a much larger data set, 203 samples (organs, swabs 
and tracheal washes) from 102 snakes were tested for the presence of ferlaviruses by PCR and 
virus isolation (Papp et al., 2010a). From these 102 snakes, at least one organ sample was 
either PCR- or virus isolation-positive in 16 snakes (in our data set, fresh organ samples from 
seven  snakes,  that were tested  by  virus  isolation  and  PCR,  were  positive  by  PCR  or virus 
isolation). Of these 16 snakes tested by Papp et al. (2010a), 36 out of 51 organ samples were 
PCR-positive (71%) and three were positive by virus isolation (3/51 = 6%). Of the seven snakes 
from our data set, 17 out of 21 organ samples (pooling the results of liver and kidney) were 
positive by PCR (81%) and five were positive by virus isolation (5/21 = 24%). There are several 
reasons why our PCR and virus isolation results cannot be directly compared to those of Papp 
et al. (2010a). For example, different paramyxoviruses were of interest, the organs that were 
sampled were not standardised and the PCR and virus isolation methods were not the same. 
However, in both investigations, PCR detected the paramyxovirus of interest more reliably 
than virus isolation. 
 
The samples from the second submission, Berrimah Veterinary Laboratories (BVL), were tested 
by virus isolation and PCR (Table 7.2). Freshly-frozen samples were used for virus isolation and 
FFPE material was used for PCR. Under these testing conditions, Sunshine virus was detected 
more commonly by PCR (7/8 = 88%) than virus isolation (4/6 = 67%). In one snake from this 
submission, jungle carpet python 2, a virus was isolated but PCR testing on FFPE material was 
negative. This snake was part of a collection (2A) where a virus had been isolated in other 
snakes that had been identified as Sunshine virus by PCR, so the virus isolated from jungle 
carpet python 2 was likely the same virus suggesting that the PCR result was a false negative. 
Sample degradation in the FFPE material would provide one explanation for this result. 
 
No serum sample tested positive for Sunshine virus by PCR (n=13) but considering the onset 
and duration of viraemia has not been determined, the significance of this finding is undefined. 241 | P a g e  
 
7.1.3 PCR Testing on Swab Samples 
Swab samples were collected from Sample Submission Three over a 105-day period and tested 
for Sunshine virus by PCR. Results are summarised in Table 7.3. 242 | P a g e  
 
Species  Clinical History  day 0  day 19  day 45  day 105 
Spotted python 1 (Antaresia maculosa)  Asymptomatic  -  n.s.  deceased
*a  n/a 
Diamond python (Morelia spilota spilota)  Weakness, regurgitation, decreased righting 
reflex 
-  +  deceased
*a  n/a 
Spotted python 2  Weakness, lack of coordination  n.s.  -  euthanased
*b  n/a 
Spotted python 3  Asymptomatic  n.s.  +  -  - 
Spotted python 4  Weakness  n.s.  n.s.  +
#  - 
Spotted python 5  Asymptomatic  n.s.  n.s.  +
#  - 
Coastal carpet python 1 (Morelia spilota 
mcdowelli) 
Asymptomatic  n.s.  n.s.  -  - 
Coastal carpet python 2  Asymptomatic  n.s.  n.s.  -  - 
Coastal carpet python 3  Asymptomatic  n.s.  n.s.  -  - 
Coastal carpet python 4  Asymptomatic  n.s.  n.s.  -  - 
Coastal carpet python 5  Asymptomatic  n.s.  n.s.  -  n.s. 
Coastal carpet python 6  Asymptomatic  n.s.  n.s.  -  - 
Coastal carpet python 7  Asymptomatic  n.s.  n.s.  -  - 
Coastal carpet python 8  Weakness, lethargy, inappetence  n.s.  n.s.  +
#  n.s. 
Coastal carpet python 9  Asymptomatic  n.s.  n.s.  n.s.  - 
Coastal carpet python 10  Asymptomatic  n.s.  n.s.  n.s.  - 
Boa constrictor 1 (Boa constrictor)  Asymptomatic  n.s.  n.s.  -  - 
Boa constrictor 2  Asymptomatic  n.s.  n.s.  -  - 
Boa constrictor 3  Asymptomatic  n.s.  n.s.  -  - 
Centralian carpet python (Morelia spilota bredli)  Asymptomatic  n.s.  n.s.  -  - 
Jungle carpet python (Morelia spilota cheynei)  Asymptomatic  n.s.  n.s.  -  - 
Scrub python (Morelia amethistina)  Asymptomatic  n.s.  n.s.  -  - 
Yellow anaconda (Eunectes notaeus)  Asymptomatic  n.s.  n.s.  -  - 
Table 7.3 Polymerase chain reaction (PCR) results of combined oral-cloacal swabs from a zoological collection in Queensland (Sample Submission Three).  - = 
negative. + = positive. n.s. = not sampled. * = dead prior to this sampling date. a = organ samples not retrieved for further testing. b = organ samples retrieved for 
further testing. # = separate cloacal-only and oral-only swabs were also PCR positive. n/a = not applicable.  The “Spotted python 2” in this table is the same snake as 
the “Spotted python 2” mentioned in Table 7.2. 243 | P a g e  
 
During an outbreak of disease in a Queensland zoological collection, seven out of 32 snakes 
died  and/or  were  positive  for  Sunshine  virus  by  PCR  (Table  7.3).  Spotted  python  1  was 
asymptomatic,  tested  negative  on  day  zero  and  then  died  without  further  investigation. 
Whether this snake was infected with Sunshine virus is unknown. 
 
The diamond python was symptomatic, tested negative on day zero, positive on day 19 and 
then died. Although this is the only example where a subsequent PCR test detected Sunshine 
virus where the first did not, this one result does suggest that serial sampling of animals may 
be important if trying to screen animals for the presence of Sunshine virus infection. This result 
does not provide enough data to recommend an appropriate sampling interval. 
 
Spotted python 2 was symptomatic, tested negative on day 19, was later euthanased and 
organ samples were collected that tested positive. This case suggests that an organ sample is 
more likely to detect Sunshine virus than a combined cloacal-oral swab but there is insufficient 
data to validate this conclusion. 
 
Spotted python 3 was asymptomatic, tested positive on day 19 but was then negative on days 
45 and 105. Spotted pythons 4 (symptomatic) and 5 (asymptomatic) tested positive on all 
three swabs (oral-only, cloacal-only and combined oral-cloacal) on day 45 but combined oral-
cloacal swabs collected on day 105 tested negative. Coastal carpet python 8 was symptomatic, 
tested positive on all three swabs on day 45 but was not tested at any other time. Although it 
may be tempting to think that this data may be able to provide an insight into the duration of 
Sunshine  virus  shedding,  crucial  pieces  of  information  are  missing.  First,  the  start  of  the 
shedding period cannot be determined in any of these cases. Second, the data is limited to 
only a few cases. Third, the sampling period and intervals between samples may not have been 
adequate  to  identify  if  Sunshine  virus  is  shed  intermittently.  To  answer  many  of  these 
questions, a controlled transmission experiment would be needed and this should form a 244 | P a g e  
 
priority of future studies on Sunshine virus. The shedding duration of another paramyxovirus 
of  snakes,  ferlavirus,  may  extend  for  several  months  (Lloyd  and  Flanagan,  1991)  but    for 
paramyxoviruses in other species, the shedding periods are usually brief (Lamb and Parks, 
2007; Aldous et al., 2010; Dortmans et al., 2011; MacLachlan and Dubovi, 2011). 
 
Despite their limitations, these results from spotted pythons 3-5 and coastal carpet python 8 
do still provide some useful information. All four of these snakes were still alive one month 
beyond the last time of sampling, and two of these snakes never displayed overt signs of 
disease, so a positive PCR swab was not always associated with imminent death. The value of 
an  animal  should  be  measured  against  the  value  of  a  collection  but  at  this  time  there  is 
insufficient evidence to recommend that an individual animal that tests positive by PCR for 
Sunshine virus on a combined oral-cloacal swab should be immediately euthanased. 
 
Where the combined oral-cloacal swab was positive for Sunshine virus by PCR and oral-only 
and cloacal-only swabs were available (n=3), both the oral-only and cloacal-only swabs also 
tested positively. Superficially, this suggests that the mouth, the cloaca or both sites combined, 
form equally appropriate areas to sample. However, this is limited by a small number of cases 
and future work may provide different conclusions. Future work into this area should consider 
utilising real time PCR to provide an estimate of the viral load that is shed from each site. This 
could help determine the relative value in sampling each site. 
7.1.4 General Comments about PCR Testing 
The clinical signs associated with Sunshine virus infection are discussed in greater detail later 
(section 7.2 – Clinical Signs) but a brief discussion that compares these clinical signs to the PCR 
results is presented here. There was little correlation between clinical signs (if any) and the 
organs that Sunshine virus was subsequently detected in by PCR (Table 7.2). However, in all 
cases, organs were only collected  during  necropsy and  therefore  may  not  be  an  accurate 
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presence of clinical disease may reflect clearance of the viral nucleic acid from an organ(s) that 
has not recovered from injury. Conversely, a positive PCR result in the absence of clinical 
disease may reflect the presence of viral nucleic acid from an organ that is still able to meet 
the animal’s needs. In these instances, histopathological assessment of these organs may have 
provided  further  insight  into  the  association  between  tissue  lesions  and  a  PCR  result.  In 
summary,  the  data  presented  here  suggest  that  clinical  signs  should  not  dictate  sample 
selection. 
 
PCR was able to positively detect Sunshine virus in pythons more often than virus isolation and 
so  PCR  is  recommended  for  screening  samples  that  may  contain  Sunshine  virus  that  is 
presumed to be closely related to previously detected strains of this virus. However, given that 
virus isolation does not rely on previously known sequence information, it continues to be an 
important tool of viral discovery. 
 
Non-specific bands were occasionally seen when using the primer pair SunshineAS1-Sunshine 
S1 (153bp amplicon). On one occasion, a 167bp product was amplified and sequenced which 
was most closely related to an endonuclease (GenBank accession number: XM_003224137). 
Also  with  this  primer  pair,  unsequenced  bands  that  were  approximately  400  and  900 
nucleotides were often seen with total nucleic acid (DNA and RNA) templates derived from 
organ  samples  that  were  negative  for  Sunshine  virus.  Non-specific  bands  have  not  been 
detected  using  the  primer  pairs  SunshineAS2-SunshineS2  (230bp  amplicon) or  SunshineS2-
SunshineAS1 (357bp amplicon). All amplicons from all primer pairs that were determined to be 
Sunshine  virus  by  sequencing  (n=24)  showed  very  little  variation.  Single-base  sequence 
variation was seen in two positions but both mutations were silent (Figure 7.1). No sequence 
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Black-headed python 1 (SS 1)   TA ATC GCC ATC ACT TCT CTC CAC TAT CAA GGT CAA ACT AGA GAA AAA ATA AAT CAT GAA CAC TTG GAC TCA GTT 
Spotted python 3 (SS 3)          .. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
Jungle carpet python 1 (SS 2A)   .. ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
Translated sequence          I   A   I   T   S   L   H   Y   Q   G   Q   T   R   E   K   I   N   H   E   H   L   D   S   V 
                             * 
Black-headed python 1 (SS 1)    AAG AGA TTT TTG AAG ACT TTC ACT GAG TTT AAC AGT GCA ATG GGA CAT GAA TTA AAA GTA GAG GAG ACG ATA ATA  
Spotted python 3 (SS 3)         ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ...  
Jungle carpet python 1 (SS 2A)      ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ..G ... ... ... ... ... ... ... ...  
Translated sequence       K   R   F   L   K   T   F   T   E   F   N   S   A   M   G   H   E   L   K   V   E   E   T   I   I   
                       * 
Black-headed python 1 (SS 1)    TCT AGA GAG ATC TTT GTA TAT TCC AAG AAA ATA TAT AGG AAA GGG AGG TCT ATG GGA ATC CCG GGA AAG AAA GTA 
Spotted python 3 (SS 3)         ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
Jungle carpet python 1 (SS 2A)      ... ... ... ... ... ... ... ... ..A ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
Translated sequence       S   R   E   I   F   V   Y   S   K   K   I   Y   R   K   G   R   S   M   G   I   P   G   K   K   V   
 
Black-headed python 1 (SS 1)    ATG AAA TCC TTT TGT TTT GAC CCT GAT GCA AAG ATG AAT TTC CTC TCA AGT GTT GCA CTC TAT GAG TCA TGT ATT 
Spotted python 3 (SS 3)         ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
Jungle carpet python 1 (SS 2A)      ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... ... 
Translated sequence       M   K   S   F   C   F   D   P   D   A   K   M   N   F   L   S   S   V   A   L   Y   E   S   C   I   
 
Black-headed python 1 (SS 1)    AGC TCA GGG ATT AAA GAA GGC TT 
Spotted python 3 (SS 3)         ... ... ... ... ... ... ... .. 
Jungle carpet python 1 (SS 2A)      ... ... ... ... ... ... ... .. 
Translated sequence       S   S   G   I   K   E   G        
Figure 7.1 Partial sequences of three Sunshine virus polymerase genes amplified using the primer pair, SunshineAS1 and SunshineS2. Each sequence is compared to black-headed 
python 1 (Collection 1) and where there is no sequence variation a period (.) is inserted into the corresponding nucleotide position. Two base positions are marked with an asterisk 
(*) where silent mutations have been detected. SS = Sample Submission. Refer to page 234 for descriptions of each sample submission.  247 | P a g e  
 
In  the  Queensland  zoological  collection  (Sample  Submission  Three)  there  were  also  eight 
venomous snakes from the black snake (Pseudechis spp.), taipan (Oxyuranus spp.), death adder 
(Acanthophis spp.) and tiger snake (Notechis spp.) genera. None of these snakes were showing 
overt signs of ill-health. For human safety reasons, these snakes were not sampled and so the 
susceptibility of these genera is unknown. Therefore, at this time, the range of host species 
that are susceptible to Sunshine virus cannot be reported beyond the family Pythonidae. 
 
In conclusion, the data presented here make it difficult to make specific recommendations 
about optimum sample selection when screening snakes for infection with Sunshine virus. 
Therefore, collecting serial swabs and recovering samples of the brain, liver, kidney and lung 
for the purposes of PCR testing would seem to be the most appropriate recommendation that 
can be made at this time. 
7.2  Clinical Signs 
There were a variety of clinical signs in animals that were either PCR or virus isolation positive 
for Sunshine virus. Some infected animals displayed no overt signs of disease while for others, 
the  clinical  signs  were  neurological,  neurorespiratory  or  non-specific.  Neurological  signs 
included  head  tremors,  opisthotonus,  incoordination,  diminished  righting  reflexes, 
uncoordinated  movement  of  the  cranial  and  caudal  body  and  erratic  mouth  gaping. 
Respiratory  signs  included  a  mild  discharge  of  clear  viscous  fluid  from  the  mouth  and 
dyspnoea. Non-specific signs included anorexia, stomatitis, weakness, lethargy, regurgitation 
and inappetence. This suggests that the presence of neurorespiratory disease should alert the 
clinician’s mind to the possibility of Sunshine virus infection but also, the absence of it is non-
excluding  of  this  disease.  These  clinical  signs  should  not  be  seen  as  pathognomonic  for 
Sunshine  virus  as  they  would  be  difficult  to  differentiate  from  the  signs  associated  with 
inclusion body disease (IBD) and infection with ferlavirus (Table 2.1) or reovirus (Girling and 
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The pathological findings associated with Sunshine virus infection were reported by Dr Cathy 
Shilton (BSc, DVM, DVSc, MACVSc) from Berrimah Veterinary Laboratories (BVL). These findings 
contributed  to  a  submitted  manuscript  about  diagnosing  Sunshine  virus.  Dr  Shilton  is  an 
experienced and published anatomical veterinary pathologist. In these next two sections (7.3 – 
Gross  Pathology  and  7.4 –  Histopathology)  work  is  presented  in  text  boxes that  was  not 
performed by the author of this thesis. It is included here nevertheless so that this thesis can 
contain the most complete account of the current knowledge on Sunshine virus. 
7.3  Gross Pathology 
All the Sunshine virus positive snakes from the veterinary diagnostic laboratory cases were in 
good to excellent body condition with moderately-sized to large coelomic fat bodies. Gross 
pathological findings were largely unremarkable and limited to mild or moderate pulmonary 
congestion  and  oedema  in  four  snakes  and  fibrinonecrotic  exudate  adherent  to  the  oral 
mucosa in one snake. 
7.4  Histopathology 
The most consistent histological lesions of Sunshine virus positive snakes were in the brain. All 
cases  exhibited  mild  to  severe  spongiosis  of  primarily  the  white  matter  of  the  hindbrain 
(Figures 7.2 and 7.3). In a minority of cases, the spongiosis also involved white matter tracts of 
the midbrain or the parenchyma of the cerebellum. In snakes with severe histological lesions, 
spongiosis and rarefaction of the parenchyma of the hindbrain extended the complete dorso-
ventral height of the tissue and thus involved the intermingled grey matter (Figure 7.3). In 
three of these severely affected snakes, neuronal chromatolysis or necrosis was evident in the 
hindbrain  (Figure  7.3  inset).  Mild  to  marked  gliosis,  composed  of  both  astrocytosis  and 
microgliosis, generally accompanied the spongiosis (Figures 7.2 and 7.3) and in four cases 
extended anteriorly to a lesser degree into the grey matter of the forebrain and olfactory bulb. 
Severely  affected  areas  contained  necrotic  cell  debris  and  low  numbers  of  Gitter  cells, 249 | P a g e  
 
primarily  located  in  the  meninges  and  surrounding  parenchymal  blood  vessels. 
Lymphoplasmacytic perivascular cuffing and meningeal infiltration were prominent in only one 
snake.  Axonal  swellings  and  Wallerian  degeneration  were  uncommon  in  the  hindbrain. 
Intracytoplasmic  eosinophilic  or  pale  basophilic  inclusion  bodies  were  rarely  observed  in 
astrocytes,  ependymal  cells  and  the  epithelium  of  the  choroid  plexus  and  in  most  cases 
deemed equivocal. The tinctorial properties of the inclusions tended to vary in the brain and in 
other tissues with the relative strength of the eosin or haematoxylin staining in the particular 
slide. In the two snakes in which cervical spinal cord was examined histologically, the tissue 
was normal in one snake while the other snake, which also had prominent hindbrain lesions, 
exhibited  moderate  spongiosis  of  the  cervical  white  matter  with  accompanying  Wallerian 
degeneration. 
 
Figure 7.2 Dorsal hindbrain, Berrimah Veterinary Laboratories, Collection A, jungle carpet python 1. 
Moderate patchy spongiosis involving primarily the white matter of the hindbrain (HB) and to a mild 
degree, the granular layer of the cerebellum (CB).  Note mild degree of associated gliosis and lack of 
inflammatory  cellular  infiltrate  in  the  meninges  (M).  CP=  choroid  plexus  in  the  fourth  ventricle. 
Haematoxylin and eosin stain. Bar = 200 µm. 
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Figure  7.3  Brainstem,  Berrimah  Veterinary  Laboratories,  Collection  B,  carpet  python  2.    Severe 
spongiosis involving the complete dorsoventral height of the hindbrain (HB) with relative sparing of the 
cerebellum (CB), midbrain (MB, including optic tectum (OT)), cranial extent of the spinal cord (SP) and 
caudal extent of the forebrain (FB). The rectangle outlines the area of the inset in which moderate 
gliosis and neuronal necrosis (arrowheads) are evident. Haematoxylin and eosin stain. Main bar = 500 
µm. Inset bar = 50 µm. 
 
Five snakes exhibited changes indicative of mild to moderate bronchointerstitial pneumonia, 
variably including pulmonary septal and/or faveolar oedema or mild heterophil infiltration, 
mild to moderate hyperplasia, erosion or necrosis of the luminal respiratory epithelium with 
associated patchy lymphoplasmacytic infiltration (Figure 7.4). One snake exhibited moderate 
diffuse  type  2  pneumocyte  hyperplasia.  Rare  equivocal  intracytoplasmic  inclusions  were 
present in the respiratory epithelium, particularly in areas of eroded or necrotic epithelium. 
The most convincing possible viral inclusions were observed in the distal renal tubular system 
(primarily collecting ducts) in two snakes (Figure 7.5). In the five snakes in which spleen was 
examined, notable findings were mild to moderate lymphoid depletion in two snakes, marked 
lymphoid hyperplasia in one snake and a few small parenchymal heterophilic granulomas in 
another snake. All snakes exhibited a mild to moderate degree of macrovesicular vacuolation 251 | P a g e  
 
of hepatocyte cytoplasm (hepatic lipidosis, which is a common finding in captive snakes and 
considered  incidental).  Other  miscellaneous  histological  findings  were  mild  renal  tubular 
degeneration  or  interstitial  fibrosis  in  two  snakes,  mild  to  moderate  colonic  heterophil 
infiltration in two snakes and necrotising stomatitis in one snake.  All other organs examined 
were histologically unremarkable. 
 
 
Figure 7.4 Lung, Berrimah Veterinary Laboratories, Collection A, carpet python. Mild hyperplasia and 
jumbling  of  the  luminal  respiratory  epithelium  (LRE)  with  scattered  necrotic  cells  and  associated 
moderate lymphoplasmacytic infiltration. Generalised moderate vascular congestion and mild septal (S) 
oedema. The few red blood cells in the air spaces (faveolae) between septae are interpreted as post-
mortem artefact rather than pre-mortem haemorrhage. Haematoxylin and eosin stain. Bar = 50 µm. 
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Figure 7.5 Renal collecting duct, Berrimah Veterinary Laboratories, Collection A, jungle carpet python 3. 
Basophilic intracytoplasmic inclusion bodies in epithelial cells (arrows). Haematoxylin and eosin stain. 
Bar = 10 µm. 
 
Published  descriptions  of  the  brain  pathology  associated  with  previously  described 
paramyxoviruses in snakes are limited, with most publications focusing on the lung pathology 
since respiratory signs typically predominate in the infections (Jacobson et al., 1981; Jacobson 
et  al.,  1997;  Kolesnikovas  et  al.,  2006;  Jacobson,  2007).  However,  in  the  few  publications 
where the brain histology is reported, lesions are variably described as absent, ballooning 
degeneration  and  demyelination  of  the  brainstem,  degeneration  of  axon  fibres,  gliosis, 
lymphohistiocytic  meningoencephalitis,  neuronal  degeneration  and  few  eosinophilic 
intracytoplasmic inclusions in glial cells (Jacobson et al., 1980b; Jacobson et al., 1992; West et 
al., 2001). Thus the brain lesions seen in these cases associated with Sunshine virus infection 
include many of the histological features of other paramyxoviral infections in snakes. Aspects 
of the brain lesions in the cases described in this report that may emerge with further study as 
particular features associated with Sunshine virus versus other snake paramyxoviruses are the 
predominance  of  lesions  involving  the  hindbrain  and  their  severity.  From  a  comparative 253 | P a g e  
 
pathology standpoint it is notable how similar the brain lesions associated with Sunshine virus 
infection are to those due to canine distemper virus in which the brainstem is frequently the 
most severely affected region and white matter lesions of spongiosis (intramyelenic oedema) 
may  predominate  early  in  the  infection  with  eventual  development  of  nonsuppurative 
inflammation, demyelination and the presence of Gitter cells (Summers et al., 1995; Caswell 
and Williams, 2007; Zachary, 2007). 
   
The  respiratory  lesions  in  snake  paramyxovirus  infections  and  canine  distemper  virus  are 
described  as  bronchointerstitial  pneumonia  with  hyperplasia  of  type  2  pneumocytes  and 
variable  neutrophilic/heterophilic  and/or  lymphocytic  infiltrates,  commonly  with 
superimposed secondary bacterial bronchopneumonia (Jacobson et al., 1992; Jacobson et al., 
1997; Kolesnikovas et al., 2006; Caswell and Williams, 2007; MacLachlan and Dubovi, 2011).  In 
the present cases of Sunshine virus, bronchointerstitial pneumonia was present in most cases 
although  lesions  were  fairly  mild,  suggesting  that  Sunshine  virus  may  be  relatively  less 
pneumotropic  and  more  neurotropic  compared  to  these  other  paramyxoviruses.  
Paramyxovirus infections may result in intracytoplasmic or intranuclear eosinophilic inclusion 
bodies in neurons, glial cells and a variety of epithelia, notably those of the respiratory and 
urinary systems (Caswell and Williams 2007, MacLachlan and Dubovy 2011, West et al 2001). 
In only a few cases of Sunshine virus infection were possible intracytoplasmic eosinophilic 
inclusions  seen  in  the  glial  cells  and  respiratory  epithelium,  and  those  were  considered 
equivocal since they occurred in areas of severe inflammation and could have represented 
fragments  of  necrotic  cells  or  tissue,  rather  than  viral  inclusions.  The  most  distinct 
intracytoplasmic inclusions seen in these Sunshine virus cases were in the otherwise normal 
renal  distal  tubule  and  collecting  duct  epithelia.  Future  work  should  include  transmission 
electron microscopy of the inclusions seen in Sunshine virus, to determine if they are viral in 
nature. 
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Along with paramyxoviral infection, inclusion body disease (IBD) is another infectious disease 
of snakes that is capable of causing neurological signs (Schumacher et al., 1994; Jacobson et 
al.,  2001b;  Vancraeynest  et  al.,  2006;  Jacobson,  2007;  Chang  and  Jacobson,  2010). 
Neurohistopathology  associated  with  this  syndrome  includes  diffuse  spongiosis, 
demyelination,  neuronal  degeneration,  gliosis  and  nonsuppurative  or  lymphoplasmacytic 
meningoencephalitis (Schumacher et al., 1994; Carlisle-Nowak et al., 1998; Jacobson et al., 
2001b; Vancraeynest et al., 2006).  The histopathology associated with Sunshine virus infection 
overlaps somewhat with that associated with IBD.  However, in most cases of IBD, bright 
eosinophilic  intracytoplasmic  inclusions  are  readily  appreciable  within  neurons  and  in 
abundance in epithelial cells in a variety of tissues (Schumacher et al., 1994; Carlisle-Nowak et 
al., 1998; Chang and Jacobson, 2010), a feature that was not present in the Sunshine virus 
cases detailed here. 
 
Reoviruses have been either identified by electron microscopy or isolated from various snakes, 
some with clinical signs of neurological dysfunction (Ahne et al., 1987b; Vieler et al., 1994; 
Rose et al., 2005; Abbas et al., 2011). Unfortunately, the brain was not examined histologically 
in  these  reports,  therefore  any  neuropathology  that  is  associated  with  reovirus  infection 
remains undescribed.  Finally, an intranuclear inclusion disorder has been described in Morelia 
sp. that was associated with writhing and bloating (Boyer et al 2000). Electron microscopy of 
the  brain  revealed  accumulations  of  particles  that  resembled  retroviruses.  However,  the 
defining  histological  lesion  in  this  syndrome  was  abundant  prominent  eosinophilic  or 
amphophilic intranuclear inclusion bodies in glial cells in the brain (described in (Boyer et al., 
2000)  and  images  reproduced  in  (Ritchie,  2006)),  inconsistent  with  the  rare,  equivocal 
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7.5  Chapter Summary 
The development of a PCR that can detect Sunshine virus in a range of clinical samples has 
allowed infected animals to be rapidly identified. Consequently, clinical data that is associated 
with infection can be obtained. PCR testing was performed on freshly-frozen samples of brain, 
lung, kidney and liver, formalin-fixed paraffin-embedded (FFPE) tissues, serum, combined oral-
cloacal swabs, cloacal-only swabs and oral-only swabs. In total, 141 samples from 48 snakes 
from six collections were tested for Sunshine virus by PCR. From these, 42 samples were 
positive: 25 freshly-frozen samples (samples from eight brains, seven kidneys, five lungs and 
five livers), six FFPE tissues and 11 swabs. 
 
A number of conclusions could be drawn from the results of the PCR testing described in this 
chapter. They are summarised as follows: 
1.  The PCR described is capable of detecting Sunshine virus in freshly-frozen tissue samples, 
FFPE material and oral and cloacal swabs, 
2.  Sunshine virus was detected most often in samples of brain, followed by (in order) kidney, 
liver and lung, 
3.  PCR  was  able  to  identify  snakes  infected  with  Sunshine  virus  more  often  than  virus 
isolation, 
4.  Virus isolation remains an important component of virus discovery as it is not reliant on 
previously determined sequence information, 
5.  It is likely that Sunshine virus will be detected more commonly in tissue samples than 
swabs, 
6.  Sunshine virus was not detected in serum samples, 
7.  There is a poor correlation between infection with Sunshine virus and the presence or type 
of clinical signs. Clinical signs are not always associated with Sunshine virus but when they 
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neurological  (e.g.  opisthotonus,  head  tremors)  or  neurorespiratory  (e.g.  viscous  clear 
discharge from mouth, open mouth gaping). 
8.  Not all snakes infected with Sunshine virus face imminent death,  
9.  Serial testing of swabs is recommended as Sunshine virus may not be detected in the first 
swab sample, and 
10. Sunshine virus has so far only been detected in pythons. 
 
Dr  Cathy  Shilton,  an  anatomical  veterinary  pathologist  from  the  Berrimah  Veterinary 
Laboratories (BVL) in the Northern Territory described the gross pathology and histological 
findings associated with Sunshine virus infection. Gross pathology is usually unremarkable but 
pulmonary congestion has been seen occasionally. The most consistent histological lesions 
exhibited  by  snakes  that  are  infected  with  Sunshine  virus  occur  in  the  hindbrain  and  are 
characterised by white matter spongiosis and gliosis with extension to the surrounding grey 
matter and neuronal necrosis evident in severe cases. Most infected snakes also exhibit mild 
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Chapter 8 – Thesis Summary and General Discussion 
In 1972, an outbreak of neurorespiratory disease in a Swiss collection of 446 snakes formed 
the basis for the first description of a paramyxovirus isolated from a snake (Folsch and Leloup, 
1976). In the forty years that has passed since this outbreak, there have been approximately 
50 published reports describing the paramyxoviruses found in other similarly-affected reptiles. 
Reptilian paramyxoviruses have been found in several European countries (Ahne et al., 1987a; 
Blahak, 1995; Manvell et al., 2000; Franke et al., 2001), USA (Jacobson et al., 1980b; Jacobson 
et al., 1981;  Potgieter et al., 1987; Richter et al., 1996) and Brazil (Nogueira et al., 2002; 
Kolesnikovas  et  al.,  2006).  These  paramyxoviruses  have  only  ever  clustered  within  the 
proposed genus Ferlavirus (Marschang, 2011) and prior to the work presented here, reptilian 
paramyxoviruses had not been reported in Australia. Not only does this thesis provide the first 
description  of  a  paramyxovirus  isolated  from  an  Australian  snake  but  this  paramyxovirus, 
named Sunshine virus, is novel and only distantly related to the ferlaviruses.  
8.1  Thesis Summary 
In  Australia,  snakes  displaying  neurorespiratory  signs  have  been  presented  to  Australian 
veterinarians for at least the last few decades (Johnson, 2011). Histopathological examination 
of some of these snakes has shown interstitial pneumonia and demyelinating nonsuppurative 
encephalopathy, consistent with, but not pathognomonic for, a paramyxoviral infection. In 
some  instances,  the  attending  veterinarian  has  pursued  agent-specific  diagnostic  tests 
available only in USA or Europe. Testing formalin-fixed paraffin-embedded tissues by in situ 
hybridisation and freshly-frozen serum by haemagglutination inhibition provided results that 
were  suggestive  of  a  ferlaviral  infection.  It  has  been  shown  that  there  was  considerable 
discordance between the HI results provided by three American laboratories (Allender et al., 
2008). These Australian snake samples were only submitted to one of these laboratories and 
furthermore, paired serum samples (where the second sample is collected after a period of 
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irrefutable evidence of the presence of ferlavirus in Australia. In brief, the histological findings 
and diagnostic test results in Australian symptomatic snakes had provided a justification for an 
investigation of these snakes to find a scientifically-supported explanation for their clinical 
signs.  
 
Australian  veterinarians  from  six  of  Australia’s  eight  states  and  territories  submitted  463 
samples  that  had  been  collected  from  192  snakes  from  36  collections  from  May  2007 to 
October 2009. 217 samples were analysed using a haemagglutination assay, five were analysed 
by a neuraminidase assay, 86 by a haemagglutination inhibition assay, 50 by polymerase chain 
reaction (PCR) and 161 by virus isolation. In 2007, during an outbreak of neurorespiratory 
disease  in  a  Queensland  zoological  collection,  two  cloacal  swabs  from  two  asymptomatic 
snakes  were  collected  that  were  found  to  contain  haemagglutinating  and  neuraminidase 
activity. Further testing by electron microscopy (EM) and PCR did not identify a virus. In 2008, 
during a separate outbreak of neurorespiratory disease, this time in a private Queensland 
collection of pythons, a virus was isolated from two pythons: a black-headed python (BHP1) 
with low grade respiratory signs and stomatitis, and a jungle python with subtle neurological 
signs. The cytopathic effect (CPE) in viper heart (VH2) cells primarily consisted of syncytial cell 
formation. Viruses with similar CPE in VH2 cells were also isolated from freshly-frozen samples 
that  were  submitted  by  Dr  Cathy  Shilton,  an  anatomical  veterinary  pathologist  from  the 
Northern  Territory.  One  of  these  viruses  from  the  Queensland  outbreak,  BHP1-Lung,  was 
selected for further investigation. 
 
Despite widespread and repeatable CPE, the identity of BHP1-Lung (the viral family it belonged 
to) escaped discovery for over a year despite utilising a suite of traditional virological methods: 
positive  and  negative  staining  transmission  electron  microscopy  of  infected  VH2  cells  and 
supernatant  respectively;  haemagglutination  and  haemadsorption  assays;  neuraminidase 
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acid, chloroform and ether. The results of this testing were either negative or equivocal and 
the low viral titre (TCID50 = 10
2.75 mL
-1) was believed to have contributed to at least some of 
these results. The identity of BHP1-Lung could also not be determined by PCR using primers 
designed  to  detect  a  broad  range  of  paramyxoviruses,  reoviruses,  adenoviruses  and 
herpesviruses. 
 
Eventually,  BHP1-Lung  was  identified  as  a  novel  paramyxovirus  using  high-throughput 
sequencing. This method provides sequence-independent amplification of a sample without 
requiring prior knowledge about the identity of the virus being investigated. 10,544,936 reads 
(each 38 nucleotides in length) were sequenced and assembled into 5,818 unique contigs. A 
batch search of GenBank using BLASTN (Basic Local Alignment Search Tool for Nucleotides) 
provided a result that contained the word “virus” for 326 of these contigs. The open reading 
frames (ORFs) were determined for each of these contigs and only one contained ORFs with 
sequence similarity to a paramyxovirus. Further analysis of this contig was able to identify six 
ORFs common to most paramyxoviruses: 3’ nucleocapsid (N) – putative phosphoprotein (P) – 
matrix (M)  – fusion (F) – putative attachment protein  – polymerase (L). This analysis was 
unable  to  classify  the  putative  attachment  protein  as  haemagglutinin-neuraminidase  (HN), 
haemagglutinin (H) or glycoprotein (G). Phylogenetic analysis of BHP1-Lung performed by Dr 
James Wellehan placed this virus within Paramyxoviridae but outside of existing subfamilies. 
BHP1-Lung was named Sunshine virus after the geographical origin of the first isolate, the 
Sunshine  Coast  of  Queensland.  Several  paramyxoviruses  have  been  named  this  way:  
Menangle virus, Newcastle disease virus, Hendra virus, Nipah virus, Beilong virus, Sendai virus, 
Mossman virus and Salem virus. 
 
Sequence  information  of  Sunshine  virus  that  had  been  determined  from  high-throughput 
sequencing  allowed  PCR primers  to  be  designed  that  could  rapidly  identify  this  virus  in  a 
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allow the clinical signs, gross pathology and histological findings that are associated with this 
infection to be reported. The samples provided by Dr Cathy Shilton along with those from the 
submission that produced BHP1, and a third set of samples from an outbreak of neurological 
disease from Queensland, were tested for Sunshine virus by PCR. In total, 141 samples (71 
freshly-frozen tissues, 47 swabs, 13 serum samples and ten FFPE sections of various tissues) 
from 48 snakes from six collections were tested and from these, 42 samples were positive. This 
newly-designed  PCR  had  been  able  to  detect  Sunshine  virus  in  freshly-frozen  brain,  liver, 
kidney and lung; FFPE sections; and cloacal and oral swabs. The virus could not be detected in 
13 serum samples. 
 
Dr Cathy Shilton described the pathological findings associated with Sunshine virus infection. 
Gross pathology was usually unremarkable and the most consistent histopathology was seen in 
the hindbrain as white matter spongiosis and gliosis with extension to the surrounding grey 
matter and neuronal necrosis evident in severe cases.   Mild  bronchointerstitial  pneumonia 
was seen in most infected snakes. 
 
The work provided in this thesis describes a novel paramyxovirus named Sunshine virus that 
was isolated from Australian snakes and is often associated with neurorespiratory clinical signs 
and pathology. Although a considerable volume of useful information is provided in this thesis, 
it has only provided an introduction to a new virus that is associated with disease. 
8.2  The Aims of the Project 
The broad aims of this thesis were listed in the first chapter (section 1.1 – Purpose of Project) 
but can now be reviewed to see if each aim was met. 
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1.  To isolate and identify a virus from Australian snakes that could explain the clinical signs, 
pathological findings and overseas diagnostic test results that have been suggestive but not 
conclusive of a paramyxovirus infection. 
 
To achieve this aim, a virus would need to be isolated (and identified) from Australian snakes 
that could explain the clinical signs, pathological findings and the  overseas diagnostic test 
results that had been recorded in these animals that were all consistent with a paramyxoviral 
infection. Discussed earlier in Chapter 3 – Paramyxoviruses in Australian Snakes, the clinical 
signs recorded in many of these snakes can be localised to the neurorespiratory systems, the 
gross pathology is often unremarkable, the histopathology often describes a demyelinating 
encephalopathy and anti-ferlaviral antibodies and ferlaviral nucleic acid has been detected by 
haemagglutination inhibition and in situ hybridisation, respectively, in overseas laboratories. 
 
Samples from 192 snakes were screened for the presence of a range of viruses and nine 
viruses were isolated from five snakes (Table 5.3). One of these isolates was analysed further 
and was identified as a novel paramyxovirus named Sunshine virus. The clinical signs and 
pathological  findings  that  were  associated  with  Sunshine  virus  infection  are  described  in 
Chapter 7 – Diagnosing Sunshine virus.  The clinical signs associated with Sunshine virus can 
often be localised to the neurorespiratory systems (section 7.2 – Clinical Signs). Additionally, 
the gross and histopathological findings seen with Sunshine virus infection are also consistent 
with the changes described in Chapter 3. However, the results of overseas diagnostic testing 
are difficult to explain if the animals that were tested were infected with Sunshine virus and 
not ferlavirus. 
 
Significant titres (> 8) of anti-ferlaviral antibody could not be detected in the serum samples 
from  a  private  collection  of  pythons,  infected  with  Sunshine  virus,  during  an  outbreak  of 
neurorespiratory  disease  (Figure  5.18).  This  may  have  been  because  the  snakes  in  this 262 | P a g e  
 
collection had not developed a detectable immune response to ferlavirus because they were 
not  infected  with  this  virus  and  secondly,  because  there  is  no  cross-reactivity  between 
Sunshine virus and the ferlavirus used in this antibody assay. So the presence of Sunshine virus 
in some Australian snakes does not explain the presence of anti-ferlaviral antibodies in other 
snakes. However, the possibility that the significant anti-ferlaviral antibody titres of the snakes 
that were tested overseas were in fact false results, should not be excluded. The results of this 
study are unable to provide further clarification. 
 
Some  Australian  snake  samples  were  sent  overseas  where  in  situ  hybridisation  (ISH)  was 
positive for ferlavirus. It is possible that these results were false positives where the probe 
annealed to a target that was not ferlavirus but assuming these results were true then the 
presence of Sunshine virus in some Australian snakes is not able to explain this result in other 
Australian snakes. 
 
In this project, 86 serum samples were tested for the presence of anti-ferlaviral antibodies. 
These samples were from snakes with neurorespiratory disease or from snakes that were in 
direct or indirect contact with affected snakes. Significant titres were not found in any sample 
(0/86). Testing for ferlavirus by polymerase chain reaction (PCR) in 50 samples from similarly 
affected snakes also failed to detect the presence of ferlavirus (0/50). These results are in stark 
contrast  to  the  results  of  overseas  testing  where  significant  titres  (  >  8)  of  anti-ferlaviral 
antibodies were found in 52 out of the 65 samples from similarly affected snakes (52/65,Table 
3.1).  These  positive  anti-ferlaviral  antibody  titres  are  supported  by  ISH  results.  Ferlaviral 
nucleic acid was detected in samples from some snakes that had previously tested positive for 
the presence of anti-ferlaviral antibodies. If it is assumed that all these sets of results are true, 
then ferlavirus is present in Australia and this project was unable to detect any evidence of it in 
50 samples suitable for PCR testing and 86 serum samples. If  the ferlaviral results of this 
project  are  false  and  the  results of  overseas testing  are  true  than  ferlavirus  is  present  in 263 | P a g e  
 
Australia and the screening for ferlavirus that was performed in this project is inappropriate 
for the detection of ferlavirus. In the final hypothetical situation, where the results of this 
project are true and the results of the overseas testing are false, there is no  unequivocal 
evidence for the presence of ferlavirus in Australia but in at least some of the Australian snakes 
with clinical signs and pathological findings consistent with a paramyxoviral infection, Sunshine 
virus  is  one  possibility  to  explain  these  findings.  Future  studies  testing  the  positive  and 
negative predictive values of the testing regimes used in both this project and those that are 
used overseas would be needed to provide further insight into the validity of these results. 
 
In conclusion, this aim was partially met as the isolation and identification of Sunshine virus is 
explanatory for the neurorespiratory clinical signs and pathological findings in at least some 
Australian snakes but is not explanatory for the results of overseas diagnostic testing. This aim 
was partially achieved. 
 
2.  To investigate if the association between disease and the presence of this isolated virus, is 
causative. 
 
The results of this project have demonstrated that Sunshine virus is explanatory for the clinical 
signs and pathological findings (that were consistent with a paramyxoviral infection) seen in at 
least some Australian snakes. However, this project does not provide evidence that Sunshine 
virus was the cause of these findings. To meet this aim, a transmission study is needed. This 
was not performed due to time and financial restraints. This aim was not achieved and should 
form a priority of future studies and is discussed in greater detail on page 264. 
 
3.  To produce a diagnostic test that could rapidly screen Australian snakes for the presence of 
this virus. 
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Following the isolation of Sunshine virus from Australian snakes and identifying it as a unique 
paramyxovirus that is only distantly related to the proposed genus Ferlavirus, it became clear 
that testing for the presence of ferlavirus would not be adequate to detect the presence of 
Sunshine virus. A PCR that could rapidly identify Sunshine virus was designed, produced and 
validated  on  positive  control  material  and  a  range  of  clinical  samples  (section  6.5  – 
Development and Validation of a Sunshine virus Polymerase Chain Reaction Primer Set). This 
aim was achieved. 
 
4.  To  apply  this  diagnostic  test  to  Australian  snake  samples  to  provide  clinically  useful 
information  about  the  biology  of  this  viral  infection  e.g.  shedding  patterns,  tissue 
predilections. 
 
141 samples were screened using a PCR primer set that was produced for its capability to 
rapidly screen samples for the presence of Sunshine virus. 42 of these samples were found to 
be infected with Sunshine virus and by identifying these positive samples,  clinically useful 
information about the biology of Sunshine virus infection could be described. Ten specific 
conclusions were drawn from this testing (page 255). However, this list of conclusions is far 
from complete and there is still a considerable amount of information to be revealed. For 
example, the onset and duration of Sunshine virus shedding has not been fully elucidated. This 
aim was partially achieved. 
 
There is still a large amount of important research that should follow this project to extend the 
findings discovered so far. Some directions that this research may take are discussed. 
8.3  Future Directions of Research 
Transmission Study, Immunohistochemistry and In situ Hybridisation 
Investigations should be pursued that might help determine if Sunshine virus has a causative 
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paramyxoviruses and a paramyxovirus is explanatory for the clinical signs and histopathological 
findings reported here, a causative link between Sunshine virus infection and disease has not 
yet been proven. A transmission study would provide an opportunity to demonstrate Koch’s 
postulates. This has already been reported for two other pathogenic snake viruses: ferlavirus 
(Jacobson et al., 1997) and a reptilian orthoreovirus (Lamirande et al., 1999). 
 
A transmission study could also provide important information about disease pathogenesis. 
The onset, nature and duration of clinical signs could be observed. Also, by serially sampling 
and testing oral and cloacal swabs for the presence of Sunshine virus, the onset and duration 
of viral shedding from each site could be determined. This would have direct relevance to 
diagnosing this disease. For example, if it was discovered that Sunshine virus had a very short 
shedding period, it could be unwise to serially collect and test swabs for the presence of virus 
over an extended period of time. As another example, if it was discovered that the onset of 
clinical signs and/or viral shedding did not occur for several months, this information could 
form the basis for extended quarantine period recommendations in situations where agent-
specific testing is not performed. 
 
Serially sampling and testing serum could reveal the onset and duration of viremia. Finally, 
during such a study, the animal’s environment (e.g. water bowls, hideboxes  etc) could be 
swabbed and tested for the presence of Sunshine virus. This could provide insight into the 
environmental persistence of this virus. All these results would provide valuable information 
that could improve the ability to diagnose and manage cases of Sunshine virus infection. 
 
Immunohistochemistry (IHC) and in situ hybridisation (ISH) can demonstrate if an antigen or 
nucleic acid, respectively, is temporally and spatially associated with histological lesions. Put 
more simply, these methods could demonstrate that Sunshine virus (or parts of the virus) was 
present  in  histological  lesions  (a  spatial  association)  at  the  time  of  death  (a  temporal 266 | P a g e  
 
association). These methods can help delineate a causal association from one that is non-
causal. Using Sunshine virus that had been purified by density gradient ultracentrifugation 
would allow both monoclonal and polyclonal antibodies to be produced that could be used in 
IHC. These assays (IHC and/or ISH) could potentially identify the cell types and intracellular 
locations where virus is commonly found. These assays could also be used diagnostically. 
Reviewing the Sunshine Virus Polymerase Chain Reaction 
The non-degenerate primer sets for the detection of Sunshine virus that are described in this 
thesis should be reviewed. This is particularly important considering the minimal sequence 
variation that has been identified in the sequenced amplicons to date. Although the minimal 
sequence  variation  may  be  explained  by  the  highly  conserved  part  of  the  paramyxoviral 
genome (the polymerase gene) that these primers target (Kurath et al., 2004), the ability of 
these primer sets to detect significant differences between different strains of Sunshine virus 
has not been demonstrated and so the application of these primers for diagnostic use may be 
limited.  Degenerate  primers  may  broaden  the  detection  capabilities  for  Sunshine  virus, 
possibly revealing closely-related viruses. 
 
Robust controls should also be incorporated into this diagnostic PCR. In addition to positive 
and negative control samples, the integrity of the RNA in the test samples should be able to be 
assessed by this assay. Using the transcripts of housekeeping genes (e.g. 18S rRNA, beta-actin) 
may  provide  some  insight  into  the  quality  of  the  viral  RNA.  Additionally,  spiking  positive 
controls (that can be differentiated from true positives) into each test sample would control 
for each nucleic acid extraction. Following a positive PCR result, consideration should also be 
given to a restriction enzyme digestion to provide a method of positive conformation that is 
faster than sequencing. 
 
The PCR designed for the detection of Sunshine virus that is described in this thesis is being 
offered to Australian veterinarians as a diagnostic tool. It is hoped that the ability to detect 267 | P a g e  
 
Sunshine  virus  will  allow  the  health  of  Australian  snakes  to  be  better  managed.  Only  by 
screening samples with these primers will pitfalls in the PCR be able to be detected. 
 
In the not-too-distant future, the Sunshine virus PCR will be applied to free-ranging snakes to 
investigate the possibility that this virus is present in non-captive animals. 
Humoral Assays 
The  ability  to  screen  snakes  for  an  immune  response  to  Sunshine  virus  infection  would 
complement PCR-testing. A PCR test can only detect a virus if there is viral nucleic acid in the 
sample, so if the duration of Sunshine virus shedding was brief, testing swabs for the presence 
of this virus may not detect all infected animals. In contrast, the presence of viral nucleic acid is 
not needed to detect circulating anti-virus antibodies. However, humoral assays are reliant on 
these circulating anti-virus antibodies being present in detectable quantities at the time of 
sampling and this requires a period of convalescence to have elapsed. For Sunshine virus, the 
length of this period of convalescence (the time to seroconvert) is not known but might be 
determined during a transmission study. 
 
For  other  reptilian  viruses,  humoral  assays  (e.g.  haemagglutination  inhibition  and  virus 
neutralisation) are available at a small number of diagnostic laboratories (Heard et al., 2004). 
Although a single antibody titre will not always reliably distinguish between prior and current 
exposure to viral antigen (especially if the sample could contain both IgY from IgM), it may still 
help to decide the fate of animals, especially those that are PCR-negative where it is unclear if 
the PCR result is merely a reflection of an animal that is no longer shedding virus. 
 
Subsequent to the work presented in this thesis, Sunshine virus has been sent to Dr Rachel 
Marschang in Germany for future studies. Initially, this virus will be used for antibody assays 
(virus  neutralisation)  in  an  investigation  to  see  if  there  is  immunological evidence  for the 
presence of Sunshine virus in Europe. 268 | P a g e  
 
Treatment and Vaccination 
The isolation of Sunshine virus into cell culture allows in vitro testing of antivirals and also the 
propagation of virus that could be used in vaccines. Anti-paramyxoviral agents such as ribavirin 
(Virazole®) and BCX 2798 (reviewed on page 26) would be reasonable candidates to assess the 
impact that they may have on the viral titre of Sunshine virus. Screening anti-viral agents in an 
in vitro environment may decrease the number of animals needed for in vivo studies. The 
development of a reptilian vaccine that protects against a virus has not yet been achieved but 
lessons  learnt  from  previous  attempts  (Jacobson  et  al.,  1991;  Lloyd  and  Flanagan,  1991; 
Marschang et al., 2001b) could help to develop a vaccine that protects against Sunshine virus 
infection. A DNA vaccine may provide a novel opportunity to develop a vaccine that cannot 
revert to virulence but still provides protective immunity. 
8.4  Conclusion 
This thesis has described the isolation of a novel paramyxovirus named Sunshine virus from 
Australian snakes. A set of PCR primers was subsequently designed to facilitate the detection 
of this new virus in clinical samples. This PCR has enabled clinical data that is associated with 
Sunshine  virus  infection  to  be  described.  Future  research  directions  have  been  clearly 
identified that will hopefully continue to contribute to the collective knowledge of reptilian 
viruses for many years to come. 269 | P a g e  
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